Leping

Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 EUROPEAN HEALTH AND DIGITAL EXECUTIVE AGENCY (HADEA) HADEA.A – Health and Food A.1 – EU4Health GRANT AGREEMENT Project 101075284 — CraNE PREAMBLE This Agreement (‘the Agreement’) is between the following parties: on the one part, the European Health and Digital Executive Agency (HADEA) (‘EU executive agency’ or ‘granting authority’), under the powers delegated by the European Commission (‘European Commission’), and on the other part, 1. ‘the coordinator’: NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), PIC 948891346, established in TRUBARJEVA CESTA 2, LJUBLJANA 1000, Slovenia, and the following other beneficiaries, if they sign their ‘accession form’ (see Annex 3 and Article 40): 2. SCIENSANO (Sciensano), PIC 906160809, established in JULIETTE WYTSMANSTRAAT 14, ELSENE 1050, Belgium, 3. UNIVERSITETSKA SPETSIALIZIRANA BOLNITSA ZA AKTIVNO LECHENIE PO ONKOLOGIYA EAD (USHATO), PIC 952486263, established in PLOVDIVSKO POLE STR 6, SOFIA 1756, Bulgaria, 4. HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (CIPH), PIC 998128255, established in ROCKEFELLEROVA 7, ZAGREB 10000, Croatia, 5. Ministry of Health of the Republic of Cyprus (MOH), PIC 994267946, established in 1 Prodromou Street & 17 Chilonos Street 1 & 17, Nicosia 1448, Cyprus, 6. FAKULTNI NEMOCNICE V MOTOLE (UH MOTOL), PIC 964458391, established in V UVALU 84, PRAHA 5 150 06, Czechia, 7. SOTSIAALMINISTEERIUM (MSAE), PIC 998429731, established in Suur-Ameerika 1, TALLINN 10122, Estonia, 8. INSTITUT NATIONAL DU CANCER GIP (INCa), PIC 999953892, established in AVENUE ANDRE MORIZET 52, BOULOGNE BILLANCOURT 92513, France, 1 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 9. BUNDESMINISTERIUM FUER GESUNDHEIT (BMG), PIC 998954889, established in ROCHUSTRASSE 1, BONN 53123, Germany, 10. 1ST YGEIONOMIKI PERIFEREIA DYPE ATTIKIS (1ST YPE), PIC 998963910, established in ODOS ZACHAROF 3, ATHINA 11521, Greece, 11. Orszagos Onkologiai Intezet (OOI), PIC 991549909, established in RATH GYORGY UTCA 7-9., Budapest 1122, Hungary, 12. DEPARTMENT OF HEALTH (DOH), PIC 972459824, established in Block 1, Miesian Plaza, 50 – 58 Lower Baggot Street, Dublin D02 XW14, Ireland, 13. ALLEANZA CONTRO IL CANCRO (ACC), PIC 999563661, established in VIA GIORGIO RIBOTTA 5, ROMA 00144, Italy, 14. RIGAS AUSTRUMU KLINISKA UNIVERSITATES SLIMNICA SIA (REUH), PIC 973366483, established in HIPOKRATA IELA 2, RIGA 1038, Latvia, 15. LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM LT), PIC 933839468, established in VILNIAUS G 33, VILNIUS LT 01506, Lithuania, 16. INSTITUT NATIONAL DU CANCER (INC), PIC 889777509, established in 1A-B, RUE THOMAS EDISON, STRASSEN 1445, Luxembourg, 17. Ministry for Health - Government of Malta (MFH), PIC 974144423, established in Palazzo Castellania, Merchants Street 15, Valletta VLT 200, Malta, 18. OSLO UNIVERSITETSSYKEHUS HF (OUS), PIC 991104000, established in KIRKEVEIEN 166 TARNBYGGET, OSLO 0450, Norway, 19. NARODOWY INSTYTUT ZDROWIA PUBLICZNEGO PZH - PANSTWOWY INSTYTUT BADAWCZY (NIZP-PZH), PIC 998403735, established in CHOCIMSKA 24, WARSZAWA 00791, Poland, 20. MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA (MS), PIC 986364095, established in Av. João Crisóstomo, 9, LISBOA 1049-062, Portugal, 21. INSTITUTUL ONCOLOGIC PROF DR ION CHIRICUTA CLUJ-NAPOCA (IOCN), PIC 989404075, established in STRADA REPUBLICII 34-36, CLUJ NAPOCA 400015, Romania, 22. NARODNY ONKOLOGICKY USTAV (NOU), PIC 889061940, established in KLENOVA 1, BRATISLAVA 883 10, Slovakia, 23. INSTITUT CATALA D'ONCOLOGIA (ICO), PIC 998420031, established in AV GRAN VIA DE L'HOSPITALET 199-203, L'HOSPITALET DEL LLOBREGAT 08908, Spain, 24. SOCIALSTYRELSEN (NBHW), PIC 998248147, established in RALAMBSVAGEN 3, STOCKHOLM 106 30, Sweden, 25. GESUNDHEIT OSTERREICH GMBH (GÖG), PIC 928836208, established in STUBENRING 6, WIEN 1010, Austria, 2 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Unless otherwise specified, references to ‘beneficiary’ or ‘beneficiaries’ include the coordinator and affiliated entities (if any). If only one beneficiary signs the grant agreement (‘mono-beneficiary grant’), all provisions referring to the ‘coordinator’ or the ‘beneficiaries’ will be considered — mutatis mutandis — as referring to the beneficiary. The parties referred to above have agreed to enter into the Agreement. By signing the Agreement and the accession forms, the beneficiaries accept the grant and agree to implement the action under their own responsibility and in accordance with the Agreement, with all the obligations and terms and conditions it sets out. The Agreement is composed of: Preamble Terms and Conditions (including Data Sheet) Annex 1 Description of the action1 Annex 2 Estimated budget for the action Annex 2a Additional information on unit costs and contributions (if applicable) Annex 3 Accession forms (if applicable)2 Annex 3a Declaration on joint and several liability of affiliated entities (if applicable)3 Annex 4 Model for the financial statements Annex 5 Specific rules (if applicable) 1 Template published on Portal Reference Documents. 2 Template published on Portal Reference Documents. 3 Template published on Portal Reference Documents. 3 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 TERMS AND CONDITIONS TABLE OF CONTENTS GRANT AGREEMENT.................................................................................................................................................... 1 PREAMBLE........................................................................................................................................................................1 TERMS AND CONDITIONS...........................................................................................................................................4 DATASHEET...................................................................................................................................................................... 9 CHAPTER 1 GENERAL..............................................................................................................................................15 ARTICLE 1 — SUBJECT OF THE AGREEMENT ..................................................................................... 15 ARTICLE 2 — DEFINITIONS........................................................................................................................15 CHAPTER 2 ACTION................................................................................................................................................. 16 ARTICLE 3 — ACTION................................................................................................................................. 16 ARTICLE 4 — DURATION AND STARTING DATE...................................................................................16 CHAPTER 3 GRANT...................................................................................................................................................16 ARTICLE 5 — GRANT...................................................................................................................................16 5.1 Form of grant......................................................................................................................................16 5.2 Maximum grant amount..................................................................................................................... 17 5.3 Funding rate........................................................................................................................................17 5.4 Estimated budget, budget categories and forms of funding.............................................................. 17 5.5 Budget flexibility................................................................................................................................17 ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS AND CONTRIBUTIONS......................................18 6.1 General eligibility conditions............................................................................................................. 18 6.2 Specific eligibility conditions for each budget category................................................................... 19 6.3 Ineligible costs and contributions...................................................................................................... 23 6.4 Consequences of non-compliance...................................................................................................... 24 CHAPTER 4 GRANT IMPLEMENTATION............................................................................................................ 24 SECTION 1 CONSORTIUM: BENEFICIARIES, AFFILIATED ENTITIES AND OTHER PARTICIPANTS........................................................................................................................................ 24 ARTICLE 7 — BENEFICIARIES................................................................................................................... 24 ARTICLE 8 — AFFILIATED ENTITIES....................................................................................................... 26 ARTICLE 9 — OTHER PARTICIPANTS INVOLVED IN THE ACTION................................................... 28 9.1 Associated partners.............................................................................................................................28 9.2 Third parties giving in-kind contributions to the action.................................................................... 28 9.3 Subcontractors.....................................................................................................................................28 4 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 9.4 Recipients of financial support to third parties..................................................................................28 ARTICLE 10 — PARTICIPANTS WITH SPECIAL STATUS....................................................................... 29 10.1 Non-EU participants......................................................................................................................... 29 10.2 Participants which are international organisations...........................................................................29 10.3 Pillar-assessed participants............................................................................................................... 30 SECTION 2 RULES FOR CARRYING OUT THE ACTION...........................................................................32 ARTICLE 11 — PROPER IMPLEMENTATION OF THE ACTION............................................................ 32 11.1 Obligation to properly implement the action................................................................................... 32 11.2 Consequences of non-compliance.................................................................................................... 32 ARTICLE 12 — CONFLICT OF INTERESTS.............................................................................................. 32 12.1 Conflict of interests.......................................................................................................................... 32 12.2 Consequences of non-compliance.................................................................................................... 32 ARTICLE 13 — CONFIDENTIALITY AND SECURITY............................................................................ 33 13.1 Sensitive information........................................................................................................................33 13.2 Classified information...................................................................................................................... 33 13.3 Consequences of non-compliance.................................................................................................... 34 ARTICLE 14 — ETHICS AND VALUES...................................................................................................... 34 14.1 Ethics.................................................................................................................................................34 14.2 Values................................................................................................................................................ 34 14.3 Consequences of non-compliance.................................................................................................... 34 ARTICLE 15 — DATA PROTECTION.......................................................................................................... 34 15.1 Data processing by the granting authority....................................................................................... 34 15.2 Data processing by the beneficiaries............................................................................................... 35 15.3 Consequences of non-compliance.................................................................................................... 35 ARTICLE 16 — INTELLECTUAL PROPERTY RIGHTS (IPR) — BACKGROUND AND RESULTS — ACCESS RIGHTS AND RIGHTS OF USE................................................................................ 35 16.1 Background and access rights to background..................................................................................35 16.2 Ownership of results.........................................................................................................................36 16.3 Rights of use of the granting authority on materials, documents and information received for policy, information, communication, dissemination and publicity purposes...................................36 16.4 Specific rules on IPR, results and background................................................................................ 37 16.5 Consequences of non-compliance.................................................................................................... 37 ARTICLE 17 — COMMUNICATION, DISSEMINATION AND VISIBILITY............................................ 37 17.1 Communication — Dissemination — Promoting the action........................................................... 37 17.2 Visibility — European flag and funding statement......................................................................... 37 17.3 Quality of information — Disclaimer..............................................................................................38 5 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 17.4 Specific communication, dissemination and visibility rules............................................................38 17.5 Consequences of non-compliance.................................................................................................... 38 ARTICLE 18 — SPECIFIC RULES FOR CARRYING OUT THE ACTION............................................... 39 18.1 Specific rules for carrying out the action........................................................................................ 39 18.2 Consequences of non-compliance.................................................................................................... 39 SECTION 3 GRANT ADMINISTRATION......................................................................................................... 39 ARTICLE 19 — GENERAL INFORMATION OBLIGATIONS.................................................................... 39 19.1 Information requests......................................................................................................................... 39 19.2 Participant Register data updates..................................................................................................... 39 19.3 Information about events and circumstances which impact the action............................................39 19.4 Consequences of non-compliance.................................................................................................... 40 ARTICLE 20 — RECORD-KEEPING............................................................................................................ 40 20.1 Keeping records and supporting documents.................................................................................... 40 20.2 Consequences of non-compliance.................................................................................................... 41 ARTICLE 21 — REPORTING........................................................................................................................ 41 21.1 Continuous reporting........................................................................................................................ 41 21.2 Periodic reporting: Technical reports and financial statements....................................................... 41 21.3 Currency for financial statements and conversion into euros..........................................................42 21.4 Reporting language...........................................................................................................................43 21.5 Consequences of non-compliance.................................................................................................... 43 ARTICLE 22 — PAYMENTS AND RECOVERIES — CALCULATION OF AMOUNTS DUE................. 43 22.1 Payments and payment arrangements.............................................................................................. 43 22.2 Recoveries.........................................................................................................................................43 22.3 Amounts due.....................................................................................................................................44 22.4 Enforced recovery.............................................................................................................................48 22.5 Consequences of non-compliance.................................................................................................... 49 ARTICLE 23 — GUARANTEES....................................................................................................................50 23.1 Prefinancing guarantee..................................................................................................................... 50 23.2 Consequences of non-compliance.................................................................................................... 50 ARTICLE 24 — CERTIFICATES................................................................................................................... 50 24.1 Operational verification report (OVR).............................................................................................50 24.2 Certificate on the financial statements (CFS).................................................................................. 50 24.3 Certificate on the compliance of usual cost accounting practices (CoMUC).................................. 51 24.4 Systems and process audit (SPA).....................................................................................................51 24.5 Consequences of non-compliance.................................................................................................... 51 6 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 ARTICLE 25 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION OF FINDINGS..................................................................................................................................... 51 25.1 Granting authority checks, reviews and audits................................................................................ 51 25.2 European Commission checks, reviews and audits in grants of other granting authorities..............53 25.3 Access to records for assessing simplified forms of funding.......................................................... 53 25.4 OLAF, EPPO and ECA audits and investigations........................................................................... 53 25.5 Consequences of checks, reviews, audits and investigations — Extension of results of reviews, audits or investigations.................................................................................................................... 54 25.6 Consequences of non-compliance.................................................................................................... 55 ARTICLE 26 — IMPACT EVALUATIONS................................................................................................... 55 26.1 Impact evaluation............................................................................................................................. 55 26.2 Consequences of non-compliance.................................................................................................... 55 CHAPTER 5 CONSEQUENCES OF NON-COMPLIANCE.................................................................................. 55 SECTION 1 REJECTIONS AND GRANT REDUCTION.................................................................................56 ARTICLE 27 — REJECTION OF COSTS AND CONTRIBUTIONS...........................................................56 27.1 Conditions......................................................................................................................................... 56 27.2 Procedure.......................................................................................................................................... 56 27.3 Effects............................................................................................................................................... 56 ARTICLE 28 — GRANT REDUCTION........................................................................................................ 56 28.1 Conditions......................................................................................................................................... 56 28.2 Procedure.......................................................................................................................................... 57 28.3 Effects............................................................................................................................................... 57 SECTION 2 SUSPENSION AND TERMINATION............................................................................................57 ARTICLE 29 — PAYMENT DEADLINE SUSPENSION............................................................................. 57 29.1 Conditions......................................................................................................................................... 57 29.2 Procedure.......................................................................................................................................... 57 ARTICLE 30 — PAYMENT SUSPENSION...................................................................................................58 30.1 Conditions......................................................................................................................................... 58 30.2 Procedure.......................................................................................................................................... 58 ARTICLE 31 — GRANT AGREEMENT SUSPENSION..............................................................................59 31.1 Consortium-requested GA suspension............................................................................................. 59 31.2 EU-initiated GA suspension.............................................................................................................59 ARTICLE 32 — GRANT AGREEMENT OR BENEFICIARY TERMINATION......................................... 60 32.1 Consortium-requested GA termination............................................................................................ 60 32.2 Consortium-requested beneficiary termination................................................................................ 61 32.3 EU-initiated GA or beneficiary termination.................................................................................... 63 7 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 SECTION 3 OTHER CONSEQUENCES: DAMAGES AND ADMINISTRATIVE SANCTIONS............... 66 ARTICLE 33 — DAMAGES...........................................................................................................................66 33.1 Liability of the granting authority....................................................................................................66 33.2 Liability of the beneficiaries............................................................................................................ 66 ARTICLE 34 — ADMINISTRATIVE SANCTIONS AND OTHER MEASURES....................................... 66 SECTION 4 FORCE MAJEURE.......................................................................................................................... 67 ARTICLE 35 — FORCE MAJEURE.............................................................................................................. 67 CHAPTER 6 FINAL PROVISIONS...........................................................................................................................67 ARTICLE 36 — COMMUNICATION BETWEEN THE PARTIES...............................................................67 36.1 Forms and means of communication — Electronic management................................................... 67 36.2 Date of communication.................................................................................................................... 67 36.3 Addresses for communication.......................................................................................................... 68 ARTICLE 37 — INTERPRETATION OF THE AGREEMENT.....................................................................68 ARTICLE 38 — CALCULATION OF PERIODS AND DEADLINES..........................................................68 ARTICLE 39 — AMENDMENTS.................................................................................................................. 68 39.1 Conditions......................................................................................................................................... 68 39.2 Procedure.......................................................................................................................................... 69 ARTICLE 40 — ACCESSION AND ADDITION OF NEW BENEFICIARIES........................................... 69 40.1 Accession of the beneficiaries mentioned in the Preamble............................................................. 69 40.2 Addition of new beneficiaries.......................................................................................................... 69 ARTICLE 41 — TRANSFER OF THE AGREEMENT................................................................................. 70 ARTICLE 42 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE GRANTING AUTHORITY.................................................................................................................................70 ARTICLE 43 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES.............................................. 70 43.1 Applicable law..................................................................................................................................70 43.2 Dispute settlement............................................................................................................................ 70 ARTICLE 44 — ENTRY INTO FORCE.........................................................................................................71 8 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 DATA SHEET 1. General data Project summary: Project summary The CraNE Joint Action is proposed for funding in response to the flagship number 5 of the Europe’s Beating Cancer Plan, which defines that the European Commission will establish by 2025, an EU Network linking recognised National Comprehensive Cancer Centres (CCCs) in every Member State. In order to facilitate the establishment of such an EU Network, CraNE will prepare the necessary preconditions, administrative, professional, and those related to high-quality performance. This is necessary to facilitate both the integration of the existing CCCs as well as to support the Member States who still need to develop and certify such centres. The CraNE JA will also provide an assessment on sustainability and feasibility as well as link the development of an EU Network of CCCs and CCCs in individual Member States to the development of national and regional CCCNs. This way, the existing organisational and functional models of cancer care will be taken into account and incorporated into the proposed solution. Keywords: not defined Project number: 101075284 Project name: Network of Comprehensive Cancer Centres: Preparatory activities on creation of National Comprehensive Cancer Centres and EU Networking Project acronym: CraNE Call: EU4H-2021-JA-IBA Topic: EU4H-2021-JA-03 Type of action: EU4H Project Grants Granting authority: European Health and Digital Executive Agency Grant managed through EU Funding & Tenders Portal: Yes (eGrants) Project starting date: fixed date: 1 October 2022 Project end date: 30 September 2024 Project duration: 24 months Consortium agreement: Yes 2. Participants List of participants: Short Total eligible costs Max grant N° Role Legal name Ctry PIC name (BEN and AE) amount 1 COO NIJZ NACIONALNI INSTITUT ZA JAVNO ZDRAVJE SI 948891346 471 558.63 377 246.85 1.1 AE OIL ONKOLOSKI INSTITUT LJUBLJANA SI 986222475 15 067.74 12 054.19 2 BEN Sciensano SCIENSANO BE 906160809 355 101.44 284 081.15 2.1 AE UZA UNIVERSITAIR ZIEKENHUIS ANTWERPEN BE 996727866 32 918.55 26 334.84 3 BEN USHATO UNIVERSITETSKA SPETSIALIZIRANA BOLNITSA ZA BG 952486263 15 440.10 12 352.08 AKTIVNO LECHENIE PO ONKOLOGIYA EAD 4 BEN CIPH HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO HR 998128255 74 493.40 59 594.72 5 BEN MOH Ministry of Health of the Republic of Cyprus CY 994267946 17 462.40 13 969.92 6 BEN UH FAKULTNI NEMOCNICE V MOTOLE CZ 964458391 17 280.50 13 824.40 MOTOL 9 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Short Total eligible costs Max grant N° Role Legal name Ctry PIC name (BEN and AE) amount 7 BEN MSAE SOTSIAALMINISTEERIUM EE 998429731 15 709.74 12 567.79 7.1 AE UT TARTU ULIKOOL EE 999895013 5 296.50 4 237.20 8 BEN INCa INSTITUT NATIONAL DU CANCER GIP FR 999953892 216 493.10 173 194.48 8.1 AE UNICANCERUNICANCER FR 952728375 97 289.75 77 831.80 8.2 AE FHF FEDERATION HOSPITALIERE DE FRANCE FR 999562109 72 385.50 57 908.40 8.3 AE INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA FR 999997833 29 853.00 23 882.40 RECHERCHE MEDICALE 9 BEN BMG BUNDESMINISTERIUM FUER GESUNDHEIT DE 998954889 11 293.85 9 035.08 9.1 AE DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM DE 999990073 13 375.00 10 700.00 HEIDELBERG 9.2 AE DKG DEUTSCHE KREBSGESELLSCHAFT EV DE 922313831 312 284.85 249 827.88 9.3 AE DKH STIFTUNG DEUTSCHE KREBSHILFE DE 888636983 26 750.00 21 400.00 9.4 AE TUD TECHNISCHE UNIVERSITAET DRESDEN DE 999897729 110 745.00 88 596.00 10 BEN 1ST YPE 1ST YGEIONOMIKI PERIFEREIA DYPE ATTIKIS EL 998963910 103 629.50 82 903.60 10.1 AE AGIOS GENIKO ANTIKARKINIKO OGKOLOGIKO EL 897642560 35 390.25 28 312.20 SAVVAS NOSOKOMEIO ATHINON O AGIOS SAVVAS 10.2 AE LGHA GENIKO LAIKO NOSOKOMEIO ATHINON*GENERAL EL 954350409 26 509.25 21 207.40 HOSPITAL OF ATHENS LAIKO 11 BEN OOI Orszagos Onkologiai Intezet HU 991549909 27 145.90 21 716.72 12 BEN DOH DEPARTMENT OF HEALTH IE 972459824 44 065.17 35 252.13 13 BEN ACC ALLEANZA CONTRO IL CANCRO IT 999563661 242 783.00 194 226.40 13.1 AE MoH MINISTERO DELLA SALUTE IT 999531942 8 560.00 6 848.00 13.2 AE IDI FONDAZIONE LUIGI MARIA MONTI IT 918519870 22 042.00 17 633.60 14 BEN REUH RIGAS AUSTRUMU KLINISKA UNIVERSITATES LV 973366483 29 007.70 23 206.16 SLIMNICA SIA 15 BEN SAM LT LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS LT 933839468 16 980.90 13 584.72 MINISTERIJA 15.1 AE KK LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LT 923616832 8 287.15 6 629.72 LIGONINE KAUNO KLINIKOS 15.2 AE VULSK VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE LT 991636530 13 535.50 10 828.40 SANTAROS KLINIKOS 15.3 AE NCI NACIONALINIS VEZIO INSTITUTAS LT 912763114 18 960.40 15 168.32 16 BEN INC INSTITUT NATIONAL DU CANCER LU 889777509 165 946.30 132 757.04 16.1 AE LIH LUXEMBOURG INSTITUTE OF HEALTH LU 998331858 33 919.00 27 135.20 17 BEN MFH Ministry for Health - Government of Malta MT 974144423 27 285.00 21 828.00 18 BEN OUS OSLO UNIVERSITETSSYKEHUS HF NO 991104000 476 299.80 381 039.84 19 BEN NIZP- NARODOWY INSTYTUT ZDROWIA PUBLICZNEGO PZH PL 998403735 192 493.00 153 994.40 PZH - PANSTWOWY INSTYTUT BADAWCZY 20 BEN MS MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA PT 986364095 20 651.00 16 520.80 21 BEN IOCN INSTITUTUL ONCOLOGIC PROF DR ION CHIRICUTA RO 989404075 81 202.30 64 961.84 CLUJ-NAPOCA 22 BEN NOU NARODNY ONKOLOGICKY USTAV SK 889061940 46 994.40 37 595.52 23 BEN ICO INSTITUT CATALA D'ONCOLOGIA ES 998420031 113 837.30 91 069.84 23.1 AE IDIVAL FUNDACION INSTITUTO DE INVESTIGACION ES 946556944 20 116.00 16 092.80 MARQUES DE VALDECILLA 24 BEN NBHW SOCIALSTYRELSEN SE 998248147 40 446.00 32 356.80 25 BEN GÖG GESUNDHEIT OSTERREICH GMBH AT 928836208 23 112.00 18 489.60 Total 3 749 997.87 2 999 998.23 10 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Coordinator: – NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ) 3. Grant Maximum grant amount, total estimated eligible costs and contributions and funding rate: Total eligible costs Funding rate Maximum grant amount Maximum grant amount (BEN and AE) (%) (Annex 2) (award decision) 3 749 997.87 80 2 999 998.23 2 999 998.23 Grant form: Budget-based Grant mode: Action grant Budget categories/activity types: - A. Personnel costs - A.1 Employees, A.2 Natural persons under direct contract, A.3 Seconded persons - A.4 SME owners and natural person beneficiaries - B. Subcontracting costs - C. Purchase costs - C.1 Travel and subsistence - C.2 Equipment - C.3 Other goods, works and services - D. Other cost categories - D.1 Financial support to third parties - E. Indirect costs Cost eligibility options: - Standard supplementary payments - Limitation for subcontracting - Travel and subsistence: - Travel: Unit or Actual costs - Accommodation: Unit or Actual costs - Subsistence: Unit or Actual costs - Equipment: depreciation only - Costs for providing financial support to third parties (actual cost; max amount for each recipient: EUR 0.00) - Indirect cost flat-rate: 7% of the eligible direct costs (categories A-D, except volunteers costs and exempted specific cost categories, if any) - VAT: Yes - Other ineligible costs Budget flexibility: Yes (no flexibility cap) 4. Reporting, payments and recoveries 11 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 4.1 Continuous reporting (art 21) Deliverables: see Funding & Tenders Portal Continuous Reporting tool 4.2 Periodic reporting and payments Reporting and payment schedule (art 21, 22): Reporting Payments Deadline Reporting periods Type Deadline Type (time to pay) RP No Month from Month to 30 days from entry into force/10 days before starting date/ Initial prefinancing financial guarantee (if required) – whichever is the latest 1 1 24 Periodic report 60 days after end Final payment 90 days from of reporting period receiving periodic report Prefinancing payments and guarantees: Prefinancing payment Prefinancing guarantee Guarantee Type Amount Division per participant amount Prefinancing 1 (initial) 2 100 005.76 n/a 1 - NIJZ n/a 1.1 - OIL n/a 2 - Sciensano n/a 2.1 - UZA n/a 3 - USHATO n/a 4 - CIPH n/a 5 - MOH n/a 6 - UH MOTOL n/a 7 - MSAE n/a 7.1 - UT n/a 8 - INCa n/a 8.1 - UNICANCER n/a 8.2 - FHF n/a 8.3 - INSERM n/a 9 - BMG n/a 9.1 - DKFZ n/a 9.2 - DKG n/a 9.3 - DKH n/a 9.4 - TUD n/a 10 - 1ST YPE n/a 10.1 - AGIOS SAVVAS n/a 10.2 - LGHA n/a 11 - OOI n/a 12 - DOH n/a 12 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Prefinancing payment Prefinancing guarantee Guarantee Type Amount Division per participant amount 13 - ACC n/a 13.1 - MoH n/a 13.2 - IDI n/a 14 - REUH n/a 15 - SAM LT n/a 15.1 - KK n/a 15.2 - VULSK n/a 15.3 - NCI n/a 16 - INC n/a 16.1 - LIH n/a 17 - MFH n/a 18 - OUS n/a 19 - NIZP-PZH n/a 20 - MS n/a 21 - IOCN n/a 22 - NOU n/a 23 - ICO n/a 23.1 - IDIVAL n/a 24 - NBHW n/a 25 - GÖG n/a Reporting and payment modalities (art 21, 22): Mutual Insurance Mechanism (MIM): No Restrictions on distribution of initial prefinancing: The prefinancing may be distributed only if the minimum number of beneficiaries set out in the call condititions (if any) have acceded to the Agreement and only to beneficiaries that have acceded. Interim payment ceiling (if any): 90% of the maximum grant amount No-profit rule: Yes Late payment interest: ECB + 3.5% Bank account for payments: SI56011006000043188 Conversion into euros: Double conversion Reporting language: Language of the Agreement 4.3 Certificates (art 24): Certificates on the financial statements (CFS): Conditions: Schedule: interim/final payment, if threshold is reached 13 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Standard threshold (beneficiary-level): - financial statement: requested EU contribution to costs ≥ EUR 325 000.00 4.4 Recoveries (art 22) First-line liability for recoveries: Beneficiary termination: Beneficiary concerned Final payment: Coordinator After final payment: Beneficiary concerned Joint and several liability for enforced recoveries (in case of non-payment): Limited joint and several liability of other beneficiaries — up to the maximum grant amount of the beneficiary Joint and several liability of affiliated entities — n/a 5. Consequences of non-compliance, applicable law & dispute settlement forum Applicable law (art 43): Standard applicable law regime: EU law + law of Belgium Dispute settlement forum (art 43): Standard dispute settlement forum: EU beneficiaries: EU General Court + EU Court of Justice (on appeal) Non-EU beneficiaries: Courts of Brussels, Belgium (unless an international agreement provides for the enforceability of EU court judgements) 6. Other Specific rules (Annex 5): Yes Standard time-limits after project end: Confidentiality (for X years after final payment): 5 Record-keeping (for X years after final payment): 5 (or 3 for grants of not more than EUR 60 000) Reviews (up to X years after final payment): 5 (or 3 for grants of not more than EUR 60 000) Audits (up to X years after final payment): 5 (or 3 for grants of not more than EUR 60 000) Extension of findings from other grants to this grant (no later than X years after final payment): 5 (or 3 for grants of not more than EUR 60 000) Impact evaluation (up to X years after final payment): 5 (or 3 for grants of not more than EUR 60 000) 14 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 CHAPTER 1 GENERAL ARTICLE 1 — SUBJECT OF THE AGREEMENT This Agreement sets out the rights and obligations and terms and conditions applicable to the grant awarded for the implementation of the action set out in Chapter 2. ARTICLE 2 — DEFINITIONS For the purpose of this Agreement, the following definitions apply: Actions — The project which is being funded in the context of this Agreement. Grant — The grant awarded in the context of this Agreement. EU grants — Grants awarded by EU institutions, bodies, offices or agencies (including EU executive agencies, EU regulatory agencies, EDA, joint undertakings, etc.). Participants — Entities participating in the action as beneficiaries, affiliated entities, associated partners, third parties giving in-kind contributions, subcontractors or recipients of financial support to third parties. Beneficiaries (BEN) — The signatories of this Agreement (either directly or through an accession form). Affiliated entities (AE) — Entities affiliated to a beneficiary within the meaning of Article 187 of EU Financial Regulation 2018/10464 which participate in the action with similar rights and obligations as the beneficiaries (obligation to implement action tasks and right to charge costs and claim contributions). Associated partners (AP) — Entities which participate in the action, but without the right to charge costs or claim contributions. Purchases — Contracts for goods, works or services needed to carry out the action (e.g. equipment, consumables and supplies) but which are not part of the action tasks (see Annex 1). Subcontracting — Contracts for goods, works or services that are part of the action tasks (see Annex 1). In-kind contributions — In-kind contributions within the meaning of Article 2(36) of EU Financial 4 For the definition, see Article 187 Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012 (‘EU Financial Regulation’) (OJ L 193, 30.7.2018, p. 1): “affiliated entities [are]: (a) entities that form a sole beneficiary [(i.e. where an entity is formed of several entities that satisfy the criteria for being awarded a grant, including where the entity is specifically established for the purpose of implementing an action to be financed by a grant)]; (b) entities that satisfy the eligibility criteria and that do not fall within one of the situations referred to in Article 136(1) and 141(1) and that have a link with the beneficiary, in particular a legal or capital link, which is neither limited to the action nor established for the sole purpose of its implementation”. 15 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Regulation 2018/1046, i.e. non-financial resources made available free of charge by third parties. Fraud — Fraud within the meaning of Article 3 of EU Directive 2017/13715 and Article 1 of the Convention on the protection of the European Communities’ financial interests, drawn up by the Council Act of 26 July 19956, as well as any other wrongful or criminal deception intended to result in financial or personal gain. Irregularities — Any type of breach (regulatory or contractual) which could impact the EU financial interests, including irregularities within the meaning of Article 1(2) of EU Regulation 2988/957. Grave professional misconduct — Any type of unacceptable or improper behaviour in exercising one’s profession, especially by employees, including grave professional misconduct within the meaning of Article 136(1)(c) of EU Financial Regulation 2018/1046. Applicable EU, international and national law — Any legal acts or other (binding or non-binding) rules and guidance in the area concerned. Portal — EU Funding & Tenders Portal; electronic portal and exchange system managed by the European Commission and used by itself and other EU institutions, bodies, offices or agencies for the management of their funding programmes (grants, procurements, prizes, etc.). CHAPTER 2 ACTION ARTICLE 3 — ACTION The grant is awarded for the action 101075284 — CraNE (‘action’), as described in Annex 1. ARTICLE 4 — DURATION AND STARTING DATE The duration and the starting date of the action are set out in the Data Sheet (see Point 1). CHAPTER 3 GRANT ARTICLE 5 — GRANT 5.1 Form of grant The grant is an action grant8 which takes the form of a budget-based mixed actual cost grant (i.e. a 5 Directive (EU) 2017/1371 of the European Parliament and of the Council of 5 July 2017 on the fight against fraud to the Union’s financial interests by means of criminal law (OJ L 198, 28.7.2017, p. 29). 6 OJ C 316, 27.11.1995, p. 48. 7 Council Regulation (EC, Euratom) No 2988/95 of 18 December 1995 on the protection of the European Communities financial interests (OJ L 312, 23.12.1995, p. 1). 8 For the definition, see Article 180(2)(a) EU Financial Regulation 2018/1046: ‘action grant’ means an EU grant to finance “an action intended to help achieve a Union policy objective”. 16 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 grant based on actual costs incurred, but which may also include other forms of funding, such as unit costs or contributions, flat-rate costs or contributions, lump sum costs or contributions or financing not linked to costs). 5.2 Maximum grant amount The maximum grant amount is set out in the Data Sheet (see Point 3) and in the estimated budget (Annex 2). 5.3 Funding rate The funding rate for costs is 80% of the action’s eligible costs. Contributions are not subject to any funding rate. 5.4 Estimated budget, budget categories and forms of funding The estimated budget for the action is set out in Annex 2. It contains the estimated eligible costs and contributions for the action, broken down by participant and budget category. Annex 2 also shows the types of costs and contributions (forms of funding)9 to be used for each budget category. If unit costs or contributions are used, the details on the calculation will be explained in Annex 2a. 5.5 Budget flexibility The budget breakdown may be adjusted — without an amendment (see Article 39) — by transfers (between participants and budget categories), as long as this does not imply any substantive or important change to the description of the action in Annex 1. However: - changes to the budget category for volunteers (if used) always require an amendment - changes to budget categories with lump sums costs or contributions (if used; including financing not linked to costs) always require an amendment - changes to budget categories with higher funding rates or budget ceilings (if used) always require an amendment - addition of amounts for subcontracts not provided for in Annex 1 either require an amendment or simplified approval in accordance with Article 6.2 - other changes require an amendment or simplified approval, if specifically provided for in Article 6.2 - flexibility caps: not applicable. 9 See Article 125 EU Financial Regulation 2018/1046. 17 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS AND CONTRIBUTIONS In order to be eligible, costs and contributions must meet the eligibility conditions set out in this Article. 6.1 General eligibility conditions The general eligibility conditions are the following: (a) for actual costs: (i) they must be actually incurred by the beneficiary (ii) they must be incurred in the period set out in Article 4 (with the exception of costs relating to the submission of the final periodic report, which may be incurred afterwards; see Article 21) (iii) they must be declared under one of the budget categories set out in Article 6.2 and Annex 2 (iv) they must be incurred in connection with the action as described in Annex 1 and necessary for its implementation (v) they must be identifiable and verifiable, in particular recorded in the beneficiary’s accounts in accordance with the accounting standards applicable in the country where the beneficiary is established and with the beneficiary’s usual cost accounting practices (vi) they must comply with the applicable national law on taxes, labour and social security and (vii) they must be reasonable, justified and must comply with the principle of sound financial management, in particular regarding economy and efficiency (b) for unit costs or contributions (if any): (i) they must be declared under one of the budget categories set out in Article 6.2 and Annex 2 (ii) the units must: - be actually used or produced by the beneficiary in the period set out in Article 4 (with the exception of units relating to the submission of the final periodic report, which may be used or produced afterwards; see Article 21) - be necessary for the implementation of the action and (iii) the number of units must be identifiable and verifiable, in particular supported by records and documentation (see Article 20) (c) for flat-rate costs or contributions (if any): (i) they must be declared under one of the budget categories set out in Article 6.2 and Annex 2 18 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (ii) the costs or contributions to which the flat-rate is applied must: - be eligible - relate to the period set out in Article 4 (with the exception of costs or contributions relating to the submission of the final periodic report, which may be incurred afterwards; see Article 21) (d) for lump sum costs or contributions (if any): (i) they must be declared under one of the budget categories set out in Article 6.2 and Annex 2 (ii) the work must be properly implemented by the beneficiary in accordance with Annex 1 (iii) the deliverables/outputs must be achieved in the period set out in Article 4 (with the exception of deliverables/outputs relating to the submission of the final periodic report, which may be achieved afterwards; see Article 21) (e) for unit, flat-rate or lump sum costs or contributions according to usual cost accounting practices (if any): (i) they must fulfil the general eligibility conditions for the type of cost concerned (ii) the cost accounting practices must be applied in a consistent manner, based on objective criteria, regardless of the source of funding (f) for financing not linked to costs (if any): the results must be achieved or the conditions must be fulfilled as described in Annex 1. In addition, for direct cost categories (e.g. personnel, travel & subsistence, subcontracting and other direct costs) only costs that are directly linked to the action implementation and can therefore be attributed to it directly are eligible. They must not include any indirect costs (i.e. costs that are only indirectly linked to the action, e.g. via cost drivers). 6.2 Specific eligibility conditions for each budget category For each budget category, the specific eligibility conditions are as follows: Direct costs A. Personnel costs A.1 Costs for employees (or equivalent) are eligible as personnel costs if they fulfil the general eligibility conditions and are related to personnel working for the beneficiary under an employment contract (or equivalent appointing act) and assigned to the action. They must be limited to salaries, social security contributions, taxes and other costs linked to the remuneration, if they arise from national law or the employment contract (or equivalent appointing act) and be calculated on the basis of the costs actually incurred, in accordance with the following method: 19 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 {daily rate for the person multiplied by number of day-equivalents worked on the action (rounded up or down to the nearest half-day)}. The daily rate must be calculated as: {annual personnel costs for the person divided by 215}. The number of day-equivalents declared for a person must be identifiable and verifiable (see Article 20). The total number of day-equivalents declared in EU grants, for a person for a year, cannot be higher than 215. The personnel costs may also include supplementary payments for personnel assigned to the action (including payments on the basis of supplementary contracts regardless of their nature), if: - it is part of the beneficiary’s usual remuneration practices and is paid in a consistent manner whenever the same kind of work or expertise is required - the criteria used to calculate the supplementary payments are objective and generally applied by the beneficiary, regardless of the source of funding used. A.2 and A.3 Costs for natural persons working under a direct contract other than an employment contract and costs for seconded persons by a third party against payment are also eligible as personnel costs, if they are assigned to the action, fulfil the general eligibility conditions and: (a) work under conditions similar to those of an employee (in particular regarding the way the work is organised, the tasks that are performed and the premises where they are performed) and (b) the result of the work belongs to the beneficiary (unless agreed otherwise). They must be calculated on the basis of a rate which corresponds to the costs actually incurred for the direct contract or secondment and must not be significantly different from those for personnel performing similar tasks under an employment contract with the beneficiary. A.4 The work of SME owners for the action (i.e. owners of beneficiaries that are small and medium- sized enterprises10 not receiving a salary) or natural person beneficiaries (i.e. beneficiaries that are natural persons not receiving a salary) may be declared as personnel costs, if they fulfil the general 10 For the definition, see Commission Recommendation 2003/361/EC: micro, small or medium-sized enterprise (SME) are enterprises - engaged in an economic activity, irrespective of their legal form (including, in particular, self- employed persons and family businesses engaged in craft or other activities, and partnerships or associations regularly engaged in an economic activity) and - employing fewer than 250 persons (expressed in ‘annual working units’ as defined in Article 5 of the Recommendation) and which have an annual turnover not exceeding EUR 50 million, and/or an annual balance sheet total not exceeding EUR 43 million. 20 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 eligibility conditions and are calculated as unit costs in accordance with the method set out in Annex 2a. B. Subcontracting costs Subcontracting costs for the action (including related duties, taxes and charges, such as non- deductible or non-refundable value added tax (VAT)) are eligible, if they are calculated on the basis of the costs actually incurred, fulfil the general eligibility conditions and are awarded using the beneficiary’s usual purchasing practices — provided these ensure subcontracts with best value for money (or if appropriate the lowest price) and that there is no conflict of interests (see Article 12). Beneficiaries that are ‘contracting authorities/entities’ within the meaning of the EU Directives on public procurement must also comply with the applicable national law on public procurement. Subcontracting may cover only a limited part of the action. The tasks to be subcontracted and the estimated cost for each subcontract must be set out in Annex 1 and the total estimated costs of subcontracting per beneficiary must be set out in Annex 2 (or may be approved ex post in the periodic report, if the use of subcontracting does not entail changes to the Agreement which would call into question the decision awarding the grant or breach the principle of equal treatment of applicants; ‘simplified approval procedure’). C. Purchase costs Purchase costs for the action (including related duties, taxes and charges, such as non-deductible or non-refundable value added tax (VAT)) are eligible if they fulfil the general eligibility conditions and are bought using the beneficiary’s usual purchasing practices — provided these ensure purchases with best value for money (or if appropriate the lowest price) and that there is no conflict of interests (see Article 12). Beneficiaries that are ‘contracting authorities/entities’ within the meaning of the EU Directives on public procurement must also comply with the applicable national law on public procurement. C.1 Travel and subsistence Purchases for travel, accommodation and subsistence must be calculated as follows: - travel: as unit costs in accordance with the method set out in Annex 2a if covered by Decision C(2021)3511 or otherwise as costs actually incurred and in line with the beneficiary’s usual practices on travel - accommodation: as unit costs in accordance with the method set out in Annex 2a if covered by Decision C(2021)3512 or otherwise as costs actually incurred and in line with the beneficiary’s usual practices on travel - subsistence: as unit costs in accordance with the method set out in Annex 2a if covered by 11 Commission Decision of 12 January 2021 authorising the use of unit costs for travel, accommodation and subsistence costs under an action or work programme under the 2021-2027 multi-annual financial framework (C(2021)35). 12 Commission Decision of 12 January 2021 authorising the use of unit costs for travel, accommodation and subsistence costs under an action or work programme under the 2021-2027 multi-annual financial framework (C(2021)35). 21 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Decision C(2021)3513 or otherwise as costs actually incurred and in line with the beneficiary’s usual practices on travel. C.2 Equipment Purchases of equipment, infrastructure or other assets used for the action must be declared as depreciation costs, calculated on the basis of the costs actually incurred and written off in accordance with international accounting standards and the beneficiary’s usual accounting practices. Only the portion of the costs that corresponds to the rate of actual use for the action during the action duration can be taken into account. Costs for renting or leasing equipment, infrastructure or other assets are also eligible, if they do not exceed the depreciation costs of similar equipment, infrastructure or assets and do not include any financing fees. C.3 Other goods, works and services Purchases of other goods, works and services must be calculated on the basis of the costs actually incurred. Such goods, works and services include, for instance, consumables and supplies, promotion, dissemination, protection of results, translations, publications, certificates and financial guarantees, if required under the Agreement. D. Other cost categories D.1 Financial support to third parties Costs for providing financial support to third parties (in the form of grants, prizes or similar forms of support; if any) are eligible, if and as declared eligible in the call conditions, if they fulfil the general eligibility conditions, are calculated on the basis of the costs actually incurred and the support is implemented in accordance with the conditions set out in Annex 1. These conditions must ensure objective and transparent selection procedures and include at least the following: (a) for grants (or similar): (i) the maximum amount of financial support for each third party (‘recipient’); this amount may not exceed the amount set out in the Data Sheet (see Point 3) or otherwise agreed with the granting authority (ii) the criteria for calculating the exact amount of the financial support (iii) the different types of activity that qualify for financial support, on the basis of a closed list (iv) the persons or categories of persons that will be supported and (v) the criteria and procedures for giving financial support 13 Commission Decision of 12 January 2021 authorising the use of unit costs for travel, accommodation and subsistence costs under an action or work programme under the 2021-2027 multi-annual financial framework (C(2021)35). 22 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (b) for prizes (or similar): (i) the eligibility and award criteria (ii) the amount of the prize and (iii) the payment arrangements. Indirect costs E. Indirect costs Indirect costs will be reimbursed at the flat-rate of 7% of the eligible direct costs (categories A-D, except volunteers costs and exempted specific cost categories, if any). Contributions Not applicable 6.3 Ineligible costs and contributions The following costs or contributions are ineligible: (a) costs or contributions that do not comply with the conditions set out above (Article 6.1 and 6.2), in particular: (i) costs related to return on capital and dividends paid by a beneficiary (ii) debt and debt service charges (iii) provisions for future losses or debts (iv) interest owed (v) currency exchange losses (vi) bank costs charged by the beneficiary’s bank for transfers from the granting authority (vii) excessive or reckless expenditure (viii) deductible or refundable VAT (including VAT paid by public bodies acting as public authority) (ix) costs incurred or contributions for activities implemented during grant agreement suspension (see Article 31) (x) in-kind contributions by third parties (b) costs or contributions declared under other EU grants (or grants awarded by an EU Member State, non-EU country or other body implementing the EU budget), except for the following cases: (i) Synergy actions: not applicable 23 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (ii) if the action grant is combined with an operating grant14 running during the same period and the beneficiary can demonstrate that the operating grant does not cover any (direct or indirect) costs of the action grant (c) costs or contributions for staff of a national (or regional/local) administration, for activities that are part of the administration’s normal activities (i.e. not undertaken only because of the grant) (d) costs or contributions (especially travel and subsistence) for staff or representatives of EU institutions, bodies or agencies (e) other : (i) country restrictions for eligible costs: not applicable (ii) costs or contributions declared specifically ineligible in the call conditions. 6.4 Consequences of non-compliance If a beneficiary declares costs or contributions that are ineligible, they will be rejected (see Article 27). This may also lead to other measures described in Chapter 5. CHAPTER 4 GRANT IMPLEMENTATION SECTION 1 CONSORTIUM: BENEFICIARIES, AFFILIATED ENTITIES AND OTHER PARTICIPANTS ARTICLE 7 — BENEFICIARIES The beneficiaries, as signatories of the Agreement, are fully responsible towards the granting authority for implementing it and for complying with all its obligations. They must implement the Agreement to their best abilities, in good faith and in accordance with all the obligations and terms and conditions it sets out. They must have the appropriate resources to implement the action and implement the action under their own responsibility and in accordance with Article 11. If they rely on affiliated entities or other participants (see Articles 8 and 9), they retain sole responsibility towards the granting authority and the other beneficiaries. They are jointly responsible for the technical implementation of the action. If one of the beneficiaries fails to implement their part of the action, the other beneficiaries must ensure that this part is implemented by someone else (without being entitled to an increase of the maximum grant amount and subject to an amendment; see Article 39). The financial responsibility of each beneficiary in case of recoveries is governed by Article 22. 14 For the definition, see Article 180(2)(b) of EU Financial Regulation 2018/1046: ‘operating grant’ means an EU grant to finance “the functioning of a body which has an objective forming part of and supporting an EU policy”. 24 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 The beneficiaries (and their action) must remain eligible under the EU programme funding the grant for the entire duration of the action. Costs and contributions will be eligible only as long as the beneficiary and the action are eligible. The internal roles and responsibilities of the beneficiaries are divided as follows: (a) Each beneficiary must: (i) keep information stored in the Portal Participant Register up to date (see Article 19) (ii) inform the granting authority (and the other beneficiaries) immediately of any events or circumstances likely to affect significantly or delay the implementation of the action (see Article 19) (iii) submit to the coordinator in good time: - the prefinancing guarantees (if required; see Article 23) - the financial statements and certificates on the financial statements (CFS) (if required; see Articles 21 and 24.2 and Data Sheet, Point 4.3) - the contribution to the deliverables and technical reports (see Article 21) - any other documents or information required by the granting authority under the Agreement (iv) submit via the Portal data and information related to the participation of their affiliated entities. (b) The coordinator must: (i) monitor that the action is implemented properly (see Article 11) (ii) act as the intermediary for all communications between the consortium and the granting authority, unless the Agreement or granting authority specifies otherwise, and in particular: - submit the prefinancing guarantees to the granting authority (if any) - request and review any documents or information required and verify their quality and completeness before passing them on to the granting authority - submit the deliverables and reports to the granting authority - inform the granting authority about the payments made to the other beneficiaries (report on the distribution of payments; if required, see Articles 22 and 32) (iii) distribute the payments received from the granting authority to the other beneficiaries without unjustified delay (see Article 22). The coordinator may not delegate or subcontract the above-mentioned tasks to any other beneficiary or third party (including affiliated entities). 25 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 However, coordinators which are public bodies may delegate the tasks set out in Point (b)(ii) last indent and (iii) above to entities with ‘authorisation to administer’ which they have created or which are controlled by or affiliated to them. In this case, the coordinator retains sole responsibility for the payments and for compliance with the obligations under the Agreement. Moreover, coordinators which are ‘sole beneficiaries’15 (or similar, such as European research infrastructure consortia (ERICs)) may delegate the tasks set out in Point (b)(i) to (iii) above to one of their members. The coordinator retains sole responsibility for compliance with the obligations under the Agreement. The beneficiaries must have internal arrangements regarding their operation and co-ordination, to ensure that the action is implemented properly. If required by the granting authority (see Data Sheet, Point 1), these arrangements must be set out in a written consortium agreement between the beneficiaries, covering for instance: - the internal organisation of the consortium - the management of access to the Portal - different distribution keys for the payments and financial responsibilities in case of recoveries (if any) - additional rules on rights and obligations related to background and results (see Article 16) - settlement of internal disputes - liability, indemnification and confidentiality arrangements between the beneficiaries. The internal arrangements must not contain any provision contrary to this Agreement. ARTICLE 8 — AFFILIATED ENTITIES The following entities which are linked to a beneficiary will participate in the action as ‘affiliated entities’: - ONKOLOSKI INSTITUT LJUBLJANA (OIL), PIC 986222475, linked to NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ) - UNIVERSITAIR ZIEKENHUIS ANTWERPEN (UZA), PIC 996727866, linked to SCIENSANO (Sciensano) - TARTU ULIKOOL (UT), PIC 999895013, linked to SOTSIAALMINISTEERIUM (MSAE) - UNICANCER (UNICANCER), PIC 952728375, linked to INSTITUT NATIONAL DU CANCER GIP (INCa) - FEDERATION HOSPITALIERE DE FRANCE (FHF), PIC 999562109, linked to INSTITUT NATIONAL DU CANCER GIP (INCa) 15 For the definition, see Article 187(2) EU Financial Regulation 2018/1046: “Where several entities satisfy the criteria for being awarded a grant and together form one entity, that entity may be treated as the sole beneficiary, including where it is specifically established for the purpose of implementing the action financed by the grant.” 26 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 - INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), PIC 999997833, linked to INSTITUT NATIONAL DU CANCER GIP (INCa) - DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (DKFZ), PIC 999990073, linked to BUNDESMINISTERIUM FUER GESUNDHEIT (BMG) - DEUTSCHE KREBSGESELLSCHAFT EV (DKG), PIC 922313831, linked to BUNDESMINISTERIUM FUER GESUNDHEIT (BMG) - STIFTUNG DEUTSCHE KREBSHILFE (DKH), PIC 888636983, linked to BUNDESMINISTERIUM FUER GESUNDHEIT (BMG) - TECHNISCHE UNIVERSITAET DRESDEN (TUD), PIC 999897729, linked to BUNDESMINISTERIUM FUER GESUNDHEIT (BMG) - GENIKO ANTIKARKINIKO OGKOLOGIKO NOSOKOMEIO ATHINON O AGIOS SAVVAS (AGIOS SAVVAS), PIC 897642560, linked to 1ST YGEIONOMIKI PERIFEREIA DYPE ATTIKIS (1ST YPE) - GENIKO LAIKO NOSOKOMEIO ATHINON*GENERAL HOSPITAL OF ATHENS LAIKO (LGHA), PIC 954350409, linked to 1ST YGEIONOMIKI PERIFEREIA DYPE ATTIKIS (1ST YPE) - MINISTERO DELLA SALUTE (MoH), PIC 999531942, linked to ALLEANZA CONTRO IL CANCRO (ACC) - FONDAZIONE LUIGI MARIA MONTI (IDI), PIC 918519870, linked to ALLEANZA CONTRO IL CANCRO (ACC) - LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS (KK), PIC 923616832, linked to LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM LT) - VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS (VULSK), PIC 991636530, linked to LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM LT) - NACIONALINIS VEZIO INSTITUTAS (NCI), PIC 912763114, linked to LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM LT) - LUXEMBOURG INSTITUTE OF HEALTH (LIH), PIC 998331858, linked to INSTITUT NATIONAL DU CANCER (INC) - FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA (IDIVAL), PIC 946556944, linked to INSTITUT CATALA D'ONCOLOGIA (ICO) Affiliated entities can charge costs and contributions to the action under the same conditions as the beneficiaries and must implement the action tasks attributed to them in Annex 1 in accordance with Article 11. Their costs and contributions will be included in Annex 2 and will be taken into account for the calculation of the grant. 27 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 The beneficiaries must ensure that all their obligations under this Agreement also apply to their affiliated entities. The beneficiaries must ensure that the bodies mentioned in Article 25 (e.g. granting authority, OLAF, Court of Auditors (ECA), etc.) can exercise their rights also towards the affiliated entities. Breaches by affiliated entities will be handled in the same manner as breaches by beneficiaries. Recovery of undue amounts will be handled through the beneficiaries. If the granting authority requires joint and several liability of affiliated entities (see Data Sheet, Point 4.4), they must sign the declaration set out in Annex 3a and may be held liable in case of enforced recoveries against their beneficiaries (see Article 22.2 and 22.4). ARTICLE 9 — OTHER PARTICIPANTS INVOLVED IN THE ACTION 9.1 Associated partners Not applicable 9.2 Third parties giving in-kind contributions to the action Other third parties may give in-kind contributions to the action (i.e. personnel, equipment, other goods, works and services, etc. which are free-of-charge), if necessary for the implementation. Third parties giving in-kind contributions do not implement any action tasks. They may not charge costs or contributions to the action and the costs for the in-kind contributions are not eligible. The third parties and their in-kind contributions should be set out in Annex 1. 9.3 Subcontractors Subcontractors may participate in the action, if necessary for the implementation. Subcontractors must implement their action tasks in accordance with Article 11. The costs for the subcontracted tasks (invoiced price from the subcontractor) are eligible and may be charged by the beneficiaries, under the conditions set out in Article 6. The costs will be included in Annex 2 as part of the beneficiaries’ costs. The beneficiaries must ensure that their contractual obligations under Articles 11 (proper implementation), 12 (conflict of interest), 13 (confidentiality and security), 14 (ethics), 17.2 (visibility), 18 (specific rules for carrying out action), 19 (information) and 20 (record-keeping) also apply to the subcontractors. The beneficiaries must ensure that the bodies mentioned in Article 25 (e.g. granting authority, OLAF, Court of Auditors (ECA), etc.) can exercise their rights also towards the subcontractors. 9.4 Recipients of financial support to third parties If the action includes providing financial support to third parties (e.g. grants, prizes or similar forms of support), the beneficiaries must ensure that their contractual obligations under Articles 12 (conflict of interest), 13 (confidentiality and security), 14 (ethics), 17.2 (visibility), 18 (specific rules for carrying 28 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 out action), 19 (information) and 20 (record-keeping)also apply to the third parties receiving the support (recipients). The beneficiaries must also ensure that the bodies mentioned in Article 25 (e.g. granting authority, OLAF, Court of Auditors (ECA), etc.) can exercise their rights also towards the recipients. ARTICLE 10 — PARTICIPANTS WITH SPECIAL STATUS 10.1 Non-EU participants Participants which are established in a non-EU country (if any) undertake to comply with their obligations under the Agreement and: - to respect general principles (including fundamental rights, values and ethical principles, environmental and labour standards, rules on classified information, intellectual property rights, visibility of funding and protection of personal data) - for the submission of certificates under Article 24: to use qualified external auditors which are independent and comply with comparable standards as those set out in EU Directive 2006/43/EC16 - for the controls under Article 25: to allow for checks, reviews, audits and investigations (including on-the-spot checks, visits and inspections) by the bodies mentioned in that Article (e.g. granting authority, OLAF, Court of Auditors (ECA), etc.). Special rules on dispute settlement apply (see Data Sheet, Point 5). 10.2 Participants which are international organisations Participants which are international organisations (IOs; if any) undertake to comply with their obligations under the Agreement and: - to respect general principles (including fundamental rights, values and ethical principles, environmental and labour standards, rules on classified information, intellectual property rights, visibility of funding and protection of personal data) - for the submission of certificates under Article 24: to use either independent public officers or external auditors which comply with comparable standards as those set out in EU Directive 2006/43/EC - for the controls under Article 25: to allow for the checks, reviews, audits and investigations by the bodies mentioned in that Article, taking into account the specific agreements concluded by them and the EU (if any). For such participants, nothing in the Agreement will be interpreted as a waiver of their privileges or immunities, as accorded by their constituent documents or international law. Special rules on applicable law and dispute settlement apply (see Article 43 and Data Sheet, Point 5). 16 Directive 2006/43/EC of the European Parliament and of the Council of 17 May 2006 on statutory audits of annual accounts and consolidated accounts or similar national regulations (OJ L 157, 9.6.2006, p. 87). 29 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 10.3 Pillar-assessed participants Pillar-assessed participants (if any) may rely on their own systems, rules and procedures, in so far as they have been positively assessed and do not call into question the decision awarding the grant or breach the principle of equal treatment of applicants or beneficiaries. ‘Pillar-assessment’ means a review by the European Commission on the systems, rules and procedures which participants use for managing EU grants (in particular internal control system, accounting system, external audits, financing of third parties, rules on recovery and exclusion, information on recipients and protection of personal data; see Article 154 EU Financial Regulation 2018/1046). Participants with a positive pillar assessment may rely on their own systems, rules and procedures, in particular for: - record-keeping (Article 20): may be done in accordance with internal standards, rules and procedures - currency conversion for financial statements (Article 21): may be done in accordance with usual accounting practices - guarantees (Article 23): for public law bodies, prefinancing guarantees are not needed - certificates (Article 24): - certificates on the financial statements (CFS): may be provided by their regular internal or external auditors and in accordance with their internal financial regulations and procedures - certificates on usual accounting practices (CoMUC): are not needed if those practices are covered by an ex-ante assessment and use the following specific rules, for: - recoveries (Article 22): in case of financial support to third parties, there will be no recovery if the participant has done everything possible to retrieve the undue amounts from the third party receiving the support (including legal proceedings) and non-recovery is not due to an error or negligence on its part - checks, reviews, audits and investigations by the EU (Article 25): will be conducted taking into account the rules and procedures specifically agreed between them and the framework agreement (if any) - impact evaluation (Article 26): will be conducted in accordance with the participant’s internal rules and procedures and the framework agreement (if any) - grant agreement suspension (Article 31): certain costs incurred during grant suspension are eligible (notably, minimum costs necessary for a possible resumption of the action and costs relating to contracts which were entered into before the pre-information letter was received and which could not reasonably be suspended, reallocated or terminated on legal grounds) - grant agreement termination (Article 32): the final grant amount and final payment will be calculated taking into account also costs relating to contracts due for execution only after 30 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 termination takes effect, if the contract was entered into before the pre-information letter was received and could not reasonably be terminated on legal grounds - liability for damages (Article 33.2): the granting authority must be compensated for damage it sustains as a result of the implementation of the action or because the action was not implemented in full compliance with the Agreement only if the damage is due to an infringement of the participant’s internal rules and procedures or due to a violation of third parties’ rights by the participant or one of its employees or individual for whom the employees are responsible. Participants whose pillar assessment covers procurement and granting procedures may also do purchases, subcontracting and financial support to third parties (Article 6.2) in accordance with their internal rules and procedures for purchases, subcontracting and financial support. Participants whose pillar assessment covers data protection rules may rely on their internal standards, rules and procedures for data protection (Article 15). The participants may however not rely on provisions which would breach the principle of equal treatment of applicants or beneficiaries or call into question the decision awarding the grant, such as in particular: - eligibility (Article 6) - consortium roles and set-up (Articles 7-9) - security and ethics (Articles 13, 14) - IPR (including background and results, access rights and rights of use), communication, dissemination and visibility (Articles 16 and 17) - information obligation (Article 19) - payment, reporting and amendments (Articles 21, 22 and 39) - rejections, reductions, suspensions and terminations (Articles 27, 28, 29-32) If the pillar assessment was subject to remedial measures, reliance on the internal systems, rules and procedures is subject to compliance with those remedial measures. Participants whose assessment has not yet been updated to cover (the new rules on) data protection may rely on their internal systems, rules and procedures, provided that they ensure that personal data is: - processed lawfully, fairly and in a transparent manner in relation to the data subject - collected for specified, explicit and legitimate purposes and not further processed in a manner that is incompatible with those purposes - adequate, relevant and limited to what is necessary in relation to the purposes for which they are processed - accurate and, where necessary, kept up to date 31 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 - kept in a form which permits identification of data subjects for no longer than is necessary for the purposes for which the data is processed and - processed in a manner that ensures appropriate security of the personal data. Participants must inform the coordinator without delay of any changes to the systems, rules and procedures that were part of the pillar assessment. The coordinator must immediately inform the granting authority. Pillar-assessed participants that have also concluded a framework agreement with the EU, may moreover — under the same conditions as those above (i.e. not call into question the decision awarding the grant or breach the principle of equal treatment of applicants or beneficiaries) — rely on the provisions set out in that framework agreement. SECTION 2 RULES FOR CARRYING OUT THE ACTION ARTICLE 11 — PROPER IMPLEMENTATION OF THE ACTION 11.1 Obligation to properly implement the action The beneficiaries must implement the action as described in Annex 1 and in compliance with the provisions of the Agreement, the call conditions and all legal obligations under applicable EU, international and national law. 11.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 12 — CONFLICT OF INTERESTS 12.1 Conflict of interests The beneficiaries must take all measures to prevent any situation where the impartial and objective implementation of the Agreement could be compromised for reasons involving family, emotional life, political or national affinity, economic interest or any other direct or indirect interest (‘conflict of interests’). They must formally notify the granting authority without delay of any situation constituting or likely to lead to a conflict of interests and immediately take all the necessary steps to rectify this situation. The granting authority may verify that the measures taken are appropriate and may require additional measures to be taken by a specified deadline. 12.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28) and the grant or the beneficiary may be terminated (see Article 32). 32 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Such breaches may also lead to other measures described in Chapter 5. ARTICLE 13 — CONFIDENTIALITY AND SECURITY 13.1 Sensitive information The parties must keep confidential any data, documents or other material (in any form) that is identified as sensitive in writing (‘sensitive information’) — during the implementation of the action and for at least until the time-limit set out in the Data Sheet (see Point 6). If a beneficiary requests, the granting authority may agree to keep such information confidential for a longer period. Unless otherwise agreed between the parties, they may use sensitive information only to implement the Agreement. The beneficiaries may disclose sensitive information to their personnel or other participants involved in the action only if they: (a) need to know it in order to implement the Agreement and (b) are bound by an obligation of confidentiality. The granting authority may disclose sensitive information to its staff and to other EU institutions and bodies. It may moreover disclose sensitive information to third parties, if: (a) this is necessary to implement the Agreement or safeguard the EU financial interests and (b) the recipients of the information are bound by an obligation of confidentiality. The confidentiality obligations no longer apply if: (a) the disclosing party agrees to release the other party (b) the information becomes publicly available, without breaching any confidentiality obligation (c) the disclosure of the sensitive information is required by EU, international or national law. Specific confidentiality rules (if any) are set out in Annex 5. 13.2 Classified information The parties must handle classified information in accordance with the applicable EU, international or national law on classified information (in particular, Decision 2015/44417 and its implementing rules). Deliverables which contain classified information must be submitted according to special procedures agreed with the granting authority. 17 Commission Decision 2015/444/EC, Euratom of 13 March 2015 on the security rules for protecting EU classified information (OJ L 72, 17.3.2015, p. 53). 33 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Action tasks involving classified information may be subcontracted only after explicit approval (in writing) from the granting authority. Classified information may not be disclosed to any third party (including participants involved in the action implementation) without prior explicit written approval from the granting authority. Specific security rules (if any) are set out in Annex 5. 13.3 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 14 — ETHICS AND VALUES 14.1 Ethics The action must be carried out in line with the highest ethical standards and the applicable EU, international and national law on ethical principles. Specific ethics rules (if any) are set out in Annex 5. 14.2 Values The beneficiaries must commit to and ensure the respect of basic EU values (such as respect for human dignity, freedom, democracy, equality, the rule of law and human rights, including the rights of minorities). Specific rules on values (if any) are set out in Annex 5. 14.3 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 15 — DATA PROTECTION 15.1 Data processing by the granting authority Any personal data under the Agreement will be processed under the responsibility of the data controller of the granting authority in accordance with and for the purposes set out in the Portal Privacy Statement. For grants where the granting authority is the European Commission, an EU regulatory or executive agency, joint undertaking or other EU body, the processing will be subject to Regulation 2018/172518. 18 Regulation (EU) 2018/1725 of the European Parliament and of the Council of 23 October 2018 on the protection of natural persons with regard to the processing of personal data by the Union institutions, bodies, offices and agencies 34 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 15.2 Data processing by the beneficiaries The beneficiaries must process personal data under the Agreement in compliance with the applicable EU, international and national law on data protection (in particular, Regulation 2016/67919). They must ensure that personal data is: - processed lawfully, fairly and in a transparent manner in relation to the data subjects - collected for specified, explicit and legitimate purposes and not further processed in a manner that is incompatible with those purposes - adequate, relevant and limited to what is necessary in relation to the purposes for which they are processed - accurate and, where necessary, kept up to date - kept in a form which permits identification of data subjects for no longer than is necessary for the purposes for which the data is processed and - processed in a manner that ensures appropriate security of the data. The beneficiaries may grant their personnel access to personal data only if it is strictly necessary for implementing, managing and monitoring the Agreement. The beneficiaries must ensure that the personnel is under a confidentiality obligation. The beneficiaries must inform the persons whose data are transferred to the granting authority and provide them with the Portal Privacy Statement. 15.3 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 16 — INTELLECTUAL PROPERTY RIGHTS (IPR) — BACKGROUND AND RESULTS —ACCESS RIGHTS AND RIGHTS OF USE 16.1 Background and access rights to background The beneficiaries must give each other and the other participants access to the background identified as needed for implementing the action, subject to any specific rules in Annex 5. ‘Background’ means any data, know-how or information — whatever its form or nature (tangible or intangible), including any rights such as intellectual property rights — that is: and on the free movement of such data, and repealing Regulation (EC) No 45/2001 and Decision No 1247/2002/EC (OJ L 295, 21.11.2018, p. 39). 19 Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (‘GDPR’) (OJ L 119, 4.5.2016, p. 1). 35 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (a) held by the beneficiaries before they acceded to the Agreement and (b) needed to implement the action or exploit the results. If background is subject to rights of a third party, the beneficiary concerned must ensure that it is able to comply with its obligations under the Agreement. 16.2 Ownership of results The granting authority does not obtain ownership of the results produced under the action. ‘Results’ means any tangible or intangible effect of the action, such as data, know-how or information, whatever its form or nature, whether or not it can be protected, as well as any rights attached to it, including intellectual property rights. 16.3 Rights of use of the granting authority on materials, documents and information received for policy, information, communication, dissemination and publicity purposes The granting authority has the right to use non-sensitive information relating to the action and materials and documents received from the beneficiaries (notably summaries for publication, deliverables, as well as any other material, such as pictures or audio-visual material, in paper or electronic form) for policy, information, communication, dissemination and publicity purposes — during the action or afterwards. The right to use the beneficiaries’ materials, documents and information is granted in the form of a royalty-free, non-exclusive and irrevocable licence, which includes the following rights: (a) use for its own purposes (in particular, making them available to persons working for the granting authority or any other EU service (including institutions, bodies, offices, agencies, etc.) or EU Member State institution or body; copying or reproducing them in whole or in part, in unlimited numbers; and communication through press information services) (b) distribution to the public (in particular, publication as hard copies and in electronic or digital format, publication on the internet, as a downloadable or non-downloadable file, broadcasting by any channel, public display or presentation, communicating through press information services, or inclusion in widely accessible databases or indexes) (c) editing or redrafting (including shortening, summarising, inserting other elements (e.g. meta-data, legends, other graphic, visual, audio or text elements), extracting parts (e.g. audio or video files), dividing into parts, use in a compilation) (d) translation (e) storage in paper, electronic or other form (f) archiving, in line with applicable document-management rules (g) the right to authorise third parties to act on its behalf or sub-license to third parties the modes of use set out in Points (b), (c), (d) and (f), if needed for the information, communication and publicity activity of the granting authority 36 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (h) processing, analysing, aggregating the materials, documents and information received and producing derivative works. The rights of use are granted for the whole duration of the industrial or intellectual property rights concerned. If materials or documents are subject to moral rights or third party rights (including intellectual property rights or rights of natural persons on their image and voice), the beneficiaries must ensure that they comply with their obligations under this Agreement (in particular, by obtaining the necessary licences and authorisations from the rights holders concerned). Where applicable, the granting authority will insert the following information: “© – [year] – [name of the copyright owner]. All rights reserved. Licensed to the [name of granting authority] under conditions.” 16.4 Specific rules on IPR, results and background Specific rules regarding intellectual property rights, results and background (if any) are set out in Annex 5. 16.5 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such a breach may also lead to other measures described in Chapter 5. ARTICLE 17 — COMMUNICATION, DISSEMINATION AND VISIBILITY 17.1 Communication — Dissemination — Promoting the action Unless otherwise agreed with the granting authority, the beneficiaries must promote the action and its results by providing targeted information to multiple audiences (including the media and the public), in accordance with Annex 1 and in a strategic, coherent and effective manner. Before engaging in a communication or dissemination activity expected to have a major media impact, the beneficiaries must inform the granting authority. 17.2 Visibility — European flag and funding statement Unless otherwise agreed with the granting authority, communication activities of the beneficiaries related to the action (including media relations, conferences, seminars, information material, such as brochures, leaflets, posters, presentations, etc., in electronic form, via traditional or social media, etc.), dissemination activities and any infrastructure, equipment, vehicles, supplies or major result funded by the grant must acknowledge EU support and display the European flag (emblem) and funding statement (translated into local languages, where appropriate): 37 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 The emblem must remain distinct and separate and cannot be modified by adding other visual marks, brands or text. Apart from the emblem, no other visual identity or logo may be used to highlight the EU support. When displayed in association with other logos (e.g. of beneficiaries or sponsors), the emblem must be displayed at least as prominently and visibly as the other logos. For the purposes of their obligations under this Article, the beneficiaries may use the emblem without first obtaining approval from the granting authority. This does not, however, give them the right to exclusive use. Moreover, they may not appropriate the emblem or any similar trademark or logo, either by registration or by any other means. 17.3 Quality of information — Disclaimer Any communication or dissemination activity related to the action must use factually accurate information. Moreover, it must indicate the following disclaimer (translated into local languages where appropriate): “Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or [name of the granting authority]. Neither the European Union nor the granting authority can be held responsible for them.” 17.4 Specific communication, dissemination and visibility rules Specific communication, dissemination and visibility rules (if any) are set out in Annex 5. 17.5 Consequences of non-compliance 38 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 18 — SPECIFIC RULES FOR CARRYING OUT THE ACTION 18.1 Specific rules for carrying out the action Specific rules for implementing the action (if any) are set out in Annex 5. 18.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such a breach may also lead to other measures described in Chapter 5. SECTION 3 GRANT ADMINISTRATION ARTICLE 19 — GENERAL INFORMATION OBLIGATIONS 19.1 Information requests The beneficiaries must provide — during the action or afterwards and in accordance with Article 7 — any information requested in order to verify eligibility of the costs or contributions declared, proper implementation of the action and compliance with the other obligations under the Agreement. The information provided must be accurate, precise and complete and in the format requested, including electronic format. 19.2 Participant Register data updates The beneficiaries must keep — at all times, during the action or afterwards — their information stored in the Portal Participant Register up to date, in particular, their name, address, legal representatives, legal form and organisation type. 19.3 Information about events and circumstances which impact the action The beneficiaries must immediately inform the granting authority (and the other beneficiaries) of any of the following: (a) events which are likely to affect or delay the implementation of the action or affect the EU’s financial interests, in particular: (i) changes in their legal, financial, technical, organisational or ownership situation (including changes linked to one of the exclusion grounds listed in the declaration of honour signed before grant signature) (ii) linked action information: not applicable 39 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (b) circumstances affecting: (i) the decision to award the grant or (ii) compliance with requirements under the Agreement. 19.4 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 20 — RECORD-KEEPING 20.1 Keeping records and supporting documents The beneficiaries must — at least until the time-limit set out in the Data Sheet (see Point 6) — keep records and other supporting documents to prove the proper implementation of the action in line with the accepted standards in the respective field (if any). In addition, the beneficiaries must — for the same period — keep the following to justify the amounts declared: (a) for actual costs: adequate records and supporting documents to prove the costs declared (such as contracts, subcontracts, invoices and accounting records); in addition, the beneficiaries’ usual accounting and internal control procedures must enable direct reconciliation between the amounts declared, the amounts recorded in their accounts and the amounts stated in the supporting documents (b) for flat-rate costs and contributions (if any): adequate records and supporting documents to prove the eligibility of the costs or contributions to which the flat-rate is applied (c) for the following simplified costs and contributions: the beneficiaries do not need to keep specific records on the actual costs incurred, but must keep: (i) for unit costs and contributions (if any): adequate records and supporting documents to prove the number of units declared (ii) for lump sum costs and contributions (if any): adequate records and supporting documents to prove proper implementation of the work as described in Annex 1 (iii) for financing not linked to costs (if any): adequate records and supporting documents to prove the achievement of the results or the fulfilment of the conditions as described in Annex 1 (d) for unit, flat-rate and lump sum costs and contributions according to usual cost accounting practices (if any): the beneficiaries must keep any adequate records and supporting documents to prove that their cost accounting practices have been applied in a consistent manner, based on objective criteria, regardless of the source of funding, and that they comply with the eligibility conditions set out in Articles 6.1 and 6.2. 40 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Moreover, the following is needed for specific budget categories: (e) for personnel costs: time worked for the beneficiary under the action must be supported by declarations signed monthly by the person and their supervisor, unless another reliable time-record system is in place; the granting authority may accept alternative evidence supporting the time worked for the action declared, if it considers that it offers an adequate level of assurance (f) additional record-keeping rules: not applicable The records and supporting documents must be made available upon request (see Article 19) or in the context of checks, reviews, audits or investigations (see Article 25). If there are on-going checks, reviews, audits, investigations, litigation or other pursuits of claims under the Agreement (including the extension of findings; see Article 25), the beneficiaries must keep these records and other supporting documentation until the end of these procedures. The beneficiaries must keep the original documents. Digital and digitalised documents are considered originals if they are authorised by the applicable national law. The granting authority may accept non-original documents if they offer a comparable level of assurance. 20.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, costs or contributions insufficiently substantiated will be ineligible (see Article 6) and will be rejected (see Article 27), and the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 21 — REPORTING 21.1 Continuous reporting The beneficiaries must continuously report on the progress of the action (e.g. deliverables, milestones, outputs/outcomes, critical risks, indicators, etc; if any), in the Portal Continuous Reporting tool and in accordance with the timing and conditions it sets out (as agreed with the granting authority). Standardised deliverables (e.g. progress reports not linked to payments, reports on cumulative expenditure, special reports, etc; if any) must be submitted using the templates published on the Portal. 21.2 Periodic reporting: Technical reports and financial statements In addition, the beneficiaries must provide reports to request payments, in accordance with the schedule and modalities set out in the Data Sheet (see Point 4.2): - for additional prefinancings (if any): an additional prefinancing report - for interim payments (if any) and the final payment: a periodic report. The prefinancing and periodic reports include a technical and financial part. 41 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 The technical part includes an overview of the action implementation. It must be prepared using the template available in the Portal Periodic Reporting tool. The financial part of the additional prefinancing report includes a statement on the use of the previous prefinancing payment. The financial part of the periodic report includes: - the financial statements (individual and consolidated; for all beneficiaries/affiliated entities) - the explanation on the use of resources (or detailed cost reporting table, if required) - the certificates on the financial statements (CFS) (if required; see Article 24.2 and Data Sheet, Point 4.3). The financial statements must detail the eligible costs and contributions for each budget category and, for the final payment, also the revenues for the action (see Articles 6 and 22). All eligible costs and contributions incurred should be declared, even if they exceed the amounts indicated in the estimated budget (see Annex 2). Amounts that are not declared in the individual financial statements will not be taken into account by the granting authority. By signing the financial statements (directly in the Portal Periodic Reporting tool), the beneficiaries confirm that: - the information provided is complete, reliable and true - the costs and contributions declared are eligible (see Article 6) - the costs and contributions can be substantiated by adequate records and supporting documents (see Article 20) that will be produced upon request (see Article 19) or in the context of checks, reviews, audits and investigations (see Article 25) - for the final periodic report: all the revenues have been declared (if required; see Article 22). Beneficiaries will have to submit also the financial statements of their affiliated entities (if any). In case of recoveries (see Article 22), beneficiaries will be held responsible also for the financial statements of their affiliated entities. 21.3 Currency for financial statements and conversion into euros The financial statements must be drafted in euro. Beneficiaries with general accounts established in a currency other than the euro must convert the costs recorded in their accounts into euro, at the average of the daily exchange rates published in the C series of the Official Journal of the European Union (ECB website), calculated over the corresponding reporting period. If no daily euro exchange rate is published in the Official Journal for the currency in question, they must be converted at the average of the monthly accounting exchange rates published on the European Commission website (InforEuro), calculated over the corresponding reporting period. 42 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Beneficiaries with general accounts in euro must convert costs incurred in another currency into euro according to their usual accounting practices. 21.4 Reporting language The reporting must be in the language of the Agreement, unless otherwise agreed with the granting authority (see Data Sheet, Point 4.2). 21.5 Consequences of non-compliance If a report submitted does not comply with this Article, the granting authority may suspend the payment deadline (see Article 29) and apply other measures described in Chapter 5. If the coordinator breaches its reporting obligations, the granting authority may terminate the grant or the coordinator’s participation (see Article 32) or apply other measures described in Chapter 5. ARTICLE 22 — PAYMENTS AND RECOVERIES — CALCULATION OF AMOUNTS DUE 22.1 Payments and payment arrangements Payments will be made in accordance with the schedule and modalities set out in the Data Sheet (see Point 4.2). They will be made in euro to the bank account indicated by the coordinator (see Data Sheet, Point 4.2) and must be distributed without unjustified delay (restrictions may apply to distribution of the initial prefinancing payment; see Data Sheet, Point 4.2). Payments to this bank account will discharge the granting authority from its payment obligation. The cost of payment transfers will be borne as follows: - the granting authority bears the cost of transfers charged by its bank - the beneficiary bears the cost of transfers charged by its bank - the party causing a repetition of a transfer bears all costs of the repeated transfer. Payments by the granting authority will be considered to have been carried out on the date when they are debited to its account. 22.2 Recoveries Recoveries will be made, if — at beneficiary termination, final payment or afterwards — it turns out that the granting authority has paid too much and needs to recover the amounts undue. The general liability regime for recoveries (first-line liability) is as follows: At final payment, the coordinator will be fully liable for recoveries, even if it has not been the final recipient of the undue amounts. At beneficiary termination or after final payment, recoveries will be made directly against the beneficiaries concerned. Beneficiaries will be fully liable for repaying the debts of their affiliated entities. 43 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 In case of enforced recoveries (see Article 22.4): - the beneficiaries will be jointly and severally liable for repaying debts of another beneficiary under the Agreement (including late-payment interest), if required by the granting authority (see Data Sheet, Point 4.4) - affiliated entities will be held liable for repaying debts of their beneficiaries under the Agreement (including late-payment interest), if required by the granting authority (see Data Sheet, Point 4.4). 22.3 Amounts due 22.3.1 Prefinancing payments The aim of the prefinancing is to provide the beneficiaries with a float. It remains the property of the EU until the final payment. For initial prefinancings (if any), the amount due, schedule and modalities are set out in the Data Sheet (see Point 4.2). For additional prefinancings (if any), the amount due, schedule and modalities are also set out in the Data Sheet (see Point 4.2). However, if the statement on the use of the previous prefinancing payment shows that less than 70% was used, the amount set out in the Data Sheet will be reduced by the difference between the 70% threshold and the amount used. Prefinancing payments (or parts of them) may be offset (without the beneficiaries’ consent) against amounts owed by a beneficiary to the granting authority — up to the amount due to that beneficiary. For grants where the granting authority is the European Commission or an EU executive agency, offsetting may also be done against amounts owed to other Commission services or executive agencies. Payments will not be made if the payment deadline or payments are suspended (see Articles 29 and 30). 22.3.2 Amount due at beneficiary termination — Recovery In case of beneficiary termination, the granting authority will determine the provisional amount due for the beneficiary concerned. Payments (if any) will be made with the next interim or final payment. The amount due will be calculated in the following step: Step 1 — Calculation of the total accepted EU contribution Step 1 — Calculation of the total accepted EU contribution The granting authority will first calculate the ‘accepted EU contribution’ for the beneficiary for all reporting periods, by calculating the ‘maximum EU contribution to costs’ (applying the funding rate to the accepted costs of the beneficiary), taking into account requests for a lower contribution to costs and CFS threshold cappings (if any; see Article 24.5) and adding the contributions (accepted unit, flat-rate or lump sum contributions and financing not linked to costs, if any). 44 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 After that, the granting authority will take into account grant reductions (if any). The resulting amount is the ‘total accepted EU contribution’ for the beneficiary. The balance is then calculated by deducting the payments received (if any; see report on the distribution of payments in Article 32), from the total accepted EU contribution: {total accepted EU contribution for the beneficiary minus {prefinancing and interim payments received (if any)}}. If the balance is positive, the amount will be included in the next interim or final payment to the consortium. If the balance is negative, it will be recovered in accordance with the following procedure: The granting authority will send a pre-information letter to the beneficiary concerned: - formally notifying the intention to recover, the amount due, the amount to be recovered and the reasons why and - requesting observations within 30 days of receiving notification. If no observations are submitted (or the granting authority decides to pursue recovery despite the observations it has received), it will confirm the amount to be recovered and ask this amount to be paid to the coordinator (confirmation letter). The amounts will later on also be taken into account for the next interim or final payment. 22.3.3 Interim payments Interim payments reimburse the eligible costs and contributions claimed for the implementation of the action during the reporting periods (if any). Interim payments (if any) will be made in accordance with the schedule and modalities set out the Data Sheet (see Point 4.2). Payment is subject to the approval of the periodic report. Its approval does not imply recognition of compliance, authenticity, completeness or correctness of its content. The interim payment will be calculated by the granting authority in the following steps: Step 1 — Calculation of the total accepted EU contribution Step 2 — Limit to the interim payment ceiling Step 1 — Calculation of the total accepted EU contribution The granting authority will calculate the ‘accepted EU contribution’ for the action for the reporting period, by first calculating the ‘maximum EU contribution to costs’ (applying the funding rate to the accepted costs of each beneficiary), taking into account requests for a lower contribution to costs, and CFS threshold cappings (if any; see Article 24.5) and adding the contributions (accepted unit, flat-rate or lump sum contributions and financing not linked to costs, if any). 45 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 After that, the granting authority will take into account grant reductions from beneficiary termination (if any). The resulting amount is the ‘total accepted EU contribution’. Step 2 — Limit to the interim payment ceiling The resulting amount is then capped to ensure that the total amount of prefinancing and interim payments (if any) does not exceed the interim payment ceiling set out in the Data Sheet (see Point 4.2). Interim payments (or parts of them) may be offset (without the beneficiaries’ consent) against amounts owed by a beneficiary to the granting authority — up to the amount due to that beneficiary. For grants where the granting authority is the European Commission or an EU executive agency, offsetting may also be done against amounts owed to other Commission services or executive agencies. Payments will not be made if the payment deadline or payments are suspended (see Articles 29 and 30). 22.3.4 Final payment — Final grant amount — Revenues and Profit — Recovery The final payment (payment of the balance) reimburses the remaining part of the eligible costs and contributions claimed for the implementation of the action (if any). The final payment will be made in accordance with the schedule and modalities set out in the Data Sheet (see Point 4.2). Payment is subject to the approval of the final periodic report. Its approval does not imply recognition of compliance, authenticity, completeness or correctness of its content. The final grant amount for the action will be calculated in the following steps: Step 1 — Calculation of the total accepted EU contribution Step 2 — Limit to the maximum grant amount Step 3 — Reduction due to the no-profit rule Step 1 — Calculation of the total accepted EU contribution The granting authority will first calculate the ‘accepted EU contribution’ for the action for all reporting periods, by calculating the ‘maximum EU contribution to costs’ (applying the funding rate to the total accepted costs of each beneficiary), taking into account requests for a lower contribution to costs, CFS threshold cappings (if any; see Article 24.5) and adding the contributions (accepted unit, flat-rate or lump sum contributions and financing not linked to costs, if any). After that, the granting authority will take into account grant reductions (if any). The resulting amount is the ‘total accepted EU contribution’. Step 2 — Limit to the maximum grant amount If the resulting amount is higher than the maximum grant amount set out in Article 5.2, it will be limited to the latter. 46 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Step 3 — Reduction due to the no-profit rule If the no-profit rule is provided for in the Data Sheet (see Point 4.2), the grant must not produce a profit (i.e. surplus of the amount obtained following Step 2 plus the action’s revenues, over the eligible costs and contributions approved by the granting authority). ‘Revenue’ is all income generated by the action, during its duration (see Article 4), for beneficiaries that are profit legal entities. If there is a profit, it will be deducted in proportion to the final rate of reimbursement of the eligible costs approved by the granting authority (as compared to the amount calculated following Steps 1 and 2 minus the contributions). The balance (final payment) is then calculated by deducting the total amount of prefinancing and interim payments already made (if any), from the final grant amount: {final grant amount minus {prefinancing and interim payments made (if any)}}. If the balance is positive, it will be paid to the coordinator. The final payment (or part of it) may be offset (without the beneficiaries’ consent) against amounts owed by a beneficiary to the granting authority — up to the amount due to that beneficiary. For grants where the granting authority is the European Commission or an EU executive agency, offsetting may also be done against amounts owed to other Commission services or executive agencies. Payments will not be made if the payment deadline or payments are suspended (see Articles 29 and 30). If the balance is negative, it will be recovered in accordance with the following procedure: The granting authority will send a pre-information letter to the coordinator: - formally notifying the intention to recover, the final grant amount, the amount to be recovered and the reasons why - requesting observations within 30 days of receiving notification. If no observations are submitted (or the granting authority decides to pursue recovery despite the observations it has received), it will confirm the amount to be recovered (confirmation letter), together with a debit note with the terms and date for payment. If payment is not made by the date specified in the debit note, the granting authority will enforce recovery in accordance with Article 22.4. 22.3.5 Audit implementation after final payment — Revised final grant amount — Recovery If — after the final payment (in particular, after checks, reviews, audits or investigations; see 47 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Article 25) — the granting authority rejects costs or contributions (see Article 27) or reduces the grant (see Article 28), it will calculate the revised final grant amount for the beneficiary concerned. The beneficiary revised final grant amount will be calculated in the following step: Step 1 — Calculation of the revised total accepted EU contribution Step 1 — Calculation of the revised total accepted EU contribution The granting authority will first calculate the ‘revised accepted EU contribution’ for the beneficiary, by calculating the ‘revised accepted costs’ and ‘revised accepted contributions’. After that, it will take into account grant reductions (if any). The resulting ‘revised total accepted EU contribution’ is the beneficiary revised final grant amount. If the revised final grant amount is lower than the beneficiary’s final grant amount (i.e. its share in the final grant amount for the action), it will be recovered in accordance with the following procedure: The beneficiary final grant amount (i.e. share in the final grant amount for the action) is calculated as follows: {{total accepted EU contribution for the beneficiary divided by total accepted EU contribution for the action} multiplied by final grant amount for the action}. The granting authority will send a pre-information letter to the beneficiary concerned: - formally notifying the intention to recover, the amount to be recovered and the reasons why and - requesting observations within 30 days of receiving notification. If no observations are submitted (or the granting authority decides to pursue recovery despite the observations it has received), it will confirm the amount to be recovered (confirmation letter), together with a debit note with the terms and the date for payment. Recoveries against affiliated entities (if any) will be handled through their beneficiaries. If payment is not made by the date specified in the debit note, the granting authority will enforce recovery in accordance with Article 22.4. 22.4 Enforced recovery If payment is not made by the date specified in the debit note, the amount due will be recovered: (a) by offsetting the amount — without the coordinator or beneficiary’s consent — against any amounts owed to the coordinator or beneficiary by the granting authority. In exceptional circumstances, to safeguard the EU financial interests, the amount may be offset before the payment date specified in the debit note. 48 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 For grants where the granting authority is the European Commission or an EU executive agency, debts may also be offset against amounts owed by other Commission services or executive agencies. (b) by drawing on the financial guarantee(s) (if any) (c) by holding other beneficiaries jointly and severally liable (if any; see Data Sheet, Point 4.4) (d) by holding affiliated entities jointly and severally liable (if any, see Data Sheet, Point 4.4) (e) by taking legal action (see Article 43) or, provided that the granting authority is the European Commission or an EU executive agency, by adopting an enforceable decision under Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 100(2) of EU Financial Regulation 2018/1046. The amount to be recovered will be increased by late-payment interest at the rate set out in Article 22.5, from the day following the payment date in the debit note, up to and including the date the full payment is received. Partial payments will be first credited against expenses, charges and late-payment interest and then against the principal. Bank charges incurred in the recovery process will be borne by the beneficiary, unless Directive 2015/236620 applies. For grants where the granting authority is an EU executive agency, enforced recovery by offsetting or enforceable decision will be done by the services of the European Commission (see also Article 43). 22.5 Consequences of non-compliance 22.5.1 If the granting authority does not pay within the payment deadlines (see above), the beneficiaries are entitled to late-payment interest at the rate applied by the European Central Bank (ECB) for its main refinancing operations in euros (‘reference rate’), plus the rate specified in the Data Sheet (Point 4.2). The reference rate is the rate in force on the first day of the month in which the payment deadline expires, as published in the C series of the Official Journal of the European Union. If the late-payment interest is lower than or equal to EUR 200, it will be paid to the coordinator only on request submitted within two months of receiving the late payment. Late-payment interest is not due if all beneficiaries are EU Member States (including regional and local government authorities or other public bodies acting on behalf of a Member State for the purpose of this Agreement). If payments or the payment deadline are suspended (see Articles 29 and 30), payment will not be considered as late. 20 Directive (EU) 2015/2366 of the European Parliament and of the Council of 25 November 2015 on payment services in the internal market, amending Directives 2002/65/EC, 2009/110/EC and 2013/36/EU and Regulation (EU) No 1093/2010, and repealing Directive 2007/64/EC (OJ L 337, 23.12.2015, p. 35). 49 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Late-payment interest covers the period running from the day following the due date for payment (see above), up to and including the date of payment. Late-payment interest is not considered for the purposes of calculating the final grant amount. 22.5.2 If the coordinator breaches any of its obligations under this Article, the grant may be reduced (see Article 29) and the grant or the coordinator may be terminated (see Article 32). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 23 — GUARANTEES 23.1 Prefinancing guarantee If required by the granting authority (see Data Sheet, Point 4.2), the beneficiaries must provide (one or more) prefinancing guarantee(s) in accordance with the timing and the amounts set out in the Data Sheet. The coordinator must submit them to the granting authority in due time before the prefinancing they are linked to. The guarantees must be drawn up using the template published on the Portal and fulfil the following conditions: (a) be provided by a bank or approved financial institution established in the EU or — if requested by the coordinator and accepted by the granting authority — by a third party or a bank or financial institution established outside the EU offering equivalent security (b) the guarantor stands as first-call guarantor and does not require the granting authority to first have recourse against the principal debtor (i.e. the beneficiary concerned) and (c) remain explicitly in force until the final payment and, if the final payment takes the form of a recovery, until five months after the debit note is notified to a beneficiary. They will be released within the following month. 23.2 Consequences of non-compliance If the beneficiaries breach their obligation to provide the prefinancing guarantee, the prefinancing will not be paid. Such breaches may also lead to other measures described in Chapter 5. ARTICLE 24 — CERTIFICATES 24.1 Operational verification report (OVR) Not applicable 24.2 Certificate on the financial statements (CFS) If required by the granting authority (see Data Sheet, Point 4.3), the beneficiaries must provide 50 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 certificates on their financial statements (CFS), in accordance with the schedule, threshold and conditions set out in the Data Sheet. The coordinator must submit them as part of the periodic report (see Article 21). The certificates must be drawn up using the template published on the Portal, cover the costs declared on the basis of actual costs and costs according to usual cost accounting practices (if any), and fulfil the following conditions: (a) be provided by a qualified approved external auditor which is independent and complies with Directive 2006/43/EC21 (or for public bodies: by a competent independent public officer) (b) the verification must be carried out according to the highest professional standards to ensure that the financial statements comply with the provisions under the Agreement and that the costs declared are eligible. The certificates will not affect the granting authority's right to carry out its own checks, reviews or audits, nor preclude the European Court of Auditors (ECA), the European Public Prosecutor’s Office (EPPO) or the European Anti-Fraud Office (OLAF) from using their prerogatives for audits and investigations under the Agreement (see Article 25). If the costs (or a part of them) were already audited by the granting authority, these costs do not need to be covered by the certificate and will not be counted for calculating the threshold (if any). 24.3 Certificate on the compliance of usual cost accounting practices (CoMUC) Not applicable 24.4 Systems and process audit (SPA) Not applicable 24.5 Consequences of non-compliance If a beneficiary does not submit a certificate on the financial statements (CFS) or the certificate is rejected, the accepted EU contribution to costs will be capped to reflect the CFS threshold. If a beneficiary breaches any of its other obligations under this Article, the granting authority may apply the measures described in Chapter 5. ARTICLE 25 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION OF FINDINGS 25.1 Granting authority checks, reviews and audits 25.1.1 Internal checks The granting authority may — during the action or afterwards — check the proper implementation of 21 Directive 2006/43/EC of the European Parliament and of the Council of 17 May 2006 on statutory audits of annual accounts and consolidated accounts or similar national regulations (OJ L 157, 9.6.2006, p. 87). 51 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 the action and compliance with the obligations under the Agreement, including assessing costs and contributions, deliverables and reports. 25.1.2 Project reviews The granting authority may carry out reviews on the proper implementation of the action and compliance with the obligations under the Agreement (general project reviews or specific issues reviews). Such project reviews may be started during the implementation of the action and until the time-limit set out in the Data Sheet (see Point 6). They will be formally notified to the coordinator or beneficiary concerned and will be considered to start on the date of the notification. If needed, the granting authority may be assisted by independent, outside experts. If it uses outside experts, the coordinator or beneficiary concerned will be informed and have the right to object on grounds of commercial confidentiality or conflict of interest. The coordinator or beneficiary concerned must cooperate diligently and provide — within the deadline requested — any information and data in addition to deliverables and reports already submitted (including information on the use of resources). The granting authority may request beneficiaries to provide such information to it directly. Sensitive information and documents will be treated in accordance with Article 13. The coordinator or beneficiary concerned may be requested to participate in meetings, including with the outside experts. For on-the-spot visits, the beneficiary concerned must allow access to sites and premises (including to the outside experts) and must ensure that information requested is readily available. Information provided must be accurate, precise and complete and in the format requested, including electronic format. On the basis of the review findings, a project review report will be drawn up. The granting authority will formally notify the project review report to the coordinator or beneficiary concerned, which has 30 days from receiving notification to make observations. Project reviews (including project review reports) will be in the language of the Agreement. 25.1.3 Audits The granting authority may carry out audits on the proper implementation of the action and compliance with the obligations under the Agreement. Such audits may be started during the implementation of the action and until the time-limit set out in the Data Sheet (see Point 6). They will be formally notified to the beneficiary concerned and will be considered to start on the date of the notification. The granting authority may use its own audit service, delegate audits to a centralised service or use external audit firms. If it uses an external firm, the beneficiary concerned will be informed and have the right to object on grounds of commercial confidentiality or conflict of interest. The beneficiary concerned must cooperate diligently and provide — within the deadline requested — 52 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 any information (including complete accounts, individual salary statements or other personal data) to verify compliance with the Agreement. Sensitive information and documents will be treated in accordance with Article 13. For on-the-spot visits, the beneficiary concerned must allow access to sites and premises (including for the external audit firm) and must ensure that information requested is readily available. Information provided must be accurate, precise and complete and in the format requested, including electronic format. On the basis of the audit findings, a draft audit report will be drawn up. The auditors will formally notify the draft audit report to the beneficiary concerned, which has 30 days from receiving notification to make observations (contradictory audit procedure). The final audit report will take into account observations by the beneficiary concerned and will be formally notified to them. Audits (including audit reports) will be in the language of the Agreement. 25.2 European Commission checks, reviews and audits in grants of other granting authorities Where the granting authority is not the European Commission, the latter has the same rights of checks, reviews and audits as the granting authority. 25.3 Access to records for assessing simplified forms of funding The beneficiaries must give the European Commission access to their statutory records for the periodic assessment of simplified forms of funding which are used in EU programmes. 25.4 OLAF, EPPO and ECA audits and investigations The following bodies may also carry out checks, reviews, audits and investigations — during the action or afterwards: - the European Anti-Fraud Office (OLAF) under Regulations No 883/201322 and No 2185/9623 - the European Public Prosecutor’s Office (EPPO) under Regulation 2017/1939 - the European Court of Auditors (ECA) under Article 287 of the Treaty on the Functioning of the EU (TFEU) and Article 257 of EU Financial Regulation 2018/1046. If requested by these bodies, the beneficiary concerned must provide full, accurate and complete information in the format requested (including complete accounts, individual salary statements or 22 Regulation (EU, Euratom) No 883/2013 of the European Parliament and of the Council of 11 September 2013 concerning investigations conducted by the European Anti-Fraud Office (OLAF) and repealing Regulation (EC) No 1073/1999 of the European Parliament and of the Council and Council Regulation (Euratom) No 1074/1999 (OJ L 248, 18/09/2013, p. 1). 23 Council Regulation (Euratom, EC) No 2185/1996 of 11 November 1996 concerning on-the-spot checks and inspections carried out by the Commission in order to protect the European Communities' financial interests against fraud and other irregularities (OJ L 292, 15/11/1996, p. 2). 53 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 other personal data, including in electronic format) and allow access to sites and premises for on-the-spot visits or inspections — as provided for under these Regulations. To this end, the beneficiary concerned must keep all relevant information relating to the action, at least until the time-limit set out in the Data Sheet (Point 6) and, in any case, until any ongoing checks, reviews, audits, investigations, litigation or other pursuits of claims have been concluded. 25.5 Consequences of checks, reviews, audits and investigations — Extension of results of reviews, audits or investigations 25.5.1 Consequences of checks, reviews, audits and investigations in this grant Findings in checks, reviews, audits or investigations carried out in the context of this grant may lead to rejections (see Article 27), grant reduction (see Article 28) or other measures described in Chapter 5. Rejections or grant reductions after the final payment will lead to a revised final grant amount (see Article 22). Findings in checks, reviews, audits or investigations during the action implementation may lead to a request for amendment (see Article 39), to change the description of the action set out in Annex 1. Checks, reviews, audits or investigations that find systemic or recurrent errors, irregularities, fraud or breach of obligations in any EU grant may also lead to consequences in other EU grants awarded under similar conditions (‘extension to other grants’). Moreover, findings arising from an OLAF or EPPO investigation may lead to criminal prosecution under national law. 25.5.2 Extension from other grants Results of checks, reviews, audits or investigations in other grants may be extended to this grant, if: (a) the beneficiary concerned is found, in other EU grants awarded under similar conditions, to have committed systemic or recurrent errors, irregularities, fraud or breach of obligations that have a material impact on this grant and (b) those findings are formally notified to the beneficiary concerned — together with the list of grants affected by the findings — within the time-limit for audits set out in the Data Sheet (see Point 6). The granting authority will formally notify the beneficiary concerned of the intention to extend the findings and the list of grants affected. If the extension concerns rejections of costs or contributions: the notification will include: (a) an invitation to submit observations on the list of grants affected by the findings (b) the request to submit revised financial statements for all grants affected (c) the correction rate for extrapolation, established on the basis of the systemic or recurrent errors, to calculate the amounts to be rejected, if the beneficiary concerned: 54 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (i) considers that the submission of revised financial statements is not possible or practicable or (ii) does not submit revised financial statements. If the extension concerns grant reductions: the notification will include: (a) an invitation to submit observations on the list of grants affected by the findings and (b) the correction rate for extrapolation, established on the basis of the systemic or recurrent errors and the principle of proportionality. The beneficiary concerned has 60 days from receiving notification to submit observations, revised financial statements or to propose a duly substantiated alternative correction method/rate. On the basis of this, the granting authority will analyse the impact and decide on the implementation (i.e. start rejection or grant reduction procedures, either on the basis of the revised financial statements or the announced/alternative method/rate or a mix of those; see Articles 27 and 28). 25.6 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, costs or contributions insufficiently substantiated will be ineligible (see Article 6) and will be rejected (see Article 27), and the grant may be reduced (see Article 28). Such breaches may also lead to other measures described in Chapter 5. ARTICLE 26 — IMPACT EVALUATIONS 26.1 Impact evaluation The granting authority may carry out impact evaluations of the action, measured against the objectives and indicators of the EU programme funding the grant. Such evaluations may be started during implementation of the action and until the time-limit set out in the Data Sheet (see Point 6). They will be formally notified to the coordinator or beneficiaries and will be considered to start on the date of the notification. If needed, the granting authority may be assisted by independent outside experts. The coordinator or beneficiaries must provide any information relevant to evaluate the impact of the action, including information in electronic format. 26.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the granting authority may apply the measures described in Chapter 5. CHAPTER 5 CONSEQUENCES OF NON-COMPLIANCE 55 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 SECTION 1 REJECTIONS AND GRANT REDUCTION ARTICLE 27 — REJECTION OF COSTS AND CONTRIBUTIONS 27.1 Conditions The granting authority will — at beneficiary termination, interim payment, final payment or afterwards — reject any costs or contributions which are ineligible (see Article 6), in particular following checks, reviews, audits or investigations (see Article 25). The rejection may also be based on the extension of findings from other grants to this grant (see Article 25). Ineligible costs or contributions will be rejected. 27.2 Procedure If the rejection does not lead to a recovery, the granting authority will formally notify the coordinator or beneficiary concerned of the rejection, the amounts and the reasons why. The coordinator or beneficiary concerned may — within 30 days of receiving notification — submit observations if it disagrees with the rejection (payment review procedure). If the rejection leads to a recovery, the granting authority will follow the contradictory procedure with pre-information letter set out in Article 22. 27.3 Effects If the granting authority rejects costs or contributions, it will deduct them from the costs or contributions declared and then calculate the amount due (and, if needed, make a recovery; see Article 22). ARTICLE 28 — GRANT REDUCTION 28.1 Conditions The granting authority may — at beneficiary termination, final payment or afterwards — reduce the grant for a beneficiary, if: (a) the beneficiary (or a person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed: (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under this Agreement or during its award (including improper implementation of the action, non-compliance with the call conditions, submission of false information, failure to provide required information, breach of ethics or security rules (if applicable), etc.), or (b) the beneficiary (or a person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed — in other EU grants 56 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant (see Article 25). The amount of the reduction will be calculated for each beneficiary concerned and proportionate to the seriousness and the duration of the errors, irregularities or fraud or breach of obligations, by applying an individual reduction rate to their accepted EU contribution. 28.2 Procedure If the grant reduction does not lead to a recovery, the granting authority will formally notify the coordinator or beneficiary concerned of the reduction, the amount to be reduced and the reasons why. The coordinator or beneficiary concerned may — within 30 days of receiving notification — submit observations if it disagrees with the reduction (payment review procedure). If the grant reduction leads to a recovery, the granting authority will follow the contradictory procedure with pre-information letter set out in Article 22. 28.3 Effects If the granting authority reduces the grant, it will deduct the reduction and then calculate the amount due (and, if needed, make a recovery; see Article 22). SECTION 2 SUSPENSION AND TERMINATION ARTICLE 29 — PAYMENT DEADLINE SUSPENSION 29.1 Conditions The granting authority may — at any moment — suspend the payment deadline if a payment cannot be processed because: (a) the required report (see Article 21) has not been submitted or is not complete or additional information is needed (b) there are doubts about the amount to be paid (e.g. ongoing audit extension procedure, queries about eligibility, need for a grant reduction, etc.) and additional checks, reviews, audits or investigations are necessary, or (c) there are other issues affecting the EU financial interests. 29.2 Procedure The granting authority will formally notify the coordinator of the suspension and the reasons why. The suspension will take effect the day the notification is sent. If the conditions for suspending the payment deadline are no longer met, the suspension will be lifted — and the remaining time to pay (see Data Sheet, Point 4.2) will resume. If the suspension exceeds two months, the coordinator may request the granting authority to confirm if the suspension will continue. 57 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 If the payment deadline has been suspended due to the non-compliance of the report and the revised report is not submitted (or was submitted but is also rejected), the granting authority may also terminate the grant or the participation of the coordinator (see Article 32). ARTICLE 30 — PAYMENT SUSPENSION 30.1 Conditions The granting authority may — at any moment — suspend payments, in whole or in part for one or more beneficiaries, if: (a) a beneficiary (or a person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed or is suspected of having committed: (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under this Agreement or during its award (including improper implementation of the action, non-compliance with the call conditions, submission of false information, failure to provide required information, breach of ethics or security rules (if applicable), etc.), or (b) a beneficiary (or a person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed — in other EU grants awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant. If payments are suspended for one or more beneficiaries, the granting authority will make partial payment(s) for the part(s) not suspended. If suspension concerns the final payment, the payment (or recovery) of the remaining amount after suspension is lifted will be considered to be the payment that closes the action. 30.2 Procedure Before suspending payments, the granting authority will send a pre-information letter to the beneficiary concerned: - formally notifying the intention to suspend payments and the reasons why and - requesting observations within 30 days of receiving notification. If the granting authority does not receive observations or decides to pursue the procedure despite the observations it has received, it will confirm the suspension (confirmation letter). Otherwise, it will formally notify that the procedure is discontinued. At the end of the suspension procedure, the granting authority will also inform the coordinator. The suspension will take effect the day after the confirmation notification is sent. If the conditions for resuming payments are met, the suspension will be lifted. The granting authority will formally notify the beneficiary concerned (and the coordinator) and set the suspension end date. 58 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 During the suspension, no prefinancing will be paid to the beneficiaries concerned. For interim payments, the periodic reports for all reporting periods except the last one (see Article 21) must not contain any financial statements from the beneficiary concerned (or its affiliated entities). The coordinator must include them in the next periodic report after the suspension is lifted or — if suspension is not lifted before the end of the action — in the last periodic report. ARTICLE 31 — GRANT AGREEMENT SUSPENSION 31.1 Consortium-requested GA suspension 31.1.1 Conditions and procedure The beneficiaries may request the suspension of the grant or any part of it, if exceptional circumstances — in particular force majeure (see Article 35) — make implementation impossible or excessively difficult. The coordinator must submit a request for amendment (see Article 39), with: - the reasons why - the date the suspension takes effect; this date may be before the date of the submission of the amendment request and - the expected date of resumption. The suspension will take effect on the day specified in the amendment. Once circumstances allow for implementation to resume, the coordinator must immediately request another amendment of the Agreement to set the suspension end date, the resumption date (one day after suspension end date), extend the duration and make other changes necessary to adapt the action to the new situation (see Article 39) — unless the grant has been terminated (see Article 32). The suspension will be lifted with effect from the suspension end date set out in the amendment. This date may be before the date of the submission of the amendment request. During the suspension, no prefinancing will be paid. Costs incurred or contributions for activities implemented during grant suspension are not eligible (see Article 6.3). 31.2 EU-initiated GA suspension 31.2.1 Conditions The granting authority may suspend the grant or any part of it, if: (a) a beneficiary (or a person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed or is suspected of having committed: (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under this Agreement or during its award (including improper implementation of the action, non-compliance with the call conditions, 59 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 submission of false information, failure to provide required information, breach of ethics or security rules (if applicable), etc.), or (b) a beneficiary (or a person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed — in other EU grants awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant (c) other: (i) linked action issues: not applicable (ii) additional GA suspension grounds: not applicable. 31.2.2 Procedure Before suspending the grant, the granting authority will send a pre-information letter to the coordinator: - formally notifying the intention to suspend the grant and the reasons why and - requesting observations within 30 days of receiving notification. If the granting authority does not receive observations or decides to pursue the procedure despite the observations it has received, it will confirm the suspension (confirmation letter). Otherwise, it will formally notify that the procedure is discontinued. The suspension will take effect the day after the confirmation notification is sent (or on a later date specified in the notification). Once the conditions for resuming implementation of the action are met, the granting authority will formally notify the coordinator a lifting of suspension letter, in which it will set the suspension end date and invite the coordinator to request an amendment of the Agreement to set the resumption date (one day after suspension end date), extend the duration and make other changes necessary to adapt the action to the new situation (see Article 39) — unless the grant has been terminated (see Article 32). The suspension will be lifted with effect from the suspension end date set out in the lifting of suspension letter. This date may be before the date on which the letter is sent. During the suspension, no prefinancing will be paid. Costs incurred or contributions for activities implemented during suspension are not eligible (see Article 6.3). The beneficiaries may not claim damages due to suspension by the granting authority (see Article 33). Grant suspension does not affect the granting authority’s right to terminate the grant or a beneficiary (see Article 32) or reduce the grant (see Article 28). ARTICLE 32 — GRANT AGREEMENT OR BENEFICIARY TERMINATION 32.1 Consortium-requested GA termination 32.1.1 Conditions and procedure 60 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 The beneficiaries may request the termination of the grant. The coordinator must submit a request for amendment (see Article 39), with: - the reasons why - the date the consortium ends work on the action (‘end of work date’) and - the date the termination takes effect (‘termination date’); this date must be after the date of the submission of the amendment request. The termination will take effect on the termination date specified in the amendment. If no reasons are given or if the granting authority considers the reasons do not justify termination, it may consider the grant terminated improperly. 32.1.2 Effects The coordinator must — within 60 days from when termination takes effect — submit a periodic report (for the open reporting period until termination). The granting authority will calculate the final grant amount and final payment on the basis of the report submitted and taking into account the costs incurred and contributions for activities implemented before the end of work date (see Article 22). Costs relating to contracts due for execution only after the end of work are not eligible. If the granting authority does not receive the report within the deadline, only costs and contributions which are included in an approved periodic report will be taken into account (no costs/contributions if no periodic report was ever approved). Improper termination may lead to a grant reduction (see Article 28). After termination, the beneficiaries’ obligations (in particular Articles 13 (confidentiality and security), 16 (IPR), 17 (communication, dissemination and visibility), 21 (reporting), 25 (checks, reviews, audits and investigations), 26 (impact evaluation), 27 (rejections), 28 (grant reduction) and 42 (assignment of claims)) continue to apply. 32.2 Consortium-requested beneficiary termination 32.2.1 Conditions and procedure The coordinator may request the termination of the participation of one or more beneficiaries, on request of the beneficiary concerned or on behalf of the other beneficiaries. The coordinator must submit a request for amendment (see Article 39), with: - the reasons why - the opinion of the beneficiary concerned (or proof that this opinion has been requested in writing) - the date the beneficiary ends work on the action (‘end of work date’) 61 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 - the date the termination takes effect (‘termination date’); this date must be after the date of the submission of the amendment request. If the termination concerns the coordinator and is done without its agreement, the amendment request must be submitted by another beneficiary (acting on behalf of the consortium). The termination will take effect on the termination date specified in the amendment. If no information is given or if the granting authority considers that the reasons do not justify termination, it may consider the beneficiary to have been terminated improperly. 32.2.2 Effects The coordinator must — within 60 days from when termination takes effect — submit: (i) a report on the distribution of payments to the beneficiary concerned (ii) a termination report from the beneficiary concerned, for the open reporting period until termination, containing an overview of the progress of the work, the financial statement, the explanation on the use of resources, and, if applicable, the certificate on the financial statement (CFS; see Articles 21 and 24.2 and Data Sheet, Point 4.3) (iii) a second request for amendment (see Article 39) with other amendments needed (e.g. reallocation of the tasks and the estimated budget of the terminated beneficiary; addition of a new beneficiary to replace the terminated beneficiary; change of coordinator, etc.). The granting authority will calculate the amount due to the beneficiary on the basis of the report submitted and taking into account the costs incurred and contributions for activities implemented before the end of work date (see Article 22). Costs relating to contracts due for execution only after the end of work are not eligible. The information in the termination report must also be included in the periodic report for the next reporting period (see Article 21). If the granting authority does not receive the termination report within the deadline, only costs and contributions which are included in an approved periodic report will be taken into account (no costs/ contributions if no periodic report was ever approved). If the granting authority does not receive the report on the distribution of payments within the deadline, it will consider that: - the coordinator did not distribute any payment to the beneficiary concerned and that - the beneficiary concerned must not repay any amount to the coordinator. If the second request for amendment is accepted by the granting authority, the Agreement is amended to introduce the necessary changes (see Article 39). If the second request for amendment is rejected by the granting authority (because it calls into question the decision awarding the grant or breaches the principle of equal treatment of applicants), the grant may be terminated (see Article 32). 62 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Improper termination may lead to a reduction of the grant (see Article 31) or grant termination (see Article 32). After termination, the concerned beneficiary’s obligations (in particular Articles 13 (confidentiality and security), 16 (IPR), 17 (communication, dissemination and visibility), 21 (reporting), 25 (checks, reviews, audits and investigations), 26 (impact evaluation), 27 (rejections), 28 (grant reduction) and 42 (assignment of claims)) continue to apply. 32.3 EU-initiated GA or beneficiary termination 32.3.1 Conditions The granting authority may terminate the grant or the participation of one or more beneficiaries, if: (a) one or more beneficiaries do not accede to the Agreement (see Article 40) (b) a change to the action or the legal, financial, technical, organisational or ownership situation of a beneficiary is likely to substantially affect the implementation of the action or calls into question the decision to award the grant (including changes linked to one of the exclusion grounds listed in the declaration of honour) (c) following termination of one or more beneficiaries, the necessary changes to the Agreement (and their impact on the action) would call into question the decision awarding the grant or breach the principle of equal treatment of applicants (d) implementation of the action has become impossible or the changes necessary for its continuation would call into question the decision awarding the grant or breach the principle of equal treatment of applicants (e) a beneficiary (or person with unlimited liability for its debts) is subject to bankruptcy proceedings or similar (including insolvency, winding-up, administration by a liquidator or court, arrangement with creditors, suspension of business activities, etc.) (f) a beneficiary (or person with unlimited liability for its debts) is in breach of social security or tax obligations (g) a beneficiary (or person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has been found guilty of grave professional misconduct (h) a beneficiary (or person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed fraud, corruption, or is involved in a criminal organisation, money laundering, terrorism-related crimes (including terrorism financing), child labour or human trafficking (i) a beneficiary (or person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) was created under a different jurisdiction with the intent to circumvent fiscal, social or other legal obligations in the country of origin (or created another entity with this purpose) (j) a beneficiary (or person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed: 63 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under this Agreement or during its award (including improper implementation of the action, non-compliance with the call conditions, submission of false information, failure to provide required information, breach of ethics or security rules (if applicable), etc.) (k) a beneficiary (or person having powers of representation, decision-making or control, or person essential for the award/implementation of the grant) has committed — in other EU grants awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant (extension of findings from other grants to this grant; see Article 25) (l) despite a specific request by the granting authority, a beneficiary does not request — through the coordinator — an amendment to the Agreement to end the participation of one of its affiliated entities or associated partners that is in one of the situations under points (d), (f), (e), (g), (h), (i) or (j) and to reallocate its tasks, or (m) other: (i) linked action issues: not applicable (ii) additional GA termination grounds: not applicable. 32.3.2 Procedure Before terminating the grant or participation of one or more beneficiaries, the granting authority will send a pre-information letter to the coordinator or beneficiary concerned: - formally notifying the intention to terminate and the reasons why and - requesting observations within 30 days of receiving notification. If the granting authority does not receive observations or decides to pursue the procedure despite the observations it has received, it will confirm the termination and the date it will take effect (confirmation letter). Otherwise, it will formally notify that the procedure is discontinued. For beneficiary terminations, the granting authority will — at the end of the procedure — also inform the coordinator. The termination will take effect the day after the confirmation notification is sent (or on a later date specified in the notification; ‘termination date’). 32.3.3 Effects (a) for GA termination: The coordinator must — within 60 days from when termination takes effect — submit a periodic report (for the last open reporting period until termination). The granting authority will calculate the final grant amount and final payment on the basis of the report submitted and taking into account the costs incurred and contributions for activities 64 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 implemented before termination takes effect (see Article 22). Costs relating to contracts due for execution only after termination are not eligible. If the grant is terminated for breach of the obligation to submit reports, the coordinator may not submit any report after termination. If the granting authority does not receive the report within the deadline, only costs and contributions which are included in an approved periodic report will be taken into account (no costs/contributions if no periodic report was ever approved). Termination does not affect the granting authority’s right to reduce the grant (see Article 28) or to impose administrative sanctions (see Article 34). The beneficiaries may not claim damages due to termination by the granting authority (see Article 33). After termination, the beneficiaries’ obligations (in particular Articles 13 (confidentiality and security), 16 (IPR), 17 (communication, dissemination and visibility), 21 (reporting), 25 (checks, reviews, audits and investigations), 26 (impact evaluation), 27 (rejections), 28 (grant reduction) and 42 (assignment of claims)) continue to apply. (b) for beneficiary termination: The coordinator must — within 60 days from when termination takes effect — submit: (i) a report on the distribution of payments to the beneficiary concerned (ii) a termination report from the beneficiary concerned, for the open reporting period until termination, containing an overview of the progress of the work, the financial statement, the explanation on the use of resources, and, if applicable, the certificate on the financial statement (CFS; see Articles 21 and 24.2 and Data Sheet, Point 4.3) (iii) a request for amendment (see Article 39) with any amendments needed (e.g. reallocation of the tasks and the estimated budget of the terminated beneficiary; addition of a new beneficiary to replace the terminated beneficiary; change of coordinator, etc.). The granting authority will calculate the amount due to the beneficiary on the basis of the report submitted and taking into account the costs incurred and contributions for activities implemented before termination takes effect (see Article 22). Costs relating to contracts due for execution only after termination are not eligible. The information in the termination report must also be included in the periodic report for the next reporting period (see Article 21). If the granting authority does not receive the termination report within the deadline, only costs and contributions included in an approved periodic report will be taken into account (no costs/ contributions if no periodic report was ever approved). If the granting authority does not receive the report on the distribution of payments within the deadline, it will consider that: 65 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 - the coordinator did not distribute any payment to the beneficiary concerned and that - the beneficiary concerned must not repay any amount to the coordinator. If the request for amendment is accepted by the granting authority, the Agreement is amended to introduce the necessary changes (see Article 39). If the request for amendment is rejected by the granting authority (because it calls into question the decision awarding the grant or breaches the principle of equal treatment of applicants), the grant may be terminated (see Article 32). After termination, the concerned beneficiary’s obligations (in particular Articles 13 (confidentiality and security), 16 (IPR), 17 (communication, dissemination and visibility), 21 (reporting), 25 (checks, reviews, audits and investigations), 26 (impact evaluation), 27 (rejections), 28 (grant reduction) and 42 (assignment of claims)) continue to apply. SECTION 3 OTHER CONSEQUENCES: DAMAGES AND ADMINISTRATIVE SANCTIONS ARTICLE 33 — DAMAGES 33.1 Liability of the granting authority The granting authority cannot be held liable for any damage caused to the beneficiaries or to third parties as a consequence of the implementation of the Agreement, including for gross negligence. The granting authority cannot be held liable for any damage caused by any of the beneficiaries or other participants involved in the action, as a consequence of the implementation of the Agreement. 33.2 Liability of the beneficiaries The beneficiaries must compensate the granting authority for any damage it sustains as a result of the implementation of the action or because the action was not implemented in full compliance with the Agreement, provided that it was caused by gross negligence or wilful act. The liability does not extend to indirect or consequential losses or similar damage (such as loss of profit, loss of revenue or loss of contracts), provided such damage was not caused by wilful act or by a breach of confidentiality. ARTICLE 34 — ADMINISTRATIVE SANCTIONS AND OTHER MEASURES Nothing in this Agreement may be construed as preventing the adoption of administrative sanctions (i.e. exclusion from EU award procedures and/or financial penalties) or other public law measures, in addition or as an alternative to the contractual measures provided under this Agreement (see, for instance, Articles 135 to 145 EU Financial Regulation 2018/1046 and Articles 4 and 7 of Regulation 2988/9524). 24 Council Regulation (EC, Euratom) No 2988/95 of 18 December 1995 on the protection of the European Communities financial interests (OJ L 312, 23.12.1995, p. 1). 66 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 SECTION 4 FORCE MAJEURE ARTICLE 35 — FORCE MAJEURE A party prevented by force majeure from fulfilling its obligations under the Agreement cannot be considered in breach of them. ‘Force majeure’ means any situation or event that: - prevents either party from fulfilling their obligations under the Agreement, - was unforeseeable, exceptional situation and beyond the parties’ control, - was not due to error or negligence on their part (or on the part of other participants involved in the action), and - proves to be inevitable in spite of exercising all due diligence. Any situation constituting force majeure must be formally notified to the other party without delay, stating the nature, likely duration and foreseeable effects. The parties must immediately take all the necessary steps to limit any damage due to force majeure and do their best to resume implementation of the action as soon as possible. CHAPTER 6 FINAL PROVISIONS ARTICLE 36 — COMMUNICATION BETWEEN THE PARTIES 36.1 Forms and means of communication — Electronic management EU grants are managed fully electronically through the EU Funding & Tenders Portal (‘Portal’). All communications must be made electronically through the Portal, in accordance with the Portal Terms and Conditions and using the forms and templates provided there (except if explicitly instructed otherwise by the granting authority). Communications must be made in writing and clearly identify the grant agreement (project number and acronym). Communications must be made by persons authorised according to the Portal Terms and Conditions. For naming the authorised persons, each beneficiary must have designated — before the signature of this Agreement — a ‘legal entity appointed representative (LEAR)’. The role and tasks of the LEAR are stipulated in their appointment letter (see Portal Terms and Conditions). If the electronic exchange system is temporarily unavailable, instructions will be given on the Portal. 36.2 Date of communication The sending date for communications made through the Portal will be the date and time of sending, as indicated by the time logs. 67 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 The receiving date for communications made through the Portal will be the date and time the communication is accessed, as indicated by the time logs. Formal notifications that have not been accessed within 10 days after sending, will be considered to have been accessed (see Portal Terms and Conditions). If a communication is exceptionally made on paper (by e-mail or postal service), general principles apply (i.e. date of sending/receipt). Formal notifications by registered post with proof of delivery will be considered to have been received either on the delivery date registered by the postal service or the deadline for collection at the post office. If the electronic exchange system is temporarily unavailable, the sending party cannot be considered in breach of its obligation to send a communication within a specified deadline. 36.3 Addresses for communication The Portal can be accessed via the Europa website. The address for paper communications to the granting authority (if exceptionally allowed) is the official mailing address indicated on its website. For beneficiaries, it is the legal address specified in the Portal Participant Register. ARTICLE 37 — INTERPRETATION OF THE AGREEMENT The provisions in the Data Sheet take precedence over the rest of the Terms and Conditions of the Agreement. Annex 5 takes precedence over the Terms and Conditions; the Terms and Conditions take precedence over the Annexes other than Annex 5. Annex 2 takes precedence over Annex 1. ARTICLE 38 — CALCULATION OF PERIODS AND DEADLINES In accordance with Regulation No 1182/7125, periods expressed in days, months or years are calculated from the moment the triggering event occurs. The day during which that event occurs is not considered as falling within the period. ‘Days’ means calendar days, not working days. ARTICLE 39 — AMENDMENTS 39.1 Conditions The Agreement may be amended, unless the amendment entails changes to the Agreement which would call into question the decision awarding the grant or breach the principle of equal treatment of applicants. 25 Regulation (EEC, Euratom) No 1182/71 of the Council of 3 June 1971 determining the rules applicable to periods, dates and time-limits (OJ L 124, 8/6/1971, p. 1). 68 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 Amendments may be requested by any of the parties. 39.2 Procedure The party requesting an amendment must submit a request for amendment signed directly in the Portal Amendment tool. The coordinator submits and receives requests for amendment on behalf of the beneficiaries (see Annex 3). If a change of coordinator is requested without its agreement, the submission must be done by another beneficiary (acting on behalf of the other beneficiaries). The request for amendment must include: - the reasons why - the appropriate supporting documents and - for a change of coordinator without its agreement: the opinion of the coordinator (or proof that this opinion has been requested in writing). The granting authority may request additional information. If the party receiving the request agrees, it must sign the amendment in the tool within 45 days of receiving notification (or any additional information the granting authority has requested). If it does not agree, it must formally notify its disagreement within the same deadline. The deadline may be extended, if necessary for the assessment of the request. If no notification is received within the deadline, the request is considered to have been rejected. An amendment enters into force on the day of the signature of the receiving party. An amendment takes effect on the date of entry into force or other date specified in the amendment. ARTICLE 40 — ACCESSION AND ADDITION OF NEW BENEFICIARIES 40.1 Accession of the beneficiaries mentioned in the Preamble The beneficiaries which are not coordinator must accede to the grant by signing the accession form (see Annex 3) directly in the Portal Grant Preparation tool, within 30 days after the entry into force of the Agreement (see Article 44). They will assume the rights and obligations under the Agreement with effect from the date of its entry into force (see Article 44). If a beneficiary does not accede to the grant within the above deadline, the coordinator must — within 30 days — request an amendment (see Article 39) to terminate the beneficiary and make any changes necessary to ensure proper implementation of the action. This does not affect the granting authority’s right to terminate the grant (see Article 32). 40.2 Addition of new beneficiaries In justified cases, the beneficiaries may request the addition of a new beneficiary. 69 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 For this purpose, the coordinator must submit a request for amendment in accordance with Article 39. It must include an accession form (see Annex 3) signed by the new beneficiary directly in the Portal Amendment tool. New beneficiaries will assume the rights and obligations under the Agreement with effect from the date of their accession specified in the accession form (see Annex 3). Additions are also possible in mono-beneficiary grants. ARTICLE 41 — TRANSFER OF THE AGREEMENT In justified cases, the beneficiary of a mono-beneficiary grant may request the transfer of the grant to a new beneficiary, provided that this would not call into question the decision awarding the grant or breach the principle of equal treatment of applicants. The beneficiary must submit a request for amendment (see Article 39), with - the reasons why - the accession form (see Annex 3) signed by the new beneficiary directly in the Portal Amendment tool and - additional supporting documents (if required by the granting authority). The new beneficiary will assume the rights and obligations under the Agreement with effect from the date of accession specified in the accession form (see Annex 3). ARTICLE 42 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE GRANTING AUTHORITY The beneficiaries may not assign any of their claims for payment against the granting authority to any third party, except if expressly approved in writing by the granting authority on the basis of a reasoned, written request by the coordinator (on behalf of the beneficiary concerned). If the granting authority has not accepted the assignment or if the terms of it are not observed, the assignment will have no effect on it. In no circumstances will an assignment release the beneficiaries from their obligations towards the granting authority. ARTICLE 43 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES 43.1 Applicable law The Agreement is governed by the applicable EU law, supplemented if necessary by the law of Belgium. Special rules may apply for beneficiaries which are international organisations (if any; see Data Sheet, Point 5). 43.2 Dispute settlement 70 Project: 101075284 — CraNE — EU4H-2021-JA-IBA EU4H Ref. Associated with document MGAAres(2022)6379367 — Multi & Mono:-v1.0 15/09/2022 If a dispute concerns the interpretation, application or validity of the Agreement, the parties must bring action before the EU General Court — or, on appeal, the EU Court of Justice — under Article 272 of the Treaty on the Functioning of the EU (TFEU). For non-EU beneficiaries (if any), such disputes must be brought before the courts of Brussels, Belgium — unless an international agreement provides for the enforceability of EU court judgements. For beneficiaries with arbitration as special dispute settlement forum (if any; see Data Sheet, Point 5), the dispute will — in the absence of an amicable settlement — be settled in accordance with the Rules for Arbitration published on the Portal. If a dispute concerns administrative sanctions, offsetting or an enforceable decision under Article 299 TFEU (see Articles 22 and 34), the beneficiaries must bring action before the General Court — or, on appeal, the Court of Justice — under Article 263 TFEU. For grants where the granting authority is an EU executive agency (see Preamble), actions against offsetting and enforceable decisions must be brought against the European Commission (not against the granting authority; see also Article 22). ARTICLE 44 — ENTRY INTO FORCE The Agreement will enter into force on the day of signature by the granting authority or the coordinator, depending on which is later. SIGNATURES For the coordinator For the granting authority [--TGSMark#signature-948891346_75_210--] [--TGSMark#signature-service_75_210--] Branko GABROVEC with ECAS id ngabbran signed in the Participant Signed by Florina TELEA with ECAS id teleafa as an authorised Portal on 16/09/2022 at 08:51:15 (transaction id SigId-3699-d6O57n representative on 16-09-2022 10:38:26 (transaction id SigId-4539- WeUL89zlnQu2wjhWrCPNqtlP2lSjXgZLKReQFAK1lp6jzW1U7umkg3b 7y78tgJjF4JX8VsCzi9YVuf1cbHbQYSKsq3Cv6G4qoD9JjiiWpTffdPmY v6DEk7STwKIYRuv0zzg0szer7zm-yntOf97TTHq0czkUCLqKUS-ja7pnZ X09m9JbY5DaEUI8ouPByR7OJ5TEye-yntOf97TTHq0czkUCLqKUS-Z IBkPcssJ3yUhkrmxpmGlJlFXjzfSzUYvWhr3uId9zfC4ckzcqVFGOQp97P DH812YAmzeNUtUTstaUjK54rmCWccTv41MXkclIASRmjzJvBk8BrG zosLnFZ1x1k94fvzPFR9NfUm). Timestamp by third party at DLuza5bCDzTK2G2oazdzvTcinnslpzl5gC) 2022.09.16 09:51:22 CEST 2022.09.16 10:38:39 CEST 71  Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ANNEX 1 EU4 Health Programme (EU4H) Description of the action (DoA) Part A Part B Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 DESCRIPTION OF THE ACTION (PART A) COVER PAGE Part A of the Description of the Action (DoA) must be completed directly on the Portal Grant Preparation screens. PROJECT Grant Preparation (General Information screen) — Enter the info. Project number: 101075284 Project name: Network of Comprehensive Cancer Centres: Preparatory activities on creation of National Comprehensive Cancer Centres and EU Networking Project acronym: CraNE Call: EU4H-2021-JA-IBA Topic: EU4H-2021-JA-03 Type of action: EU4H-PJG Service: HADEA/A/01 Project starting date: fixed date: 1 October 2022 Project duration: 24 months TABLE OF CONTENTS Project summary ......................................................................................................................................................3 List of participants .................................................................................................................................................. 3 List of work packages .............................................................................................................................................6 Staff effort ............................................................................................................................................................. 13 List of deliverables ................................................................................................................................................16 List of milestones (outputs/outcomes) .................................................................................................................. 25 List of critical risks ............................................................................................................................................... 27 2 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 PROJECT SUMMARY Project summary Grant Preparation (General Information screen) — Provide an overall description of your project (including context and overall objectives, planned activities and main achievements, and expected results and impacts (on target groups, change procedures, capacities, innovation etc)). This summary should give readers a clear idea of what your project is about. Use the project summary from your proposal. The CraNE Joint Action is proposed for funding in response to the flagship number 5 of the Europe’s Beating Cancer Plan, which defines that the European Commission will establish by 2025, an EU Network linking recognised National Comprehensive Cancer Centres (CCCs) in every Member State. In order to facilitate the establishment of such an EU Network, CraNE will prepare the necessary preconditions, administrative, professional, and those related to high-quality performance. This is necessary to facilitate both the integration of the existing CCCs as well as to support the Member States who still need to develop and certify such centres. The CraNE JA will also provide an assessment on sustainability and feasibility as well as link the development of an EU Network of CCCs and CCCs in individual Member States to the development of national and regional CCCNs. This way, the existing organisational and functional models of cancer care will be taken into account and incorporated into the proposed solution. LIST OF PARTICIPANTS PARTICIPANTS Grant Preparation (Beneficiaries screen) — Enter the info. Number Role Short name Legal name Country PIC 1 COO NIJZ NACIONALNI INSTITUT ZA JAVNO ZDRAVJE SI 948891346 1.1 AE OIL ONKOLOSKI INSTITUT LJUBLJANA SI 986222475 2 BEN Sciensano SCIENSANO BE 906160809 2.1 AE UZA UNIVERSITAIR ZIEKENHUIS ANTWERPEN BE 996727866 3 BEN USHATO UNIVERSITETSKA SPETSIALIZIRANA BG 952486263 BOLNITSA ZA AKTIVNO LECHENIE PO ONKOLOGIYA EAD 4 BEN CIPH HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO HR 998128255 5 BEN MOH Ministry of Health of the Republic of Cyprus CY 994267946 6 BEN UH MOTOL FAKULTNI NEMOCNICE V MOTOLE CZ 964458391 7 BEN MSAE SOTSIAALMINISTEERIUM EE 998429731 7.1 AE UT TARTU ULIKOOL EE 999895013 8 BEN INCa INSTITUT NATIONAL DU CANCER GIP FR 999953892 8.1 AE UNICANCER UNICANCER FR 952728375 8.2 AE FHF FEDERATION HOSPITALIERE DE FRANCE FR 999562109 8.3 AE INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA FR 999997833 RECHERCHE MEDICALE 9 BEN BMG BUNDESMINISTERIUM FUER GESUNDHEIT DE 998954889 9.1 AE DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM DE 999990073 HEIDELBERG 3 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 PARTICIPANTS Grant Preparation (Beneficiaries screen) — Enter the info. Number Role Short name Legal name Country PIC 9.2 AE DKG DEUTSCHE KREBSGESELLSCHAFT EV DE 922313831 9.3 AE DKH STIFTUNG DEUTSCHE KREBSHILFE DE 888636983 9.4 AE TUD TECHNISCHE UNIVERSITAET DRESDEN DE 999897729 10 BEN 1ST YPE 1ST YGEIONOMIKI PERIFEREIA DYPE EL 998963910 ATTIKIS 10.1 AE AGIOS SAVVAS GENIKO ANTIKARKINIKO OGKOLOGIKO EL 897642560 NOSOKOMEIO ATHINON O AGIOS SAVVAS 10.2 AE LGHA GENIKO LAIKO NOSOKOMEIO EL 954350409 ATHINON*GENERAL HOSPITAL OF ATHENS LAIKO 11 BEN OOI Orszagos Onkologiai Intezet HU 991549909 12 BEN DOH DEPARTMENT OF HEALTH IE 972459824 13 BEN ACC ALLEANZA CONTRO IL CANCRO IT 999563661 13.1 AE MoH MINISTERO DELLA SALUTE IT 999531942 13.2 AE IDI FONDAZIONE LUIGI MARIA MONTI IT 918519870 14 BEN REUH RIGAS AUSTRUMU KLINISKA LV 973366483 UNIVERSITATES SLIMNICA SIA 15 BEN SAM LT LIETUVOS RESPUBLIKOS SVEIKATOS LT 933839468 APSAUGOS MINISTERIJA 15.1 AE KK LIETUVOS SVEIKATOS MOKSLU LT 923616832 UNIVERSITETO LIGONINE KAUNO KLINIKOS 15.2 AE VULSK VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LT 991636530 LIGONINE SANTAROS KLINIKOS 15.3 AE NCI NACIONALINIS VEZIO INSTITUTAS LT 912763114 16 BEN INC INSTITUT NATIONAL DU CANCER LU 889777509 16.1 AE LIH LUXEMBOURG INSTITUTE OF HEALTH LU 998331858 17 BEN MFH Ministry for Health - Government of Malta MT 974144423 18 BEN OUS OSLO UNIVERSITETSSYKEHUS HF NO 991104000 19 BEN NIZP-PZH NARODOWY INSTYTUT ZDROWIA PL 998403735 PUBLICZNEGO PZH - PANSTWOWY INSTYTUT BADAWCZY 20 BEN MS MINISTERIO DA SAUDE - REPUBLICA PT 986364095 PORTUGUESA 21 BEN IOCN INSTITUTUL ONCOLOGIC PROF DR ION RO 989404075 CHIRICUTA CLUJ-NAPOCA 22 BEN NOU NARODNY ONKOLOGICKY USTAV SK 889061940 23 BEN ICO INSTITUT CATALA D'ONCOLOGIA ES 998420031 23.1 AE IDIVAL FUNDACION INSTITUTO DE INVESTIGACION ES 946556944 MARQUES DE VALDECILLA 4 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 PARTICIPANTS Grant Preparation (Beneficiaries screen) — Enter the info. Number Role Short name Legal name Country PIC 24 BEN NBHW SOCIALSTYRELSEN SE 998248147 25 BEN GÖG GESUNDHEIT OSTERREICH GMBH AT 928836208 5 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 LIST OF WORK PACKAGES Work packages Grant Preparation (Work Packages screen) — Enter the info. Work Work Package name Lead Beneficiary Effort Start End Deliverables Package No (Person- Month Month Months) WP1 Coordination 1 - NIJZ 93.86 1 24 D1.1 – Report from kick-off meeting D1.2 – Final Report WP2 Dissemination 10 - 1ST YPE 53.60 1 24 D2.1 – Dissemination Strategy D2.2 – Dissemination Report D2.3 – Layman’s version of final report (in simple language for general public) WP3 Evaluation 21 - IOCN 55.40 1 24 D3.1 – Evaluation Strategy D3.2 – Evaluation Report WP4 Sustainability 2 - Sciensano 86.50 1 24 D4.1 – Blueprint of the development and Integration of comprehensive cancer care scenarios into cancer care and control WP5 The EU Network of Comprehensive Cancer 13 - ACC 70.90 1 24 D5.1 – Process for membership of CCCs to Centres: composition, governance, joining process, the EU Network and functioning D5.2 – Integration with EU and national initiatives D5.3 – Governance Model and operating procedures WP6 Organization of comprehensive, high-quality 2 - DKG 99.04 1 24 D6.1 – Definition and description of cancer care in Comprehensive Cancer Care interfaces Networks (CCCNs) D6.2 – Training concept for set-up of a CCCN D6.3 – Set of Standards for Lung Cancer Care and Set of Quality Indicators for Lung Cancer 6 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Work packages Grant Preparation (Work Packages screen) — Enter the info. Work Work Package name Lead Beneficiary Effort Start End Deliverables Package No (Person- Month Month Months) D6.4 – Patient Pathway for Lung Cancer Patients D6.5 – Set-up of two CCCN for Lung Cancer WP7 Framework and criteria to enable the 8 - INCa 57.25 1 24 D7.1 – Map of the potential pre-identified implementation of Comprehensive Cancer Centres CCC and potential new CCCs, according within an EU Network the agreed common approach D7.2 – Set of criteria for CCCs D7.3 – A quality improvement process WP8 Equitable access to high-quality care and research: 23 - ICO 29.50 1 24 D8.1 – Organisational models of networks networks in the context of CCCs built around a CCC D8.2 – Pathways implemented through networking cancer services D8.3 – Impact of networking research into patients’ care D8.4 – Models and good practices to improve cancer survivors’ return to work in the MS 7 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Work package WP1 – Coordination Work Package Number WP1 Lead Beneficiary 1. NIJZ Work Package Name Coordination Start Month 1 End Month 24 Objectives The main objective of the Coordination Work Package is to ensure that the CraNE JA achieves its general and specific objectives, whilst also meeting all necessary reporting and financial requirements, though sound project management principles. Description WP 1 will consist of three main tasks, Task 1.1. - defining and implementing the Management and Meeting Structure, Task 1.2 - Preparation of Key Project Documents and Task 1.3 - Reporting and financial management. Work package WP2 – Dissemination Work Package Number WP2 Lead Beneficiary 10. 1ST YPE Work Package Name Dissemination Start Month 1 End Month 24 Objectives The specific objective of this WP is to disseminate all the activities and outcomes of the overall progress of the WPs and inform all the related stakeholders (WP leaders, MS participants/ representative of the JA, patient associations, NGOs, professional organizations, Ministries of Health, policymakers, hospitals and treatment centres etc). Description Futher objectives of WP 2 are: ▪ To ensure the dissemination of the main recommendations, and deliverables that have been developed in CraNE JA, ▪ To create a dissemination strategy for the JA, ▪ To provide a network of experts and/ or organizations for sharing experience, information and data and to communicate fundamental outcomes, for the improvement of cancer care across MSs (European Union Countries/ European Economic Area), ▪ To increase awareness of cancer prevention, cancer care and cancer control in the general public and main stakeholders. Work package WP3 – Evaluation Work Package Number WP3 Lead Beneficiary 21. IOCN Work Package Name Evaluation Start Month 1 End Month 24 Objectives The main objective of WP 3 is to evaluate whether the JA as a whole has produced planned results, delivered expected benefits, and made desired change (evaluation of process, outputs and outcomes). Description 8 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Further WP 3 objectives include: ▪ To evaluate if project processes are going according to plan ▪ To evaluate whether the participants (WP leaders, stakeholders, MS representatives, etc.) are satisfied with the project’s processes ▪ To assess the outcomes of iPAAC Joint Action ▪ To monitor whether deliverables are produced on time and in accordance with the proposed objectives (JA outputs) ▪ To evaluate the ability to implement the new findings of this JA in Member States (the implementability factor; JA outcomes) Work package WP4 – Sustainability Work Package Number WP4 Lead Beneficiary 2. Sciensano Work Package Name Sustainability Start Month 1 End Month 24 Objectives - To endorse the sustainability of the outputs of the CraNE Joint Action towards future implementation into cancer care structures in the Member States Other objectives: -Establish a workable interaction with the MS policy makers -Develop a tool to monitor the transgression towards the novel cancer care organization including pilot/use case experiences -Develop a Blueprint for establishing the novel cancer care organization into local cancer care -Establish a workable interaction with the MS policy makers to evaluate the readiness of HCS to integrate the scenarios developed in CraNe -Develop a tool to monitor the transgression towards the novel cancer care organization including feasibility approach and pilot/use case experiences -Develop a Blueprint for establishing the novel cancer care organization into local cancer care Description The WP4 endorses the sustainability of the outputs of this JA towards a future implementation into the cancer care in the Member States. It is thus uttermost important to establish a solid relation with the representatives at the MSs level. As raised by various members in the Governmental Board of the Joint action iPAAC, collecting and integrating all outputs from the numerous initiatives in the EBCP is a major challenge for the Healthcare policy makers. (Task 4.1: Organisation of the Governmental Board of the Joint Action). As a second task, this WP will develop a framework to support MS in developing and establishing either two of the proposed cancer care structures within their Healthcare systems: a CCC centres based system of a CCC network based system or any intermediate/alternative organisation. It is clear that the current organisation and contextual factors are major drivers in such development. WP4 will integrate the conclusions of W5-8 in this framework. For this, WP4 will develop a so-called ‘Maturity-level’ model that enables MSs to assess how their current cancer care organisation figures in respect to the CCC/N universe. To reach this objective, WP4 will closely work together with WPs 5 & 6 to ensure to collect the perspective of health authorities and end-users on (1) what are their needs/expectations and on (2) the recommendations made. Here for, surveys, Delphi analyses and SWOT exercises could be explored. (Task4.2: Maturity model as a tool for monitoring the transition from “As is” to “To be”). To test and sharpen the thinking on development of CCC/N organisation of cancer care, use cases in some MS/regions could be an interesting asses to better identify the clarity and appropriateness of developed criteriaby the WPs. As context and level of organisation in the MS are key determinants in the introduction of this novel cancer care organisation in the HCS, it would be good to identify a number of candidates to participate in the model development based on their different local organisation. (T4.3: Testing the Maturity model in volunteered countries as a use case ). 9 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Finally, the WP4 will ensure to develop a coherent output integrating the outputs of the different WPs working on specific aspects of the CCC/N universe into a Blueprint for Member states including a layman section allowing all to understand this novel initiative in organisations of cancer care locally. Task (T4.4: Develop a Blueprint for CCC and CCCN introduction into national cancer plans or strategies). Work package WP5 – The EU Network of Comprehensive Cancer Centres: composition, governance, joining process, and functioning Work Package Number WP5 Lead Beneficiary 13. ACC Work Package Name The EU Network of Comprehensive Cancer Centres: composition, governance, joining process, and functioning Start Month 1 End Month 24 Objectives ▪ To create a European network of national CCCs to improve cancer care and avoid the unacceptable disparities currently present across the EU Other objectives: ▪ To develop a governance model for the EU Network of CCCs ▪ To guarantee a high standard of care and research in each CCC through a continuous update mechanism ▪ To foster collaboration within the Network and with other European initiatives Description WP5 aims to provide a solid framework for the creation and operation of the EU Network of CCCs, addressing the challenges to obtain a consistent approach to selection and centre development, as well as to define an effective governance system that reflects and supports the Network’s mission. Comprehensive Cancer Centres are vital institutions for integrating high quality care and research. International quality accreditation mechanisms already exist, and many CCCs already adhere to them. One of the main objectives of WP5 is to build on experience and approaches already developed, and to identify accredited centers to establish the foundation of the Network. At the same time, rules of admission for new CCCs need to be defined, in close collaboration with WP6 and WP7, with a flexible approach that takes into account the regional context, but sets clear content, selection and evaluation criteria. For the EU Network to become fully operational and achieve its mission, it is of paramount importance to develop a governance model that delineates the decision-making process, for key matters as well as for daily management. WP5 will oversee the definition of the composition and duties of the governance bodies of the Network, and of the supporting secretariat. Ultimately, networking is a strategy to reduce inequalities in care, strengthen the quality of research, and integrate clinical care and research. WP5 will ensure that available resources (e.g. expertise, research, education, samples, data, trials, core facilities) will be leveraged by devising activities to foster collaboration within the Network, to create links to other relevant EU initiatives and to actively engage patients and other key stakeholders. Work package WP6 – Organization of comprehensive, high-quality cancer care in Comprehensive Cancer Care Networks (CCCNs) Work Package Number WP6 Lead Beneficiary 2. DKG Work Package Name Organization of comprehensive, high-quality cancer care in Comprehensive Cancer Care Networks (CCCNs) Start Month 1 End Month 24 Objectives ▪ To further develop the access and availability of the comprehensive high quality of care in CCCNs to all European 10 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 member states (MS) and align the high standards in cancer care for all quality assured institutions with a focus on the interfaces between care and research (CCCN and CCC). Description Using the in iPAAC developed tools (see section above) the tumor-specific CCCN approach will be expanded and field tested with another tumour-entity and a stronger focus on the patient centeredness as well as a training concept and supporting instruments for the set-up of CCCNs. Comprehensive Cancer Care Networks (CCCNs) together with CCCs will be the foundation to reach the goal of EBCP to ensure high standards in cancer care and delivering higher quality care. In the previous Joint Actions (JA) CanCon and iPAAC Comprehensive Cancer Care Networks (CCCN) where defined and successfully piloted with the aim to ensure higher-quality care and reducing inequalities across the EU. And with this approach achieving that 90% of the patients benefit from diagnosis and treatment close to home till 2030. The proposed WP is therefore a continuation of the theoretical framework of CCCNs developed during the JA CanCon and its translation into practice which was successfully achieved in WP 10, “Governance of integrated and comprehensive cancer care” of JA iPAAC. In iPAAC, WP 10 developed practical instruments to govern oncological care successfully (e.g., methodology to develop tumour and stage specific patient pathways and to derive quality indicators, Set of Standards for CCCNs (generic and tumour-specific) as well as a monitoring framework for the implementation of CCCNs). These instruments were field- tested in two pilot sites and evaluated. The evaluation recommended that the concept is suitable for roll-out to other volunteering member states but highlights that to implement CCCNs successfully, further support and training at the policy and institutional level are necessary. Work package WP7 – Framework and criteria to enable the implementation of Comprehensive Cancer Centres within an EU Network Work Package Number WP7 Lead Beneficiary 8. INCa Work Package Name Framework and criteria to enable the implementation of Comprehensive Cancer Centres within an EU Network Start Month 1 End Month 24 Objectives ▪ To develop a consensus of Comprehensive cancer centers, both standalone centres, and centres which are part of University or General Hospitals Description The specific objective is to establish a framework to enable the implementation of Comprehensive cancer centres (CCCs). WP7 aims to map the existing landscape of Comprehensive Cancer Centres and potential comprehensive cancer centres for the purposes of the proposed EU network. In this mapping it will need to take into account different health systems and organisation of secondary/tertiary cancer care and research. One important aspect to cover is the position of University Hospitals and very large General Hospitals treating many cancer patients which have not yet formed themselves into high-performing Cancer Centres incorporating research. Recommended governance structures will be defined by this WP. The main tasks of WP7 concern the construction of consensus quality standards for research, innovation, prevention, integration with care, education, and governance for CCCs. These core standards need to be straightforward and applicable in a wide variety of centres, and compatible with some existing quality and accreditation/certification systems in Europe. The WP also needs to design processes for centres which are not yet in readiness to be able to develop, and processes for all centres to actively improve care, research and education. Work package WP8 – Equitable access to high-quality care and research: networks in the context of CCCs Work Package Number WP8 Lead Beneficiary 23. ICO 11 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Work Package Name Equitable access to high-quality care and research: networks in the context of CCCs Start Month 1 End Month 24 Objectives - To assess how CCCs organise cancer care in the real world action of health systems at the regional and local level, assessing the use of molecular tumour boards, ways of translating research progress in the networks, survivorship issues associated with follow up and return to work and potential uses of real-world data to ensure equitable access to all cancer patients under the CCC hub and spoke in each healthcare. Description WP8 will be based on bottom up approaches. Current practices and models of organisation in real-life settings will be key references to assess how high-quality care and research is available to all cancer patients in a given regional and local levels through networking models. The objectives of WP8 are: 1. Analysis of real-world activities from networks built around a CCC in providing common care and translation of research responses to patients with frequent tumours. 2. Assessment of pathways’ implementation in different CCCNs contexts whereby cancer care is organised to equitably provide timely diagnosis and access to high-quality care 3. Assessment of how molecular tumour boards (MTB) are implemented in networking contexts where external clinicians to CCCs discuss their cases and receive advice on patient-tailored therapeutic planning. 4. Assessment of the continuity of cancer care in networks, including the potential for involvement of primary care and factors related to return to work along the follow up of patient after active treatment. 12 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 STAFF EFFORT Staff effort per participant Grant Preparation (Work packages - Effort screen) — Enter the info. Participant WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8 Total Person-Months 1 - NIJZ 72.40 5.50 3.50 2.00 83.40 1.1 - OIL 0.25 0.25 0.25 0.25 1.33 1.40 3.73 2 - Sciensano 0.70 0.70 0.70 30.00 5.00 37.10 2.1 - UZA 0.25 0.25 0.25 0.25 3.75 4.75 3 - USHATO 0.70 0.70 0.70 0.70 0.50 3.30 4 - CIPH 0.70 0.70 16.00 0.70 2.00 1.50 21.60 5 - MOH 0.70 0.70 0.70 0.70 0.50 3.30 6 - UH MOTOL 0.70 0.70 0.70 0.70 0.70 0.50 0.70 4.70 7 - MSAE 0.70 0.70 0.70 0.70 0.33 3.13 7.1 - UT 0.25 0.25 0.25 0.25 1.00 8 - INCa 0.70 0.70 0.70 5.00 11.00 1.00 19.10 8.1 - UNICANCER 0.25 0.25 0.25 0.25 3.45 4.00 1.00 9.45 8.2 - FHF 0.25 0.25 0.25 0.25 2.00 4.00 7.00 8.3 - INSERM 0.25 0.25 0.25 0.25 0.75 0.75 2.50 9 - BMG 0.70 0.25 0.25 0.25 1.45 9.1 - DKFZ 1.40 1.40 9.2 - DKG 0.25 0.70 0.70 0.70 26.24 1.40 5.50 35.49 9.4 - TUD 0.25 0.25 0.25 0.25 14.00 15.00 10 - 1ST YPE 1.20 16.50 1.20 1.20 0.70 2.80 1.00 24.60 13 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Staff effort per participant Grant Preparation (Work packages - Effort screen) — Enter the info. Participant WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8 Total Person-Months 10.1 - AGIOS SAVVAS 0.25 6.00 0.25 0.25 1.00 7.75 10.2 - LGHA 0.25 6.00 0.25 0.25 1.40 8.15 11 - OOI 0.70 0.70 0.70 0.70 1.40 4.20 12 - DOH 0.70 0.70 0.70 0.70 1.33 1.40 5.53 13 - ACC 0.70 0.70 0.70 0.70 55.00 1.00 1.40 60.20 13.1 - MoH 1.00 1.00 13.2 - IDI 0.25 0.25 0.25 0.25 2.00 3.00 14 - REUH 0.70 0.70 0.70 0.70 1.00 1.40 5.20 15 - SAM LT 0.70 0.70 0.70 0.70 0.20 3.00 15.1 - KK 0.25 0.25 0.25 0.25 0.33 1.33 15.2 - VULSK 0.25 0.25 0.25 0.25 1.00 2.00 15.3 - NCI 0.25 0.25 0.25 0.25 0.33 1.50 2.83 16 - INC 0.70 0.70 0.70 0.70 12.00 14.80 16.1 - LIH 0.25 0.25 0.25 0.25 1.40 2.40 17 - MFH 0.70 0.70 0.70 0.70 1.50 4.30 18 - OUS 0.86 0.70 0.70 0.70 3.00 1.00 11.00 2.00 19.96 19 - NIZP-PZH 0.70 0.70 0.70 30.00 17.50 49.60 20 - MS 0.70 0.70 0.70 0.70 3.50 6.30 21 - IOCN 0.70 0.70 16.00 0.70 5.00 1.40 24.50 22 - NOU 0.70 0.70 0.70 0.70 1.40 4.20 23 - ICO 0.70 0.70 0.70 0.70 2.00 1.00 17.00 22.80 14 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Staff effort per participant Grant Preparation (Work packages - Effort screen) — Enter the info. Participant WP1 WP2 WP3 WP4 WP5 WP6 WP7 WP8 Total Person-Months 23.1 - IDIVAL 0.25 0.25 0.25 0.25 2.00 3.00 24 - NBHW 0.70 0.70 0.70 1.00 2.10 5.20 25 - GÖG 0.70 0.70 0.70 0.70 2.80 Total Person-Months 93.86 53.60 55.40 86.50 70.90 99.04 57.25 29.50 546.05 15 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 LIST OF DELIVERABLES Deliverables Grant Preparation (Deliverables screen) — Enter the info. The labels used mean: Public — fully open ( automatically posted online) Sensitive — limited under the conditions of the Grant Agreement EU classified —RESTREINT-UE/EU-RESTRICTED, CONFIDENTIEL-UE/EU-CONFIDENTIAL, SECRET-UE/EU-SECRET under Decision 2015/444 Deliverable Deliverable Name Work Lead Beneficiary Type Dissemination Level Due Date No Package (month) No D1.1 Report from kick-off meeting WP1 1 - NIJZ R — Document, report PU - Public 2 D1.2 Final Report WP1 1 - NIJZ R — Document, report PU - Public 24 D2.1 Dissemination Strategy WP2 10 - 1ST YPE R — Document, report SEN - Sensitive 2 D2.2 Dissemination Report WP2 10 - 1ST YPE R — Document, report PU - Public 24 D2.3 Layman’s version of final report (in simple WP2 10 - 1ST YPE R — Document, report PU - Public 24 language for general public) D3.1 Evaluation Strategy WP3 21 - IOCN R — Document, report SEN - Sensitive 4 D3.2 Evaluation Report WP3 21 - IOCN R — Document, report PU - Public 24 D4.1 Blueprint of the development and Integration WP4 2 - Sciensano R — Document, report PU - Public 23 of comprehensive cancer care scenarios into cancer care and control D5.1 Process for membership of CCCs to the EU WP5 13 - ACC R — Document, report PU - Public 14 Network D5.2 Integration with EU and national initiatives WP5 13 - ACC R — Document, report PU - Public 18 D5.3 Governance Model and operating WP5 13 - ACC R — Document, report PU - Public 24 procedures 16 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Deliverables Grant Preparation (Deliverables screen) — Enter the info. The labels used mean: Public — fully open ( automatically posted online) Sensitive — limited under the conditions of the Grant Agreement EU classified —RESTREINT-UE/EU-RESTRICTED, CONFIDENTIEL-UE/EU-CONFIDENTIAL, SECRET-UE/EU-SECRET under Decision 2015/444 Deliverable Deliverable Name Work Lead Beneficiary Type Dissemination Level Due Date No Package (month) No D6.1 Definition and description of interfaces WP6 9 - BMG R — Document, report SEN - Sensitive 24 D6.2 Training concept for set-up of a CCCN WP6 19 - NIZP-PZH R — Document, report SEN - Sensitive 18 D6.3 Set of Standards for Lung Cancer Care and WP6 9 - BMG R — Document, report SEN - Sensitive 12 Set of Quality Indicators for Lung Cancer D6.4 Patient Pathway for Lung Cancer Patients WP6 9 - BMG R — Document, report SEN - Sensitive 18 D6.5 Set-up of two CCCN for Lung Cancer WP6 9 - BMG DEM — Demonstrator, SEN - Sensitive 24 pilot, prototype D7.1 Map of the potential pre-identified CCC and WP7 18 - OUS R — Document, report PU - Public 12 potential new CCCs, according the agreed common approach D7.2 Set of criteria for CCCs WP7 8 - INCa R — Document, report PU - Public 18 D7.3 A quality improvement process WP7 8 - INCa R — Document, report PU - Public 24 D8.1 Organisational models of networks built WP8 23 - ICO R — Document, report PU - Public 8 around a CCC D8.2 Pathways implemented through networking WP8 23 - ICO R — Document, report PU - Public 14 cancer services D8.3 Impact of networking research into patients’ WP8 23 - ICO R — Document, report PU - Public 20 care 17 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Deliverables Grant Preparation (Deliverables screen) — Enter the info. The labels used mean: Public — fully open ( automatically posted online) Sensitive — limited under the conditions of the Grant Agreement EU classified —RESTREINT-UE/EU-RESTRICTED, CONFIDENTIEL-UE/EU-CONFIDENTIAL, SECRET-UE/EU-SECRET under Decision 2015/444 Deliverable Deliverable Name Work Lead Beneficiary Type Dissemination Level Due Date No Package (month) No D8.4 Models and good practices to improve WP8 23 - ICO R — Document, report PU - Public 20 cancer survivors’ return to work in the MS 18 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Deliverable D1.1 – Report from kick-off meeting Deliverable Number D1.1 Lead Beneficiary 1. NIJZ Deliverable Name Report from kick-off meeting Type R — Document, report Dissemination Level PU - Public Due Date (month) 2 Work Package No WP1 Description Summary report from CraNE JA kick-off meeting for dissemination to key target audiences and wider stakeholder community in order to increase active participation in JA from onset Deliverable D1.2 – Final Report Deliverable Number D1.2 Lead Beneficiary 1. NIJZ Deliverable Name Final Report Type R — Document, report Dissemination Level PU - Public Due Date (month) 24 Work Package No WP1 Description Final report produced detailing the achievements and financial progress for the entire JA, with focus on outputs and sustainability Deliverable D2.1 – Dissemination Strategy Deliverable Number D2.1 Lead Beneficiary 10. 1ST YPE Deliverable Name Dissemination Strategy Type R — Document, report Dissemination Level SEN - Sensitive Due Date (month) 2 Work Package No WP2 Description In the first month of the project, a JA dissemination plan will be developed to describe the steps and methods to achieve this plan. All partners should contribute to this plan. Roles, responsibilities deadlines and milestones of each partner will be discussed to clearly address the objectives of JA. Deliverable D2.2 – Dissemination Report Deliverable Number D2.2 Lead Beneficiary 10. 1ST YPE Deliverable Name Dissemination Report Type R — Document, report Dissemination Level PU - Public Due Date (month) 24 Work Package No WP2 Description 19 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Report detailing the dissemination activities throughout the JA, with key events and outcomes described, as well as how target groups were approached Deliverable D2.3 – Layman’s version of final report (in simple language for general public) Deliverable Number D2.3 Lead Beneficiary 10. 1ST YPE Deliverable Name Layman’s version of final report (in simple language for general public) Type R — Document, report Dissemination Level PU - Public Due Date (month) 24 Work Package No WP2 Description Report of the CraNE JA in layman’s terms, meant for general public and key stakeholders, for wide dissemination through different channels Deliverable D3.1 – Evaluation Strategy Deliverable Number D3.1 Lead Beneficiary 21. IOCN Deliverable Name Evaluation Strategy Type R — Document, report Dissemination Level SEN - Sensitive Due Date (month) 4 Work Package No WP3 Description Key strategic document for evaluation of the CraNE Joint Action -contains all the basic elements of process evaluation, including key evaluation objectives and key process evaluation activities. Deliverable D3.2 – Evaluation Report Deliverable Number D3.2 Lead Beneficiary 21. IOCN Deliverable Name Evaluation Report Type R — Document, report Dissemination Level PU - Public Due Date (month) 24 Work Package No WP3 Description Report summarizing the results of the process evaluation indicators (questionnaires after important meetings, WPL’s workshop summary, documents, deliverables analysis) andan overview of outputs, outcomes and implementability of the JA. Deliverable D4.1 – Blueprint of the development and Integration of comprehensive cancer care scenarios into cancer care and control Deliverable Number D4.1 Lead Beneficiary 2. Sciensano Deliverable Name Blueprint of the development and Integration of comprehensive cancer care scenarios into cancer care and control 20 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Type R — Document, report Dissemination Level PU - Public Due Date (month) 23 Work Package No WP4 Description Report - publication Deliverable D5.1 – Process for membership of CCCs to the EU Network Deliverable Number D5.1 Lead Beneficiary 13. ACC Deliverable Name Process for membership of CCCs to the EU Network Type R — Document, report Dissemination Level PU - Public Due Date (month) 14 Work Package No WP5 Description Agreed process (including accreditation) for admission of CCCs to the Network; process for ongoing development; initial list of CCCs in the EU Network Deliverable D5.2 – Integration with EU and national initiatives Deliverable Number D5.2 Lead Beneficiary 13. ACC Deliverable Name Integration with EU and national initiatives Type R — Document, report Dissemination Level PU - Public Due Date (month) 18 Work Package No WP5 Description Identification of existing EU initiatives relevant to the mission of the Network; identification of processes and resources to enable the EU Network to link with those initiatives Deliverable D5.3 – Governance Model and operating procedures Deliverable Number D5.3 Lead Beneficiary 13. ACC Deliverable Name Governance Model and operating procedures Type R — Document, report Dissemination Level PU - Public Due Date (month) 24 Work Package No WP5 Description Governance model for the efficient coordination of the activities of the Network and the supporting permanent secretariat Deliverable D6.1 – Definition and description of interfaces Deliverable Number D6.1 Lead Beneficiary 9. BMG Deliverable Name Definition and description of interfaces 21 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Type R — Document, report Dissemination Level SEN - Sensitive Due Date (month) 24 Work Package No WP6 Description Definition of Comprehensive Cancer Care Networks (CCCN) and its interfaces with Comprehensive Cancer Centres (CCC) Deliverable D6.2 – Training concept for set-up of a CCCN Deliverable Number D6.2 Lead Beneficiary 19. NIZP-PZH Deliverable Name Training concept for set-up of a CCCN Type R — Document, report Dissemination Level SEN - Sensitive Due Date (month) 18 Work Package No WP6 Description Development of support instruments to set-up CCCN Deliverable D6.3 – Set of Standards for Lung Cancer Care and Set of Quality Indicators for Lung Cancer Deliverable Number D6.3 Lead Beneficiary 9. BMG Deliverable Name Set of Standards for Lung Cancer Care and Set of Quality Indicators for Lung Cancer Type R — Document, report Dissemination Level SEN - Sensitive Due Date (month) 12 Work Package No WP6 Description Set of Standards and set of quality indicators for lung cancer will be developed and implemented in CCCN Deliverable D6.4 – Patient Pathway for Lung Cancer Patients Deliverable Number D6.4 Lead Beneficiary 9. BMG Deliverable Name Patient Pathway for Lung Cancer Patients Type R — Document, report Dissemination Level SEN - Sensitive Due Date (month) 18 Work Package No WP6 Description Enhancing patient centeredness in CCCNs with patient pathways Deliverable D6.5 – Set-up of two CCCN for Lung Cancer Deliverable Number D6.5 Lead Beneficiary 9. BMG Deliverable Name Set-up of two CCCN for Lung Cancer 22 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Type DEM — Demonstrator, Dissemination Level SEN - Sensitive pilot, prototype Due Date (month) 24 Work Package No WP6 Description Certified CCCN for Lung Cancer including implementation of deliverables 6.2-6.4 Deliverable D7.1 – Map of the potential pre-identified CCC and potential new CCCs, according the agreed common approach Deliverable Number D7.1 Lead Beneficiary 18. OUS Deliverable Name Map of the potential pre-identified CCC and potential new CCCs, according the agreed common approach Type R — Document, report Dissemination Level PU - Public Due Date (month) 12 Work Package No WP7 Description Map of the potential pre-identified CCC and potential new CCCs, according the agreed common approach Deliverable D7.2 – Set of criteria for CCCs Deliverable Number D7.2 Lead Beneficiary 8. INCa Deliverable Name Set of criteria for CCCs Type R — Document, report Dissemination Level PU - Public Due Date (month) 18 Work Package No WP7 Description An integrated and straightforward set of criteria for CCCs covering all aspects of Governance, Research, Education and Care (liaising with WP6), which enable the creation of a full Network. Deliverable D7.3 – A quality improvement process Deliverable Number D7.3 Lead Beneficiary 8. INCa Deliverable Name A quality improvement process Type R — Document, report Dissemination Level PU - Public Due Date (month) 24 Work Package No WP7 Description A quality improvement process to “raise the bar” in order to be in a continuous improvement process. 23 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Deliverable D8.1 – Organisational models of networks built around a CCC Deliverable Number D8.1 Lead Beneficiary 23. ICO Deliverable Name Organisational models of networks built around a CCC Type R — Document, report Dissemination Level PU - Public Due Date (month) 8 Work Package No WP8 Description Organisational models of cancer networks available in EU countries will be described based on a discussion with key informants from CCCNs designated by cancer plans. Deliverable D8.2 – Pathways implemented through networking cancer services Deliverable Number D8.2 Lead Beneficiary 23. ICO Deliverable Name Pathways implemented through networking cancer services Type R — Document, report Dissemination Level PU - Public Due Date (month) 14 Work Package No WP8 Description A multiple-case study method will be applied to assess the barriers and faciliators in implementing CCCNs Deliverable D8.3 – Impact of networking research into patients’ care Deliverable Number D8.3 Lead Beneficiary 23. ICO Deliverable Name Impact of networking research into patients’ care Type R — Document, report Dissemination Level PU - Public Due Date (month) 20 Work Package No WP8 Description A survey will be conducted to evaluate the use of molecultar tumour boards by networked providers of cancer care. Deliverable D8.4 – Models and good practices to improve cancer survivors’ return to work in the MS Deliverable Number D8.4 Lead Beneficiary 23. ICO Deliverable Name Models and good practices to improve cancer survivors’ return to work in the MS Type R — Document, report Dissemination Level PU - Public Due Date (month) 20 Work Package No WP8 Description A literature review will assess the pathways to return to work and associated risk factors for cancer survivors considering the different time points in patients’ follow up. 24 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 LIST OF MILESTONES Milestones Grant Preparation (Milestones screen) — Enter the info. Milestone Milestone Name Work Package No Lead Beneficiary Means of Verification Due Date No (month) 1 Kick-off meeting WP1 1-NIJZ Report held with minutes and attendance lists 1 2 Project and Financial Policy WP1 1-NIJZ Two key documents, agreed upon by all partners 4 3 Dissemination Strategy /Graphic identity and WP2 10-1ST YPE Logo and visual identity agreed upon within 2 leaflet the WPL team with key document templates prepared. 4 CraNE website WP2 10-1ST YPE Website online and fully functional with key 2 functionalities in place. 5 Broader communication tools (events, WP2 10-1ST YPE Creation of social media accounts, organized 6 webinars, newsletter and online debate) events, published newsletters (8 in total). 6 Indicators WP3 4-CIPH SMART indicators prepared with cooperation of 2 all WP Leaders, accepted by Steering Committee 7 WP Leader’s Workshop WP3 4-CIPH Workshop Report 14 8 Interim report WP3 21-IOCN Document available on the official web site 12 9 GB Process WP4 2-Sciensano Number of MS representatives participating in 3 GB (at least 20) 10 Maturity Model Concept WP4 19-NIZP-PZH Report - Publication 6 11 Identification of countries to test the Maturity WP4 19-NIZP-PZH At least 3 participating countries 12 Model 12 Testing the Maturity Model Concept WP4 19-NIZP-PZH Report - publication 21 13 Draft agreement on process for admission and WP5 13-ACC Interim meeting reports 12 governance model of the future EU Network 25 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Milestones Grant Preparation (Milestones screen) — Enter the info. Milestone Milestone Name Work Package No Lead Beneficiary Means of Verification Due Date No (month) 14 Set of Standards and Set of QI for Lung WP6 9-BMG Documents are finalized and agreed in the WP 12 Cancer 15 CCCN set-up training concept WP6 19-NIZP-PZH Concept is finalized and agreed in the WP 18 16 Set-up of two CCCN for Lung Cancer WP6 9-BMG Peer-review and awarding of certificate 24 17 State of the art and common approach WP7 18-OUS Paper summarizing the preparatory activities by 3 lead and co-lead on agreed common approach on all the 7.2 subtasks and on the governance issue (7.3) 18 Agreed methodology for standards definition WP7 8-INCa Paper by lead and co-lead on agreed methodology 6 & data collection and format of standards for CCCs with contributions from other participants through first work-shop 19 Results of the survey on pre identified CCC WP7 18-OUS Paper on survey results and from issues launched 9 Standards and first sketches of governance during further work in WP7.2 groups and the model presenting the results from the survey 20 First sketches of CCC Standards and second WP7 8-INCa Paper prepared as the main reference for 15 sketches of governance mode discussions at the second work-shop and summarized the feed-back at the work-shop 21 Model with adjustable and realistic criteria WP7 8-INCa Final report with recommendations on standards, 24 for a continuous improvement of care and development and improvement process and on research governance model 22 Organisational models should be defined WP8 23-ICO Report 9 before case-study and survey application 26 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 LIST OF CRITICAL RISKS Critical risks & risk management strategy Grant Preparation (Critical Risks screen) — Enter the info. Risk Description Work Package Proposed Mitigation Measures number No(s) 1 Partners will not fulfil their planned obligations, WP1 Deliverables will be tracked by each WPL and by the PMT, who will discuss the status of all will not deliver planned outputs, or will do so planned deliverables in the reporting period at SC meetings. 1 month prior to the delivery of with significant delay, changes to consortium. the milestone /deliverable the PMT will be in touch with the WP about the status, helping to Likelihood: Low / Impact: High find a solution if a delay is expected. Real-time consortium changes will be monitored for possible amendments, tasks will then be re-shifted between partners. 2 Partners will not adhere to planned budget and will WP1 Regular 6 monthly reports will be gathered by the PMT to monitor financial expenditure under or over spend. Likelihood: Medium / Impact: and propose redistribution of budgets if necessary. Bilateral communication will be held Medium between the PMT and individual partners regarding expenditure, partner specific feedback will be given on budgets following every 6 month report. 3 JA Partners may not be timely notifying the WP2 The Dissemination Team will be in ongoing contact with JA Coordinator and WPLs. Dissemination Team of content for the website Standardisation of procedures and video calls in order to proactively follow WP update (website page and newsletter). Likelihood: developments. Medium/ Impact: Medium 4 Not enough traffic to website, users on website WP2 Statistics on the use of the website and social channels will be reviewed periodically to not interacting with content, navigating sub-pages. monitor visitor flow and increase interactivity. WP 1 and 2 will engage together to maximise Likelihood: Medium/ Impact: Medium quality of published docs. The JA visibility will be fostered by using all partner organizations’ channels (e.g. local media, national networks). 5 Risk of producing deliverables that are not complete WP3 A clear Evaluation strategy with task mapping. Meetings and regular communication with or behind the schedule. Likelihood: Low/ Impact: partners within the WP in order to clearly define the tasks and responsibilities. High 6 Lower data quality for evaluation due to the possible WP3 Using appropriate methods to ensure the highest data quality from online type of meetings continuation of COVID-19 situation (if most of the meetings will be held in online form) Likelihood: High/ Impact: Medium 7 Lack of institutional support for the activities WP3 Detailing the contractual obligations and resources needed for successful work on the WP 27 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Critical risks & risk management strategy Grant Preparation (Critical Risks screen) — Enter the info. Risk Description Work Package Proposed Mitigation Measures number No(s) envisaged within the WP Likelihood: Medium/ Impact: High 8 Low interest in candidates for use cases Likelihood: WP4 All partnering countries could function as a candidate use case, in case no other local Low/ Impact: High organisations wish to collaborate 9 Few attendees at GB meetings Likelihood: Medium/ WP4 Maximize the integration of GB contact with other initiatives – close interaction with DG Impact: Low Santé 10 Delayed receipt of criteria from the other WPs WP4 Close collaboration with WPs, 7 and 8 and WP1 to strictly manage the project plan Likelihood: Low/ Impact: High 11 No follow-up on developed outputs Likelihood: WP4 Close collaboration with e.g. EC-JRC Knowledge Centre on Cancer Low/ Impact: High 12 Risk that the WP would propose criteria or processes WP5, WP7 The GB of Member States will be critical to mitigate this risk by building consent for the of admission for CCCs that are not acceptable outputs of WP 5 and 7. This GB will be convened by WP4. to some MS which would hamper the consistent formation of the new EU-level network Likelihood: Medium/ Impact: High 13 Risk that the benefits from forming a new Network WP5, WP7 The entire JA should define the benefits for research and care as a part of an early milestone of CCCs in the EU are not clearly articulated in such of the JA. a way as to secure ‘buy in’ and motivation of CCCs as well as MS Likelihood: Low/ Impact: High. 14 Risk that criteria for CCCs are set too high to WP5, WP7 WPs need to define development processes which allow for inclusivity and well as requiring include centres in certain Member States, or so low continuous improvement in all CCCs, whatever their baseline. that some centres have less motivation to improve. Likelihood: Medium/ Impact: High 15 Partners do not deliver the agreed upon products WP6 Closely accompany the milestones of the tasks and stay in regular contact with all task leaders (e.g. reports, training-concept, patient pathway) Likelihood: Low/ Impact: Medium 28 Project: 101075284 — CraNE — EU4H-2021-JA-IBA Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Critical risks & risk management strategy Grant Preparation (Critical Risks screen) — Enter the info. Risk Description Work Package Proposed Mitigation Measures number No(s) 16 Feasibility study will not be finished in time WP6 Following a strict timetable and offering constant support Likelihood: Low/ Impact: Medium 17 Lack of partners' logistical support in organising WP8 Using the kick-off meeting to disseminate rapid and comprehensive information on this need the different case studies (T8.2). Likelihood: Low/ as well as WPL involvement. Impact: High 18 Risk of selecting poor examples of molecular WP8 A comparative analysis and consensus discussion will be conducted to shed light on the most tumour board integration between CCCs and advanced cases in EU health systems. associated providers. Likelihood: Medium/ Impact: High 29 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU4Health Programme (EU4H) Application Form Technical Description (Part B) – CraNE Joint Action (EU4H Standard) Version 4.0 14 September 2022 PROJECT Network of Comprehensive Cancer Centres: Project name: Preparatory activities on creation of National Comprehensive Cancer Centres and EU Networking Project acronym: CraNE Coordinator contact: Tina Lipuscek, National Institute of Public Health Slovenia (NIJZ) 1 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 HISTORY OF CHANGES FIRST SUBMISSION, 16.12.2021 Version 1.0 SECOND SUBMISSION, 15.7.2022 Version 2.0 Part A: - Acronym for Portugese Ministry of Heatlh changed from DGS to MS, new PIC added to FT Portal = 986364095 - new Affiliated Entity to ACC; Italy: partner Ministero della Salute - acronym: MOH-IT; PIC 999531942 - new Affiliated Entity to ACC, Italy: Fondazione Luigi Maria Monti - acronym: IDI; PIC 918519870 - Deletion of OECI as Affiliated Entity to OUS, Norway - substitution of Competent Authority for Sweden, deletion of SALAR and addition of Socialstyrelsen – acronym NBHW, PIC 998248147 Part B, Technical description: -Section 1.2 – new outcome indicator added for Specific Objective 2, addition of text on how CraNE objectives adhere to the EU Better Regulation guidelines - Section 1.3 – inclusion of UK/US centres of excellence in complementarity section - Section 2.2. – Addition of two new Affiliated Entities for ACC, Italy in Section on Consortium Set-up: MOH -ITand IDI; change of OECI from Affiliated Entity to subcontractor - Section 2.4 – new text on conflict resolution within the consortium and addition within the Steering Committee meetings: scientific agenda point and patient representative - Section 4.2 – WP 1, addition of Subcontract 2.2. in Task 1.1. Meeting and Management Structure to include patients in Steering Committee meetings, text added on scientific agenda point in Steering Committee meeting; WP 5, addition of MOH-IT and IDI to Tasks 5.1 and 5.2 - WP 1, addition of Deliverable 1.1. Report from kick-off meeting - Section 4.2 – WP 6, all BMG activities allocated to DKG - Section 4.4 – Subcontracting, Addition of Task 1.1 Meeting and Management Structure to Subcontract 2.2. Patient organsation for participation in Steering Committee meetings, Addition of Subcontract 7.2 for OECI support to WPs 4-8 Part B, detailed budget table: - NIJZ new budget breakdown, previous total budget was 471,560.77 €, new total budget is 471,558.63 € - BMG new budget breakdown due to reallocation of WP 6 work effort to DKG; previous total budget was 44,335.45 €, new total budget is 11,293.85 € - DKG new budget breakdown due to reallocation of WP 6 work effort from BMG; previous total budget was 279,243.25 €, new total budget is 312,284.85 € 2 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 - ACC, new budget breakdown, previous total budget was 273,385.00 €, new total budget is 242,783.00 € - new Affiliated Entity to ACC; Italy: partner Ministero della Salute - acronym: MOH; PIC 999531942, new budget breakdown, 8,560.00 € re-allocated form ACC budget - new Affiliated Entity to ACC, Italy: Fondazione Luigi Maria Monti - acronym: IDI; PIC 918519870, new budget breakdown, 22,043.00 € re-allocated from ACC budget - INC budget reallocation between the sub-categories of A.1 Employees within WP6 - OUS new subcontracting costs for subcontractor OECI in the amount of 187.000 €; and OECI removed as an Affiliated partner to OUS THIRD SUBMISSION, 18.8.2022 Version 3.0 - Deletion of D 1.2 Interim Report in WP 1 FOURTH SUBMISSION, 14.9.2022 Version 4.0 - Deletion of “Aghia Sofia” Children’s Hospital and Andreas Syggros Hospital for Cutaneous and Venereal Diseases as the Affiliated Entities of Greece, reallocation of budget to the Competent Authority of Greece 1st YPE 3 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 TECHNICAL DESCRIPTION (PART B) TABLE OF CONTENTS TECHNICAL DESCRIPTION (PART B) .......................................................................................................................... 4 PROJECT SUMMARY ................................................................................................................................................. 5 1. RELEVANCE ........................................................................................................................................................... 5 1.1 Background and general objectives .................................................................................................................... 5 1.2 Needs analysis and specific objectives ............................................................................................................... 6 1.3 Complementarity with other actions and innovation — European added value .................................................... 8 2. QUALITY ................................................................................................................................................................. 9 2.1 Concept and methodology .................................................................................................................................. 9 2.2 Consortium set-up............................................................................................................................................. 10 2.3 Project teams, staff and experts ........................................................................................................................ 15 2.4 Consortium management and decision-making................................................................................................. 15 2.5 Project management, quality assurance and monitoring and evaluation strategy .............................................. 16 2.6 Cost effectiveness and financial management .................................................................................................. 17 2.7 Risk management ............................................................................................................................................. 18 3. IMPACT ................................................................................................................................................................. 21 3.1 Impact and ambition .......................................................................................................................................... 21 3.2 Communication, dissemination and visibility...................................................................................................... 21 3.3 Sustainability and continuation .......................................................................................................................... 22 4. WORK PLAN, WORK PACKAGES, TIMING AND SUBCONTRACTING .............................................................. 24 4.1 Work plan ......................................................................................................................................................... 24 4.2 Work packages and activities ............................................................................................................................ 25 Work Package 1……………………………………………………………………………………………………..……..22 Work Package 2……………………………………………………………………………………………………………25 Work Package 3……………………………………………………………………………………………………………30 Work Package 4……………………………………………………………………………………………………………33 Work Package 5……………………………………………………………………………………………………………36 Work Package 6……………………………………………………………………………………………………………40 Work Package 7……………………………………………………………………………………………………………45 Work Package 8……………………………………………………………………………………………………………50 4.3 Timetable .......................................................................................................................................................... 58 4.4 Subcontracting .................................................................................................................................................. 65 5. OTHER .................................................................................................................................................................. 72 5.1 Ethics ................................................................................................................................................................ 72 5.2 Security............................................................................................................................................................. 72 6. DECLARATIONS ................................................................................................................................................... 72 ANNEXES ..................................................................................................................................................................... 73 4 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 PROJECT SUMMARY Project summary The CraNE Joint Action is proposed for funding in response to the flagship number 5 of the Europe’s Beating Cancer Plan, which defines that the European Commission will establish by 2025, an EU Network linking recognised National Comprehensive Cancer Centres (CCCs) in every Member State. In order to facilitate the establishment of such an EU Network, CraNE will prepare the necessary preconditions, administrative, professional, and those related to high-quality performance. This is necessary to facilitate both the integration of the existing CCCs as well as to support the Member States who still need to develop and certify such centres. The CraNE JA will also provide an assessment on sustainability and feasibility as well as link the development of an EU Network of CCCs and CCCs in individual Member States to the development of national and regional CCCNs. This way, the existing organisational and functional models of cancer care will be taken into account and incorporated into the proposed solution. 1. RELEVANCE 1.1 Background and general objectives Background and general objectives One of the flagship initiatives of Europe’s Beating Cancer Plan (EBCP) is the establishment by 2025 of an European Union (EU) Network linking recognised National Comprehensive Cancer Centres (CCCs) in every Member State (MS), to facilitate the uptake of quality-assured diagnosis and treatment, including training, research, and clinical trials across the Union. The EBCP aims to ensure that 90% of eligible patients have access to such centres by 2030. The award of a direct grant as referred to in Article 13 (5) of Regulation (EU) 2021/522 is duly justified because this action can only be carried out by Member States (MSs) authorities that have the required competence and responsibility to implement the Union policies at national level. This Joint Action (JA) supports the implementation of a flagship initiative of EBCP objective to deliver higher-quality care and implements the EU4Health Programme’s general objective of improving and fostering health in the Union (Article 3, point (a)) through the specific objectives defined in Article 4, points (a) and (g) of Regulation (EU) 2021/522. CCCs have grown to be important providers of advanced cancer care, research and education in most MSs of the EU. Their numbers differ across countries, but generally, most EU MSs have at least one CCC. So far, their quality assurance through certification/accreditation was primarily done by two mechanisms, one established as a part of an accreditation process within the European Organisation of Cancer Institutes (OECI) and the other by the German Cancer Aid, whose activity has not been limited to Germany. Given the typology of cancer care organization in the EU, different types of cancer care networks are important alongside the CCCs in delivering high quality standardised cancer care in EU MSs. Previously, JA CanCon was focusing on the development of a definition for a Comprehensive Cancer Care Network (CCCN). The European Guide on Quality Improvement in Comprehensive Cancer Control developed under the JA CanCon (www.cancercontrol.eu) recommends as a priority the establishment of Comprehensive Cancer Care Networks (CCCNs), and likewise the Horizon Europe Cancer Mission Board recommends the establishment of comprehensive cancer infrastructures in all MSs and the networking of CCCs at Union level. Furthermore, the final outputs of the WP10 of the Innovative Partnership for Action Against Cancer (iPAAC) JA dealt with Sets of Standards for CCCNs and the certification of CCCNs. EBCP identified CCCs as key structures for high-quality care, education and research. The JA approach will be pragmatic and a part of a continuous quality improvement process.The definition of the criteria for a CCC will be based on quality standards to be developed by the JA. A high focus will be on the integration of translational research and clinical care. The criteria should be realistic, reasonable and progressive. Indeed, due to different organisations and levels of integration in MSs, the CCC model will be able to allow progressive development and will thus provide the criteria required at different stages of their development. Thus the process will be dynamic; initial entry, followed by quality improvement. Criteria for eligibility should include overall governance structures; research standards (inputs and outputs), educational and care standards and processes at an institutional level, ensuring quality at tumour group (MDT) level. CraNE will convene the main actors who will be concerned in the future development of the network of CCCs: representatives of MSs, networks of CCCs, European organizations, and experts. The JA will address the main objective of the call by developing a sound model of the EU Network of CCCs, including the professional, scientific, educational and administrative framework for a sustainable structure. It will contribute with the following issues: 1 Future improvement in the quality of cancer care through standardisation and certification and by reducing the differences in high-level cancer care between MSs. 2 Better collaboration among CCCs both at the national and at the EU level, facilitating 5 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 transnational cooperation, research and care. 3 Increasing the competence of professionals through joint training programs and training standards. 1.2 Needs analysis and specific objectives Needs analysis and specific objectives There is a need to establish the specific tools and definitions for the Network of CCCs as well as for the establishment of the secretariat of such a Network. Alongside the Network of CCCs, there is also a need to develop adequate definitions for the setup of the CCCNs, where CCCs stand as the central institution according to the hub-and-spoke model. The main aim of this JA is to create an EU network of the already existing and newly established CCCs, to support the implementation of quality-assured early detection, screening, diagnosis, treatment, support to cancer survivors, and training of the cancer workforce. To achieve the wider-ranging goals of the EU Cancer Mission and EBCP, i.e reducing cancer incidence, and achieving overall improvement of survival of and quality of life of cancer patients, we believe that the precise objectives of an EU Network of CCCs should be: (a) reducing inequalities of diagnosis, treatment and care, and access to clinical trials; (b) strengthening the quality of translational, clinical and outcomes research; (c) integrating clinical care and research and evaluating the quality of cancer care throughout. Namely, the current picture of CCCs and Networks in MSs shows patchy development, as well as variability in aims, scope, and governance. Diverse international quality accreditation mechanisms already exist, and many CCCs already adhere to them. Moreover, for defined purposes, a range of EU networks of CCCs also exist, which are national, cancer-specific, or have formed to address specific issues. Significant achievements of pre-existing networks should be considered, to exploit them and avoid duplication of efforts. This JA will address the challenge to define a consistent approach to selection and centre development, building on experience and approaches already developed, taking into account the regional context, but at the same time setting clear content, selection and evaluation criteria. The EU Network of National CCCs will support the implementation of quality-assured early detection, screening, diagnosis, treatment, support to cancer survivors, and training of the cancer workforce. In order to achieve the overall aims of the JA, the specific objectives are: Specific objective 1: To endorse the sustainability of the outputs of the CraNE JA towards future implementation into cancer care structures in the MS The WP4 endorses the sustainability of the outputs of this JA towards a future implementation into the cancer care in the MSs. It is thus uttermost important to establish a solid relation with the representatives at the MSs level. As raised by various members in the Governmental Board of the iPAAC JA, collecting and integrating all outputs from the numerous initiatives in the EBCP is a major challenge for the Healthcare policy makers. (Task 4.1: Establish process for interaction with the MS representatives). Process indicator: Regular interaction between Member State representatives and the CraNE Joint Action, Target Value: Three executed Governmental Board meetings Output indicator: Maturity model testing framework, Target Value: At least two countries testing the framework Outcome indicator: Blueprint report, Target Value: One report and one scientific publication published Specific objective 2: To create a European network of national CCCs to improve cancer care and avoid the unacceptable disparities currently present across the EU The formation of the EU Network is regarded as a fundamental step to improve cancer care and avoid the unacceptable disparities currently present across the EU, particularly for timely and high quality diagnosis and treatment. The Tasks will define the requirements to access the Network, its structure, governance, functioning, and monitoring. The activities of the Network should guarantee a high standard of care and research in each CCC through the certification and continuous monitoring of the progress of and should initiate the development of new scientific knowledge and thus the continuous updating of clinical practice to ensure a high standard of care in each MS. Moreover, the Network should promote collaboration at all possible levels among the CCCs and a continuous interaction with EU stakeholders, including citizen and patient organizations. The EU Network will consensually define the format for CCCs, which will allow for the different practical organisational models in the MSs, where they might be standalone centres or parts of university or general hospitals. At the same time, CraNE JA will develop a framework, which will enable the future implementation of CCCs in the EU. 6 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Process indicator: Consensus regarding draft agreement on accreditation principles, Target Value: One consensus meeting of partners at M12 Output indicator: Final document describing the admission process, Target Value: One completed Deliverable 5.1. at M 14 - Agreed process (including accreditation) for admission of CCCs to the Network; process for ongoing development; initial list of CCCs in the EU Network. Outcome indicator: Setting up framework for the creation or upgrading of CCCs in EU Member States, to reach the 2025 targets of the Europe's Beating Cancer Plan. Target Value : one report/blueprint summarising the framework to be established for the definition of CCCs and the implementation processes Specific objective 3: To further develop the access and availability of the comprehensive high quality of care in CCCNs to all European Member States (MS) and align the high standards in cancer care for all quality assured institutions with a focus on the interfaces between care and research (CCCN and CCC). We propose the continuation of the theoretical framework of CCCNs developed during the CanCon JA and its translation into practice which was successfully achieved in WP 10, “Governance of integrated and comprehensive cancer care” of iPAAC JA. Namely, in iPAAC JA, WP 10 developed practical instruments to govern oncological care successfully (e.g., methodology to develop tumour and stage specific patient pathways and to derive quality indicators, Set of Standards for CCCNs (generic and tumour-specific) as well as a monitoring framework for the implementation of CCCNs). These instruments were field-tested in two pilot sites and evaluated. The evaluation recommended that the concept is suitable for roll-out to other volunteering member states but highlights that to implement CCCNs successfully, further support and training at the policy and institutional level are necessary. We plan to dedicate to this important topic a WP and set out to further develop the access and availability of the comprehensive high quality of care in CCCNs to all EU MSs and align the high standards in cancer care for all quality assured institutions with a focus on the interfaces between care and research (CCCN and CCC). Using the tools developed in the frame of iPAAC JA (see section above) the tumor-specific CCCN approach will be expanded and field tested with another tumour-entity and a stronger focus on the patient centeredness as well as a training concept and supporting instruments for the set-up of CCCNs. Process indicator: Identification of CCCN lung cancer pilot sites, Target Value: At least two countries where CCCN for lung cancer care will be piloted Output Indicator: Development of training concepts with support instruments to enable and empower member states to set up quality assured CCCNs, Target Value: Training concept for lung cancer developed Outcome Indicator:-Implementation of the set of standards, quality indicators and patient pathway for lung cancer care in pilot-CCCN, Target Value: At least one CCCN has implemented the set of standards, quality indicators and patient pathway for lung cancer care Specific objective 4: To develop a consensus model for CCCs, both standalone centres as well as centres, which are part of University or General Hospitals The objective is to develop a consensus model for CCCs, which will incorporate the varied European experience in the organisation of cancer care, including self-standing or standalone CCCs, those that are part of CCCNs and those, which operationally and structurally belong to university or general hospitals. Process indicator: Identification of existing landscape of Comprehensive Cancer Centres and potential comprehensive cancer centres, Target Value: One exhaustive mapping exercise Output indicator: Development of a set of straightforward standards for CCCs applicable in a wide variety of centres and compatible with some existing quality and accreditation systems in Europe,Target Value: One set of standards developed Outcome indicator: A consensus model for CCCs, which will include the different typologies of CCCs in Europe. Target Value: One consensus model developed 7 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Specific objective 5: To identify and analyze the current practices and models of organisation in real-life settings as key references to assess how high-quality care and research are available to all cancer patients in a given regional and local levels through networking models. Analysis of the different models of comprehensive cancer care involving networks, be it CCCNs, molecular tumour boards or other types of networking of cancer care providers, whether involving CCCs or not. Process indicator: Analysis of best practices in Member States in molecular tumour boards (MTB) implementation in CCCN contexts, Target Value: At least one best practice per Member State Output indicator: Main CCC networking models in EU countries will be mapped, Target Value: At least four CCC models included Outcome indicator: Equity of access to MTB: Percentage of patients being discussed in MTB will be analysed for a given healthcare area, highlighting potential differences between patients treated in CCCs and patients treated in CCC associated providers within a network, Target Value: Data from at least six MTB The set out CraNE objectives are in line with the EU Better Regulation guidelines, as they fulfill the following criteria: - Embedded in planning and policy cycle – The CraNE JA is informed by a decade of work on cancer control Joint Actions, spanning EPAAC, CANCON and finally iPAAC. The work on cancer control has been informed by initial mapping work on National Cancer Control Programmes in EPAAC, recommendations from the CANCON Guide on Quality Improvement in Comprehensive Cancer Control and the iPAAC Roadmap on Implementation and Sustainability of Cancer Control Actions. - Evidence-based – CraNE objectives are based on a variety of evidence that CCCs and CCCNs are integral to high quality cancer care, spanning three previous cancer control JAs. - Participatory/open to stakeholder views – CraNE will take into account the most relevant perspectives for the objectives at hand – policymaker view, expert view and patient perspective, through inclusion in management boards within WP 1 and WP 4. - Respecting principles of subsidiarity and propotionality – CraNE sets out to further increase added value for all participating MS by establishing an EU Network of CCCs, as set out in Objective 2 - Appropriately resourced and organised – by using sound project management principles, this experienced consortium of partners will fulfill the set objectives in the most rational and efficient manner, complete with set out milestones, deliverables and detailed budgets. 1.3 Complementarity with other actions and innovation — European added value Complementarity with other actions and innovation CraNE JA builds directly on the achievements and outputs of the iPAAC JA. It will continue to develop the theme of the necessity of the integration of cancer care, research and education throughout the patient pathway, and prior to that, in the areas of prevention and screening of the population. iPAAC has successfully built upon the CanCon JA definition of Comprehensive CCCNs by defining care standards for such networks (pan-cancer) and for cancers-specific tumours (colorectal and pancreatic) and piloting those standards in two MSs (Poland and Germany). iPAAC has also defined methodologies for depicting patient pathways across networks, for quality indicators in colorectal and pancreatic, and in constructing Patient Reported Outcomes Measures (PROMs). All these tools will be capitalised upon in CraNE. The new element in the JA is the emphasis on CCCs as hubs of integrated research, education and care in the secondary/tertiary care setting. Ideally, at least one CCC or large Clinical Centre would sit at the hub of every CCCN, but the JA recognises that many CCCs or MSs have not yet established a full infrastructure of CCCNs, in order to meet the EBCP’s goal of reaching 90% of eligible patients by 2030. The first emphasis of CraNE is to establish the criteria for the creation of an EU network of CCCs throughout all MSs on a consistent basis. This vision and objectives engage all MSs equally. Furthermore, in CraNE special attention will be given to developing CCCs and CCCNs in MSs where these do not exist or where they are underdeveloped – thus driving for equality of access for patients and citizens throughout the EU. The entire project will facilitate cross-border collaboration in the three main areas of care, research and education. CraNE will be closely aligned with JANE, the JA on the creation of Networks of Excellence for specific cancers and particular conditions within cancer as well as with the CSA UNCan.eu, which also deals 8 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 with some topics relevant to the organisational framework. Formal liaison between these three projects will be ensured by governance processes and colloquia, as well as through the establishment of a coordination, which will focus primarily on the issues of common interest, which are definitions and the delineation of some of the common tasks and challenges. Throughout the duration of the JA, we will seek to contact other centres of excellence from outside the EU, namely the UK and USA, in order to increase synergy and potentially invite representatives to collaborate via online working meetings or other opportunitites for external partners, such as Stakeholder Forum or the Final Conference. 2. QUALITY 2.1 Concept and methodology Concept and methodology Outline the approach and methodology behind the project. Explain why they are the most suitable for achieving the project’s objectives. The work of CraNE JA will be built on reaching a consensus in order to define the organisational and operational framework for the EU Network of CCCs. Most of the deliverables and the central deliverable of the establishment of the EU Network of CCCs will be developed within the framework, which is the main and key product of the entire CraNE. The following methodologies will be adopted: 1) Establishment of solid relations with the representatives at the MSs level (Task 4.1: Establish process for interaction with the MS representatives) by setting up a Governmental Board with the aim of providing the discussion forum for the proposed solutions. 2) Development of a so-called ‘Maturity-level’ model that enables MS to assess how their current cancer care organisation figures in respect to the CCC/N universe. (Task4.2: Maturity model as a tool for monitoring the transition from “As is” to “To be”). To reach this objective, WP4 will closely work together with WPs 5 & 6 to ensure to collect the perspective of health authorities and end-users on (1) what are their needs/expectations and on (2) the recommendations made. Delphi analyses and SWOT exercises will be explored and subsequently incorporated. 3) Piloting the models of CCCNs and development of less mature CCCs in some MSs and/or regions could be an interesting asset to better identify the clarity and appropriateness of developed criteria/indicators by the WPs. (T4.3: Testing the Maturity model in 2/3 countries/regions as a use case) 4) Conducting of a survey within MSs (first methodology for the mapping) for the definitions of CCCs. An online survey tool will be created which allows the competent authorities and other experts to complete information about existing cancer centres or secondary cancer treatment structures within their MS. 5) Developing a coherent output integrating the outputs of the different WPs working on specific aspects of the CCC/N universe into a Blueprint for MSs including a layman section allowing all to understand this novel initiative in organisations of cancer care locally (WP 4). Task (T4.4: Develop a Blueprint for CCC and CCCN introduction into the cancer care and control) 6) Providing a solid framework (WP 5) for the creation and operation of the EU Network of CCCs, by defining the process for admission to the Network for both pre-accredited centers and new members, setting clear content, selection and evaluation criteria in strict collaboration with WP6 and WP7. It is of foremost importance to guarantee a consistent approach for CCC selection and development, avoiding variability in different MSs. The smooth running of the Network, the implementation of key decisions and the outreach of planned activities will be ensured by a governance model that delineates the decision- making process, the composition and duties of directive, executive and advisory bodies of the Network, the role of the supporting secretariat, as well as the processes to effectively connect with other relevant EU cancer policy initiatives. Available resources within the Network (e.g. expertise, research, education, samples, data, trials, core facilities) will be leveraged by devising activities to foster collaboration within the Network and with regional and local networks, and to formalize the role of patients and other key stakeholders in the co-creation of CCCs and of the Network. 7) Working out a consensus (WP 6) in a consultation process with the other WP for the Definition of the role of CCCN within the landscape of national governance of oncological care with a focus on the interfaces with CCCs (T 6.1). Based on a mixed-method approach, a training concept will be initiated that uses the identified tools to enable and empower MS to set up quality assured CCCN (T6.2). The tools developed in iPAAC will be used to define a set of standards and quality indicators for lung cancer, one of the most common tumour entities for which no uniform European quality standards currently exist (T6.3). To promote patient-centredness in CCCN and CCC, the methodology developed in iPAAC WP 10 will be applied and enhanced to create a patient pathway that can be used by lung cancer patients and 9 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 clinicians. Furthermore, interoperability guidelines for digitalization of patient pathways in CCCNs and CCCs will be prepared (T6.4). In a feasibility study the results of T6.2-T6.4 will be piloted in two MS (T6.5). 8) WP7 will through the work within T7.2 (series of standards on research, innovation, integration, prevention and education) use the methodology, which will be targeted to research of existing quality standards world-wide. The main producers of such standards in North America, Australasia and Europe are well-known and in the public domain, but this research will be supplemented by literature searches. Finally, a consensus process among stakeholders will be adopted to gain a consistent level of standards. 9) WP8 will develop its analysis through the use of the following methodologies: a) Mapping of organisational models of networks built around a CCC using a mode of hub and spoke or other models based on university hospitals for cancer care services in the EU; b) Assessment of the models of implemented pathways in different CCC networking experiences (e.g. tumour-based networks); c) Analysis of the use of network approaches between CCCs and associated providers of cancer care; d) Evaluation of the risk factors related to the return to work for cancer survivors 2.2 Consortium set-up Consortium cooperation and division of roles The CraNE JA brings together 25 Competent Authorities and 19 Affiliated Entities from 25 different countries, marking 44 partners in total. The CraNE partners are uniquely placed to implement the network of CCCs in Europe - the diagram shows the structure of CraNE partners, WP Leaders are also underlined below: -Slovenian National Institute of Public Health (NIJZ) is the central Slovene institution for public health practice, research and education. Its academic staff work on various tasks covering the areas of epidemiology of communicable and non-communicable diseases, health promotion, health protection, health system research and national coordination of preventive programmes in primary health care. The main function of NIJZ is to provide research in the field of health, protect and increase the level of health of the population by raising the awareness of population and carrying out other preventive measures. NIJZ is organised as one central unit with nine regional offices and employs over 600 staff members. NIJZ has successfully coordinated and participated in various international projects. NIJZ has also taken on the role of coordinator in 5 prominent EU-funded JAs: European Partnership for Action Against Cancer (EPAAC), Cross-border Patients’ Registries Initiative (PARENT), Development of a European Guide on Quality Improvement in Comprehensive Cancer Control (CanCon), Joint Action on Implementation of Validated Best Practices in Nutrition (Best ReMaP) and iPAAC. The majority of the Project Management Team have been working in the cancer field since the EPAAC JA from 2011 onwards. The Project coordination team in place for secretariat and financial management, as well as scientific coordination is very experienced, with over ten years of joint experience in the cancer policy field at EU level. -The team of senior and junior experts/researchers at the Institute of Oncology Ljubljana, Slovenia (OIL, Affiliated Entity) consist of clinical experts, a public health specialist and a basic oncology researcher. They have experience in the health system and its perfomance at a national and international level, with which they can contribute to the different outcomes of the proposed JA. The clinical experts will be more involved in the development and implementation of practical instruments for cancer care quality 10 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 improvement that have been/will be developed. All will participate with their specific point of view in the activities related to CCC and CCCN. -The National Institute of Public Health Austria (GÖG) employees will contribute their expertise regarding CCCs by using their competences acquired by being part of the national Oncology Advisory Board, developing the cancer framework programme and with contacts to CCCs in Austria. -Sciensano is the scientific reference in the field of public health in Belgium. For 112 years, they have supported health policy and policy-making through innovative research, analyses, monitoring activities and expert advice. An experienced team will be leading WP 4, building on previous experience leading WP 4 in iPAAC. Affiliated entity Antwerp University Hospital (UZA) is an academic centre renowned for leading clinical and customer-friendly patient care, high-quality academic education and ground- breaking scientific research with a major international dimension. With over 570 beds, the hospital offers a wide range of diagnostic and treatment services. Offering comprehensive care for patients with complex disorders, 578 physicians specializing in 38 different fields treat more than 650.000 patients every year. About 3000 employees work at UZA. - University Specialized Hospital in Active Treatment in Oncology (USHATO) is a university clinical and scientific centre for research and development in the fields of experimental and clinical oncology and it is only one of the oncology hospitals network in Bulgaria. It was established in the early fifties of the 20th century. The activities of USHATO include highly specialized diagnostic, treatment and consultancy activities to oncology patients at national level in Bulgaria as well as Centre for residency, doctorants and other postgraduate education in Medical Oncology, Radiotherapy, Nuclear Medicine as well as other various CME courses for upgrading the qualification of specialists from various oncology subspecialties. As the natural successor of the National Oncology Centre, USHATO has the leadership in organizing and coordinating the rest of Oncology centres in Bulgaria by providing them with strategy, methodology and expertise, and controlling their effectiveness in oncology patient management. -The Croatian Institute of Public Health (CIPH) is a central public health institute in the Republic of Croatia. CIPH deals with public health, health promotion and education, disease prevention, microbiology, environmental health, school medicine, mental health care and addiction prevention. CIPH’s main tasks are to plan, promote and implement measures for the enhancement of population health and reduction of health problems. It prepares and implements prevention programmes such as HPV vaccination campaigns and other health care measures aimed at promoting healthy lifestyle. CIPH was involved as a Task leader in WP9 (Screening) in the CanCon JA, and our Expert currently leads the WP3 (Evaluation) in the still ongoing iPAAC JA. Other members of the team bring a lot of experience in working on the EU projects, along with enthusiasm for improving the overall cancer care in Croatia and EU. -The Ministry of Health Cyprus (MOH-CY) and the National Cancer Committee of the Ministry will provide administrative and technical support at local level and e will give scientific knowledge and expertise in the field of cancer. -Motol University Hospital (UH MOTOL) Czechia will contribute to the state of the art governance of CCC network based on the Czech CCC network, defining the criteria for accreditation and re- accreditation of a CCC. -Ministry of Social Affairs of Estonia (MSAE) is responsible for developing strategies and coordinates the implementation of policies in the field of health. Its competencies include the leading role in coordination of public health policies, prevention of no communicable diseases and development of respective strategies. Its Affiliated Entity will be the University of Tartu (UT), who will participate via the Department of Haematology and Oncology. UT is Estonia's leading centre of research and training. It preserves the culture of the Estonian people and spearheads the country's reputation in research and provision of higher education. The UT belongs to the top 1.2% of world's best universities. -The French National Cancer Institute –Institut national du cancer (INCa) is the national agency for health and scientific expertise in oncology. INCa’s mandate encompasses all activity areas in the cancer control chain, from research to prevention and screening, to the organisation of cancer care and information for patients and their relatives. INCa is a trusted source of evidence-based information, providing reliable advice on cancer control to government and guidance to health professionals and the community. INCa drives the implementation of the French decennial strategy against cancer (2021-2030). It plays a pivotal role in maximising coordination amongst cancer control stakeholders to enhance impact. INCa has a strong European commitment and a significant experience in European projects. The French consortium is also composed of 3 Affiliated Entities: 1) UNICANCER is the only French hospital federation 100% dedicated to the fight against cancer.Through its health cooperation group (GCS), Unicancer is also the only national hospital network exclusively specialized in oncology. It brings together 18 French cancer centers and an affiliated member (Sainte-Catherine, Institut du Cancer Avignon-Provence - ICAP), all offering a public service and playing a major role in healthcare and research in France. Unicancer and its affiliated centres will be highly involved in WP5, WP7 and WP8, bringing their unique expertise as a network of French comprehensive cancer centres, with a strong focus on care, education and research. 2) The French Hospital Federation-FHF, founded in 1924, brings together more than 1,000 public health establishments (hospitals) and as many medico-social facilities (retirement homes and specialized independent care homes), i.e. almost all the establishments in the public sector. This legitimacy and its national dimension make the FHF a leading player in the health sector, and one that is all the more listened 11 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 to because it is truly trans-political, as shown by the composition of its board of directors. 3) INSERM is the only French public research organization entirely dedicated to human health. Its objective: to improve the health of all through the advancement of knowledge about living organisms and diseases, innovation in treatments and public health research. Inserm has more than 350 research structures, spread throughout France and abroad. The scientific leadership of the major fields of biomedical and health research is provided by Inserm's 9 thematic institutes. One thematic institute is dedicated to cancer. Complementarity characterizes this consortium. The expertise of each member will enable them to actively contribute to the project -The German Consortium comprises 5 institutions/organisations: BMG, DKG (Deutsche Krebsgesellschaft-the German Cancer Society), DKFZ (the German Cancer Research Centre), DKH (the German Cancer Aid Foundation) and TUD (the Technical University of Dresden). The BMG will be the competent authority and at the same time represent the consortium in legal terms. At DKFZ, more than 1,000 scientists investigate in approximately 100 research units how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The translation of the results into the clinic is conducted in the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden. DKG is the largest scientific society in oncology in German-speaking countries. We are committed to a cancer care based on evidence-based medicine and interdisciplinarity. Our aim is high quality oncological care. Therefore, our focus is on the certification of centers of oncological care, the development of evidence-based, independent treatment guidelines and patient guidance,knowledge development and knowledge transfer in oncology and reliable patient information. DKH supports high quality research projects to improve prevention, diagnosis, therapy, after-care and self-help for the benefit of cancer patients. With its programme for funding CCCs, the DKH has managed to implement a CCC- Network in Germany that sets nationwide standards for clinical cancer care (https://www.ccc- netzwerk.de/startseite.html). A CCC funded by the DKH is expected to be a major source of significant advancements in investigating the nature of cancer and in the development of more effective approaches to prevention, diagnosis and therapy. TUD in particular the Research Group Digital Health deals with the analysis, design and maintenance of information systems - primarily in the healthcare sector. The focus of research and development activities is on the theoretical foundation, design and optimization of complex information systems, as they are found in integrated care, patient-oriented and process-oriented information system design. The focus further is on the design-oriented and engineering-like problem solving of information challenges, the generation of evidence on digital healthcare solutions as well as the theoretical foundation and reflection of complex design decisions. -1st YPE mission is to provide high quality health care across the Attica Region in Greece. To achieve this, 1st YPE acts in partnership with more than forty hospitals and primary care centres from which 1 st YPE has a supervising and coordinating role. 1st YPE has an advisory role to the Greek Ministry of Health (MoH). Within the field of mission 1st YPE has the authority to hire new staff, form health policies, and guide health services, supports the development and implementation of effective prevention strategies and policies including cancer, has set up a network of cancer infrastructures to increase capacity in cancer care, develops and implements quality standards to improve quality of life in cancer patients. Affiliated Entities include 1) LAIKO General Hospital of Athens (LGHA) is one of Greece's leading healthcare providers and one of the largest Public Hospitals in Greece. It is a tertiary Hospital, which has a blend of University Departments/Clinics/Units of the Medical School of the National and Kapodistrian University of Athens and Departments/Clinics/Units of National Health System (acronym ESY). At the “Laiko” General Hospital there are clinics with scientific staff of the highest quality placing emphasis on the excellent education of the students of Medical School of National and kapodistrian University of Athens. Multidisciplinary team of experts has been involved in the development of National and International Guidelines and participated in multicenter studies focusing at diagnosis, treatment and follow-up of patients with haematological malignancies. 2) “Agios Savvas” is the largest oncological hospital in the Attica Region with many years of experience in cancer care. -National Institute of Oncology (Országos Onkológiai Intézet, OOI) has been the epidemiological, organizational, methodological, treatment, research and training center of Hungarian oncology for more than half a century. The OOI coordinates the Hungarian Oncology Network and is accredited by OECI as a Comprehensive Cancer Center (CCC, most recent accreditation completed in 2018). As such, the NIO is the only accredited CCC in Central and Eastern Europe. Members of senior management of the Institute have played a major role in defining the criteria for OECI accreditation and networking for the past decades. With these extensive experiences, the staff of the NIO can make a significant contribution to meeting the JA’s objectives, especially WP 7. -There are two main entities in Ireland who will work for CraNE - The Department of Health (DOH) and the Health Service Executive’s National Cancer Control Programme (Executive agency tasked with delivering healthcare services in Ireland, which falls under the remit of the Department of Health). The Department of Health is a public body whose role is to serve the public and support the Minister for Health, Ministers of State and the Government. The HSE’s National Cancer Control Programme (NCCP) was established in 2007 to ensure that all elements of this cancer policy are delivered to the maximum possible extent. NCCP continues to reorganise cancer services to achieve better outcomes for patients. -Alliance Against Cancer (Alleanza Contro il Cancro, ACC) is the Italian Oncology Network founded by the Italian Ministry of Health. To date, members of ACC include 28 Italian CCCs, the Italian Association 12 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 of cancer patients (AIMaC), the National Center for Hadrontherapy and the Italian National Institute of Health. The mission of ACC is to bring technological and organizational innovation from basic research to clinical practice, raising and unifying the level of care, treatment, and rehabilitation of cancer patients throughout the country. ACC operates in three main areas: translational and clinical cancer research, cancer diagnosis and therapy, education and communication in oncology. Since its foundation in 2002, ACC has regularly collaborated with the Italian Ministry of Health, assuming a leading role in numerous national and European research projects as well as networking activities. Affiliated Entities include: 1) the Italian Ministry of Health (MOH-IT) represents the central level of the Italian National Health Service and has the mission to protect the fundamental right to health of every Italian citizen. IT-MOH is the lead agency for the national health information system, and is responsible for the overall coordination of prevention programs, for management of the resources for operational health research, and for legislation on medical devices and health professionals. IT-MOH is also the main public body funding biomedical research and innovation in Italy and promotes the creation and sustainability of highly specialized and technologically advanced networks of excellence for research and care. 2) Fondazione Luigi Maria Monti-Istituto Dermopatico dell’Immacolata (IDI) is a member of the ACC Network and a centre of regional and national excellence for dermatology and oncology, where a highly specialized multidisciplinary approach is applied to diagnosis and patient care. Altogether, the Italian consortium has both technical expertise and strategic role to contribute to the success of the JA. -REUH is the largest and leading emergency multi-profile health care provider in Latvia – not only in terms of the number of treated patients per year and in terms of variety of healthcare services provided, but also with respect to the number of employed personnel. It comprises five clinical centres - the Latvian Oncology Centre, “Gaiļezers”, “Biķernieki”, Latvian Centre of Infectious Diseases, Centre of Tuberculosis and Lung Diseases. REUH works in Multidisciplinary teams ensuring that patient receives the highest possible care. As REUH consists of various profiles providing acute care, surgery, inflammations and infections treatment, cardiovascular treatment and rehabilitation and gerontology services and is a basis for residents and scientists, we believe that our professionals will provide knowledge and expertise in all areas covering this Joint Action. REUH will bring professionals in Oncology, Chemotherapy, Haematology, Radiology, Pathology, Laboratory, Education and Science. Our professionals have wide experience in collaboration between different organisations, Universities, Hospitals which has lead to great past results. -The Ministry of Health of the Republic of Lithuania (SAM LT) is an institution that exercises executive powers, carries out State administration functions established by the laws and other legal acts in the health care sector, and implements State policy in the health care sector. Mission is to form and implement health policy that ensures public health, high quality health promotion activities, and rational use of resources. Vilnius University Hospital Santaros Klinikos (VULSK) is one of the major hospitals in Lithuania, founded by Vilnius University and Lithuanian Ministry of Health, is the leading tertiary level health care and research institution in the Baltic States. It has more than 35 specialized medical centres. VULSK is a full member of 8 European Reference Networks, including the one of childhood cancer. Therefore, VULSK has the required expertise and experience to participate in WP 5. Hospital of Lithuanian University of health Sciences Kauno klinikos (Kauno klinikos (KK) is a public health care institution, providing health and personal care services at all levels, in accordance with European standards. National Cancer Institute (NCI) is the only specialised oncology institution in Lithuania. The Institute acts as the clinical cancer centre, certified and accredited by the Organisation of European Cancer Institutes (OECI). NCI implements the modern approach of individualized precision medicine services, including early and accurate cancer diagnostics, selection of appropriate treatment strategies, promotion of active prevention and monitoring programs, palliative medical care. -The National Cancer Institute of Luxembourg (Institut National du Cancer, INC), having been nominated as the Competent Authority for Luxembourg, will be a Beneficiary of this JA. The INC will form a consortium with the Luxembourg Institute of Health (LIH), as an Affiliated Entity. The INC, having participated in iPAAC, will continue its contribution to the development of European standards and best practices in the field of oncology and cancer care. It will provide feedback on different topics covered within, with a specific focus on Comprehensive Cancer Infrastructures (Comprehensive Cancer Care Networks, CCCs etc). The INC will participate in the co-development of the theoretical base and will set up selected experimental models required for the development of tools. Such tools can later be used for the implementation and management of such Comprehensive Infrastructures at the MS and at the EU level. The LIH’s mission is to have an impact on patients by performing excellent biomedical research and translating it into practice. In order to cover the required expertise for all topics related to research and innovation for Luxembourg (e.g. WP 7), senior experts from the LIH will participate in specific tasks. -The Ministry for Health (MFH) of Malta will follow all the activities of CraNE and provide input where and as necessary particularly through contributions that will highlight specificities from a small MS context. Special interest and active participation will be given to WPs 5 and 7. -Oslo University Hospital (OUS) is the competent authority for Norway and is the appointed Co-lead of WP7. OUS will fill this role in tight cooperation with the Organisation of European Cancer Institutes (OECI) as subcontractor. OUS has considerable experience related to CCCs. This originates both from being a OECI accredited CCC from 2017, from functioning as mentor for several Nordic Cancer Centres in their accreditation process the last five years and having central positions and playing an active role in the development of the accreditation system in OECI. OECI on the other hand has through its role and efforts the last decade a unique general competence on CCC systems, an overview over the status of 13 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 accreditation around Europe and detailed knowledge on the challenges of implementing a common structure in different health care systems across Europe. The combined competences of OUS and OECI will provide the co-leadership of WP7 with essential conditions to complete its tasks successfully. To secure this the two organizations will set up regular meeting points to coordinate our efforts and contributions in WP 7 (in strong cooperation with the leading role of INCA). This will also encompass our interaction with the active participation in several of the other WPs where our consortium plan to play an active role (WP4, 5, 6 and 8). Being through the CCC accreditation OUS has extensive experience on CCC related standards. This comprises both standards for research (including education) and set of governance standards of CCCs. Oslo University Hospital has specific expertise on issues of Governance of CCCs in a University Hospital context, and is a very research-active centre, working according to standards set by the OECI.. -National Institute of Public Health National Institute of Hygiene – National Research Institute, Poland (NIZP-PZHI) mission is to protect health of the Polish population through expertise, research work, monitoring and analysis of health and its determinants as well as activities in the field of health promotion and education. The Institute brings together national experts from various fields of public health. Institute deals with prevention of infectious and non-communicable diseases (including cancer) with Polish and international partners. NIZP-PZH expert was representing Poland in Concord and Eurocare study on epidemiology of cancer in European and World scale. The Institute was nominated by Ministry of Health as a Competent Authority to work in iPAAC JA, in particular on the field of increasing the quality of cancer care, including patient pathways, within the model of Comprehensive Cancer Care Network which was successfully implemented regionally in Lower Silesian Oncology Centre and completed with iPAAC certificate. The second Polish Pilot Study in iPAAC concerned national monitoring of cancer care quality and oncological care cost based on linked clinical and administrative databases. - Directorate-General of Health (Direção-Geral da Saúde) (MS) Portugal mission is to regulate, guide and coordinate activities to promote health and disease prevention, defining the technical conditions for providing adequate health care, plan and program the national policy for quality in the health system and ensure the development and implementation the National Health Plan and also the coordination of international relations of the Ministry of Health. -The Oncology Institute "Prof. Dr. Ion Chiricuta" Cluj – Napoca, Romania (IOCN) is appointed as the leading institution for WP 3 in CraNE JA based on its previous experience in coordinating the Evaluation part and due to its active involvement in CanCon. IOCN is the largest cancer institute in Romania providing preventive, curative, and palliative medical services in the field of oncology, as well as carrying out extensive teaching and research. The Romanian National Cancer Registry is also a constituent part of IOCN. -Partners in Slovakia are members of the Scientific Council of the National Oncology Institute (NOU) with a leading position in different areas of oncological care and research in Slovakia. NOU serves as a clinical research, academic and educational cooperation platform for the implementation of activities that help fulfill the Slovak National Oncology Program in five specific areas: epidemiology; research and development; prevention and screening; diagnostics and treatment; supportive care. The National Cancer Institute, which is a healthcare provider, established the National Cancer Institute. The delegated participants have expertise in different areas however they have been already working together in assessing crucial scientific questions in terms of research and cancer care in oncology, participating in updating the concept of cancer care and selecting priority clinical research areas in Slovakia for assessment. -CraNE will be developed within Spain by the Catalan Institute of Oncology (ICO) which is a public non- profit institute, created in March 1995 and assigned to the Catalan Health Service (CatSalut). ICO is a leader in cancer care in Catalonia, with a high international recognition. Its approach to the disease is comprehensive, combining, all in one organisation, prevention, care, specialised training and research. ICO comprises four centres (L'Hospitalet, Badalona, Girona and Tarragona i Terres de l'Ebre) and is an oncology referral for almost 45% of the adult population of Catalonia. Research and innovation for a better future is one of its values. ICO translational research is structured in 4 programmes (Cancer epidemiology, Hereditary cancer, therapeutic research/ProCURE Programme and Cancer Prevention and Control Program), and each programme is fully equipped in order to meet with the basic need of the investigators. ICO is one of 50 CCCs throughout Europe. Specifically the project will be developed within the Catalan Cancer Plan. ICO will support the JA at three levels: first, considering its expertise in the use of networks and based on its position as a CCC, ICO will support the deployment of research at European level. Second, its long experience in the European projects management that include organizational components will facilitate to address the set of experiences involved in the CraNE project through an integrated care perspective. Finally, the practices and knowledge accumulated in the field of cancer control and planning will contribute to reinforcing the practicality of measures developed within the framework of the project. IDIVAL will participate as an Affiliated Entity of ICO. IDIVAL will participate in WP5 and WP7, and will be one of the pilots of the action. Valdecilla Research Institute (IDIVAL; www.idival.org) is the main institution dedicated to biomedical research in the autonomous region of Cantabria. It is patronized by the University of Cantabria (UC) and the Cantabrian Health Service (Servicio Cántabro de Salud, SCS), which is the public organism in charge of providing medical assistance to the vast majority of the population (more than 99% of which is covered by public medical assistance).Nevertheless, IDIVAL included both clinically-oriented groups, as well as groups focused on more basic research, but the overall goal of the 14 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 institution is to foster high quality patient and disease-oriented translational research. The quality of IDIVAL research led the institution to be recognized as an accredited Health Research Institute (“Instituto de Investigación Sanitaria”) by the Spanish Government. -In Sweden,the competent authority will be Socialstyrelsen (NBHW). The National Board of Health and Welfare is a government agency under the Ministry of Health and Social Affairs, with a very wide range of activities and many different duties within the fields of social services, health and medical services, patient safety and epidemiology. The majority of its activities focus on staff, managers and decision makers in the abovementioned areas. NBHW produce and develop statistics, regulations and knowledge in a number of different areas, such as oncology, patient safety and eHealth. They will also bring experience with the national cancer plan and the ongoing process of accreditation of 2 CCC, Gothenburg and Lund and from CCC Karolinska University Hospital. 2.3 Project teams, staff and experts This extensive table of the project teams and staff from all CraNE partners is attached as Annex 2 to Part B. Outside resources (subcontracting, seconded staff, etc) There are a total of 14 subcontracts planned for CraNe, amounting to a total of 364,680.00 EUR or 9.72% of the total JA budget (direct costs). It is necessary to subcontract these services, as the CraNE consortium lacks the in-house knowledge for these tasks (more detailed information in Section 4). Subcontracting in CraNE can be categorised as: -Strategic expert support for key tasks, particularly in WP 6 Feasibility Study Poland, Germany and WP 7 Expert Support for CCCs from OECI/State of the art mapping exercise Norway, but also external evaluator for CraNE Croatia, -Technical support for digital solutions and piloting (WP 6 Feasibility Study Belgium, CraNE website Greece) - Dissemination and event/audit planning (patient organisations, Slovenia coordination, events in Luxembourg and Slovakia) Experts There will be a significant number of national and international experts involved in the CraNE Joint Action - 102 senior experts, researchers and advisers will be working on the CraNE Joint Action, from all Competent Authorities and Affiliated Entities. These senior experts come from 24 different European countries, ensuring a diverse range of expertise, competence and regional/local view. The specific expertise of these experts is detailed more in depth in the Annex 2- Project Teams and Staff. Additionally, several Ministries of Health and national health institutes have indicated that they will engage further national experts to participate in CraNE, most often coming from national Colleges of Oncology (Belgium), National Cancer Committees (Cyprus), Cancer Control Programmes (Ireland). Nine different experts will be subcontracted from bodies outside the Consortium to provide further oncological and technical expertise the consortium of partners lacks related to specific CCC issues (more details in 4.4 Subcontracting Table). 2.4 Consortium management and decision-making Consortium management and decision-making The CraNE JA will be led using traditional project management approaches supplemented through coordinator NIJZ’s extensive experience of coordinating other JAs and novel software solutions for project management. We will manage the JA through an experienced operational team at NIJZ (Project Management Team) dealing with day to day coordination of the JA, supplemented by a close team of WP Leaders and Partners, and finally Collaborating Partners and other key stakeholders. Our overall aim will be to track progress of JA milestones and deliverables in real-time, anticipating risks and providing mitigation measures, while closely monitoring financial expenditure and tasks as set out formally in the Grant Agreement. We will additionally use our extensive experience in having coordinated 5 other JAs to implement additional proven project management measures, such as the introduction of additional six- month financial progress reports, workshops on financial reporting, regular bi-lateral video calls between WP 1 and other WPs, monthly WP Leader video calls, close contact with HADEA and other EC bodies for 15 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 regular updating, establishing early contacts with synergistic projects and JAs at EU level to boost added value, etc. CraNE will operationally be led by the Project Management Team (close-knit team working together since 2010, bringing together scientific and project management expertise). The PMT meets once per week, where they divide tasks and provide strategic orientation for various open issues to be resolved.The next management tier is the Steering Committee (group of WP Leaders, the majority of whom have worked together over the past decade on the previous three cancer control Joint Actions). The SC will take a consensus approach to decision-making, through video calls and email communication. In order to ensure strategic oncological and expert consultation, each SC meeting will include by default an agenda point on scientific expertise and coordination, with specific focus on the work of WPs 5 and 7. To this end, the SC may also include a representative of an umbrella organisation for EU cancer patients and other invited medicial oncological experts, as deemed necessary for the specific meeting agenda. In this way, the SC will ensure strategic oncological expertise as regards the JA objectives, while also ensuring the patient and oncological perspective is inherent to strategic and expert medical decisions. All JA partners, through the JA meetings, will be updated regarding the JA progress, key deliverables and outputs, and will be consulted through video calls and email to provide consensus and input for key processes. Throughout all three tiers, HADEA and DG Sante representatives will be consulted at pivotal points throughout the JA duration in particular in regards to sustainability issues. A key added value of the CraNE JA and its network of diverse partners from across Europe is that the vast majority of the partners have worked together on some or all of the previous cancer JAs from 2011 onwards (EPAAC, CANCON, iPAAC), therefore we have a good communication network already in place and this will facilitate our good working atmosphere, allowing us to come to quick decisions without disputes. The CraNE partners shall endeavour to settle their disputes amicably. A dispute between any partners will be brought to attention of the Steering Committee (SC), which will act as a mediator and propose solutions to be agreed by the partners. The Coordinator will mediate disputes between SC members. Disputes between the Coordinator and any other partner shall primarily be settled through negotiation. The CraNE consortium shall aim to achieve decisions through a consensus approach. This approach entails discussion that aims to achieve consensus among partners in order to promptly resolve the issues at hand. Even if a unanimous decision cannot be reached, a group discussion where everyone's opinions are heard and regarded shall take place, resulting in establishing the best solution that the consortium can achieve at a given time. The consensus approach will ensure that the progress of the CraNE JA will be able to move forward in a prompt manner in order to settle the issue at hand. More details will be provided in the Project Policy and Consortium Agreement, which will be reviewed and signed by all partners. 2.5 Project management, quality assurance and monitoring and evaluation strategy Project management, quality assurance and monitoring and evaluation strategy The Project Management Team will be the key team in place that will ensure the JA is on target (Secretariat - in charge of monitoring deliverables and milestones, Project Manager - compiling reports and deliverable quality, Scientific Coordinator - facilitates expert exchange between WPs, engages stakeholders, strategic guidance for all WPs). The PMT will work hand in hand with the Steering Committee to guide the JA and mitigate any risks or delays. CraNE will use digital project management tools to ensure optimal tracking of all JA outputs and to encourage shared decision making through document sharing software, helping to facilitate a democratic and high quality control of outputs. A more in-depth diagram of the project management process for CraNE: 16 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 WP 1 will work closely with WP 3 to ensure that the various WPs are on track and meeting all process, output and outcome indicators. The evaluation team is composed of the evaluation WP Leaders from CANCON (IOCN) and iPAAC (CIPH), so both have extensive experience in quality monitoring in the field of cancer control. The quality and timeliness of project implementation will be continuously monitored by evaluation activities - checklists will allow monitoring the timeliness of activities, questionnaires that will be sent after each important meeting will assess participants' satisfaction with project processes and their quality, and a foreseen workshop will provide us with a deeper insight into WPL’s satisfaction with project’s processes and the direction of development of the JA itself. All evaluation methods and activities will be defined and described in detail in the Evaluation Strategy. Checklists will provide input into whether each indicator is reached, and, in case it happens, why some deadline was exceeded and/or why an output may differ from that originally planned. For the questionnaires, attention will be paid to achieving satisfactory response rates. To achieve this, special attention will be given to the participants’ motivation (emphasizing the importance of their input), the creation of the questions (multiple choice answers are more practical and more specific), and avoiding open-ended questions. Finally, in order to gain valuable and high-quality information, a workshop will be participants-oriented, containing engagement (to guide participants towards our topic), exploration (to generate ideas from participants), and exit (to wrap up a discussion on a particular topic and to give all participants a chance to be heard) questions. The evaluation report at M12 will assess whether the WPs are achieving all process, output and outcome indicators. The indicators will be monitored using SMART framework (Specific, Measurable, Achievable, Relevant and Time-Bound). In terms of outputs and outcomes, we will update the checklist of indicators regularly so that any future inconsistencies can be prevented and deliverables will be timely submitted. We will develop a follow-up mechanism through constant reminders so that we can be notified in advance when changes in WPs content delivery do occur. 2.6 Cost effectiveness and financial management Cost effectiveness and financial management The CraNE JA budget is very cost-efficient as the majority of costs are allocated to personnel (almost 73%). This will allow us to decrease the risks associated with outsourcing subcontractors – 10% of the CraNE budget will be allocated for external subcontractors, outsourcing only the expertise which is essential for technical and expert support of the core WPs. Only slightly over 12% of the budget is dedicated to travel and subsistence costs, as the majority of our JA meetings will be held online. Less than 5% of the budget will be dedicated to Other goods and services (technical equipment, IT tools, audits, event organisation, promotional materials, etc.). A total of just over 546 person months will be allocated to all staff working on the CraNE JA. 17 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 The financial management of the JA will be undertaken by the Project Management Team, specifically the dedicated Financial Officer. The experienced Financial Officer is well acquainted with the rules and regulations of the funding mechanism and has experience in management of JA and partner budgets. We will use dedicated project management software (4pm), which NIJZ has modified for the purposes of the specific projects we are coordinating. We will be requiring all partners to fill in timesheets and upload their financial documents (invoices, salary slips, proof of travel costs, etc.) to the system. Such a method ensures greater transparency, is more efficient and has already been used and is well-tested by NIJZ for other projects, including JAs. In this way, we will be able to have a greater overview of the partner budgets and expenditure according to the planned budget. In order to monitor expenditure, we will require partners to submit a financial progress report every six months. These reports will be carefully reviewed, with specific recommendations/action points to be issued for each partner based on their expenditure/quality of reporting. We will communicate with partners via e-mail and webinars (a series of bilateral webinars between the Project Management Team and the financial officers of the partner institutions will be organised around key financial reporting milestones, such as the interim and final reports). Additionally, each JA meeting gathering the partners will have at least one agenda point dedicated to financial management. Financial reporting will also be covered in the partnership Consortium Agreement. The Project Management Team will act as liaison on financial management between the partners and HADEA, whom we will notify if there are significant deviations from the planned budgets or partnership structure. If necessary, we will propose amendments to the Grant Agreement based on a specific need that is currently unforeseen. 2.7 Risk management Critical risks and risk management strategy Risk No Description Work Proposed risk-mitigation measures package No 1 Partners will not fulfil their 1 Deliverables will be tracked by planned obligations, will not each WPL and by the PMT, who deliver planned outputs, or will will discuss the status of all do so with significant delay, planned deliverables in the changes to consortium. reporting period at SC meetings. 1 month prior to the 18 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Likelihood: Low / Impact: High delivery of the milestone /deliverable the PMT will be in touch with the WP about the status, helping to find a solution if a delay is expected. Real-time consortium changes will be monitored for possible amendments, tasks will then be re-shifted between partners. 2 Partners will not adhere to 1 Regular 6 monthly reports will planned budget and will under be gathered by the PMT to or over spend. monitor financial expenditure and propose redistribution of Likelihood: Medium / Impact: budgets if necessary. Bilateral Medium communication will be held between the PMT and individual partners regarding expenditure, partner specific feedback will be given on budgets following every 6 month report. 3 JA Partners may not be timely 2 The Dissemination Team will be notifying the Dissemination in ongoing contact with JA Team of content for the Coordinator and WPLs. website update (website page Standardisation of procedures and newsletter). and video calls in order to proactively follow WP Likelihood: Medium/ Impact: developments. Medium 4 Not enough traffic to website, 2 Statistics on the use of the users on website not website and social channels will interacting with content, be reviewed periodically to navigating sub-pages. monitor visitor flow and increase interactivity. WP 1 and Likelihood: Medium/ Impact: 2 will engage together to Medium maximise quality of published docs. The JA visibility will be fostered by using all partner organizations’ channels (e.g. local media, national networks). 5 Risk of producing deliverables 3 A clear Evaluation strategy with that are not complete or behind task mapping. Meetings and the schedule. regular communication with partners within the WP in order to Likelihood: Low/ Impact: High clearly define the tasks and responsibilities. 6 Lower data quality for evaluation 3 Using appropriate methods to due to the possible continuation ensure the highest data quality of COVID-19 situation (if most of from online type of meetings the meetings will be held in online form) Likelihood: High/ Impact: Medium 7 Lack of institutional support for 3 Detailing the contractual the activities envisaged within obligations and resources needed the WP for successful work on the WP Likelihood: Medium/ Impact: High 19 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 8 Low interest in candidates for 4 All partnering countries could use cases function as a candidate use case, in case no other local Likelihood: Low/ Impact: High organisations wish to collaborate 9 Few attendees at GB meetings 4 Maximize the integration of GB contact with other initiatives – Likelihood: Medium/ Impact: Low close interaction with DG Santé 10 Delayed receipt of criteria from 4 Close collaboration with WPs, 7 the other WPs and 8 and WP1 to strictly manage the project plan Likelihood: Low/ Impact: High 11 No follow-up on developed 4 Close collaboration with e.g. EC- outputs JRC Knowledge Centre on Cancer Likelihood: Low/ Impact: High Risk that the WP would propose Shared risks The GB of Member States will be 12 criteria or processes of for WP 5 and critical to mitigate this risk by admission for CCCs that are not 7 building consent for the outputs of acceptable to some MS which WP 5 and 7. This GB will be would hamper the consistent convened by WP4. formation of the new EU-level network Likelihood: Medium/ Impact: High Risk that the benefits from Shared risks The entire JA should define the 13 forming a new Network of CCCs for WP 5 and benefits for research and care as a in the EU are not clearly 7 part of an early milestone of the articulated in such a way as to JA. secure ‘buy in’ and motivation of CCCs as well as MS Likelihood: Low/ Impact: High. Risk that criteria for CCCs are Shared risks WPs need to define development 14 set too high to include centres in for WP 5 and processes which allow for certain Member States, or so low 7 inclusivity and well as requiring that some centres have less continuous improvement in all motivation to improve. CCCs, whatever their baseline. Likelihood: Medium/ Impact: High 15 Partners do not deliver the 6 Closely accompany the milestones agreed upon products (e.g. of the tasks and stay in regular reports, training-concept, patient contact with all task leaders pathway) Likelihood: Low/ Impact: Medium 16 Feasibility study will not be 6 Following a strict timetable and finished in time offering constant support Likelihood: Low/ Impact: Medium Lack of partners' logistical 8 Using the kick-off meeting to 17 support in organising the disseminate rapid and different case studies (T8.2). comprehensive information on this need as well as WPL involvement. Likelihood: Low/ Impact: High Risk of selecting poor examples 8 A comparative analysis and 18 of molecular tumour board consensus discussion will be conducted to shed light on the 20 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 integration between CCCs and most advanced cases in EU health associated providers. systems. Likelihood: Medium/ Impact: High 3. IMPACT 3.1 Impact and ambition Impact and ambition — Progress beyond the state-of-the-art The main ambition of CraNE is to fulfil the main objective of delivering the organisational framework and functional profile for the Network of CCCs. As this is one of the flagships of EBCP, the complete setup of the Network will have an important impact on the future organisational models in cancer care in Europe. CraNE will prepare the design and functionalities of the EU Network of CCCs and define how the development and quality evaluation of CCCNs will enable the quality of care of CCCs to reach 90% of eligible patients by 2030. The focus will be on the added value of the EU Network, which will provide collaborations, interactions as well as research and training opportunities. The short-term effect will be in establishing closer collaboration among CCCs in the EU.This collaboration will provide the framework for broader exchanges of best practices, improvements of cancer care as well as for research. The medium-term effect will be in establishing different types of networking, cross-border collaborations and implementation projects based on the endorsement of best and good care practices within the Network. The overall impact of the JA will be to provide a complete platform for the implementation of an EU- level network of CCCs by 2025, together with a complete set of eligibility criteria, a mapping of all potential centres in the EU, an admissions process, governance systems and secretariat for the EU Network, integrated core quality standards for care for CCCs and CCCNs, education and research which take into account existing best practices, sustainability processes, recognition processes for existing centre accreditation systems, pre-selection criteria of the first centres, development processes for emerging centres, and procedures for continuous quality improvement. In addition, building on the preliminary work of iPAAC, frameworks will be established for the development and certification of CCCNs in MSs, in most cases built around recognised CCCs. Tools will be developed to support the development of CCCNs that provide access to quality care and innovative therapies, as well as equitable patient access to clinical trials and other research studies. WP4 aims to develop tools that will allow to monitor the implementation of the scenario’s into the HCS – such tools could be made available e.g. through the EC-JRC “Knowledge Centre on Cancer” The impact of the JA will be to provide a complete platform for the implementation of an EU-level network of CCCs by 2025, together with a complete set of eligibility criteria, a mapping of all potential centres in the EU, an admissions process, governance systems and secretariat for the EU Network, integrated core quality standards for care, education and research which take into account existing best practices, sustainability processes, recognition processes for existing centre accreditation systems, pre-selection criteria of the first centres, development processes for emerging centres, and procedures for continuous quality improvement. In addition, the impact will be to create a roadmap for the development of, and recognition/accreditation of, CCCNs in MSs, in most cases constructed around recognised CCCs. The roadmap/framework will address instruments for creating/developing CCCNs, achieving quality of access to high quality care including innovative therapies, and equal access of patients to clinical trials and other research studies. The target group of CraNE JA are the main actors who will be concerned in the future development of the network of CCCs: representatives of MSs, networks of CCCs, European organizations, and experts. Patient advocates and representatives will be included in the work of WPs and represented in the Stakeholder Forum organised by WP7. All actors of the target group will benefit from the JA because the EU Network will provide training opportunities, research, interactions as well as collaboration. The results of the project will be paving the way for even better cancer care, access to innovative therapies and patient access to research studies and clinical trials through the CCCNs. CraNE aims to trigger change as well. The innovative element in the JA is the emphasis on CCCs as hubs of integrated research, education and care in the secondary/tertiary care setting. It will also represent the first practical implementation of a EU-wide network of health care providers for a specific broad disease group (cf. ERNs, which are focusing on more narrowly defined categories), which represents progress beyond the state-of-the-art. 3.2 Communication, dissemination and visibility Communication, dissemination and visibility of funding 21 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 From the start of the JA, and during the phases of the development, the dissemination strategy aims to link the JA structure, methodology and outcomes/results/findings to all potential interested parties. That process will initially be established in a specific step by step approach but also it will be part of an ongoing dialogue with all participants from the MSs during the implementation of the JA. The dissemination team will be supported by communication experts, a social media manager and an ICT expert. All participants of the JA will contribute to the projects’ dissemination and communication activities. The creation of the website will become the core part of the dissemination strategy of the JA. The dissemination strategy will focus on three main activities: a) To communicate the main objectives, structure and outcomes of the project to the stakeholders in a way to inform, promote and engage relevant bodies on how to take advantage from the results of the JA. The creation of the website will become the core part of the dissemination strategy of the JA. b) To communicate scientific knowledge and information, as well as the JA results, to professionals’/ specialist audiences to inform them about the outcomes of the JA, enable them to take them up and provide guidance on how to use them. Social media will play a key role as dissemination tools. c) To bring targeted audiences together to interact (with organization of events e.g., webinar) and mainly with the establishment of a “Forum /Open Web- debate” in order to disseminate -through dialogue- the potential and the benefits of CCC development. These main efforts of the dissemination strategy will be focused to the following targeted audiences: 1 Stakeholders’ audience, to promote the re-organization and enhancement of cancer care, i.e.: patients’ bodies, specialists’ colleges, oncology hospitals (public, private) health care professionals and organizations, patient organizations, NGOs, pharmaceutical industry). 2 Health Professionals’, to address possible scientific aspects of CCCs development, i.e.: specialists’ colleges, oncology hospitals (public, private) health care professionals. 3 Influencers/Policymakers audience, to empower the potential of the CCCs introduction in the health care systems, i.e.: relevant ministries, state authorities, university departments and researchers. 4 Insurance funds, media, politicians at local, national or EU level, etc.) and other sectors of interest. The communication tools to be used are as follows: social media accounts (Twitter), stakeholders’ forums, online webinars, policy dialogues, etc. The communication strategy will have the following details: All messages will be created with the contribution of all MS aiming at reaching the specific target audiences. This means that the language used, the content, the right time to share a message, the tone, the style and the targeted audience will be strictly decided by all MS representatives before such messages become available to the target audiences. We will strictly enforce the graphic identity and statement regarding EU funding for all communication messages to all audiences. 3.3 Sustainability and continuation Sustainability, long-term impact and continuation Consensual definition of quality criteria and standards, their dissemination, and evaluation of the adequacy of local practices against the standards will help ensure not only minimal safety conditions of cancer care, but also improve access to high-quality health care and potentially stimulate optimal provision of care integrating the best of knowledge. Thus, the EU Network of CCCs should be considered as an essential partner in all EU cancer policy initiatives, and governance bodies and future activities of the Network should be sustained by EU funds as a constitutive part of the Mission on Cancer. The output of this JA will be a set of standards and processes that build on experience and approaches that have already been developed and therefore are ready for implementation. Quality assurance processes of the Network will be guaranteed by the participation of each member, and of the network itself, to the self-sustained quality assurance programs that will be appointed by the JA. These programs should be officially considered as mandatory for CCCs also at the national level. The JA’s operational and sustainable nature will be assured by defining a clear Governance Model and objectives for the future Network of CCCs. The sustainability of this project impact will be ensured by the organisational, functional, legal, and financial model proposed for the Network. This process will require an active involvement of the EC, especially of DG SANTE and DG RTD. Continuation will be ensured through the implementation project, which will be set up after the completion of this JA. The Implementation project will ensure that the conceptual framework and the resulting proposed solution should be sustainable and provide the base for the successful functioning of the Network. This implementation might include hosting independently within the EC-JRC, or in a new EU Virtual Cancer Institute, or in a body created as a result of the UNCan.eu CSA. Regarding the complementarities, further sustainability will be achieved through interaction with the existing European Reference Networks, and the new Centres of Excellence to be created as a result of JANE JA. This will also represent the gateway for the communication and interaction with the established ERNs. Furthermore, the following consensus documents and processes will be delivered by CraNE: 1) The organizational, functional, legal, and financial model proposed for the Network. 2) Sets of standards and processes in research, care and education for CCCs which are directly ready for implementation 22 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 both by the Commission and by MSs. 3) A new set of standards, quality indicators, and processes for networks in lung cancer 4) PROMs and PREMs for identified cancer sites, e.g. lung cancer. 5) Maturity model for CCCs and CCCNs. Special attention will be dedicated to the interaction with the developments under the Action ‘New Cancer diagnostics and treatments for all’. As a preparatory JA for the creation of an EU Network of CCCs with a framework for developing CCCNs, we expect the European Commission to launch further initiatives for the implementation of the outputs of this JA through using various instruments. 23 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 4. WORK PLAN, WORK PACKAGES, TIMING AND SUBCONTRACTING 4.1 Work plan Work plan Provide a brief description of the overall structure of the work plan (list of work packages or graphical presentation (Pert chart or similar)). JA CraNE will be organised in a total of eight Work Packages, four of which are standard, while four represent the core tasks on the contents of the project. The four horizontal work packages will be provided for by Slovenia - WP1, Greece - WP2, Romania and Croatia - WP3, while WP4 on sustainability will be provided jointly by Belgium and Poland. The work of the core packages can be seen as two pairs of WPs. In other words, WP5 and WP7 represent work on the EU Network of CCCs, where WP5 is providing the theoretical, practical and administrative framework, while WP7 is providing for the standards of care, research, education and training tasks. They are complementary and will be closely coordinated. On the other hand, WP 6 and WP8 focus on CCCNs. WP6 will further elaborate on the standards and quality of care of CCCNs and their relationship with CCCs, while WP8 will focus on the different organisational models of CCCNs in the EU MS, including the variations in their relationship with the respective CCCs (or even their absence thereof). The Work Plan will be coordinated by WP1, who will be responsible also for the external coordination with other closely related projects, such as JANE and UNCAN.eu. WP1 will work closely together with WPL of all core packages and in turn with the WPL of WP4 in order to secure the sustainability and feasibility of the proposed solutions. The linkages between WPs are shown in the diagram to the right. 24 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 4.2 Work packages and activities Work Package 1 Work Package 1: Coordination Duration: M1-M24 Lead Beneficiary: NIJZ Objectives ▪ The main objective of the Coordination Work Package is to ensure that the CraNE JA achieves its general and specific objectives, whilst also meeting all necessary reporting and financial requirements, though sound project management principles. Activities (what, how, where) and division of work Task No Task Name Description Participants In-kind Contributions (continuous numbering and Subcontracting linked to WP) (Yes/No and which) Name Role (COO, BEN, AE, AP, OTHER) T1.1 Management and Meeting The Management and Meeting Structure for the JA NIJZ and All Partners COO, BEN Yes, Structure will consist of a: 1) Project Management Team (BEN and AE) (0.7 PM (PMT) as an internal working group of per BEN) S2.2 - Patient administrative, financial and scientific support and AE Organisations and within NIJZ. The team will be comprised of the (0,25 PM 25 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project Manager, Scientific Coordinator, Financial per AE) for Groups (NIJZ) - Officer, Secretariat and researchers. The team will all WP 1 15.000 EUR meet at least once per week to discuss daily tasks management issues. The PMT will act as liaison between all partners and HADEA. 2)JA Steering Committee (SC) as the main oversight committee of the Joint Action. The SC will be comprised of the WP Leaders, PMT, representatives of the European Commission and other invited experts, if necessary. The SC will meet at least four times over the course of the JA and may meet more often virtually. The objective of the SC will be to monitor the overall progress of the JA and accept action plans on specific issues, where needed. In order to ensure strategic oncological and expert consultation, each SC meeting will include by default an agenda point on scientific expertise and coordination, with specific focus on the work of WPs 5 and 7. To this end, the SC may also include a representative of an umbrella organisation for EU cancer patients and other invited medicial oncological experts, as deemed necessary for the specific meeting agenda .The patient representative and other medical experts will act as key scientific advisors, reviewing all key deliverables and milestones set forth by the WPL. 3) JA meetings consisting of representatives of all Partners and the PMT. The meetings will be held to discuss progress on JA objectives with the entire consortium. Workshops on financial reporting will also be part of specific meetings prior to the submission of the interim and final reports. Three JA meetings will be held over the course of the JA. 4) Final Conference, to be held in M 24. The Final Conference will bring together all stakeholders to discuss the final outputs of the JA and discuss sustainability of project outcomes. As a particular activity of the WP1 co-ordination with other closely-related projects will be carried out. In the first place, these are JANE and 26 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 UNCAN.eu. As they need to have harmonised definitions and conceptualisation, co-ordination across the three projects will be essential. It will be done by the CraNE scientific co-ordinator, Tit Albreht. T 1.2 Preparation of key project The PMT will prepare a series of key JA NIJZ COO No documents documents, such as the Consortium Agreement, Project Policy (listing all key JA processes and procedures) and Financial Policy (listing all key financial rules, guide on use of 4pm, tips and help to submit reports). T1.3 Reporting and financial The PMT will manage the submission of the Final NIJZ and All BEN COO, BEN No management Technical and Financial Reports for the JA, as well as the continuous reporting requirement on the Participant Portal. In addition to the mandatory reporting requirements, we will require partners to submit regular six-month financial reports, in order to effectively monitor financial expenditure. The project management system for financial reporting 4pm will be used to compile financial reports. Milestones and deliverables (outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification (continuous numbering No (month number) not linked to WP) MS1 Kick-off meeting 1 NIJZ Kick-off meeting to be held with the M1 Report held with minutes entire JA consortium and attendance lists 27 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 MS2 Project and 1 NIJZ The two key JA documents are M4 Two key documents, Financial Policy prepared and accepted by all partners, agreed upon by all detailing tracking of project deliverables partners and financial management Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description (continuous numbering No Level (month number) (including format and linked to WP) language) D1.1 Report from kick- 1 NIJZ R – Document, PU — Public M2 Summary report from off meeting CraNE JA kick-off report meeting for dissemination to key target audiences and wider stakeholder community in order to increase active participation in JA from onset D1.2 Final Report 1 NIJZ R — Document, PU — Public M24 Final report produced report detailing the achievements and financial progress for the entire JA, with focus on outputs and sustainability 28 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Work Package 2 Work Package 2: Dissemination Ensure consistence with the detailed budget table (if applicable). Duration: M1 – M24 Lead Beneficiary: 1st YPE Objectives The specific objective of this WP is to disseminate all the activities and outcomes of the overall progress of the WPs and inform all the related stakeholders (WP leaders, MS participants/ representative of the JA, patient associations, NGOs, professional organizations, Ministries of Health, policymakers, hospitals and treatment centres etc). Other objectives are: ▪ To ensure the dissemination of the main recommendations, and deliverables have been developed in CraNE JA, ▪ To create a dissemination strategy for the JA, ▪ To Provide a network of experts and/ or organizations for sharing experience, information and data and to communicate fundamental outcomes, for the improvement of cancer care across MSs (European Union Countries/ European Economic Area), ▪ To increase awareness of cancer prevention, cancer care and cancer control in the general public and main stakeholders. Activities (what, how, where) and division of work Task No Task Name Description Participants In-kind Contributions (continuou and Subcontracting s (Yes/No and which) numbering linked to WP) Name Role (COO, BEN, AE, AP, OTHER) 1st YPE and all T2.1 Structure and deliver a robust This task aims to: COO, BEN No Partners (COO, Dissemination Strategy (0.7 PM BEN, AE) per BEN) 29 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 1. Target groups identification/ orientation to and AE include them in the targeted JA groups: (0,25 PM a. Stakeholders (Patient organizations, per AE) for Specialists’ Colleges, Oncology Hospitals - all WP 2 Public or Private, Health professionals) tasks b. Influential groups (State Authorities, University Dpts, insurance funds, journalists, researchers policymakers) 2. Mapping a structured dissemination strategy including components of: (i) Means (set of e-tools: SITE, newsletter, TWITTER, prof - ca - portal) and (ii) Communication methods /tools (a) Logo (making sense and attracting attention), (b) communication approaches (suitable for each of the above categories - interested parties), (c) events to strengthen JAs impact (iii) Confirm that the Strategy is suitable for the needs of all MSs 3. Establish the procedures to ensure productive co-ordination, communication and promotion of the JA activities 1st YPE and all T2.2 Development and maintenance of the This task aims to: COO, BEN Yes- Partners (COO, CraNE website and graphic identity. and AE ● Design and establish the CraNe LOGO BEN, AE) S 2.1. - Website identity, to be used by all MSs in all their development (1st Dissemination activities, YPE) - 15.000 EUR ● Create the CraNe website to publish all the achievements, available evidence and updates that are produced by all WPs. Maintain a website also 5 years after the end of the JA. ● The website will be maintained during the whole program period to provide info about core topics of the JA (as WPs outcomes) or 30 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Member States / partners’ actions (as communication events), ● Steer the WP2 action towards deepening the MSs active participation in all aspects: sharing activities, writing articles or short promoting/ informative notes 1st YPE and all T2.3 Development of additional This task aims to: COO, BEN Yes- Partners (COO, communication tools (e-tools, social and AE media or leaflets to target individual ● Develop further and broader tools, like the BEN, AE) S2.2 - Patient stakeholder groups) Social Media, towards enhancing Organisations and communication (delivering messages and Groups (NIJZ) - evidence) to the targeted audience - to be 15.000 EUR determined in the dissemination strategy, ● Organize (1-2) events to communicate the JA in all other MS, (4-6) online webinars, ● Establish “Stakeholders Forum - Open Policy Debate” regarding the CCCNs potential, i,e. discuss the usefulness to the patients and communicate the views and/or advantages for the professionals’ (one-time event). Milestones and deliverables (outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification (continuous No (month numbering not linked number) to WP) Logo and visual identity MS 3 Dissemination 2 1st YPE Logo of JA, design of key documents, M2 agreed upon within the Strategy /Graphic design of JA leaflet in pdf WPL team with key identity and document templates leaflet prepared. CraNE website Website online and fully MS 4 2 1st YPE A website will be developed to support M2 functional with key all the data and information of the JA. functionalities in place. 31 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 The content will be updated monthly to provide key stakeholders with relevant information. Creation of social media MS 5 Broader 2 1st YPE A list of tools, including social media, will M6 accounts, organized communication be created to maximize the events, published tools (events, communication efforts in order to reach newsletters (8 in total). webinars, the targeted audience and stakeholders. newsletter and CraNE envisages the use of Twitter and online debate) Linked In. Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description (continuous No Level (month (including format and numbering linked to number) language) WP) R - Document, Sensitive D 2.1 Dissemination 2 1st YPE M2 In the first month of the Report Strategy project, a JA dissemination plan will be developed to describe the steps and methods to achieve this plan. All partners should contribute to this plan. Roles, responsibilities deadlines and milestones of each partner will be discussed to clearly address the objectives of JA. R - Document, Public D 2.2. Dissemination 2 1st YPE M 24 Report detailing the Report Report dissemination activities throughout the JA, with key events and outcomes described, as well as how target groups were approached 32 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Layman’s Public D 2.3 version of final 2 1st YPE R - Document, M 24 Report of the CraNE JA report (in simple Report in layman’s terms, meant language for for general public and key general public) stakeholders, for wide dissemination through different channels Work Package 3 Work Package 3: Evaluation Ensure consistence with the detailed budget table (if applicable). Duration: M1-M24 Lead Beneficiary: IOCN, co-lead CIPH Objectives ▪ To evaluate whether the JA as a whole has produced planned results, delivered expected benefits, and made desired change (evaluation of process, outputs and outcomes). Other objectives include: ▪ To evaluate if project processes are going according to plan ▪ To evaluate whether the participants (WP leaders, stakeholders, MS representatives, etc.) are satisfied with the project’s processes ▪ To assess the outcomes of iPAAC Joint Action ▪ To monitor whether deliverables are produced on time and in accordance with the proposed objectives (JA outputs) ▪ To evaluate the ability to implement the new findings of this JA in Member States (the implementability factor; JA outcomes) Activities (what, how, where) and division of work Task No Task Name Description Participants In-kind Contributions (continuou and Subcontracting s (Yes/No and which) 33 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 numbering linked to WP) Name Role (COO, BEN, AE, AP, OTHER) T3.1 Evaluation strategy with survey Development of cohesive evaluation strategy CIPH and all Partners COO, BEN Yes- S3, External creation including creation of surveys that are going to be (BEN, AE) (0.7 PM evaluator (CIPH) - sent out to the participants after key meetings per BEN) 3.000 EUR and AE (0,25 PM per AE) for all WP 3 tasks T3.2 Workshop creation Workshop with WPLs with the aim of gaining a CIPH and all Partners COO, BEN No deeper insight into satisfaction with JA processes (BEN, AE) and AE and the direction of development of the JA itself T3.3 Checklist Creation of checklist of process, output and IOCN and all Partners COO, BEN No outcome indicators for WPs 4-8 (BEN, AE) and AE Milestones and deliverables(outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification (continuous No (month numbering not linked number) to WP) MS 6 Indicators 3 CIPH List of process, output and outcome M2 SMART indicators indicators prepared and confirmed for prepared with WPs 4-8 cooperation of all WP Leaders, accepted by Steering Committee 34 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 MS 7 WP Leader’s 3 CIPH, IOCN Workshop with WPLs to ascertain M14 Workshop Report Workshop qualitative interviews and in-depth insight into WPs and stakeholders Interim MS 8 report 3 IOCN, CIPH Key interim strategic document for M12 Document available on evaluation of the CraNE Joint Action - the official web site contains the analysis of JA progress, evaluates the level of accomplishment of each WP's objectives Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description (continuous No Level (month (including format and numbering linked to number) language) WP) Sensitive D3.1 Evaluation 3 CIPH, IOCN [R — M4 Key strategic document Strategy Document,report] for evaluation of the CraNE Joint Action - contains all the basic elements of process evaluation, including key evaluation objectives and key process evaluation activities. PU- Public D3.2 Evaluation 3 IOCN, CIPH [R — M24 Report summarizing the Report Document,report] results of the process evaluation indicators (questionnaires after important meetings, WPL’s workshop summary, documents, deliverables analysis) andan overview of outputs, outcomes and implementability of the JA. 35 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Work Package 4 Work Package 4: Sustainability Ensure consistence with the detailed budget table (if applicable). Duration: M1 – M24 Lead Beneficiary: Sciensano, co-lead NIZP-PZH Objectives List the specific objectives to which this work package is linked. - To endorse the sustainability of the outputs of the CraNE Joint Action towards future implementation into cancer care structures in the Member States Other objectives: -Establish a workable interaction with the MS policy makers -Develop a tool to monitor the transgression towards the novel cancer care organization including pilot/use case experiences -Develop a Blueprint for establishing the novel cancer care organization into local cancer care -Establish a workable interaction with the MS policy makers to evaluate the readiness of HCS to integrate the scenarios developed in CraNe -Develop a tool to monitor the transgression towards the novel cancer care organization including feasibility approach and pilot/use case experiences -Develop a Blueprint for establishing the novel cancer care organization into local cancer care The WP4 endorses the sustainability of the outputs of this JA towards a future implementation into the cancer care in the Member States. It is thus uttermost important to establish a solid relation with the representatives at the MSs level. As raised by various members in the Governmental Board of the Joint action iPAAC, collecting and integrating all outputs from the numerous initiatives in the EBCP is a major challenge for the Healthcare policy makers. (Task 4.1: Organisation of the Governmental Board of the Joint Action). As a second task, this WP will develop a framework to support MS in developing and establishing either two of the proposed cancer care structures within their Healthcare systems: a CCC centres based system of a CCC network based system or any intermediate/alternative organisation. It is clear that the current organisation and contextual factors are major drivers in such development. WP4 will integrate the conclusions of W5-8 in this framework. For this, WP4 will develop a so-called ‘Maturity-level’ model that enables MSs to assess how their current cancer care organisation figures in respect to the CCC/N universe 36 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 To reach this objective, WP4 will closely work together with WPs 5 & 6 to ensure to collect the perspective of health authorities and end-users on (1) what are their needs/expectations and on (2) the recommendations made. Here for, surveys, Delphi analyses and SWOT exercises could be explored. (Task4.2: Maturity model as a tool for monitoring the transition from “As is” to “To be”). To test and sharpen the thinking on development of CCC/N organisation of cancer care, use cases in some MS/regions could be an interesting asses to better identify the clarity and appropriateness of developed criteriaby the WPs. As context and level of organisation in the MS are key determinants in the introduction of this novel cancer care organisation in the HCS, it would be good to identify a number of candidates to participate in the model development based on their different local organisation. (T4.3: Testing the Maturity model in volunteered countries as a use case ) Finally, the WP4 will ensure to develop a coherent output integrating the outputs of the different WPs working on specific aspects of the CCC/N universe into a Blueprint for Member states including a layman section allowing all to understand this novel initiative in organisations of cancer care locally. Task (T4.4: Develop a Blueprint for CCC and CCCN introduction into national cancer plans or strategies). Activities (what, how, where) and division of work Task No Task Name Description Participants In-kind Contributions (continuou and Subcontracting s (Yes/No and which) numbering linked to WP) Name Role (COO, BEN, AE, AP, OTHER) T4.1 Organisation of the Governmental Governmental Board will consist of Member Sciensano, INCa and COO, BEN No Board of the Joint Action States representatives who will track the work of all Partners (BEN, (0.7 PM the CraNE JA, with special focus on AE) per BEN) implementability and sustainability and AE (0,25 PM per AE) for 37 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 all WP 4 tasks T4.2 Maturity model as a tool for Develop a model for estimating the level of NIZP-PZH, COO, BEN Yes- S4, Expert monitoring the transition from “As is” transgression from the current organisation of Sciensano and all and AE consultation/ to “To be” cancer care towards an organisation based on Partners (BEN, AE) supervision for CCC/CCCN different Maturity Model structures (NIZP-PZH - 4,000 EUR), also applies to Task 4.3. Yes- S7.2 OECI expert input on CCCs, also applies to Tasks 4.3 and 4.4. T4.3 Testing the Maturity model in Testing a model in different scale to reveal areas NIZP-PZH, COO, BEN See above volunteered countries as a use case of strengths and also gaps in capability to develop Sciensano and all and AE the best solution of transgression from the current Partners (BEN, AE) organisation of cancer care towards an organisation based on CCC/CCCN T4.4 Develop a Blueprint for CCC and Best Practices for CCC and CCCN introduction Sciensano, NIZP- COO, BEN See above CCCN introduction into national into the cancer care and control PZH and all Partners and AE cancer plans or strategies (BEN, AE) Milestones and deliverables (outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification (continuous No (month numbering not linked number) to WP) MS 9 GB Process 4 Belgium Establish an integrated process to M3 Number of MS manage the interaction with MS representatives policymakers participating in GB (at least 20) 38 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 MS 10 Maturity Model 4 Poland Develop the conceptual framework for M6 Report - Publication Concept the scenario setting and a maturity model MS 11 Identification of 4 Poland Protocol on testing the conceptual M 12 At least 3 participating countries to test framework – identification of testing MS countries the Maturity Model MS 12 Testing the 4 Poland Execution of testing the conceptual M 21 Report - publication Maturity Model framework, including reporting Concept Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description (continuous No Level (month (including format and numbering linked to number) language) WP) D4.1 Blueprint of the 4 Sciensano R — Document, PU — Public M 23 Report - publication development and report] Integration of comprehensive cancer care scenarios into cancer care and control 39 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Work Package 5 Work Package 5: The EU Network of Comprehensive Cancer Centres: composition, governance, joining process, and functioning Ensure consistence with the detailed budget table (if applicable). Duration: M1 – M24 Lead Beneficiary: ACC Objectives List the specific objectives to which this work package is linked. ▪ To create a European network of national CCCs to improve cancer care and avoid the unacceptable disparities currently present across the EU Other objectives: ▪ To develop a governance model for the EU Network of CCCs ▪ To guarantee a high standard of care and research in each CCC through a continuous update mechanism ▪ To foster collaboration within the Network and with other European initiatives WP5 aims to provide a solid framework for the creation and operation of the EU Network of CCCs, addressing the challenges to obtain a consistent approach to selection and centre development, as well as to define an effective governance system that reflects and supports the Network’s mission. Comprehensive Cancer Centres are vital institutions for integrating high quality care and research. International quality accreditation mechanisms already exist, and many CCCs already adhere to them. One of the main objectives of WP5 is to build on experience and approaches already developed, and to identify accredited centers to establish the foundation of the Network. At the same time, rules of admission for new CCCs need to be defined, in close collaboration with WP6 and WP7, with a flexible approach that takes into account the regional context, but sets clear content, selection and evaluation criteria. For the EU Network to become fully operational and achieve its mission, it is of paramount importance to develop a governance model that delineates the decision-making process, for key matters as well as for daily management. WP5 will oversee the definition of the composition and duties of the governance bodies of the Network, and of the supporting secretariat. Ultimately, networking is a strategy to reduce inequalities in care, strengthen the quality of research, and integrate clinical care and research. WP5 will ensure that available resources (e.g. expertise, research, education, samples, data, trials, core facilities) will be leveraged by devising activities to foster collaboration within the Network, to create links to other relevant EU initiatives and to actively engage patients and other key stakeholders. Activities (what, how, where) and division of work 40 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Task No Task Name Description Participants In-kind Contributions (continuou and Subcontracting s (Yes/No and which) numbering linked to WP) Name Role (COO, BEN, AE, AP, OTHER) T5.1 Creation of the EU Network of CCCs ACC BEN T5.1.1 Definition of the process for admission Recognition and selection of pre-accredited ACC, MOH-IT, IDI, BEN, AE Yes – S7.2 OECI, to the EU Network. CCCs through already existing accreditation CIPH, DKH, OUS, also applies to Tasks programs. Definition of the process for UNICANCER, FHF 5.1.2, 5.2.1, 5.3.1, accreditation of not already accredited CCCs. 5.3.2, 5.3 T5.1.2 Definition of the criteria for ongoing Delineation of continuous processes for ACC, MOH-IT, IDI, BEN, AE See above OECI development of the EU Network of monitoring and benchmarking. CIPH, DKH, OUS, CCCs FHF T5.2 Development of a governance model ACC BEN T5.2.1 Definition of governance rules for the Definition of the composition and role of a ACC, MOH-IT, IDI, BEN, AE See above OECI efficient coordination of the activities of decision-making body, to guarantee the smooth DKH, OUS, the Network running of the network, adopt the legal ,UNICANCER, FHF, framework for collaboration with third parties, VULSK , UH MOTOL and develop funding strategies for long-term sustainability; Definition of the composition and 41 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 role of a strategic executive board to implement decisions, assess outcomes, ensure outreach. T5.2.2 Creation of a permanent secretariat Definition of the composition and role of a ACC, MOH-IT, IDI, BEN, AE No permanent secretariat to support internal and DKH, UNICANCER external activities of the Network. T5.3 Strengthening clinical care and ACC BEN research through networking T5.3.1 Design of collaboration activities of Definition of activities to foster collaborations ACC, OUS, BEN, AE See above OECI national CCCs within the European aimed at improving care, education and research context INSERM T5.3.2 Link to other EU cancer policy initiatives Identification of existing EU initiatives relevant to ACC, BEN, AE See above OECI the mission of the Network; identification of processes and resources to enable the EU UNICANCER, Network to link with those initiatives INSERM T5.3.3 Stakeholder involvement and patient Identification of relevant stakeholders; definition ACC, FHF, BEN, AE See above OECI engagement of the processes for ensuring the involvement of stakeholders, citizens and patients in the INSERM strategy of the EU Network. Milestones and deliverables (outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification (continuous numbering No (month not linked to WP) number) 42 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 MS 13 Draft agreement 5 ACC Agreement on accreditation principles M12 Interim meeting reports on process for by governance boards of MS and admission and approval in principle of the future governance governance of the EU Network model of the future EU Network Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description (continuous numbering No Level (month (including format and linked to WP) number) language) PU D5.1 Process for 5 ACC R – Document, M14 Agreed process membership of Report (including accreditation) CCCs to the EU for admission of CCCs to Network the Network; process for ongoing development; initial list of CCCs in the EU Network D5.2 Integration with 5 ACC R – Document, PU M18 Identification of existing EU and national Report EU initiatives relevant to initiatives the mission of the Network; identification of processes and resources to enable the EU Network to link with those initiatives D5.2 Governance 5 ACC R – Document, PU M24 Governance model for Model and Report the efficient coordination operating of the activities of the procedures Network and the 43 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 supporting permanent secretariat Work Package 6 Work Package 6: Organization of comprehensive, high-quality cancer care in Comprehensive Cancer Care Networks (CCCNs) Ensure consistence with the detailed budget table (if applicable). Duration: M1 – M24 Lead Beneficiary: DKG Objectives List the specific objectives to which this work package is linked. ▪ To further develop the access and availability of the comprehensive high quality of care in CCCNs to all European member states (MS) and align the high standards in cancer care for all quality assured institutions with a focus on the interfaces between care and research (CCCN and CCC). Using the in iPAAC developed tools (see section above) the tumor-specific CCCN approach will be expanded and field tested with another tumour-entity and a stronger focus on the patient centeredness as well as a training concept and supporting instruments for the set-up of CCCNs. Comprehensive Cancer Care Networks (CCCNs) together with CCCs will be the foundation to reach the goal of EBCP to ensure high standards in cancer care and delivering higher quality care. In the previous Joint Actions (JA) CanCon and iPAAC Comprehensive Cancer Care Networks (CCCN) where defined and successfully piloted with the aim to ensure higher-quality care and reducing inequalities across the EU. And with this approach achieving that 90% of the patients benefit from diagnosis and treatment close to home till 2030. The proposed WP is therefore a continuation of the theoretical framework of CCCNs developed during the JA CanCon and its translation into practice which was successfully achieved in WP 10, “Governance of integrated and comprehensive cancer care” of JA iPAAC. In iPAAC, WP 10 developed practical instruments to govern oncological care successfully (e.g., methodology to develop tumour and stage specific patient pathways and to derive quality indicators, Set of Standards for CCCNs (generic and tumour-specific) as well as a monitoring framework for the implementation of CCCNs). These 44 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 instruments were field-tested in two pilot sites and evaluated. The evaluation recommended that the concept is suitable for roll-out to other volunteering member states but highlights that to implement CCCNs successfully, further support and training at the policy and institutional level are necessary. Activities (what, how, where) and division of work Task No Task Name Description Participants In-kind Contributions (continuous and Subcontracting numbering (Yes/No and which) linked to WP) Name Role (COO, BEN, AE, AP, OTHER) T6.1 Definition of Comprehensive Definition of the role of CCCN within the DKG, ICO (co-lead), BEN, AE Yes - S 6.1., Two Cancer Care Networks (CCCN) landscape of national governance of IOCN,INC, OUS, External Experts on and its interfaces with oncological care with a focus on the Sciensano,OI, DoH, CCC (DKH) - 25,000 REUH, ACC, NCI, EUR (relevant also Comprehensive Cancer Centres interfaces with Comprehensive Cancer FHF, UH MOTOL, for Tasks 5.1, 5.2, (CCC) Centres (CCC) (joint task with WP8 task 5) DKH, UZA, MoH-CY, 7.1, 7.2, 8.1., 8.3) MSAE, , 1ST YPE, ATTICA, NCI, ACC, S 7.2. OECI, also SAM applies to Tasks 6.2 and 6.3 T6.2 Development of support Development of a training concept with NIZP-PZH, DKG, BEN, AE See above OECI instruments to set-up CCCN in instruments to enable and empower member INC, IOCN, OUS, OI, different member states states to set up quality assured CCCNs REUH, FHF, Agios Savvas T6.3 Development of Set of Standards Apply the instruments developed under JA DKG, TU Dresden, BEN, AE Yes - S 6.2, Medical and Quality Indicators for Lung iPAAC to other tumor entities and derive a INC, NIZP-PZH, Oncology Expert Cancer Care Set of Quality Indicators for Lung Cancer IOCN, OUS, (lung cancer) (INC) 45 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 and develop a Set of Standards for lung OI, REUH, Agios for Tasks 6.3 - 6.5 - cancer care. Savvas, FHF 16,080 EUR See above OECI T6.4 Enhancing patient centeredness To promote patient-centredness in CCCN TU Dresden, DKG, BEN, AE No in CCCNs with patient pathways and CCC, the methodology developed in NIZP-PZH, OI, KK, iPAAC WP 10 will be enhanced and applied FHF, to create a patient pathway that can be used USHATO by lung cancer patients and clinicians. In addition, interoperability guidelines for digitalization of patient pathways in CCCNs and CCC will be prepared. T6.5 Feasibility study: implementation Conducting a feasibility study for the results DKG, NIZP-PZH, BEN, AE Yes - S6.3. Pilot of results from task 2-4 in two developed under tasks 2 – 4 in two pilot INC, Sciensano, OI, Network (INC) - pilot-sites sites in two member states. 6,500 EUR, KK, MS S6.4, Pilot digital Piloting digital solution for QI data collection solution (Sciensano) in 1 pilot-site - 30,000 EUR, S6.5.CCCN peer review (DKG) - 17,100 EUR, S6.6 Feasibility site (NIZP-PZH) - 10,000 EUR Milestones and deliverables (outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification (continuous numbering No (month number) not linked to WP) 46 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 MS 14 Set of Standards 6 DKG Set of Standards and Set of QI for Lung M 12 Documents are finalized and Set of QI for Cancer have been developed and agreed in the WP Lung Cancer MS 15 CCCN set-up 6 NIZP-PZH CCCN set-up training concept M 18 Concept is finalized and training concept developed agreed in the WP MS 16 Set-up of two 6 DKG Two CCCN for Lung Cancer have been M 24 Peer-review and CCCN for Lung set-up awarding of certificate Cancer Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description (continuous numbering No Level (month number) (including format and linked to WP) language) SEN — Sensitive D6.1 Definition and 6 DKG R — Document, M24 Definition of description of report Comprehensive Cancer interfaces. Care Networks (CCCN) and its interfaces with Comprehensive Cancer Centres (CCC) PDF; English D6.2 Training concept 6 NIZP-PZH R — Document, SEN — Sensitive M18 Development of support for set-up of a report instruments to set-up CCCN CCCN PDF, English D6.3 Set of Standards 6 DKG R — Document, SEN — Sensitive M12 Set of Standards and set for Lung Cancer report of quality indicators for Care and Set of lung cancer will be 47 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Quality developed and Indicators for implemented in CCCN Lung Cancer Word, English D6.4 Patient Pathway 6 DKG R — Document, SEN — Sensitive M18 Enhancing patient for Lung Cancer report centeredness in CCCNs Patients with patient pathways PDF, English D6.5 Set-up of two 6 DKG DEM —pilot SEN — Sensitive M24 Certified CCCN for Lung CCCN for Lung Cancer including Cancer implementation of deliverables 6.2-6.4 48 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Work Package 7 Work Package 7: Framework and criteria to enable the implementation of Comprehensive Cancer Centres within an EU Network Ensure consistence with the detailed budget table (if applicable). Duration: M1 – M24 Lead Beneficiary: INCa, Co-lead: OUS Objectives List the specific objectives to which this work package is linked. ▪ To develop a consensus of Comprehensive cancer centers, both standalone centres, and centres which are part of University or General Hospitals The specific objective is to establish a framework to enable the implementation of Comprehensive cancer centres (CCCs). WP7 aims to map the existing landscape of Comprehensive Cancer Centres and potential comprehensive cancer centres for the purposes of the proposed EU network. In this mapping it will need to take into account different health systems and organisation of secondary/tertiary cancer care and research. One important aspect to cover is the position of University Hospitals and very large General Hospitals treating many cancer patients which have not yet formed themselves into high-performing Cancer Centres incorporating research. Recommended governance structures will be defined by this WP. The main tasks of WP7 concern the construction of consensus quality standards for research, innovation, prevention, integration with care, education, and governance for CCCs. These core standards need to be straightforward and applicable in a wide variety of centres, and compatible with some existing quality and accreditation/certification systems in Europe. The WP also needs to design processes for centres which are not yet in readiness to be able to develop, and processes for all centres to actively improve care, research and education. Activities (what, how, where) and division of work Task No Task Name Description Participants In-kind Contributions and Subcontracting (continuOU S Name Role (Yes/No and which) numbering linked to (COO, WP) BEN, AE, 49 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 AP, OTHER) T7.1 State of the art: Mapping of the The aim of this task is to identify existing models INCa, OUS, MFH, Yes - S7.1. Mapping potential pre-identified CCC, of CCC, and Key principles. Among these key DOH, DKH, CIPH state of the art (OUS) according the agreed common principles it will be important to identify how to DKFZ,NOU,OI, BEN and - 25,000 EUR approach develop centres towards organizational maturity. ,UNICANCER,Sciens AE ano, REUH, OOI , 7.2. OECI, also Prior to this task, a common approach will be NBHW, NOU, UH applies to Tasks determined to pre-identify CCCs MOTOL, NIZP-PZH, 7.2.1, 7.2.4 and 7.3 FHF T7.2 Standards for CCCs and quality 5 sub-tasks OUS/INCa BEN improvement T7.2.1. Defining research standards This task will explore how to evaluate the OUS, UNICANCER, BEN and See above OECI infrastructure, processes and outputs for basic, ACC,REUH,INSERM, AE translational and clinical research to understand INCa, FHF cancer and finally promote changed clinical practices. Quantification of patient accrual rates to clinical trials could be a key result indicator. T7.2.2. Defining standards to encourage The defined standards will encourage innovation OUS,IOCN, BEN and No innovation especially in Early Detection and AI and UNICANCER, ACC, AE technology transfer. Assessment of contribution LIH, FHF to the international competition in these fields could use bibliometrics in accordance with Open Science standards and value international cooperations. T7.2.3. Defining research standards on Standards on prevention understood as the INCa, ACC, BEN and No prevention characterisation of risk factors, the link between Sciensano, REUH, AE clinics and exposures, but also including the UNICANCER,, FHF social sciences and the evaluation of populational interventions. These elements should be included 50 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 in the exchanges between researchers and clinicians in order to promote an evolution of the care system that includes prevention. T7.2.4. Defining standards for integration This task will liaise with WP 6 and ensure that OUS, , IOCN , NCI, BEN and See above OECI between research and care there are standards and criteria for personalised DKG, ACC, LIH, AE medicine including molecular diagnostics, Sciensano, REUH, genomics/proteomics and AI, molecular tumour ICO ,FHF boards and personalised medicine pathways, will also deal with the multidisciplinarity of professionals. T7.2.5. Defining Education and Training Standards to include inter-speciality MDT/IPU INCa, NCI, IOCN, BEN and No standards for CCCs (integrated practice unit) training UNICANCER, ACC, AE UT, FHF T7.3 Governance of the CCCs The aim of this task is to define a governance for INCa, OUS, BEN and See above OECI the CCCs based on standards to evaluate the DKH,CIPH,OI,UNICA AE strength of such governance structures and NCER, LIH, REUH, processes OOI, UH MOTOL, NIZP-PZH, FHF, The mechanisms for the governance will take into LGHA account the specificities of Cancer Centres which are part of University and with agreements with Universities T7.4 Stakeholder Forum The stakeholder forum is a platform for INCa, OUS, IOCN, Yes- consultation of key stakeholders including expert DKH, CIPH, OI, groups, international organisations and patient UNICANCER, DKG, BEN and S7.3. External expert groups at European level in order to consider all OOI, NIZP-PZH, FHF, AE on CCC (NOU) - the tasks of this work package NOU 6,000 EUR, The stakeholder forum will include networks, S7.4. Stakeholder CCCs, experts, and European organizations Forum Slovakia (NOU) - 5,000 EUR 51 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Milestones and deliverables (outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification No (continuous (month numbering not linked number) to WP) MS 17 State of the art 7 OUS/INCa Development of detailed project plan, M3 Paper summarizing the and common establishing first contact with preparatory activities by approach participants, formulation of a paper lead and co-lead on detailing relevant issues regarding each agreed common task, survey preparation approach on all the 7.2 subtasks and on the governance issue (7.3) MS 18 Agreed 7 INCa/OUS Conducting first work-shop(s), M6 Paper by lead and co- methodology for conducting the survey involving all MS, lead on agreed standards detailed work on each task and methodology and format definition & data coordination across tasks and WPs of standards for CCCs collection with contributions from other participants through first work-shop MS 19 Results of the 7 OUS/INCa Presentation of survey outcomes, M9 Paper on survey results survey on pre ongoing work in core-groups affiliated to and from issues identified CCC each task/subtask, coordination across launched during further Standards and tasks and WPs work in WP7.2 groups first sketches of and the presenting the governance results from the survey model MS 20 First sketches of 7 INCa/OUS Conducting the second work-shop(s), M15 Paper prepared as the CCC Standards out-come discussed in core-groups main reference for and second discussions at the 52 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 sketches of second work-shop and governance summarized the feed- mode back at the work-shop MS 21 Model with 7 INCa/OUS Preparation of final report, approval M24 Final report with adjustable and process in core groups, coordination recommendations on realistic criteria with other WPs standards, development for a continuous and improvement improvement of process and on care and governance model research. Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description No Level (continuous (month (including format and numbering linked to number) language) WP) D7.1 Map of the 7 OUS R — Document, PU — Public M12 Map of the potential pre- potential pre- report identified CCC and identified CCC potential new CCCs, and potential according the agreed new CCCs, common approach according the agreed common approach D7.2 Set of criteria for 7 INCa/OUS R — Document, PU — Public M18 An integrated and CCCs report straightforward set of criteria for CCCs covering all aspects of Governance, Research, Education and Care (liaising with WP6), which 53 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 enable the creation of a full Network. D7.3 A quality 7 INCa/OUS R — Document, PU — Public M24 A quality improvement improvement report process to “raise the bar” process in order to be in a continuous improvement process. Work Package 8 Work Package 8: Equitable access to high-quality care and research: networks in the context of CCCs Ensure consistence with the detailed budget table (if applicable). Duration: M1 – M24 Lead Beneficiary: ICO Objectives List the specific objectives to which this work package is linked. - To assess how CCCs organise cancer care in the real world action of health systems at the regional and local level, assessing the use of molecular tumour boards, ways of translating research progress in the networks, survivorship issues associated with follow up and return to work and potential uses of real-world data to ensure equitable access to all cancer patients under the CCC hub and spoke in each healthcare. WP8 will be based on bottom up approaches. Current practices and models of organisation in real-life settings will be key references to assess how high-quality care and research is available to all cancer patients in a given regional and local levels through networking models. The objectives of WP8 are: 1. Analysis of real-world activities from networks built around a CCC in providing common care and translation of research responses to patients with frequent tumours. 2. Assessment of pathways’ implementation in different CCCNs contexts whereby cancer care is organised to equitably provide timely diagnosis and access to high-quality care 54 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3. Assessment of how molecular tumour boards (MTB) are implemented in networking contexts where external clinicians to CCCs discuss their cases and receive advice on patient-tailored therapeutic planning. 4. Assessment of the continuity of cancer care in networks, including the potential for involvement of primary care and factors related to return to work along the follow up of patient after active treatment. Activities (what, how, where) and division of work Task No Task Name Description Participants In-kind Contributions (continuou and Subcontracting s (Yes/No and which) numbering linked to WP) Name Role (COO, BEN, AE, AP, OTHER) T8.1 Mapping organisational models of Mapping organisational models of networks built ICO, DKH, OUS, BEN and Yes, S 7.2. OECI networks built around a CCC around a CCC using a model of hub and spoke or DKG, INCa, AE other models based on university hospitals for UNICANCER, 1st cancer care services in the EU, focusing on the YPE diverse models of organization in health systems and their perceived advantages and problems. This task will take as a reference the work done in the previous Joint Actions CANCON and JARC as well as in WP7 and will use a bottom up approach that will complement the standards’ definition of WP6 and WP7. T8.2 Pathways’ assessment and Assessing the models of implemented pathways in ICO, OUS, IOCN, BEN and No networking of cancer services different CCCs’ networking experiences (e.g., IDIVAL, UNICANCER AE tumour-based networks, global cancer networks) in EU health systems using a multiple case study approach. The selection of cases will be based on the models identified in task 1. It is planned that 5 case studies will be included and the 55 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 methodological approach will explore through qualitative and mixed methods approaches. . T8.3 Translation of research into patients’ Analysing the use of networking approaches ICO, DKG, DKH, BEN and No care between CCCs and associated providers of OUS, IDIVAL, NIZP- AE cancer care in supporting translation of research PZH, UNICANCER findings into patients’ care using lung cancer as example. Specifically, we’ll use survey and key- informants interviews to explore how molecular tumour boards (MTB) are implemented in networking contexts where external clinicians to CCCs discuss their cases and receive advice on patient-tailored therapeutic planning. T8.4 Cancer survivors’ return to work Evaluating the risk factors related to the return to DKG, ICO, OUS BEN and No work for cancer survivors and the potential time AE points where and by whom in the network of providers this issue may be addressed. This task will be mainly based on a literature review. Milestones and deliverables (outputs/outcomes) Milestone No Milestone Name Work Package Lead Beneficiary Description Due Date Means of Verification (continuous No (month numbering not linked number) to WP) MS 22 Organisational 8 ICO T8.1 should be carried out before M9 Report models should developing T8.2 (the design of the be defined before multiple-case study requires consensus case-study and on the selection of cases) and T8.3 (the survey specific research focus requires application consensus and WP8 partners should facilitate survey’s roll-out) Deliverable No Deliverable Name Work Package Lead Beneficiary Type Dissemination Due Date Description (continuous No Level (month (including format and numbering linked to number) language) WP) 56 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 D8.1 Organisational 8 ICO R PU 8 Organisational models of models of cancer networks networks built available in EU countries around a CCC will be described based on a discussion with key informants from CCCNs designated by cancer plans. Electronic, English D8.2 Pathways 8 ICO R PU 14 A multiple-case study implemented method will be applied to through assess the barriers and networking faciliators in implementing cancer services CCCNs Electronic, English D8.3 Impact of 8 ICO R PU 20 A survey will be networking conducted to evaluate the research into use of molecultar tumour patients’ care boards by networked providers of cancer care. Electronic, English D8.4 Models and good 8 ICO R PU 20 A literature review will practices to assess the pathways to improve cancer return to work and survivors’ return associated risk factors for to work in the MS cancer survivors considering the different time points in patients’ follow up. Electronic, English 57 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Estimated budget — Resources See detailed budget table (annex 1 to Part B). 4.3 Timetable Timetable (projects up to 2 years) MONTHS ACTIVITY M M M M M M M M M M M M M M M M M M M M M M M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2 4 Task 1.1 Management and Meeting Structure Task 1.2 Preparation of key project documents Task 1.3 Reporting and financial management Task 2.1 Structure and deliver a robust Dissemination Strategy Task 2.2 Development and maintenance of the CraNE website and graphic identity Task 2.3 Development of additional 58 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Timetable (projects up to 2 years) MONTHS ACTIVITY M M M M M M M M M M M M M M M M M M M M M M M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2 4 communication tools (e- tools, social media or leaflets to target individual stakeholder groups) Task 3.1 Evaluation strategy with survey creation Task 3.2 Workshop creation Task 3.3 Checklist Task 4.1 Organisation of the Governmental Board of the Joint Action Task 4.2 Maturity model as a tool for monitoring the transition from “As is” to “To be” 59 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Timetable (projects up to 2 years) MONTHS ACTIVITY M M M M M M M M M M M M M M M M M M M M M M M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2 4 Task 4.3 Testing the Maturity model in volunteered countries as a use case Task 4.4 Develop a Blueprint for CCC and CCCN introduction into national cancer plans or strategies Task 5.1.1 Definition of the process for admission to the EU Network Task 5.1.2 Definition of the criteria for ongoing development of the EU Network of CCCs Task 5.2.1 Definition of governance rules for the efficient coordination of 60 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Timetable (projects up to 2 years) MONTHS ACTIVITY M M M M M M M M M M M M M M M M M M M M M M M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2 4 the activities of the Network Task 5.2.2 Creation of a permanent secretariat Task 5.3.1 Design of collaboration activities of national CCCs within the European context Task 5.3.2 Link to other EU cancer policy initiatives Task 5.3.3 Stakeholder involvement and patient engagement Task 6.1 Definition of Comprehensive Cancer Care Networks (CCCN) and its interfaces with Comprehensive Cancer Centres (CCC) Task 6.2 Development of support instruments to 61 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Timetable (projects up to 2 years) MONTHS ACTIVITY M M M M M M M M M M M M M M M M M M M M M M M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2 4 set-up CCCN in different member states Task 6.3 Development of Set of Standards and Quality Indicators for Lung Cancer Care Task 6.4 Enhancing patient centeredness in CCCNs with patient pathways Task 6.5 Feasibility study: implementation of results from task 2-4 in two pilot-sites Task 7.1 State of the art: Mapping of the potential pre-identified CCC, according the agreed common approach Task 7.2.1 Defining research standards 62 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Timetable (projects up to 2 years) MONTHS ACTIVITY M M M M M M M M M M M M M M M M M M M M M M M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2 4 Task 7.2.2 Defining standards to encourage innovation Task 7.2.3 Defining research standards on prevention Task 7.2.4 Defining standards for integration between research and care Task 7.2.5 Defining Education and Training standards for CCCs Task 7.3 Governance of the CCCs Task 7.4 Stakeholder Forum Task 8.1 Mapping organisational models of networks built around a CCC Task 8.2 Pathways’ assessment and 63 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Timetable (projects up to 2 years) MONTHS ACTIVITY M M M M M M M M M M M M M M M M M M M M M M M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2 4 networking of cancer services Task 8.3 Translation of research into patients’ care Task 8.4 Cancer survivors’ return to work 64 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 4.4 Subcontracting Subcontracting Work Package No Subcontract No Subcontract Name Description Estimated Costs Justification Best-Value-for-Money (continuous (subcontracted action (including task number (EUR) (why is subcontracting (how do you intend to numbering linked to tasks) and BEN to which it is necessary?) ensure it?) WP) linked) 2 S2.1 Website 1ST YPE, Task: 2.2 15,000.00 No in-house team to The tender will be development construct the website, carried out in Technical support for require graphic designer, accordance with preparation of expert support to ensure national and EU website, construction continuous legislation, comparing of website and hosting feeding/update and offers to ensure best of website on server, sustainability of the price-quality ratio. IT maintenance website. 2 S2.2 Patient advocacy NIJZ, Tasks: 1.1 and 15,000.00 It is necessary to We will ensure that the groups and 2.3 subcontract involvement most activities will be organisations of patient organisations in provided for the Involvement in the order for them to actively subcontract, utilizing CraNE Steering participate in co-creating any synergies with other Committee to provide and disseminating the JA subcontracts and stategic overview of output and outcomes groups. documents from through involvement in patient perspective WPs 1 and 2. A patient Active support of rep will be involved in WP networking, 1 through the Steering organisation of events Committee and in WP 2 to include patient through dissemination perspective and voice activities. This way, in the JA CraNE will be able to secure patient voice/reach patients most effectively. External evaluator 3 S3 CIPH, Task 3.1 3,000.00 External evaluation will External evaluators will provide insight from be selected according to independent experts on the criteria of the input 65 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Expert to pride input the quality of our they can provide in into the Evaluation proposed evaluation terms of evaluation. Strategy as well as materials and the strategy key strategic by which we are planning In addition to the price indicators to assess to evaluate the Action. criteria, the offer that achievement of This will help us to ensure includes inputs on how objectives the highest possible to achieve the highest quality of data collection possible quality of for evaluation purposes, evaluation data and the as well as obtaining best ways to present quality and useful them will be taken into information exchange account. during the Workshop. The external evaluation will thus complement the Evaluation Strategy itself and provide inputs on how to ensure the highest possible quality of the JA evaluation. Expert An external expert with Based on terms of 4 S4 consultation/ NIZP-PZH, Tasks 4.2, 4,000.00 experience in use of the reference for the result supervision for 4.3 maturity model approach of WP6-WP8 scenarios different Maturity Maturity model as a in healthcare will provide of oncological care Model structures tool for estimating the consultation on content organisation the expert strengths and adaptation and validation with the most weaknesses in order method for input from appropriate experience to transition from “As WP. 6 - WP 8 to ensure will be chosen and the is” to “To be”(4.2) and appropriate validation contract will be tendered “Maturity Model method in country according to national testing” (4.3) context. and EU legislation. 6 S6.1 Two external DKH, Task: 6.1 (also 25,000.00 DKH is the coordinator Based on terms of experts on CCC relevant for Tasks and funding body of the reference that will be 5.1, 5.2, 7.1, 7.2, 8.1., German CCC network. developed the two most 8.3) Experts are not employed suitable experts from at DKH but are mandated the German CCC Experts from the by the CCC institutions to Network will be German national CCC support the work of DKH. identified and tasked network will The sub-contract shall with the representation 66 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 participate and cover the costs of two of the interests of DKH provide input for the senior experts who will (German Cancer Aid). creation of EU work for the JA on all Network of CCCs and core WPs 5-8. the development of a governance model for the EU Network. Furthermore, they will support the mapping of CCC landscape and the standard development for CCC. They will also contribute to the analysis of the network model of cancer care and its potential role in promoting translational research findings into patient's care 6 S6.2 Medical oncology INC, Tasks: 6.3, 6.4, 16,080.00 For the feasibility study Based on the project expert (lung cancer) 6.5 planned under WP6, needs, the two most Luxembourg will require suitable medical Expert support for the medical oncology expert(s) from development of Set of expertise in the domain of Luxembourg will be Standards and Quality lung cancer, which the identified and tasked Indicators for Lung INC does not have with the medical Cancer Care internally. Thus, the INC consulting of the local will solicit one of the feasibility study recognised experts in lung cancer. 6 S6.3 Pilot network INC, Task: 6.5 6,500.00 For the feasibility study Specialised event planned under WP6, companies/consultancie Feasibility study: large meetings will need s have the know-how to implementation of to be organised, for the audit visit. For this, a 67 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 results from task 2-4 contractor will be better organise large events for in two pilot-sites value for money to best value for money. request quotes from specialised consultancies within Luxembourg than INC internal staff. 6 S6.4 Feasibility study - Sciensano, Task: 6.5 30,000.00 Implementation of set of Terms of reference for pilot digital solution quality indicators for the software tool and Feasibility study: colorectal cancer provider will be Piloting digital solution developed under the JA prepared and the for QI data collection iPAAC in an oncological contract will be tendered in 1 pilot-site network via a software according to national tool to evaluate and and EU legislation. This monitor the guideline will ensure best value adherence and if for money necessary define measures to improve guideline adherence CCCN peer review 6 S6.5 DKG, Task: 6.5 17,100.00 For the feasibility study Based on European planned under WP6 Framework for the Conducting a audits with independent certification of CCCNs feasibility study for the oncological experts have in the course of iPAAC results developed to be conducted. An audit (https://www.ipaac.eu/re under tasks 2 – 4 in team consists of 3 people s/file/outputs/wp10/cccn two pilot sites in two and 2 audits are planned -certification-european- member states in Luxembourg and framework.pdf) the including peer review Poland oncological experts will to assess successful selected. implementation. Feasibility Study 6 S6.6 site NIZP-PZH, Task: 6.5 10,000.00 For the feasibility study Terms of reference for planned under WP6 the the pilot-site will be Conducting a Oncological Centre has to prepared and the feasibility study for the be subcontracted; the contract will be tendered results developed developed tool has to be in accordance with under tasks 2 – 4 in implemented in the pilot- national and EU two pilot sites in two 68 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 MS and development sites; this requires the legislation. The main of digital solution for organization of meetings, criterion for the chosen QI. Knowledge adaptation of oncological centre will exchange meetings documentation software be that the centre has between Pilot Sites for the quality indicators experience in any are planned to help in as well as input from lung international certification Standards cancer experts from the process This will implementation. pilot-site. ensure best value for money 7 S7.1 Mapping state of OUS, Task:7.1 25,000.00 Conducting the mapping This mapping is a the art exercise requires suitable prerequisite for the rest Mapping of existing tools and professional of the work in WP7. models and principles skills and routines and Alternative procedures governing CCC in the the partners within this for the mapping will be MS WP do not have these more time consuming. competencies in-house.. Using a professional subcontractor will ensure the necessary quality and efficiency in accomplishing this task.. 7 S7.2 Expert support OUS, WPs 4-8, 187,000.00 OECI has a unique OUS will directly from OECI on CCCs VariousTasks: position in regards to subcontract OECI for to WP 4-8 CCC accrediation in their work in the CraNE 4.2, 4.3, 4.4 Europe and therefore JA due to their unique 6.1, 6.2, 6.3 must have an integral role position in Europe in the in the CraNE JA, most field of CCCs. All 7.1, 7.2, 7.3 notably in WP 7, although national tender 8.1 OECI experts will legislation will be participate in support and followed and detailed implementation of tasks terms of reference will in all core WPs 4-8. be produced. A more detailed justification for this subcontract follows below.* 7 S7.3 External expert on NOU, Task: 7.4 6,000.00 A visit of an external Tender will follow CCC expert to the Slovak NCI national and EU is to facilitate the transfer legislation - value 69 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Study visit of foreign of knowledge and based on estimated CCC expert to experiences from foreign travels, board, and Slovakia CCCs for adaptation to accommodation for two Slovak context. study visits (once annually). 7 S7.4 Stakeholder Forum NOU, Task: 7.4 5,000.00 Solen ltd. is an Tender will follow Slovakia organization with more national and EU Organisation of than 16 years of legislation - value for stakeholder forum experience in organizing money based on conference in medical conferences, providing the most Slovakia to facilitate, including the leading communications reach dissemination of Slovak oncology for the event and knowledge conference, "Bratislava publications with the Oncology Days,", “Best of given funds. ASCO,” as well as publishing medical journals, including the oncology journal "Onkologia." Solen ltd. is thus of great value and is efficacious in disseminating CraNE in Slovakia. Other issues: Not applicable, subcontracting accounts for less than 10% of the overall CraNE budget. If subcontracting for the project goes beyond 30% of the total eligible costs, give specific reasons. * Further Justification for Subcontract 7.2, OECI: OECI is a European Economic Interest Group incorporated in 1979 in respect of the Council Regulation (EEC) No 2137/85, of 25 July 1985. At June 2022 it comprises 123 major Cancer Centres in Europe and beyond. As such, it is the largest network of cancer centres in the world and the biggest European EEIG in all the scientific and economic areas and it is formally recognised as “European” by the EU. OECI has established a cancer centre accreditation system since 2006 which now involves more than 59 large CCCs operating in 19 EU Member States, plus Norway, UK and Turkey. Based on its knowledge and implementation of quality standards for care, education, research and networks, OECI has unique expertise and competence to implement the tasks for all core WPs 4-8 in the CraNE JA. OECI has published extensively on quality standards and indicators for Comprehensive Cancer Centres, and on comprehensiveness in general in cancer. OECI’s experience is intensely practical in terms of quality improvement for patients and internal organisation of cancer centres. Given that its peer-reviewed* quality standards 70 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 are applied in 19 EU Member States, from well-developed Comprehensive Centres to much less mature structures, OECI is uniquely positioned to work with other partners in the CraNE JA on constructing new standards for research, clinical integration and governance for an EU network of Comprehensive Cancer Centres. No other organisation has this accumulated expertise which has been already formally recognised by several EU countries accepting the OECI A&D certification as a recognised National quality validation approach (See Italy, Portugal….). Being an existing network of 123 cancer centres also means that OECI has unique insight into how a top-level network can add value to the detailed quality initiatives in cancer centres. On June 2022, OECI is participated in by Members from 25 EU countries and already has practical contacts to involve two new entities in Luxembourg and Malta, so as to encompass the whole EU. *Oberst S, van Harten W, Sæter G, De Paoli P, Nagy P, Burrion JB, et al.100 European core quality standards for cancer care and research centres. Lancet Oncol.2020;21:1009—11. 71 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 5. OTHER 5.1 Ethics Ethics If the Call document contains a section on ethics, describe ethics issues that may arise during the project implementation and the measures you intend to take to solve/avoid them. Not applicable. 5.2 Security Security If the Call document contains a section on security, describe security issues that may arise during the project implementation and the measures you intend to take to solve/avoid them. Indicate if there is need for EU classification of information (Decision 2015/444) or any other specific security measures. Not applicable. 6. DECLARATIONS Higher funding rate (if applicable) YES/NO Do you fulfil the conditions set out in the Call document for a higher funding rate? YES If YES, explain and provide details. 37,7% of the CraNE total budget is allocated to Member States whose GNI per inhabitant is less than 90% of the Union average - these are: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Portugal, Romania, Slovakia, Slovenia and Spain. Therefore, the CraNE JA fulfils the criteria for higher funding rate due to exceptional utility. Double funding Information concerning other EU grants for this project Please note that there is a strict prohibition of double funding from the EU budget YES/NO (except under EU Synergies actions). We confirm that to our best knowledge neither the project as a whole nor any parts YES of it have benefitted from any other EU grant (including EU funding managed by authorities in EU Member States or other funding bodies, e.g. Erasmus, EU Regional Funds, EU Agricultural Funds, European Investment Bank, etc). If NO, explain and provide details. We confirm that to our best knowledge neither the project as a whole nor any parts YES of it are (nor will be) submitted for any other EU grant (including EU funding managed by authorities in EU Member States or other funding bodies, e.g. Erasmus, EU 72 Call: EU4H-2021-JA — Joint actions - CraNE EU Grants: Application form (EU4H): V2.0 – 15.7.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Regional Funds, EU Agricultural Funds, European Investment Bank, etc). If NO, explain and provide details. Financial support to third parties (if applicable) If in your project the maximum amount per third party will be more than the threshold amount set in the Call document, justify and explain why the higher amount is necessary in order to fulfil your project’s objectives. Not applicable ANNEXES LIST OF ANNEXES Standard Detailed budget table (annex 1 to Part B) — mandatory Project Teams and Staff (annex 2 to Part B) List of previous projects (annex 3 to Part B) 73  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project teams and staff Describe the project teams and how they will work together to implement the project. List the staff included in the project budget (budget category A) by function/profile (e.g. project manager, senior expert/, junior expert, trainers/teachers, technical personnel, administrative personnel etc. — use the same profiles as in the detailed budget table, if any) and describe briefly their tasks. Provide CVs of all key actors (if required). Name and function Organisation Role/tasks/professional profile and expertise Tit Albreht, Senior NIJZ Manages the overall content of the JA as Scientific Coordinator, Expert coordinates all experts and scientific content of the JA. Marjetka Jelenc, NIJZ Assists the Scientific Coordinator through dissemination work Senior Researcher (presentations at conferences, publication of scientific articles), assists WP 3 and 4 in strategic planning and reporting. Tina Lipušček, Project NIJZ Manages the JA day to day, coordinates the Project Management Manager Team, main liaison with HADEA and EC, in charge of reporting. Leader of WP 1. Karmen Hribar, Project NIJZ Desk officer, secretariat for the JA, manages administrative Manager requirements for the JA, coordinates meetings and events, reports, presentations. Nataša Voje, NIJZ Financial officer for the JA, in charge of financial overview, reporting, financial support for entire Consortium and EC reporting, Project Manager amendments. Špela Pohar, NIJZ Legal officer for the JA, will advise PMT on legal matters, such as consortium agreement, intellectual property rights, etc. Legal Officer Sonja Tomšič, OIL Team Leader for OIL, Coordinates all experts within OIL, Specialist in public health, researcher at Slovenian Cancer Registry. Senior Expert & Researcher Maja Čemažar, OIL Manages the specific content of the JA related to research in relation to CCC and governance of CCCN.Head of Research and Senior Expert & Education at the OIL. Researcher Barbara Šegedin, OIL Specialist in radiotherapy; manages the specific content of the JA related to development and implementation of practical Senior Expert & instruments for cancer care quality improvement and CCCN. Researcher Domen Ribnikar, OIL Senior resident in internal medicine – oncology; manages the specific content of the JA related to development and Junior Researcher implementation of practical instruments for cancer care quality improvement and CCCN. Nebojša Glumac, OIL Specialist in oncology surgery; manages the specific content of the Junior Researcher JA related to development and implementation of practical instruments for cancer care quality improvement and CCCN. Uroš Kuhar, OIL Financial officer for the JA/OIL. Project Manager Marc Van den Bulcke Sciensano Manages the overall content of the WP 4 as managing head of unit. Leader of WP 4. Senior Expert 1  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Marie Delnord Sciensano Scientific support for WP 4, experience from iPAAC. Regine Kiasuwa Sciensano Scientific support for WP 4 experience from iPAAC/CANCON. Souhade Tabakkalt Sciensano Project management support, administrative and financial. Project manager prof. dr. Iglika USHATO Participate In WP6; Professor in Oncology and Radiotherapy; Mihaylova Head of Dept of External Beam Radiotherapy; Clinic of Radiotherapy; More than 110 publications in Bulgarian and Junior Expert International specialised medical journals; More than 150 participations in Bulgarian and International conferences and congresses, Example of 2014 – Award “DARZALAS” – for contribution in Bulgarian oncology; Dr. Iva Gavrilova USHATO Participate In WP6; Doctor at the department of the general and abdominal surgery; surgical skills in ear, nose and facial Junior Expert reconstruction in patients with skin cancer Dr. Svitlana Bachurska USHATO Participate in WP6; Junior Expert Associate Professor – Department of General and Clinical Pathology, Medical University – Varna, Bulgaria; Head of Department, Pathologist. USHATO - Frozen section, grossing, biopsy, cytology, IHC, oncology boards Marc Peeters, UZA Scientific support for WP 4. Senior Expert Prof. Dr. Iglika USHATO Scientific support for WP 6. Professor in Oncology and Mihaylova, Radiotherapy; Head of Dept of External Beam Radiotherapy; Clinic of Radiotherapy. Junior Expert Dr. Iva Gavrilova USHATO WP 6 scientific tasks; Doctor at the department of the general and abdominal surgery; surgical skills in ear, nose and facial Junior Expert reconstruction in patients with skin cancer. Dr.Svitlana Bachurska USHATO WP 6 scientific tasks; Associate Professor – Department of General and Clinical Pathology, Medical University – Varna, Junior Expert Bulgaria; Head of Department, Pathologist. Mario Šekerija, Senior CIPH Manages the overall involvement of CIPH in CRaNE scientific Expert contributions, co-leading the WP3. Medical Doctor, with a PHD in epidemiology. Assistant Professor of Epidemiology at University of Zagreb, School of Medicine. Head of the Croatian National Cancer Registry. Bojana Raičković CIPH Project manager for CIPH, CraNE., Head of Programme and Project Management Department. Project Manager Marijan Erceg CIPH Providing expert insights in organizational and governance aspects. Head of Department for Mortality statistics within the Senior Expert Division for Epidemiology and Prevention of Noncommunicable Chronic Diseases. Assistant Professor of Epidemiology at University of Zagreb, School of Medicine. Former director of CIPH. Ivana Brkić Biloš CIPH Providing expert insights in prevention-related aspects of JA. Head of Division for Epidemiology and Prevention of Senior Expert Noncommunicable Chronic Diseases. 2  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Gordan Sarajlić CIPH Participating in dedicated tasks of the JA. Resident in Division for Epidemiology and Prevention of Noncommunicable Chronic Junior Expert Diseases. Karmen Korda CIPH Participating in evaluation-related activities, worked as junior researcher in iPAAC JA. Junior Expert Petra Čukelj CIPH Participating in evaluation-related activities, worked as junior researcher in iPAAC JA. Junior Expert Dr. Olga Kalakouta, MOH-CY Manages the overall content of the JA as Public Health Expert, Project Manager coordinates Cyprus participation to the project Irene Georgiou, MOH- CY Desk officer for the JA, manages administrative requirements for Administrative the JA, coordinates meetings and events, reports. Personnel Dr. Pavlos Drakos, MOH-CY Manages the overall content of the JA and coordinates National Senior Expert Cancer Committee experts and scientific content of the JA. Athina Pitsillidou, MOH-CY Financial officer for the JA, in charge of financial overview, Administrative reporting, financial support for entire Consortium and EC reporting, Personnel amendments. Jana Prausova, UH MOTOL Manages expert input to JA from UH MOTOL team. Senior Expert Katerina UH MOTOL Coordinates the project team from UH MOTOL. Kopeckova Project Manager Anna Sediva UH MOTOL Manages administrative requirements for the JA, UH MOTOL. Project manager Jana Jaal UT Manages the overall scientific content for UT, coordinates all experts and scientific content. Senior Expert Marju Kase UT Manages the project day to day for UT, WP 1 Senior Researcher Elina Leis UT Research work in WP 4 Junior researcher Kaarel Nurk UT Research work in WP 4 Junior researcher Jean-Baptiste Méric INCa Director Public Health and Care Division at INCa, Contributes to the lead of WP 7. Coordinates the Senior Expert experts and scientific content for this JA at INCa. Thomas Dubois, INCa Head of the European and International affairs Mission at INCa Senior Expert .Co-lead of WP7. Participates in WP 5. Aziza Khalil, INCa European project manager, Administrative and financial officer for the JA, INCa. Project Manager 3  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Alain Eychène INSERM Director of research .Will participate in WP 5 & 7. Head of the Thematic institute dedicated to cancer of INSERM. Senior researcher Xavier Troussard FHF President of the Medical Commission of the University Hospital of Caen Normandy, He is the head of FHF cancer.Haematologist, Senior Researcher head of the haematology laboratory.Will participate in WP 7. Jacques Olivier O Bay FHF Medical oncologist, participation in WP 5. Senior expert Pr Jean-Yves BLAY UNICANCER Involved in WP5 (task 1.1 creation of the EU networks of CCC, task 3: strengthening clinical care and research through networking), Senior expert WP8 (task 8.1 Define the networks and governance models for cancer care in EU taking into account the diverse models of organization in health system. Jean-Yves BLAY is General Administrator of UNICANCER as well as General director of Leon Bérard FCCC. He will manage the UNICANCER involvement in the JA. Sophie BEAUPERE UNICANCER Involved in WP5 (task 1.1 creation of the EU networks of CCC, task 3: strengthening clinical care and research through networking), Senior expert WP8 (task 8.1 Define the networks and governance models for cancer care in EU taking into account the diverse models of organization in health system. Sophie BEAUPERE is general director of UNICANCER. And will manage UNICANCER involvement in the JA. Pierre-Henri UNICANCER Pierre-Henri BERTOYE is director of Regulatory foresight, BERTOYE benchmark and Training at UNICANCER. Senior expert He will be particularly in WP5 (task 1.2, monitoring and benchamarking) Prof. Mario CAMPONE UNICANCER Mario CAMPONE is general director of the Institute of Cancer research in Western France. Senior expert He will be particularly in WP5 (task 1.2, monitoring and benchamarking) and WP8 (indicators of effectiveness of networks in cancer care, both qualitative and quantitative.) Prof. Thierry CONROY UNICANCER Thierry CONROY is general director of the Lorraine Institute of technology Senior expert He will be particularly in WP5 (task 2.1 development of a governance model) as co-lead of the task and WP7 (task 3 Governance of the CCCs). Sandrine BOUCHER UNICANCER Sandrine BOUCHER is Director of Medical Strategy and Performance Senior expert She will be particularly involved in WP5 (task 3.2 Identification of processes and resources to enable the EU Network to link with other EU cancer policy initiatives.) and WP8 (indicators of effectiveness of networks in cancer care, both qualitative and quantitative.) Prof. Marc YCHOU UNICANCER Marc YCHOU is general director of the Montpellier Cancer Institute - Val d’Aurelle Senior expert He will be particularly in WP5 (task 3.3Definition of the processes for ensuring the involvement of stakeholders, citizens and patients in the strategy of the EU Network) 4  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Prof. Frederique UNICANCER Frederique PENAULT LLORCA is general director of Jean Perrin PENAULT LLORCA Centre. Senior expert She will be particularly involved in WP7 (task 1 Mapping of the potential pre-identified CCC, according the agreed common approach and Task 2 Standards for CCCs + quality improvement) Prof. Eric LARTIGAU UNICANCER Eric LARTIGAU Is general director of Oscar Lambret Centre. Senior expert He will be particularly involved in WP7 (task 1 Mapping of the potential pre-identified CCC, according the agreed common approach) and WP8 (Assess the models of implemented care pathways). Prof. Michel UNICANCER Michel DUCREUX is Chief of the Digestive Oncology Service, DUCREUX Department of Oncologic Medicine, at Gustave Roussy Senior expert He will be particularly involved in WP7 (Task 2 Standards for CCCs + quality improvement) Prof. Jean-Pierre UNICANCER Jean-Pierre DELORD Is general director of the Claudius Regaud DELORD Institute – IUCT Oncopole. Senior expert He will be particularly involved in WP7 (task 3 Governance of the CCCs) Prof. François-Xavier UNICANCER François-Xavier MAHON is general director of the Bergonie MAHON Institute Senior expert He will be particularly involved in WP7 (task 4 – stakeholder forum) Prof. Steven LE UNICANCER Steven Le Gouill is general director of the Curie Institute GOUILL He will be particularly involved in WP7 (task 4 – stakeholder forum) Senior expert Prof. Fabrice BARLESI UNICANCER Fabrice BARLESI is the general director of Gustave Roussy Institute. Senior expert He will be particularly involved in WP8 (task 8.3: Analyze the potential role of networks in prompting translation of research findings into patients’ care) Prof. Fabrice ANDRE UNICANCER Fabrice ANDRE is the Research Director of Gustave Roussy Institute. Senior expert He will be particularly involved in WP8 (task 8.3: Analyze the potential role of networks in prompting translation of research findings into patients’ care) Karen Budewig, Senior BMG Coordinates as Scientific Expert and representative of the Expert Competent Authority/National Consortium Lead the technical and scientific input at the interface between the Ministry of Health and the JA. Ann-Cathrin Hellwig BMG Coordinates as Scientific Expert and representative of the (alternate), Competent Authority/National Consortium Lead the technical and scientific input at the interface between the Ministry of Health and Junior Expert the JA.. Andrea Wilms, Project BMG Desk officer and representative of the Competent Manager Authority/National Consortium Lead for the JA, manages administrative requirements, coordinates meetings, reports. 5  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Paul Klinkhammer, BMG Financial officer and representative of the Competent Project Manager Authority/National Consortium Lead for the JA, providing financial support for German Consortium, amendments. Sonja Loges DKFZ Participant WP7. Senior Expert Claudia Maye DKFZ Project Management Team, coordinator for international cooperation at DKFZ Project Manager Simone Wesselmann DKG Work Package Leader WP 6 Organization of Cancer Care. Senior researcher Christoph Kowalski DKG Task leader: risk factors for return to work in WP 8. Junior researcher Ellen Griesshammer DKG Deputy WP leader 6 and coordinator for the German consortium. Project manager Gerd Nettekoven DKH Collaborating stakeholder Senior expert Franz Kohlhuber DKH Collaborating stakeholder Senior expert Hannes Schlieter, TUD Manages Task 4 of WP6 as scientific coordinator, coordinates Senior Expert scientific contents of Task 4 of WP6, in charge of standardisation and liaison with other EU projects. Peggy Richter, Project TUD Manages and leads Task 4 of WP6, coordinates the work and Manager project team, in charge of development and piloting, evaluation and dissemination. Emily Hickmann, TUD Manages and conducts the scientific work within Task 4 of WP6, in Junior Researcher charge of results documentation and reports. Anastasia 1st YPE Acts as main Coordinator for the WP2, and main liaison with Balasopoulou, Coordinator of the JA. Leader of WP 2. Senior Expert Maria Agapiou, Project 1st YPE Manages the JA day to day, coordinates meetings and events, Manager reports. Wili contribute effectively to the WP8 and WP6 Olga Balaoura Agios Savvas CEO. Will contribute to the development and implementation of the dissemination plan. Will contribute mainly in the WP 6 and WP8. Senior Expert K. Konstantopoulos, General Coordinates all experts and scientific content of the JA, Greek Senior Expert Hospital of partners. Athens”Laiko (LGHA) Grigorios Kaltsas General Coordinates all experts and scientific content of the JA, Greek Hospital of partners, WP 7 tasks. Senior Expert Athens”Laiko (LGHA) Andreas Goules General Will contribute mainly in the WP 7. Hospital of Project manager 6  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Athens”Laiko (LGHA) Dimitra Stefanou, General Contribution to WP 2, medical oncologist. Hospital of Senior Expert Athens”Laiko (LGHA) Panayiotis General Professor in Haematology. Director and Head of the Hospital’s Panayiotidis Hospital of Department of Haematology and Bone Marrow Transplatation Unit. Athens”Laiko Will contribute mainly in the WP 7. Senior Expert (LGHA) József Lövey, OOI In charge of the scientific content of project participation at OOI. Senior Expert Peter Nagy, OOI In charge of the scientific content of project participation at OOI. Senior Researcher Edit Marosi, OOI Performs day to day coordination tasks related to the project at OOI. Project Manager Beáta Ungor, OOI Performs day to day coordination tasks related to the project at OOI. Project Manager Réka Bálint, OOI Performs administrative tasks related to the project at Administrative OOI.Translates project documentation. Personnel Míra Balkay, OOI Performs administrative tasks related to the project at OOI.. Administrative Translates project documentation. Personnel Réka Felhő, OOI Performs administrative tasks related to the project at OOI. Administrative Personnel Lászlóné Horváth, OOI Financial officer in charge of financial administration of the project Project Manager at OOI. Michael Conroy DoH Principal Officer, Cancer Policy Unit, Department of Health. Oversight of Ireland’s involvement in the JA. Eight years of Project Manager experience working on cancer policy formation. Sarah Rose Flynn DoH Assistant Principal Officer, Cancer Policy Unit, Department of Health. Participant in Ireland’s involvement in the JA. One years of Project Manager experience working on cancer policy formation. Ciarán Murphy DoH Administrative Officer, Cancer Policy Unit, Department of Health. Participant Ireland’s involvement in the JA. Five years of Project Manager experience working on cancer policy formation. Karl Silver DoH Executive Officer, Cancer Policy Unit, Department of Health. Financial Reporting for Ireland’s involvement in the JA. Two years Administrative of experience working on cancer policy formation. Personnel Ruggero De Maria, ACC President of ACC, the Italian Network of CCCs, which promotes technological innovation transfer to clinical practice for a better and Senior Expert more sustainable care of cancer patients. He will bring his expertise in governance and networking. Lead WP 5. 7  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Paolo De Paoli, Senior ACC General Director of ACC, the Italian Network of CCCs. His main Expert interest and expertise include accreditation systems and definition of quality standards for cancer care and research. Lead WP 5. Valentina Trapani, ACC Scientific Advisor at ACC. She has long-standing expertise in Project Manager translational cancer research and will assist in elaborating the scientific content of the JA, documents, reports, meetings, etc. Lead WP 5. Giandomenico Russo, IDI Scientific Director of the IDI Dermatological CCC and Head of the Molecular Oncology Lab; secretary of ACC working group on Senior Expert melanoma. He will contribute to defining activities to foster collaborations to improve clinical care and research. Lead WP 5. Giovanni Nicoletti MOH-IT Senior Medical Officer, with a personal back-ground in Oncology and long standing experience in EU Projects strategic planning Senior Expert (also EU4Health Steering Group Representative and Italian NFP); he has also played leadership roles in Cancer related Joint Actions such as EPAAC and CANCON. He will contribute in tasks 5.1 and 5.2. Daniela Galeone MOH-IT Senior Medical doctor, Head Of Unit of NCDs, with long-standing experience in public health, coordinating several Groups and task Senior Expert forces about Tobacco, Life Styles, Physical Activity. She will contribute in tasks 5.1 and 5.2. Maria Teresa MOH-IT Medical Officer, NCD Unit, with experience in Public Health, at Menzano present is responsible for the Sub-Unit on Cancer Control. She will contribute in tasks 5.1 and 5.2. Senior expert Ineta Derjabo, Project REUH Manages the JA day to day, coordinates the Project Team on Manager REUH side, main liaison with Sandra Lejniece, all team members from REUH and EC, in charge of reporting. Sandra Lejniece, REUH Manages and coordinates with all experts on REUH side, Senior Expert responsible for the scientific content of the JA. Agnese Ozoliņa, REUH Senior Expert in Anaesthesiology, working on WP 6 Senior Expert Iveta Kudaba, REUH Senior Advisor in Chemotherapy, working on WP 6 Senior Advisor Ilze Eņģele, REUH Senior Expert in Radiology, working on WP 6 Senior Expert Juris Šteinbergs, REUH Senior Expert in Molecular Biology, working on WP 7 Senior Expert Senior Advisor REUH Senior Advisor in Pathology, working on WP 7 Daina Baidekalne, REUH Senior Expert in Education, workin, working on WP 7g on WP 7 Senior Expert Data specialist, REUH Data specialist responsible for data collection, analysis, Technical Personnel preparation of different reports , working on WP 4. Rimma Bērziņa, REUH Desk officer for the JA on REUH side, manages administrative Administrative requirements for the JA, coordinates meetings and events, reports. Personnel Working on WP 1. 8  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Inga Cechanovičienė SAM LT Coordinates and provide expertise in the governance aspects and decision making related to the content of the JA. Manages Senior expert administrative requirements for the JA (Lithuania team), coordinates meetings and events, reports. Renata Beržanskienė SAM LT Financial officer for the JA (Lithuania), in charge of financial overview, reporting, financial support for Consortium of Lithuania Project manager and reporting Jelena Rascon, Senior VULSK Manages the content of the JA as scientific coordinator at VULSK, expert coordinates the team and preparation of JA content by VULSK. Valdas Pečeliūnas VULSK Coordinates and provide expertise in the governance aspects and decision making related to the content of the JA. Senior expert Indrė Klimantačienė VULSK Manages administrative requirements for the JA at VULSK, coordinates meetings and events, reporting. Administrative personnel Ernestas Janulionis, NCI Medical oncologist, involved in the content of the JA WP6 task 1 Senior expert as senior expert. Expert in activities (accreditation and designation programme, working goups, communication, dissemination) determining high quality of cancer care and research. Edita Baltruškevičienė, NCI Medical oncologist, involved in the content of the JA WP7 task 2 senior expert as senior expert. Expert in integration between research and care, clinical trials lead. Vincas Urbonas, NCI Medical oncologist, involved in the content of the JA WP7 task 2 Senior expert as senior expert. Expert in integration between research and care, clinical trials lead. Elona Juozaityte Kauno klinikos Manages the content of the JA as scientific coordinator at Kauno (KK) klinikos KK, coordinates the team and preparation of JA content by Senior expert Kauno klinikos KK. Rasa Janciauskiene Kauno klinikos Oncologist in charge of patient involvement, data reporting, WP 7. (KK) Senior Researcher Sigita Liutkauskiene Kauno klinikos Oncologist in charge of patient involvement, data reporting, WP 7. (KK) Senior Reseacher Irmantė Bendoriūtė Kauno klinikos Financial officer for the JA Kauno klinikos KK, in charge of financial Letukienė (KK) overview, reporting, financial support for Consortium of Lithuania and reporting Administrative Personnel Prof MD PhD Guy INC Provides insight and expertise from the medical point of view for Berchem, Luxembourg, WP 6. Senior Expert Dr Nikolai INC Provides insight and expertise from the policy point of view for Goncharenko, Luxembourg, in line with the national Cancer Plan, and oversees key deliverables (and their potential implementation), WP 6. Senior Expert Dr Kathy Jaworski, INC Project Manager coordinating the deliverables and activities of the Project Manager tasks that the INC will actively contribute to, such as WP6 task 5. 9  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Ms. Anne Drochon, INC Legal and administrative questions related to financial overview, Project Manager reporting, financial support for Luxembourg, WP 1. Prof Dr Simone Niclou, LIH Expert in cancer research, basic and translational research, research management. Senior Expert Dr Guy Fagherazzi, LIH Expert in digital epidemiology, digital health, digital biomarkers for Senior Expert patient monitoring, WP 7. Dr Claudine Backes, LIH Expert in cancer epidemiology and prevention, clinical research, occupational/environmental health and health policy and Senior Expert management, WP 7. Dr Manon LIH Expert in clinical research, regulatory and ethical aspects and Gantenbein, implementation of translational research programs and disease specific patient cohorts, WP 7. Senior Expert Dr Lars Geffers, LIH Project Manager coordinating the deliverables and activities of the Project Manager tasks that the LIH will actively contribute to, such as WP7 task 2 and 3. Miriam Dalmas, MFH Lead JA Representative for MFH, WP 4/7, Malta. Senior Expert Annalise Borg, MFH Assists Lead Project Representative for MFH, WP 4/7, Malta Senior Expert Specialist Trainee in MFH Provides support to the MFH Senior Expert Team. Trainee medical Public Health Medicine doctors undergo specialist training in PHM and they rotate with (PHM), different teams over time. Trainee will change every 6-9 months. Work on WP 7. Junior Expert Vincent Buhagiar, MFH Project Manager at the Department of Programme Implementation at MFH, WP 1. Administrative Personnel Prof Sigbjørn OUS Co-leader of the WP7. Coordinator, coordinates all experts and Smeland, scientific content of the WP7, Head of the Division of Cancer Medicine and Cancer Centre Board of OUS. Senior Expert Per Magnus Mæhle, OUS Expertise on management and development of CCCs through the Senior Advisor role as administrative leader of the Cancer Centre Board and from research on cancer politics and organization of Cancer Care. Work on WP 7. Dr Morten Tandberg OUS Head of the Division of Surgery, Transplantation and Inflammatory Eriksen, Medicine at OUS and member of the Cancer Centre Board, Has been in this core position of the CCC process of OUH from the Senior Expert beginning and specific expertise on cancer surgery and related research. Work on WP 7. Prof Kjetil Taskén OUS Head of the Cancer Research Institute, Extensive experience from translational research, innovation and of building precision Senior Expert medicine projects. Work on WP 7. Prof Åslaug Helland, OUS Head of the CCC Research Council of OUS, and member of the Senior Expert Cancer Centre Board. Have extensive expertise on both 10  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 translational and clinical cancer research and on connecting care and research. Work on WP 7. Arne Fosseng, OUS Head of the staff of Economy in the Division of Cancer Medicine. administrative Will be contributing on administrative support and follow-up during personnel the program. Work on WP 1/7. Ingrid Hanto, OUS Member of the secretariat of the Cancer Centre Board, expertise on management follow-up on performance of CCC standards. Will Junior expert also contribute with administrative support, Work on WP 1/7. Dorota Dudek- NIZP-PZH Coordinator of CraNE in Poland, co-Leader of WP 4 Sustainability: Godeau, Senior Expert performer of development and testing the Maturity Model for transformation the cancer care organisation into defined Comprehensive Cancer Centre and/or Comprehensive Cancer Care Network (Leader of Tasks WP 4.2 and WP 4.3); In WP.6 Organization of comprehensive, high-quality cancer care in Comprehensive Cancer Care Networks (CCCNs) - leader of Task 6.2. Development of support instruments to set-up CCCN in different member states and Polish coordinator of CraNE for pilot site for conducting a feasibility study for the results developed under tasks 6.2 – 6. 4. The area of expertise – monitoring, organisation and quality improvement of cancer care in the Comprehensive Cancer Care Network. Junior Expert, tbc NIZP-PZH Support Senior Expert in all actions undertaken by CA in CraNE Administrative NIZP-PZH Project administration/management, accounting services, HR Personnel, tbc services and public procurement, WP 1. José Dinis, DGS Coordinates all experts and scientific content of the JA for Portugal, WP 4/6. Senior Expert Cristina Portugal, DGS Administrative officer for DGS, WP 1,2,3. Project Manager Telma Gaspar, Project DGS Financial officer for DGS, WP 1. manager Patriciu Achimas- IOCN Manages the overall content of the WP3, coordinates all experts Cadariu, and scientific content of the WP3. Senior Expert Catalin Ioan Vlad, IOCN Monitors the indicators used for this JA and closely follows the Senior Expert stages of possible implementability of this WP. Nicoara Delia, IOCN Manages the JA day to day, coordinates the Project Management Team in charge of reporting. Leader of WP 3. Junior Expert Gavrila Iulia, IOCN Evaluates the ability to implement the new findings of this JA in Member States (the implementability factor; JA outcomes). Junior Expert Alexandra Haiduc, IOCN Financial officer for the JA for IOCN. Administrative personnel Adrian Brindusan, IOCN Coordinates meetings and events, reports, WP 3. Technical personnel 11  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Mária Rečková, M.D., NOU Coordinates all experts and scientific content of the JA for Slovakia. Ph.D., Senior Expert Prof. Stanislav Špánik, NOU Scientific expert as the observer, primarily responsible for activities M.D., C.Sc., Senior in subtask 7.1., 7.2.4. Expert Prof. Michal Mego, NOU Scientific expert as the observer, primarily responsible for activities M.D., D.Sc., in subtask 7.1., 7.2.1. Senior Expert Assoc. Prof. Alexandra NOU Scientific expert as the observer, primarily responsible for activities Kolenová, M.D., in subtask 7.1., 7.2.4. Ph.D., Senior Expert Assc. Prof. Pavol NOU Scientific expert as the observer, primarily responsible for activities Dubinský, M.D., Ph.D., in subtask 7.1., 7.2.4. MPH, Senior Expert Prof. RNDr. Silvia NOU Scientific expert as the observer, primarily responsible for activities Pastoreková, D.Sc., in subtask 7.1., 7.2.2. Senior Expert Assoc. Prof. Ľuboš NOU Scientific expert as the observer, primarily responsible for activities Drgoňa, M.D., MHA, in subtask 7.1., 7.2.1. FECMM, Senior Expert Assoc. prof. PhDr. NOU Scientific expert as the observer, primarily responsible for activities Daniela Kállayová, in subtask 7.1., 7.2.3. Ph.D., MPH, Senior Expert prof. Lukáš Plank, NOU Scientific expert as the observer, primarily responsible for activities M.D., Ph.D., C.Sc., in subtask 7.1., 7.2.4. Senior Expert Assoc. prof. Michal NOU Scientific expert as the observer, primarily responsible for activities Chovanec, M.D., in subtask 7.1., 7.2.5. Ph.D., Junior Expert RNDr. Soňa NOU Scientific expert as the observer, primarily responsible for activities Čierniková, PhD., in subtask 7.1., 7.2.2. Junior Expert Soňa Huľová, M.D., NOU Scientific expert as the observer, primarily responsible for activities PhD., in subtask 7.1., 7.2.5. Junior Expert RNDr. Andrej NOU Desk officer, manages administrative requirements, coordinates Trnovec, meetings and events, reports, WP 1, Project Manager 12  Annex 2 to CraNE Joint Action Proposal – Project Teams and Staff, Version 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Kristina Bubelinyova, NOU Financial officer, manages financial operations, WP 1. MBA Project manager Josep M Borràs, ICO Leader of WP 8. Md., PhD Medicine, epidemiologist by training. He Senior Expert has been working in cancer control and planning since 1990. He has been involved in different EU Joint Actions as a work package leader (EPAAC, JARC, and IPAAC). Leader of WP 8. Joan Prades, ICO BA Political Science, Ph.d Medicine. Senior researcher specialised in the analysis of organizational models and strategies that Senior Researcher determine health services in the field of cancer care, with a strong research focus on clinical decision-making processes. He has been involved in different EU Joint Actions (EPAAC, CanCON, JARC, and IPAAC). Deputy Leader of WP 8. Works also on WP 3, 4. Meritxell Nomen, ICO Desk officer for the JA, manages administrative requirements for Administrative the JA, coordinates meetings and events, reports. Financial officer Personnel for ICO, WP 1, 2. Ignacio Durán, Senior IDIVAL Ignacio Durán is a medical oncologist with interests in clinical and Researcher translational research and medical education. He will act as principal investigator for IDIVAL and will coordinate the participation of IDIVAL’s researchers in this JA. Carlos Lopez, IDIVAL Carlos López is a medical oncologist. He completed his medical degree (2001) and a PhD program (2016) at Universidad de Senior Researcher Cantabria. He is also specialist in Medical Oncology (H. U. Marqués de Valdecilla) (2006) and Master in Molecular Oncology by the Spanish National Cancer Research Center (CNIO) (2011). During his trainee period, he has completed a 3-month stay as a “Clinical Observer” at the Comprehensive Oncology Center Fox Chase Cancer Center in Philadelphia (USA). Works on WP 4, 8. Itziar Gardeazabal, IDIVAL Medical oncologist with interests in clinical and translational Junior Researcher research. Works on WP 8. Paloma Gonzalez and IDIVAL Desk officer in IDIVAL, both manage administrative requirements, Sarah Berrocoso, coordinate meetings and events, reports, WP 2,3. project manager Natalia Puente, IDIVAL Financial officer for IDIVAL, in charge of financial reports, financial Administrative support, budget preparation, etc. WP 1. Personnel Katarina Fredriksson NBHW PhD, MA, project manager, work on WP 7. Senior Expert Louise Strandendahl NBHW BA, programme offcer, work on WP 7. Senior Expert 13  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 List of previous projects Please provide a list of your previous projects for the last 4 years. Participant Project Reference No and Title, Period (start and Role (COO, BEN, AE, Amount Website (if any) Funding programme end date) OTHER) (EUR) NIJZ, CIPH, iPAAC Joint Action, Innovative 1.4.2018 – COO (NIJZ) 5.625.000 EUR (total www.ipaac.eu Sciensano, DKG, Partnership for Action Against 31.12.2021 budget) INCa, OIL, MOH-CY, Cancer, 3rd Health Programme; BEN (WP Leaders – CIPH, BMG, TUD, DKFZ, Grant Agreement Number: Sciensano, DKG, ICO, 4.500.000 EUR co- OOI, DOH (Ireland), 801520 INCa) funding by EC (80 %) SAM LT, VULSK, BEN (MOH- Cyprus, BMG, 844.656,64 EUR MFH (Malta), NIZP- OOI, DOH- Ireland, SAM LT, (NIJZ) PZH, IOCN, ICO, MS, MFH-Malta, NIZP-PZH, MS) OUS, OECI, INC, 160.587,10 EUR MOH-IT AE (OIL, TUD, DKFZ, (CIPH) VULSK, IOCN, MOH-IT) 731.368,75 EUR SUBCONTRACTOR (OECI) (Sciensano) COLLABORATING 317.501,66 EUR PARTNER (INC) (DKG) 416.638,92 EUR (INCa) 90.102,79 EUR (OIL) 19.927,68 EUR (MOH - Cyprus) 14.605,50 EUR (BMG) 129.861,62 EUR (TUD) 1  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 21.132,50 EUR (DKFZ) 110.955,00 EUR (OOI) 23.861,88 EUR (DOH - Ireland) 12.989,80 EUR (SAM LT) 62.488.95 EUR (VULSK) 4.697,81 EUR (MFH) 129.519,25 EUR (NIZP-PZH) 3.182,77 EUR (IOCN) 311.703,84 EUR (ICO) 78.626,70 EUR (MS) 108.235,34 EUR (OUS) 10.000 EUR (OECI) NIJZ, IOCN, CANCON Joint Action, 24.2.2014 – COO (NIJZ), BEN (WP 5.999.985 EUR (total https://cancercontrol.eu/archived/ Sciensano, INCa, European Guide on Quality 23.4.2017 Leaders – IOCN, budget) CIPH, DKG, DOH Improvement in Comprehensive Sciensano, INCa, MOH-IT) (Ireland), REUH, MFH Cancer Control, 3rd Health 2.999.984 EUR co- (Malta), OUS, ICO, Programme, Grant Agreement BEN (CIPH, DKG, DOH- funding by EC MOH-IT Number: 2013 2203 Ireland, REUH, MFH-Malta, OUS, ICO) 843.845,00 (NIJZ) 115.258,00 EUR (IOCN) 561.921, 00 EUR (Sciensano) 2  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 547.429,00 EUR (INCa) 110.658,00 EUR (CIPH) 42.384,00 EUR (DKG) 22.747,00 EUR (DOH - Ireland) 153.021,00 EUR (REUH) 73.438,00 EUR (MFH-Malta) 207.032,00 EUR (OUS) 166.791,00 EUR (ICO) NIJZ, MS, Sciensano, Best-ReMaP Joint Action; 1.10.2020 – COO (NIJZ) 7.500.000 EUR (total https://bestremap.eu/ CIPH, MOH (Cyprus), European Union’s 3rd Health 30.9.2023 budget) DoH (Ireland), MFH Programme (2014-2020); Grant BEN (MS- WPL, Sciensano, (Malta), SAM LT, Agreement Number: 951202 CIPH, MOH - Cyprus, DOH - 6.000.000 EUR co- (GÖG) Ireland, MFH - Malta, SAM funding by EC (80 %) LT) 1.028.362,84 EUR (NIJZ) AE (GÖG) 203.841,96 EUR (MS) 439.178,38 EUR (Sciensano) 96.188,01 EUR (CIPH) 108.719,49 EUR (MOH-Cyprus) 3  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 191.511,16 EUR (DOH-Ireland) 213.329,65 EUR (MFH-Malta) 29.650,13 EUR (SAM LT) 142.220,60 EUR (GÖG) NIJZ, MOH-CY JAHEE Joint Action on Health 01.06.2018 – BEN (NIJZ, MOH-CY) 2.499 997,02 EUR https://jahee.iss.it/ Equity in Europe European 30.11.2021 co-funding by EC Union’s 3rd Health Programme (2014-2020); Grant Agreement 60.568,42 EUR Number: 801600 (NIJZ) 41.051 EUR (MOH- CY) MOH-CY, NIJZ eHAction Joint Action 2018 - 2021 BEN (MOH-CY, NIJZ) 2.400 000,00 EUR http://ehaction.eu/ supporting the eHealth Network; co-funding by EC European Union’s 3rd Health Programme (2014-2020), GA 127.758 EUR (MOH- no. 801558 CY) 112.876,95 EUR (NIJZ) NIJZ, OOI CHRODIS PLUS Joint Action, 2017 - 2020 BEN (OOI - WP2, WP5, 21.935 EUR (OOI) http://chrodis.eu/ 3rd Health Programme (2014- Task 5.3 Co-Leader, NIJZ) 2020); Grant Agreement 297.813,10 EUR Number: 761307 (NIJZ) 4  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 VULSK JARC Joint Action on Rare 2016 - 2019 BEN (INCa, CIPH, ICO, 2.490.000 EUR (total https://jointactionrarecancers.eu/ Cancers; European Union’s 3rd OECI, VULSK, MOH-IT) budget) OECI Health Programme (2014-2020); Grant Agreement Number: 13.647,85 EUR KK (VULSK) 724161 CIPH 126.000 EUR (OECI) ICO 9.844 EUR (KK) INCa 197.642,98 EUR MOH-IT (ICO) 30.709,00 EUR (INCa) NIZP-PZH, NIJZ HEALTHY GATEWAYS Joint 1.05.2018 - BEN (NIJZ, NIZP-PZH) 273.401,48 EUR https://www.healthygateways.eu/ Action Preparedness and action (NIZP-PZH) at points of entry (ports, airports, 30.05.2021 and ground crossings) - 3rd Health Programme (2014-2020); 328.443,57 EUR Grant Agreement Number: (NIJZ) 801493 NIJZ, NBHW TEHDAS Joint Action Towards 1.1.2021 – BEN (NIJZ, NBHW) 46.866,00 EUR https://tehdas.eu/ the European Health Data (NIJZ) Space – 3rd Health Programme 31.7.2023 (2014-2020); Grant Agreement Number: 101035467 21.400,00 EUR (NBHW) 5  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 NIJZ, OOI INTENT Interreg Central Europe 1.7.2017 – BEN (NIJZ) 1.809.109 EUR (total https://www.interreg- Programme funded under the 31.12.2020 budget) central.eu/Content.Node/INTENT.ht European Regional OOI (WP3 Leader) ml Development Fund. OOI (198.700 EUR) 193.297, 82 EUR (NIJZ) NIJZ Covid-19 vulnerable groups, 1.9.2020 – COO (NIJZ) 6.000.000 EUR www.cepimose.si ESI fund 30.8.2023 NIJZ SOPA (Together for a 1.10.2016- COO (NIJZ) 5.844.623,91 EUR www.sopa.si Responsible Attitutde Towards Drinking), ESI fund 31.1.2022 UNICANCER MyPeBS (My Personal Breast 01.01.2018 - COO (UNICANCER) 12.436.858 EUR www.mypebs.eu Screening); European Union’s 30.06.2025 (UNICANCER) Horizon 2020 research and innovation programme; Grant Agreement Number: 755394 SCIENSANO, ACC European Call for the future 01.01.2020 - COO (Sciensano) 12.221.843,75 EUR http://oncngs.eu/ Next Generation Sequencing (Sciensano) (NGS) solutions for cancer 30.06.2025 BEN (ACC) (OncNGS); European Union’s 10.999.659,38 (ACC) Horizon 2020 research and innovation programme, Grant Agreement Number: 874467 6  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 OIL Water and soil contamination 1.2018 - 6.2021 BEN 122.783,00 EUR http://www.wasabysite.it/ and awareness on breast cancer risk in young women Institute of Oncology Ljubljana - cancer risk in young women Clinical studies (onko-i.si) (WASABY), European Commission 3rd Health Programme SCIENSANO “Risk-based Screening for 01.01.2020 - BEN 5.792.355 EUR RISCC Risk-based Screening for Cervical Cancer” (RISCC), 31.12.2024 Cervical Cancer (riscc-h2020.eu) European Union's Horizon 2020 research and innovation programme, Grant Agreement number 847845. MOH-CY, NIJZ European Human Biomonitoring 2017 - 2020 BEN (MOH-CY, NIJZ) 472.725 EUR (MOH- https://www.hbm4eu.eu/ Initiative (HBM4EU)- Horizon CY) 2020 371.000 EUR (NIJZ) INCa, ACC TRANSCAN 3 01.03.2021 – BEN 2.420.056,00 EUR http://transcan.eu/ 28.02.2026 (INCa) Grant Agreement number: 964264 — TRANSCAN-3 — 10.949.93,59 EUR H2020-SC1-BHC-2018-2020 / (ACC) H2020-SC1-2020-Single- StageRTD UNICANCER ONCOBIOME, Microbiota 01.01.2019 – BEN 14.994.551 EUR www.oncobiome.eu against cancer, International 31.12.2023 Research Programme Horizon 2020 – GA no. 825410 7  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 DKFZ ELIMINATION: Development of 01.02.2018 – BEN 1.490.825,00 EUR strategies to eliminate cancer 31.01.2023 cells from the bone marrow (ERC Starting Grant); Grant Agreement Number: 758713 DKFZ HCA/Organoid: Pilot action to 01.01.2020 – BEN 4.998.687.50 EUR https://hca-organoid.eu/ establish a multi-tissue human organoid platform within the 31.03.2022 Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research (Horizon 2020, Societal Challenge 1) DKFZ, ACC ITCC-P4 - Paediatric Preclinical 01.01.2017 – COO (DKFZ) 18.131.960.94 EUR https://www.itccp4.eu/ Proof of Concept Platform for 31.12.2022 (DKFZ) Childhood Cancers, IMI2 BEN (ACC) 7.370.000 EUR (ACC) TUD vCare, Horizon 2020; Grant 09.2017 – COO 4.040.000 EUR https://vcare-project.eu/ Agreement Number: 769807, 08.2022 TUD Gatekeeper, Horizon 2020; 10.2019 – BEN 22.600.00 EUR https://www.gatekeeper-project.eu/ Grant Agreement Number: 03.2023 857223 TUD Training Blueprint for the Digital 10.2018 – BEN 430.000 EUR http://trainblue.eu/ Transformation of Health and 07.2021 Care (TBDTHC), Erasmus+ 8  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ACC B1MG, Beyond one million 1.6.2020- BEN 4.000.000 EUR https://b1mg-project.eu/ genomes 31.5.2023 CSA H2020-SC1-DTH-2019-2 VULSK PanCare studies of the scale-up 2021-2025 BEN 4.000.000 EUR https://www.pancare.eu/projects/ and implementation of the digital (VULSK 242.606,25 Survivorship Passport to EUR) improve people-centred care for childhood cancer survivors, No. 899999 VULSK Twinning in Research and 2021-2023 COO 900.000 EUR https://siope.eu/TREL-project Education to improve survival in (VULSK 465.902,00 Childhood Solid Tumours in EUR) Lithuania (TREL) NCI An AI Platform integrating 2020-2024 BEN 9.997.870,00 EUR https://www.nvi.lt/news/565/72/Dirbti imaging data and models, nio-intelekto-platforma-apimanti- supporting precision care vaizdinimo-duomenis-ir-modelius- through prostate cancer’s tikslesniam-testiniam-prostatos- continuum (PROCANCER), vezio-gydymui/ Horizon 2020 , Ref. No. 952159, NCI Cancer Research UK Grand 2017-2022 BEN 20.000.000,00 EUR https://www.mutographs.org/mutogr Challenge Mutographs: aphs-project/ Uncovering some of the unknown causes of cancer through tell-tale signatures in DNA, Cancer Research UK 9  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 NCI Ref. No. 01.1.1-CPVA-V-701- 2019-2023 COO 7.927.999,00 EUR https://www.nvi.lt/news/569/72/Zmo 16-0001, Human Biological gaus-biologiniu-istekliu-centras/ Resource Center, European structural and investment funds, 2014-2020 Operational Programme for the European Union Funds Investments in Lithuania KK EuCanImage (A European 2020-2024 BEN 181.187,00 EUR https://encanimage.eu/ Cancer Image Platform Linked to Biological and Health Data for Next-Generation Artificial Intelligence and Precision Medicine in Oncology) Horizon 2020, Grant Agreement 952103 KK EURACAN (European Network Since 2017 - BEN N/A- https://euracan.eu/expert-centres- for Rare Adult Solid Cancer) ongoing referral- pathways/experts/?_sfm_Country=Li EURACAN membership in the thuania domain Rare Cancer of the Brain and Spinal Cord Hospital of Lithuanian University of Health Sciences Kauno klinikos has received the European Reference Network membership LIH MCS Innovative Training 2017-2020 BEN 230.000 EUR N/A Network (GLIOTRAIN), Horizon 2020 10  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 OUH Accreditation project CCC 2015-2019 BEN 100.000 EUR https://epage.byraservice.no/epage/ including mentoring several hso/2021/ous/ouhccc/ other applicants OUH The Impress Project – National 2021 - 2024 BEN 9.100.000 EUR https://impressnorway.com/ project on precision Cancer Medicine and Nordic Trial Network OUH ERN EURACAN : European 2017- AE N/A https://euracan.eu/ reference network for rare adult solid cancers - participation in Sarcoma and Rare gynecological cancers network ICO 4-IN-THE-LUNG-RUN (Towards 2019-2024 BEN 526.575 EUR https://www.i-dna.org/4-in-the-lung- individually tailored invitations, run/ screening intervals, and integrated co-morbidity reducing strategies in lung cancer screening). IDIVAL Discovery, Validation and 2016 - 2018 BEN 171.325,00 EUR N/A Implementation of Biomarkers for Precision Oncology. PIE15/00081. Funding Agency: INSTITUTO DE SALUD CARLOS III. MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD (National Project) 11  Annex 3 to Part B of CraNE Proposal – List of Previous Projects, V 4.0, submitted 14.9.2022 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 IDIVAL New immunotherapies for 2020-2022 BEN 105.270,00 EUR N/A bladder cancer. PI19/01580. Funding Agency: INSTITUTO DE SALUD CARLOS III. MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD (National Project) 12  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 8.07.2022 08:22 Project acronym: CraNE JA Participant short name: NIJZ Participant PIC: 948891346 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) WP coordination, supervision of implementation of WPs Senior experts/advisors/researchers monthly 6.400,00 7,00 44.800,00 YES, 2,3,4 tasks, milestones and deliverables, expertise work in WP WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 5.700,00 1,00 5.700,00 YES, 2,3, and evaluation tasks within WP WP coordination and alignment between tasks and other work packages, organization of events, WP meetings, Project managers monthly 3.700,00 11,00 40.700,00 YES, 2,3,4 preparation of reports, coordination of work effort between internal personnel Secretariat, financial management Administrative personnel monthly 2.500,00 48,00 120.000,00 NO IT and other technical and administrative support, legal Technical personnel monthly 2.500,00 5,40 13.500,00 NO personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 224.700,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary  SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total personnel for this WP 224.700,00 WORK PACKAGE 2 DISSEMINATION A.1 Employees (or equivalent) Participation in WP tasks, meetings and events Senior experts/advisors/researchers monthly 6.400,00 2,00 12.800,00 YES, 1,3,4 Participation in WP tasks, meetings and events Junior experts/advisors/researchers monthly 5.700,00 3,00 17.100,00 YES, 1,3, Preparation of reports, coordination of work effort Project managers monthly 3.700,00 0,50 1.850,00 YES, 1,3,4 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 31.750,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 31.750,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) Participation in WP tasks, meetings and events Senior experts/advisors/researchers monthly 6.400,00 0,50 3.200,00 YES, 1,2,4 Participation in WP tasks, meetings and events Junior experts/advisors/researchers monthly 5.700,00 2,50 14.250,00 YES, 1,2, Preparation of reports, coordination of work effort Project managers monthly 3.700,00 0,50 1.850,00 YES, 1,2,4 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 19.300,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 19.300,00 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participation in WP tasks, meetings and events Senior experts/advisors/researchers monthly 6.400,00 2,00 12.800,00 YES, 1,2,3 monthly 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 12.800,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 12.800,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00  Other [category 1] monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00  A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 288.550,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION NO Addressing representatives of one of most influential cancer patient organisations, conference meetings with 1 ECPC 15.000,00 patient organisation representatives. 2 [Subcontract short name] 0,00 Total subcontracting for this WP 15.000,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00  FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 [Subcontract short name] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Total subcontracting (all WPs) 15.000,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) Also part of other work activity/destination; number of days; number of persons (actual costs) packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 2,00 1.400,00 YES, WP3 accommodation, subsistence allowances for two persons, average price: 1,200.00 € Accomodation costs 0,00 300,00 2,00 600,00 Subsistence costs 0,00 200,00 2,00 400,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 700,00 2,00 1.400,00 YES, WP3 accommodation, subsistence allowances for two persons, average price: 1,200.00 € Accomodation costs 300,00 2,00 600,00 Subsistence costs 200,00 2,00 400,00 Participants International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 2,00 1.400,00 YES, WP3 accommodation, subsistence allowances for two persons, average price: 1,200.00 € Accomodation costs 0,00 300,00 2,00 600,00 Subsistence costs 0,00 200,00 2,00 400,00 Total travel costs for this travel 4.200,00 Total accomodation costs for this travel 1.800,00 Total subsistence costs for this travel 1.200,00 Total travel 7.200,00 2 CraNE Final conference Speakers International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 700,00 2,00 1.400,00 YES, WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 €  Accomodation costs 300,00 2,00 600,00 Subsistence costs 200,00 2,00 400,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 700,00 2,00 1.400,00 YES, WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 300,00 2,00 600,00 Subsistence costs 200,00 2,00 400,00 Participants International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, hotel accommodation, subsistence allowances for 15 Travel costs 700,00 15,00 10.500,00 YES, WP3 persones (reimbursement for speakers, invited experts) average price: 1,200.00 € Accomodation costs 300,00 15,00 4.500,00 Subsistence costs 200,00 15,00 3.000,00 Total travel costs for this travel 13.300,00 Total accomodation costs for this travel 5.700,00 Total subsistence costs for this travel 3.800,00 Total travel 22.800,00 3 WP working meetings for Coordinator Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meetings, place TBD, 1-2 days working meetings of WP 5,6,7,8; flight ticket, hotel Travel costs 0,00 700,00 8,00 5.600,00 YES, 5,6,7,8 accommodation, subsistence allowances for 8 visits; average price per person: 1,000.00 € Accomodation costs 0,00 150,00 8,00 1.200,00 Subsistence costs 0,00 150,00 8,00 1.200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 5.600,00 Total accomodation costs for this travel 1.200,00 Total subsistence costs for this travel 1.200,00 Total travel 8.000,00 Total travel costs for this WP 23.100,00 Total accomodation costs for this WP 8.700,00 Total subsistence costs for this WP 6.200,00 Total travel for this WP 38.000,00 0,00 WORK PACKAGE 2 DISSEMINATION 1 WP2 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00  Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Personnel International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for one Travel costs 0,00 700,00 1,00 700,00 NO person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP2 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for one Travel costs 0,00 700,00 1,00 700,00 NO person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 3 Dissemination events & meetings Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meetings, place TBD, 1-2 days dissemination meetings, flight ticket, hotel Travel costs 0,00 700,00 11,00 7.700,00 NO accommodation, subsistence allowances for 11 visits; average price per person: 1,000.00 € Accomodation costs 0,00 150,00 11,00 1.650,00 Subsistence costs 0,00 150,00 11,00 1.650,00  Participants Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 7.700,00 Total accomodation costs for this travel 1.650,00 Total subsistence costs for this travel 1.650,00 Total travel 11.000,00 Total travel costs for this WP 9.100,00 Total accomodation costs for this WP 1.950,00 Total subsistence costs for this WP 1.950,00 Total travel for this WP 13.000,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 WP4 1st meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for one Travel costs 0,00 700,00 1,00 700,00 NO person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP4 2nd meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for one Travel costs 0,00 700,00 1,00 700,00 NO person, average price: 1,000.00 €  Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 33.600,00 Total accomodation (all WPs) 10.950,00 Total subsistence (all WPs) 8.450,00 Total travel and subsistence (all WPs) 53.000,00 C.2 Equipment WORK PACKAGE 1 COORDINATION  C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Associated Also partwith document of other work Ref. Ares(2022)6379367 - 15/09/2022 method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a NO Project management, secretariat, financial manegement LAPTOP (2X) 3.000,00 24 24,00 100% 3.000,00 YES, 2,3,4 Scientific coordination of JA LAPTOP (1X) 1.500,00 24 24,00 50% 750,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 3.750,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 3.750,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00  ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes)  Also part of other work Description of tasks/activities for which the equipment is packages? YES/NO and which needed WP a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 [Equipment short name] 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 3.750,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables NO Kick-off & 1ST JA meeting, Final conference,... TBD Conferences, seminars, workshops, trainings & events 40.000,00 (Venue & catering) Information & publications Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 NO Costs for 2 internal audits before submission of Periodic 3 Audit fees (CFS) 6.000,00 and Final financial report 4 Project evaluation 0,00 NO Project and Financial management platform to be used by 4PM financial management platform 18.000,00 the Coordinator and all Beneficiaries NO Zoom upgrade cost for online events Zoom licence 569,00 Total goods, works and services for this WP 64.569,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much NO Materials for promotion Consumables 3.000,00 NO Stakeholder Forum/Conference (venue&catering) Conferences, seminars, workshops, trainings & events 2.840,00 NO Publication of scientific articles, registration fees Information & publications 10.000,00 Other expenses 1 IPR costs 0,00  2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 15.840,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00  3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00  4 Project evaluation 0,00 [5 short name other] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 80.409,00 Total purchase costs (all WPs) 137.159,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00  THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 440.709,00 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7%  ALL WORK PACKAGES Total indirect costs 30.849,63 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total indirect costs 30.849,63 TOTAL COSTS PARTICIPANT 471.558,63 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 471.558,63 Single Funding rate (%) 80% Maximum EU contribution 377.246,90 Requested EU contribution 377.246,85 EU CONTRIBUTION 377.246,85 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00 Financial contributions 0,00  TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Amount (EUR) Own resources 94.311,78 OWN RESOURCES 94.311,78 TOTAL INCOME PARTICIPANT 471.558,63  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: NIJZ Participant PIC: 948891346 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 224.700,00 0,00 0,00 38.000,00 23.100,00 8.700,00 6.200,00 3.750,00 64.569,00 0,00 331.019,00 WP2 DISSEMINATION 31.750,00 0,00 15.000,00 13.000,00 9.100,00 1.950,00 1.950,00 0,00 15.840,00 0,00 75.590,00 WP3 EVALUATION 19.300,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 19.300,00 WP4 SUSTAINABILITY 12.800,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 14.800,00 WP5 THE EU NETWORK OF COMPREHENSIVE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 ENABLE THE IMPLEMENTATION OF CCCs WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 288.550,00 0,00 15.000,00 53.000,00 33.600,00 10.950,00 8.450,00 3.750,00 80.409,00 0,00 30.849,63 471.558,63  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 13.09.2022 08:51 Project acronym: CraNE JA Participant short name: OIL Participant PIC: 986222475 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 0,25 600,00 YES 1,4,6,7 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 600,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 600,00 WORK PACKAGE 2 DISSEMINATION  A.1 Employees (or equivalent) Preparation of reports, coordination of work effort Project managers monthly 1.500,00 0,25 375,00 YES,1,3 Associated with document Ref. internal between Ares(2022)6379367 personnel - 15/09/2022 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 375,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 375,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) Preparation of reports, coordination of work effort Project managers monthly 1.500,00 0,25 375,00 YES,1,2 between internal personnel Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 375,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 375,00 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 0,25 600,00 YES, 1,6,7 Select a staff category monthly 0,00 0,00 0,00  Other [category 1] monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 600,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 600,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 1,33 3.192,00 YES, 1, 4, 7 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00  Total employees (or equivalent) 3.192,00 A.2 + A.3 Natural persons under direct contract and seconded persons Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 3.192,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.100,00 1,40 2.940,00 YES, 1.4,6 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 2.940,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 2.940,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00  Select a staff category monthly 0,00 0,00 0,00 Other Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 8.082,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 [Subcontract short name] 0,00  2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Total subcontracting (all WPs) 0,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES, WP3 accommodation, subsistence allowances for two persons, average price: 1,200.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 CraNE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES, WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 150,00 1,00 150,00  Subsistence costs 0,00 150,00 1,00 150,00 Participants Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 2 DISSEMINATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 W6 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00  Subsistence costs 0,00 150,00 1,00 150,00 Participants Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 W6 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 WP7 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00  Participants Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP7 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 4.200,00 Total accomodation (all WPs) 900,00 Total subsistence (all WPs) 900,00 Total travel and subsistence (all WPs) 6.000,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a  1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00  C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the Associated with document Ref. Ares(2022)6379367 - 15/09/2022 action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes)  Also part of other work Description of tasks/activities for which the equipment is packages? YES/NO and which needed WP a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION  Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much  Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much  Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 0,00 Total purchase costs (all WPs) 6.000,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00  Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00  Total other cost category D.1 for this WP 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 14.082,00 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Total indirect costs 985,74 Total indirect costs 985,74 TOTAL COSTS PARTICIPANT 15.067,74 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 15.067,74 Single Funding rate (%) 80% Maximum EU contribution 12.054,19 Requested EU contribution 12.054,19 EU CONTRIBUTION 12.054,19 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties  Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00 Financial contributions 0,00 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 3.013,55 OWN RESOURCES 3.013,55 TOTAL INCOME PARTICIPANT 15.067,74  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: OIL Participant PIC: 986222475 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 600,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.600,00 WP2 DISSEMINATION 375,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 375,00 WP3 EVALUATION 375,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 375,00 WP4 SUSTAINABILITY 600,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 600,00 WP5 THE EU NETWORK OF COMPREHENSIVE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 3.192,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 5.192,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 2.940,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 4.940,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 8.082,00 0,00 0,00 6.000,00 4.200,00 900,00 900,00 0,00 0,00 0,00 985,74 15.067,74  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 13.09.2022 09:07 Project acronym: CraNE JA Participant short name: Sciensano Participant PIC: 906160809 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) Secretariat, financial management Administrative personnel monthly 4.650,00 0,40 1.860,00 YES, 2,3,4, WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 6.045,00 0,30 1.813,50 YES, 2,3,4,6 and evaluation tasks within WP Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 3.673,50 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 3.673,50 WORK PACKAGE 2 DISSEMINATION A.1 Employees (or equivalent) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 6.045,00 0,30 1.813,50 YES, 1,3,4,6 and evaluation tasks within WP Secretariat, financial management Administrative personnel monthly 4.650,00 0,40 1.860,00 YES, 1,3,4 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 3.673,50 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 3.673,50 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 6.045,00 0,30 1.813,50 YES, 1 2,4,6 and evaluation tasks within WP Secretariat, financial management Administrative personnel monthly 4.650,00 0,40 1.860,00 YES, 1,2,4 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 3.673,50 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 3.673,50 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) WP coordination, supervision of implementation of WPs Senior experts/advisors/researchers monthly 7.440,00 10,00 74.400,00 NO tasks, milestones and deliverables, expertise work in WP  WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 6.045,00 15,00 90.675,00 YES, 1,2,3,6 and evaluation tasks within WP Secretariat, financial management Administrative personnel monthly 4.650,00 5,00 23.250,00 YES 1,2,3 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 188.325,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 188.325,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 6.045,00 5,00 30.225,00 YES, 1,2 3,4 and evaluation tasks within WP Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00  [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 30.225,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 30.225,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons  Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 229.570,50 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs NO Feasibility study for analysing guideline adherence in a 1 Feasibility study 30.000,00 colorectal cancer network 2 [Subcontract short name] 0,00 Total subcontracting for this WP 30.000,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK  1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Total subcontracting (all WPs) 30.000,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES, WP3 accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 2 CraNE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES, WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 €  Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 600,00 Total subsistence costs for this WP 400,00 Total travel for this WP 2.400,00 0,00 WORK PACKAGE 2 DISSEMINATION 1 WP2 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP2 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00  Participants Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 WP4 1st meeting / GB meeting Speakers International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for 2 Travel costs 0,00 700,00 2,00 1.400,00 NO invited speakers, average price per person 850.00 € Accomodation costs 0,00 150,00 2,00 300,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Participants International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for 25 Travel costs 0,00 700,00 25,00 17.500,00 NO persons (reimbursement for GB representatives), average price per person 850.00 € Accomodation costs 0,00 150,00 25,00 3.750,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 18.900,00 Total accomodation costs for this travel 4.050,00 Total subsistence costs for this travel 0,00 Total travel 22.950,00 2 WP4 2nd meeting / GB meeting Speakers International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for 2 Travel costs 0,00 700,00 2,00 1.400,00 NO invited speakers, average price per person 850.00 € Accomodation costs 0,00 150,00 2,00 300,00 Subsistence costs 0,00 0,00 0,00 0,00  Personnel Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Participants International meeting, place TBD, 1-2 days/ flight ticket, hotel accommodation, subsistence allowances for 25 Travel costs 0,00 700,00 25,00 17.500,00 NO persons (reimbursement for GB representatives), average price per person 850.00 € Accomodation costs 0,00 150,00 25,00 3.750,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 18.900,00 Total accomodation costs for this travel 4.050,00 Total subsistence costs for this travel 0,00 Total travel 22.950,00 Total travel costs for this WP 37.800,00 Total accomodation costs for this WP 8.100,00 Total subsistence costs for this WP 0,00 Total travel for this WP 45.900,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 WP6 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP6 2nd meeting  Speakers Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 42.000,00 Total accomodation (all WPs) 9.300,00 Total subsistence (all WPs) 1.000,00 Total travel and subsistence (all WPs) 52.300,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other  Also part of other work Description of tasks/activities for which the equipment is packages? YES/NO and which needed WP a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00  C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the Associated with document Ref. Ares(2022)6379367 - 15/09/2022 action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c  1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00  Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Associated with document Ref. Ares(2022)6379367 - 15/09/2022 C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00  Other expenses 1 IPR costs 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 YES, WP2 Symposia/WP4/GB meetings (venue&catering) Conferences, seminars, workshops, trainings & events 10.000,00 YES, WP2 Publications,publishable articles, registration fees Information & publications 4.000,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 NO Cost for internal audit before submission of Periodic/Final 3 Audit fees (CFS) 6.000,00 report 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 20.000,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00  Other expenses 1 IPR costs 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 20.000,00 Total purchase costs (all WPs) 72.300,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP  [Support scheme short name] 0,00 [Support scheme short name] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 0,00 Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 331.870,50 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Total indirect costs 23.230,94 Total indirect costs 23.230,94 TOTAL COSTS PARTICIPANT 355.101,44 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 355.101,44 Single Funding rate (%) 80% Maximum EU contribution 284.081,15 Requested EU contribution 284.081,15 EU CONTRIBUTION 284.081,15 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Financial contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00 Financial contributions 0,00 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 71.020,29 OWN RESOURCES 71.020,29 TOTAL INCOME PARTICIPANT 355.101,44  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: Sciensano Participant PIC: 906160809 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 3.673,50 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 6.073,50 WP2 DISSEMINATION 3.673,50 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 5.673,50 WP3 EVALUATION 3.673,50 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 3.673,50 WP4 SUSTAINABILITY 188.325,00 0,00 0,00 45.900,00 37.800,00 8.100,00 0,00 0,00 20.000,00 0,00 254.225,00 WP5 THE EU NETWORK OF COMPREHENSIVE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 30.225,00 0,00 30.000,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 62.225,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 229.570,50 0,00 30.000,00 52.300,00 42.000,00 9.300,00 1.000,00 0,00 20.000,00 0,00 23.230,94 355.101,44  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 5.07.2022 09:01 Project acronym: CraNE JA Participant short name: UZA Participant PIC: 996727866 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) Preparation of reports, coordination of work effort Project managers monthly 5.580,00 0,25 1.395,00 YES, 2,3 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.395,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.395,00 WORK PACKAGE 2 DISSEMINATION  A.1 Employees (or equivalent) Preparation of reports, coordination of work effort Project managers monthly 5.580,00 0,25 1.395,00 YES, 1,3 Associated with document Ref. internal between Ares(2022)6379367 personnel - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.395,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.395,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) Preparation of reports, coordination of work effort Project managers monthly 5.580,00 0,25 1.395,00 YES, 1,2 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.395,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.395,00 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 6.045,00 0,25 1.511,25 YES, 4,6 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00  Total employees (or equivalent) 1.511,25 A.2 + A.3 Natural persons under direct contract and seconded persons Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.511,25 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Select a staff category monthly 6.045,00 3,75 22.668,75 YES 4,6 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 22.668,75 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00  Other [category 1] monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 22.668,75 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00  Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary Associated with document Ref. Ares(2022)6379367 - 15/09/2022 SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 28.365,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00  2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total subcontracting (all WPs) 0,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES, WP3 accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 2 CraNE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES, WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00  Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 600,00 Total subsistence costs for this WP 400,00 Total travel for this WP 2.400,00 0,00 WORK PACKAGE 2 DISSEMINATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00  Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total travel costs (all WPs) 1.400,00 Total accomodation (all WPs) 600,00 Total subsistence (all WPs) 400,00 Total travel and subsistence (all WPs) 2.400,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c  1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00  THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Associated with document Ref. Ares(2022)6379367 - 15/09/2022 C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other  Also part of other work Description of tasks/activities for which the equipment is packages? YES/NO and which needed WP a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00  Other expenses 1 IPR costs 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 0,00 Total purchase costs (all WPs) 2.400,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00  0,00 Total other cost category D.1 for this WP 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00  Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 30.765,00 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Total indirect costs 2.153,55 Total indirect costs 2.153,55 TOTAL COSTS PARTICIPANT 32.918,55 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 32.918,55 Single Funding rate (%) 80% Maximum EU contribution 26.334,84 Requested EU contribution 26.334,84 EU CONTRIBUTION 26.334,84 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00 Financial contributions 0,00 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 6.583,71 OWN RESOURCES 6.583,71 TOTAL INCOME PARTICIPANT 32.918,55  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: UZA Participant PIC: 996727866 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 1.395,00 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 3.795,00 WP2 DISSEMINATION 1.395,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 1.395,00 WP3 EVALUATION 1.395,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 1.395,00 WP4 SUSTAINABILITY 1.511,25 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 1.511,25 WP5 THE EU NETWORK OF COMPREHENSIVE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 22.668,75 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 22.668,75 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 28.365,00 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 2.153,55 32.918,55  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 5.07.2022 09:06 Project acronym: CraNE JA Participant short name: USHATO Participant PIC: 952486263 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.600,00 0,40 640,00 YES, 1,2,3,4 and evaluation tasks within WP Secretariat, financial management Administrative personnel monthly 1.100,00 0,30 330,00 YES, 1,2,3 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 970,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 970,00 WORK PACKAGE 2 DISSEMINATION A.1 Employees (or equivalent) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.600,00 0,40 640,00 YES, 1,2,3,4 and evaluation tasks within WP Secretariat, financial management Administrative personnel monthly 1.100,00 0,30 330,00 YES, 1,2,3 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 970,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 970,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.600,00 0,40 640,00 YES, 1,2,3,4 and evaluation tasks within WP Secretariat, financial management Administrative personnel monthly 1.100,00 0,30 330,00 YES, 1,2,3 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 970,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 970,00 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.600,00 0,70 1.120,00 YES, 1,2,3,4 and evaluation tasks within WP  Select a staff category monthly 0,00 0,00 0,00 Other Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.120,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.120,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 4.000,00 0,50 2.000,00 NO Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00  [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 2.000,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 2.000,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons  Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 6.030,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK  1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Total subcontracting (all WPs) 0,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES, WP3 accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 2 CrANE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES, WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 €  Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 600,00 Total subsistence costs for this WP 400,00 Total travel for this WP 2.400,00 0,00 WORK PACKAGE 2 DISSEMINATION 1 WP2 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP2 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00  Participants Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 WP4 1st meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP4 2nd meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel  International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 WP6 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP6 2nd meeting Speakers  Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 5.600,00 Total accomodation (all WPs) 1.500,00 Total subsistence (all WPs) 1.300,00 Total travel and subsistence (all WPs) 8.400,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a  1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost)  Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also (EUR) Associated with document packages? YES/NO and which Ref. Ares(2022)6379367 needed - 15/09/2022 for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00  2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00  2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 0,00 Total purchase costs (all WPs) 8.400,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00  [Support scheme short name] 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs  Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 14.430,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Total indirect costs 1.010,10 Total indirect costs 1.010,10 TOTAL COSTS PARTICIPANT 15.440,10 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 15.440,10 Single Funding rate (%) 80% Maximum EU contribution 12.352,08 Requested EU contribution 12.352,08 EU CONTRIBUTION 12.352,08 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties Amount Associated with document Description Ref. Ares(2022)6379367 - contribution, of the contribution (type of 15/09/2022 (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00 Financial contributions 0,00 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 3.088,02 OWN RESOURCES 3.088,02 TOTAL INCOME PARTICIPANT 15.440,10  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: USHATO Participant PIC: 952486263 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 970,00 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 3.370,00 WP2 DISSEMINATION 970,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.970,00 WP3 EVALUATION 970,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 970,00 WP4 SUSTAINABILITY 1.120,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.120,00 WP5 THE EU NETWORK OF COMPREHENSIVE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 2.000,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 4.000,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 6.030,00 0,00 0,00 8.400,00 5.600,00 1.500,00 1.300,00 0,00 0,00 0,00 1.010,10 15.440,10  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 5.07.2022 09:34 Project acronym: CraNE JA Participant short name: CIPH Participant PIC: 998128255 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) WP coordination and alignment between tasks and other work packages, organization of events, WP meetings, Project managers monthly 1.800,00 0,70 1.260,00 YES, 1,2,3 preparation of reports, coordination of work effort between internal personnel Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.260,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00  Total personnel for this WP 1.260,00 WORK PACKAGE 2 DISSEMINATION Associated with document Ref. Ares(2022)6379367 - 15/09/2022 A.1 Employees (or equivalent) WP coordination and alignment between tasks and other work packages, organization of events, WP meetings, Project managers monthly 1.800,00 0,70 1.260,00 YES, 1,2,3 preparation of reports, coordination of work effort between internal personnel Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.260,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.260,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) WP coordination, supervision of implementation of WPs Senior experts/advisors/researchers monthly 3.900,00 7,00 27.300,00 YES, 3,5,7 tasks, milestones and deliverables, expertise work in WP WP coordination and alignment between tasks and other work packages, organization of events, WP meetings, Project managers monthly 1.800,00 2,00 3.600,00 YES, 1,2,3 preparation of reports, coordination of work effort between internal personnel WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.500,00 7,00 10.500,00 YES, 3,4,7 and evaluation tasks within WP Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 41.400,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00  Total personnel for this WP 41.400,00 WORK PACKAGE 4 SUSTAINABILITY Associated with document Ref. Ares(2022)6379367 - 15/09/2022 A.1 Employees (or equivalent) WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.500,00 0,70 1.050,00 YES, 3,4,7 and evaluation tasks within WP Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.050,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.050,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) WP coordination, supervision of implementation of WPs Senior experts/advisors/researchers monthly 3.900,00 2,00 7.800,00 YES, 3,5,7 tasks, milestones and deliverables, expertise work in WP Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 7.800,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 7.800,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs  A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) WP coordination, supervision of implementation of WPs Senior experts/advisors/researchers monthly 3.900,00 0,50 1.950,00 YES, 3,5,7 tasks, milestones and deliverables, expertise work in WP WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.500,00 1,00 1.500,00 YES, 3,4,7 and evaluation tasks within WP Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 3.450,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 3.450,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00  Other [category 1] monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 56.220,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION NO 1 External Auditor 3.000,00 External evaluation of Evaluation Strategy 2 [Subcontract short name] 0,00 Total subcontracting for this WP 3.000,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00  ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Total subcontracting (all WPs) 3.000,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES WP3 accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 2 CrANE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00  Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES, WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 600,00 Total subsistence costs for this WP 400,00 Total travel for this WP 2.400,00 0,00 WORK PACKAGE 2 DISSEMINATION 1 WP2 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP2 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00  Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 Associated NO with document Ref. hotel Ares(2022)6379367 accommodation, - 15/09/2022 subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 W4 1st meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP4 2nd meeting / GB meeting Speakers  Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 W5 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 W5 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00  Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 WP7 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00  2 WP7 2nd meeting Speakers Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 7.000,00 Total accomodation (all WPs) 1.800,00 Total subsistence (all WPs) 1.600,00 Total travel and subsistence (all WPs) 10.400,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement  Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes)  Also part of other work Description of tasks/activities for which the equipment is packages? YES/NO and which needed WP a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement  Total rental and leasing 0,00 Total equipment for this WP 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Also part of other work Description of tasks/activities for which the equipment is packages? YES/NO and which needed WP  Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other Associated with document Ref. Ares(2022)6379367 - 15/09/2022 a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00  3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00  3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00  4 Project evaluation 0,00 [5 short name other] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 0,00 Total purchase costs (all WPs) 10.400,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00  Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING Associated with document Ref. Ares(2022)6379367 - 15/09/2022 PROCESS AND FUNCTIONING Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs Costs (flat-rate)  Total estimated direct costs (on which indirect cost flat-rate is based, 69.620,00 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total indirect costs 4.873,40 Total indirect costs 4.873,40 TOTAL COSTS PARTICIPANT 74.493,40 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 74.493,40 Single Funding rate (%) 80% Maximum EU contribution 59.594,72 Requested EU contribution 59.594,72 EU CONTRIBUTION 59.594,72 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties  Amount Description of the contribution (type of contribution, (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total financial contributions 0,00 Financial contributions 0,00 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 14.898,68 OWN RESOURCES 14.898,68 TOTAL INCOME PARTICIPANT 74.493,40  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: CIPH Participant PIC: 998128255 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 1.260,00 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 3.660,00 WP2 DISSEMINATION 1.260,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.260,00 WP3 EVALUATION 41.400,00 0,00 3.000,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 44.400,00 WP4 SUSTAINABILITY 1.050,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.050,00 WP5 THE EU NETWORK OF COMPREHENSIVE 7.800,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 9.800,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 3.450,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 5.450,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 56.220,00 0,00 3.000,00 10.400,00 7.000,00 1.800,00 1.600,00 0,00 0,00 0,00 4.873,40 74.493,40  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 13.09.2022 09:20 Project acronym: CraNE JA Participant short name: MOH Participant PIC: 994267946 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 0,70 1.680,00 YES, 1,2,3,4,6 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.680,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.680,00 WORK PACKAGE 2 DISSEMINATION  A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 0,70 1.680,00 YES, 1,2,3,4,6 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.680,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.680,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 0,70 1.680,00 YES, 1,2,3,4,6 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.680,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.680,00 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 0,70 1.680,00 YES, 1,2,3,4,6 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00  Total employees (or equivalent) 1.680,00 A.2 + A.3 Natural persons under direct contract and seconded persons Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.680,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.400,00 0,50 1.200,00 YES, 1,2,3,4,6 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.200,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00  Other [category 1] monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.200,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00  Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary Associated with document Ref. Ares(2022)6379367 - 15/09/2022 SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 7.920,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00  2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total subcontracting (all WPs) 0,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES WP3 accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 2 CraNE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00  Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 600,00 Total subsistence costs for this WP 400,00 Total travel for this WP 2.400,00 0,00 WORK PACKAGE 2 DISSEMINATION 1 WP2 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP2 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00  Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 WP4 1st meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP4 2nd meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00  Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 WP6 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP6 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 €  Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 5.600,00 Total accomodation (all WPs) 1.500,00 Total subsistence (all WPs) 1.300,00 Total travel and subsistence (all WPs) 8.400,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Also part of other work Description of tasks/activities for which the equipment is packages? YES/NO and which needed WP  Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP document Ref. Ares(2022)6379367 - 15/09/2022 Associated with purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00  ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs  C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00  2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00  Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00  Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00  Total goods, works and services (all WPs) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total purchase costs (all WPs) 8.400,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Also used for other work Description of support scheme (estimated number of packages? recipients; maximum amount per recipient) YES/NO and which WP  Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 16.320,00 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Total indirect costs 1.142,40  Total indirect costs 1.142,40 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 TOTAL COSTS PARTICIPANT 17.462,40 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 17.462,40 Single Funding rate (%) 80% Maximum EU contribution 13.969,92 Requested EU contribution 13.969,92 EU CONTRIBUTION 13.969,92 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00  Financial contributions 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 3.492,48 OWN RESOURCES 3.492,48 TOTAL INCOME PARTICIPANT 17.462,40  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: MOH Participant PIC: 994267946 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 1.680,00 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 4.080,00 WP2 DISSEMINATION 1.680,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.680,00 WP3 EVALUATION 1.680,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 1.680,00 WP4 SUSTAINABILITY 1.680,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.680,00 WP5 THE EU NETWORK OF COMPREHENSIVE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 1.200,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.200,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 7.920,00 0,00 0,00 8.400,00 5.600,00 1.500,00 1.300,00 0,00 0,00 0,00 1.142,40 17.462,40  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 13.09.2022 09:26 Project acronym: CraNE JA Participant short name: UH MOTOL Participant PIC: 964458391 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Project managers monthly 1.000,00 0,40 400,00 YES, 1,2,3,5,7 Preparation of reports, coordination of work effort Administrative personnel monthly 500,00 0,30 150,00 YES, 1,2,3,5,7 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 550,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 550,00 WORK PACKAGE 2 DISSEMINATION A.1 Employees (or equivalent) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participation in WPs tasks, meetings and events Project managers monthly 1.000,00 0,40 400,00 YES, 1,2,3,5,7 Preparation of reports, coordination of work effort Administrative personnel monthly 500,00 0,30 150,00 YES, 1,2,3,5,7 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 550,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 550,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Project managers monthly 1.000,00 0,40 400,00 YES, 1,2,3,5,7 Preparation of reports, coordination of work effort Administrative personnel monthly 500,00 0,30 150,00 YES, 1,2,3,5,7 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 550,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 550,00 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Junior experts/advisors/researchers monthly 500,00 0,70 350,00 NO  Select a staff category monthly 0,00 0,00 0,00 Other Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 350,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 350,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Project managers monthly 1.000,00 0,30 300,00 YES, 1,2,3,5,7 Preparation of reports, coordination of work effort Administrative personnel monthly 500,00 0,40 200,00 YES, 1,2,3,5,7 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 500,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 500,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 1.500,00 0,50 750,00 NO Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00  [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 750,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 750,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Project managers monthly 1.000,00 0,30 300,00 YES, 1,2,3,5,7 Preparation of reports, coordination of work effort Administrative personnel monthly 500,00 0,40 200,00 YES, 1,2,3,5,7 between internal personnel Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 500,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 500,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons  Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 3.750,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK  1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Total subcontracting (all WPs) 0,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES WP3 accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 2 CrANE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 €  Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 600,00 Total subsistence costs for this WP 400,00 Total travel for this WP 2.400,00 0,00 WORK PACKAGE 2 DISSEMINATION 1 WP2 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel Travel costs 0,00 700,00 1,00 700,00 International meeting, place TBD, 1-2 days/ flight ticket, Accomodation costs 0,00 150,00 1,00 150,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP2 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel Travel costs 0,00 700,00 1,00 700,00 International meeting, place TBD, 1-2 days/ flight ticket, Accomodation costs 0,00 150,00 1,00 150,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Subsistence costs 0,00 150,00 1,00 150,00  Participants Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 WP4 1st meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP4 2nd meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel  International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 WP5 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP5 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 €  Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 WP6 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP6 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00  Participants Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK 1 WP7 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP7 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00  Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 8.400,00 Total accomodation (all WPs) 2.100,00 Total subsistence (all WPs) 1.900,00 Total travel and subsistence (all WPs) 12.400,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION  C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00  2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost)  Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also (EUR) Associated with document packages? YES/NO and which Ref. Ares(2022)6379367 needed - 15/09/2022 for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00  2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 0,00 Total purchase costs (all WPs) 12.400,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION  Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) Associated with document Ref. YES/NO and which WP Ares(2022)6379367 recipients; maximum amount per -recipient) 15/09/2022 [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Description of support scheme (estimated number of packages? recipients; maximum amount per recipient) YES/NO and which WP  Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 16.150,00 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Total indirect costs 1.130,50 Total indirect costs 1.130,50 TOTAL COSTS PARTICIPANT 17.280,50 PROJECT INCOME EU CONTRIBUTION (GRANT)  Amount (EUR) Total costs 17.280,50 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Single Funding rate (%) 80% Maximum EU contribution 13.824,40 Requested EU contribution 13.824,40 EU CONTRIBUTION 13.824,40 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00 Financial contributions 0,00 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 3.456,10 OWN RESOURCES 3.456,10 TOTAL INCOME PARTICIPANT 17.280,50 Associated with document Ref. Ares(2022)6379367 - 15/09/2022  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: UH MOTOL Participant PIC: 964458391 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 550,00 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 2.950,00 WP2 DISSEMINATION 550,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.550,00 WP3 EVALUATION 550,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 550,00 WP4 SUSTAINABILITY 350,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.350,00 WP5 THE EU NETWORK OF COMPREHENSIVE 500,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.500,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 750,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.750,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 500,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.500,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 3.750,00 0,00 0,00 12.400,00 8.400,00 2.100,00 1.900,00 0,00 0,00 0,00 1.130,50 17.280,50  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 5.07.2022 09:52 Project acronym: CraNE JA Participant short name: MSAE Participant PIC: 998429731 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) WP coordination and alignment between tasks and other work packages, organization of events, WP meetings, Project managers monthly 2.100,00 0,30 630,00 YES, 1,2,3 preparation of reports, coordination of work effort between internal personnel Secretariat, financial management Administrative personnel monthly 1.150,00 0,40 460,00 NO Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.090,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00  Total personnel for this WP 1.090,00 WORK PACKAGE 2 DISSEMINATION Associated with document Ref. Ares(2022)6379367 - 15/09/2022 A.1 Employees (or equivalent) WP coordination and alignment between tasks and other work packages, organization of events, WP meetings, Project managers monthly 2.100,00 0,30 630,00 YES, 1,2,3 preparation of reports, coordination of work effort between internal personnel WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.900,00 0,40 760,00 YES, 2,3,6 and evaluation tasks within WP Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.390,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.390,00 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) WP coordination and alignment between tasks and other work packages, organization of events, WP meetings, Project managers monthly 2.100,00 0,30 630,00 YES, 1,2,3 preparation of reports, coordination of work effort between internal personnel WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.900,00 0,40 760,00 YES, 2,3,6 and evaluation tasks within WP Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.390,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.390,00 WORK PACKAGE 4 SUSTAINABILITY  A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.550,00 0,70 1.785,00 NO Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 1.785,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 1.785,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) WP coordination, expertise work in WP, dissemination Junior experts/advisors/researchers monthly 1.900,00 0,33 627,00 YES, 2,3,6 and evaluation tasks within WP Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00  [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 627,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 627,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons  Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 Total personnel (all WPs) 6.282,00 B. Subcontracting costs Also used for other work Costs packages? Description of subcontracted project tasks/activities (actual costs) YES/NO and which WP WORK PACKAGE 1 COORDINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 2 DISSEMINATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 3 EVALUATION 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK  1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total subcontracting for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS 1 [Subcontract short name] 0,00 2 [Subcontract short name] 0,00 Total subcontracting for this WP 0,00 Total subcontracting (all WPs) 0,00 C. Purchase costs C.1 Travel and subsistence Costs Description (e.g. international/not international; place of Costs (unit cost) (actual costs) Also part of other work activity/destination; number of days; number of persons packages? (speakers, personnel and participants whose costs will be Amount per Total YES/NO and which WP covered); transport means; average price per person; Number of units unit ( EUR) subsistence costs/daily allowances) WORK PACKAGE 1 COORDINATION 1 CraNE Kick-off meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1st JA meeting and 1st WP3 meeting/2-3 days/ flight ticket, hotel Travel costs 0,00 700,00 1,00 700,00 YES WP3 accommodation, subsistence allowances for one person, average price: 1,200.00 € Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 2 CraNE Final conference Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD; Final conference & 3rd JA meeting with 3rd WP3 meeting/2-3 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 YES WP3 hotel accommodation, subsistence allowances for one person, average price: 1,200.00 €  Accomodation costs 0,00 300,00 1,00 300,00 Subsistence costs 0,00 200,00 1,00 200,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 300,00 Total subsistence costs for this travel 200,00 Total travel 1.200,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 600,00 Total subsistence costs for this WP 400,00 Total travel for this WP 2.400,00 0,00 WORK PACKAGE 2 DISSEMINATION 1 WP2 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP2 2nd meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00  Participants Travel costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 WORK PACKAGE 3 EVALUATION Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 4 SUSTAINABILITY 1 WP4 1st meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP4 2nd meeting / GB meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel  International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs 1 WP6 1st meeting Speakers Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 2 WP6 2nd meeting Speakers  Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Subsistence costs 0,00 0,00 0,00 0,00 Personnel International meeting, place TBD, 1-2 days/ flight ticket, Travel costs 0,00 700,00 1,00 700,00 NO hotel accommodation, subsistence allowances for one person, average price: 1,000.00 € Accomodation costs 0,00 150,00 1,00 150,00 Subsistence costs 0,00 150,00 1,00 150,00 Participants Travel costs 0,00 0,00 0,00 0,00 Accomodation costs 0,00 0,00 0,00 0,00 Subsistence costs 0,00 0,00 0,00 0,00 Total travel costs for this travel 700,00 Total accomodation costs for this travel 150,00 Total subsistence costs for this travel 150,00 Total travel 1.000,00 Total travel costs for this WP 1.400,00 Total accomodation costs for this WP 300,00 Total subsistence costs for this WP 300,00 Total travel for this WP 2.000,00 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Total travel costs for this WP 0,00 Total accomodation costs for this WP 0,00 Total subsistence costs for this WP 0,00 Total travel for this WP 0,00 0,00 Total travel costs (all WPs) 5.600,00 Total accomodation (all WPs) 1.500,00 Total subsistence (all WPs) 1.300,00 Total travel and subsistence (all WPs) 8.400,00 C.2 Equipment WORK PACKAGE 1 COORDINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a  1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 2 DISSEMINATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 3 EVALUATION C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost)  Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also (EUR) Associated with document packages? YES/NO and which Ref. Ares(2022)6379367 needed - 15/09/2022 for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00  2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total rental and leasing 0,00 Total equipment for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK C.2.1 Purchase (depreciation/full cost) Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS C.2.1 Purchase (depreciation/full cost) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Costs (actual costs) Depreciation Rate of use for the Also part of other work method (e.g. Number of months action (100% or Total Description of tasks/activities for which the equipment is Price packages? YES/NO and which 36 month or allocated to the action less if used also (EUR) needed WP 60 month) for other a b c d e =(c/b *d) * a 1 [Equipment short name] 0,00 0 0,00 0% 0,00 2 [Equipment short name] 0,00 0 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total depreciation 0,00 C.2.2 Rental and leasing (rate of use/full cost) Costs (actual costs) Rate of use for the action (100% or Also part of other work Total Description of tasks/activities for which the equipment is Monthly rent/fee Number of months of use for the action less if used also packages? YES/NO and which (EUR) needed for other WP purposes) a b c d= a*b*c 1 [Equipment short name] 0,00 0,00 0% 0,00 2 [Equipment short name] 0,00 0,00 0% 0,00 ATTENTION! Can be used only if full cost option in the grant 3 [Equipment short name] 0,00 0,00 agreement Total rental and leasing 0,00 Total equipment for this WP 0,00 Total equipment (all WPs) 0,00 C.3 Other goods, works and services WORK PACKAGE 1 COORDINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 3 EVALUATION Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses  1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00 2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Costs Also part of other work Description of tasks/activities for which the (actual costs) packages? YES/NO and which goods/services are needed; types of goods services WP needed; how much Consumables 0,00 Conferences, seminars, workshops, trainings & events 0,00 Information & publications 0,00 Other expenses 1 IPR costs 0,00  2 Bank fees (pre-financing guarantee) 0,00 3 Audit fees (CFS) 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 4 Project evaluation 0,00 [5 short name other] 0,00 [6 short name other] 0,00 Total goods, works and services for this WP 0,00 Total goods, works and services (all WPs) 0,00 Total purchase costs (all WPs) 8.400,00 D. Other cost categories D.1. Financial support to third parties WORK PACKAGE 1 COORDINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 2 DISSEMINATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 3 EVALUATION Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 4 SUSTAINABILITY Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00  [Support scheme short name] 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Total other cost category D.1 for this WP 0,00 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 IMPLEMENTATION OF CCCs WITHIN AN EU NETWORK Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 WORK PACKAGE 8 INTEGRATED CARE GOVERNANCE AND NETWORKS Also used for other work Costs Description of support scheme (estimated number of Financial support to third parties packages? (actual costs) recipients; maximum amount per recipient) YES/NO and which WP [Support scheme short name] 0,00 [Support scheme short name] 0,00 0,00 Total other cost category D.1 for this WP 0,00 Total D.1 (all WPs) 0,00 Total other cost categories (all WPs) 0,00 E. Indirect costs  Costs (flat-rate) Total estimated direct costs (on which indirect cost flat-rate is based, 14.682,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 see GA eligibility article) ALL WORK PACKAGES Flat-rate (%) 7% Total indirect costs 1.027,74 Total indirect costs 1.027,74 TOTAL COSTS PARTICIPANT 15.709,74 PROJECT INCOME EU CONTRIBUTION (GRANT) Amount (EUR) Total costs 15.709,74 Single Funding rate (%) 80% Maximum EU contribution 12.567,79 Requested EU contribution 12.567,79 EU CONTRIBUTION 12.567,79 REVENUES AND CONTRIBUTIONS BY THIRD PARTIES Revenues Income generated by the action Amount Description of the income (type of generated income and (EUR) number of users, etc) ALL WORK PACKAGES Estimated income generated by the action 0,00 Total income generated by the action 0,00 Revenues 0,00 In-kind contributions by third parties In-kind contributions by third parties Amount Description of the contribution (type of contribution, (EUR) donor, purpose etc) ALL WORK PACKAGES Estimated in-kind contributions by third parties 0,00 Total in-kind contributions 0,00 In-kind contributions 0,00 Financial contributions by third parties Financial contributions by third parties Amount Associated with document Description Ref. Ares(2022)6379367 - contribution, of the contribution (type of 15/09/2022 (EUR) donor, purpose, etc) ALL WORK PACKAGES Estimated financial contributions by third parties 0,00 Total financial contributions 0,00 Financial contributions 0,00 TOTAL REVENUES AND CONTRIBUTIONS BY THIRD PARTIES 0,00 OWN RESOURCES Amount (EUR) Own resources 3.141,95 OWN RESOURCES 3.141,95 TOTAL INCOME PARTICIPANT 15.709,74  EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Project number: 101075284 Project acronym: CraNE JA Participant short name: MSAE Participant PIC: 998429731 CONSOLIDATED COSTS PER WORK PACKAGE (PER PARTICIPANT) COSTS PER WORK PACKAGE A.1 Employees C. Purchase costs D. Other cost categories A.2 + A.3 Natural persons B. Subcontracting E. Indirect costs under direct contract and A.4 SME owners costs Total seconded persons C.1 Travel and C.3 Other goods, D.1 Financial support to C.1 Travel C.1 Accomodation C.1 Subsistence C.2 Equipment subsistence work and services third parties e = flat-rate * (a1 + a2 + a3 + a5 + b [+ a1 - a2 a3 b c1 c1a c1b c1c c2 c3 d1 c1] + [c1a + c1b + c1c] + c2 + c3 + d1 + d2 + d3 + d4 + d5 + d6) WP1 COORDINATION 1.090,00 0,00 0,00 2.400,00 1.400,00 600,00 400,00 0,00 0,00 0,00 3.490,00 WP2 DISSEMINATION 1.390,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.390,00 WP3 EVALUATION 1.390,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 1.390,00 WP4 SUSTAINABILITY 1.785,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 3.785,00 WP5 THE EU NETWORK OF COMPREHENSIVE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 CANCER CENTRES: COMPOSITION, WP6 ORGANIZATION OF COMPREHENSIVE, 627,00 0,00 0,00 2.000,00 1.400,00 300,00 300,00 0,00 0,00 0,00 2.627,00 HIGH-QUALITY CANCER CARE IN CCCNs WP7 FRAMEWORK AND CRITERIA TO ENABLE 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 THE IMPLEMENTATION OF CCCs WITHIN AN WP8 INTEGRATED CARE GOVERNANCE AND 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 NETWORKS TOTAL COSTS PARTICIPANT 6.282,00 0,00 0,00 8.400,00 5.600,00 1.500,00 1.300,00 0,00 0,00 0,00 1.027,74 15.709,74  a Associated with document Ref. Ares(2022)6379367 - 15/09/2022 EU GRANTS DETAILED BUDGET TABLE (ACTION GRANTS) Project number: 101075284 13.09.2022 09:32 Project acronym: CraNE JA Participant short name: UT Participant PIC: 999895013 ATTENTION: This table should be filled out one per participant (beneficiary, affiliated entity) ATTENTION: This table may ONLY contain eligible costs (i.e. costs that comply with the eligibility rules of the grant agreement that is part of your call documents). At proposal stage and during grant preparation, it should contain estimated costs/income. Costs must be estimated in EUR. ATTENTION! List each budgeted cost item ONLY once in this table, for the main WP. ATTENTION! White cells mean that you are required to enter data. Blue cells are calculated automatically. EU PROJECT BUDGET TABLE (PER PARTICIPANT) PROJECT COSTS A. Personnel costs Costs (actual costs) Time Rate Total Also working for other work (months/other of work on Type of rate (amount) (EUR) packages? YES/NO and which Description of project role/activities/responsibilities the action) (monthly/other) WP a b c=a*b WORK PACKAGE 1 COORDINATION A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.550,00 0,25 637,50 YES, 1,2,3,4 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 637,50 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 637,50 WORK PACKAGE 2 DISSEMINATION  A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.550,00 0,25 637,50 YES, 1,2,3,4 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 637,50 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 637,50 WORK PACKAGE 3 EVALUATION A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.550,00 0,25 637,50 YES, 1,2,3,4 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 637,50 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 637,50 WORK PACKAGE 4 SUSTAINABILITY A.1 Employees (or equivalent) Participation in WPs tasks, meetings and events Senior experts/advisors/researchers monthly 2.550,00 0,25 637,50 YES, 1,2,3,4 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00  Total employees (or equivalent) 637,50 A.2 + A.3 Natural persons under direct contract and seconded persons Associated with document Ref. Ares(2022)6379367 - 15/09/2022 Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 637,50 THE EU NETWORK OF COMPREHENSIVE CANCER WORK PACKAGE 5 CENTRES: COMPOSITION, GOVERNANCE, JOINING PROCESS AND FUNCTIONING A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 ORGANIZATION OF COMPREHENSIVE, HIGH-QUALITY WORK PACKAGE 6 CANCER CARE IN CCCNs A.1 Employees (or equivalent) Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00 Other [category 1] monthly 0,00 0,00 0,00 [category 2] monthly 0,00 0,00 0,00 Total employees (or equivalent) 0,00 A.2 + A.3 Natural persons under direct contract and seconded persons Select a staff category monthly 0,00 0,00 0,00 Select a staff category monthly 0,00 0,00 0,00  Other [category 1] monthly 0,00 0,00 0,00 Associated with document Ref. Ares(2022)6379367 - 15/09/2022 [category 2] monthly 0,00 0,00 0,00 Total natural persons under direct contract and seconded persons 0,00 A.4 SME owners and natural person beneficiaries without salary SME owners/natural person beneficiaries without salary daily 0,00 0,00 0,00 Total SME owners and natural person beneficiaries without salary 0,00 Total personnel for this WP 0,00 FRAMEWORK AND CRITERIA TO ENABLE THE WORK PACKAGE 7 Saatja: Made Bambus </o=JM/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=494361a0be4f403ab04424d850f677a2-Made Bambus> Saaja: 'Cranewp4', 'Kristiina Ojamaa', Kersti Esnar Teema: RE: Gentle reminder - Invitation JA CraNE Governmental Board Dear CraNE WP4 Coordination Team I´m pleased to announce that the representative of Estonia at the CraNE Governmental Board is Kristiina Ojamaa and she will be attend the meeting in Brussel. Kristiina Ojamaa is a medical doctor and her position is Head of the Haematology and Oncology Clinic of Tartu University Hospital. Tartu University Hospital is one of three main cancer centers in Estonia and they hold OECI accreditation as well (currently the only one in Estonia). Tartu University is stated in the CraNE as a affiliated entity. Contacts: Kristiina Ojamaa Head of the Clinic [email protected] <mailto:[email protected]> Kind regards, Made Bambus Chief Specialist Department of Health System Development Ministry of Social Affairs [email protected] 6269 754 Suur-Ameerika 1, 10122 Tallinn www.sm.ee <http://www.sm.ee> From: Cranewp4 <[email protected]> Sent: Friday, February 24, 2023 3:31 PM Subject: Gentle reminder - Invitation JA CraNE Governmental Board Importance: High Dear CraNE, competent authorities, Dear partners, Dear colleagues, We kindly ask you to provide us with the contact details (name, email address and institution) of the person who will represent your country at the CraNE Governmental Board. We would like to remind you that the first CraNE Governmental Board will be held on April 20th, 2023, from 10.00 to 17.00 in Brussels. For organizational reasons, please let us know if you will be attending the meeting in Brussels or if you wish to participate online. Best regards, The CraNE WP4 Coordination Team Rue Juliette Wytsmanstraat 14 • 1050 Brussels www.sciensano.be <https://sciensano.bams.belnet.be/fmlurlsvc/?fewReq=:B:JVA0Pz0+NCh4MzwgPihnajM+PzQ+Pyh9Z2lgb3p7fGszOTttPjs7aDg4azw4Pjk9bDxtajc7amg4ODZvPmttNzs9Pz5rPzs7Oih6Mz84OTk8PTs4Ozcof2dqMz0/QU9iakNPPjw+OTs8Iz0/QU9iakNNPjw+OTs8KHxtfnozKG0zPT0oZmpiMz4=&url=http%3a%2f%2fwww.sciensano.be%2f> ---------------------------------------------------------------------------- Dear CraNE competent authorities, Dear partners, Dear colleagues, We are pleased to come back to you asking for the designation of a CraNE (Network of Comprehensive Cancer Centres: Preparatory activities on creation of National Comprehensive Cancer Centres and EU Networking) Governmental Board (GB) representative in your country. The objective is to have a representation of experts or professionals who can help and support the thinking regarding the organization of (high quality) cancer care at the national levels towards the design of the EU Network of Comprehensive Cancer Centers. The advancements and preliminary results from the CraNE WPs 5-8 will be regularly presented and discussed to ensure their feasibility and acceptability at national levels. Two face to face meetings and two online meetings have been foreseen for the GB. GB meetings will mainly be designed to be as interactive as possible, with working sessions to get input from the GB members. Therefore, we ask you to carefully designate someone in your country who has experience with cancer care provision and organization, and who can interact in English. More details are provided in the document attached. You can simply respond to this email by providing us with the name, email address and institution of the CraNE Governmental Board member for your country. We are also pleased to inform you that the first CraNE Governmental Board will be held on April 20th, 2023 from 10.00 CET to 17.00 CET in Brussels. Can we ask you to tell us if you will be attending the meeting in Brussels or if you wish to participate online? We very much thank you in advance for your cooperation. Best regards, The CraNE WP4 Coordination Team Rue Juliette Wytsmanstraat 14 • 1050 Brussels www.sciensano.be <https://sciensano.bams.belnet.be/fmlurlsvc/?fewReq=:B:JVA0Pz0+NCh4MzwgPihnajM+PzQ+Pyh9Z2lgb3p7fGszOTttPjs7aDg4azw4Pjk9bDxtajc7amg4ODZvPmttNzs9Pz5rPzs7Oih6Mz84OTk8PTs4Ozcof2dqMz0/QU9iakNPPjw+OTs8Iz0/QU9iakNNPjw+OTs8KHxtfnozKG0zPT0oZmpiMz4=&url=http%3a%2f%2fwww.sciensano.be%2f> Saatja: Cranewp4 <[email protected]> Teema: Gentle reminder - Invitation JA CraNE Governmental Board Dear CraNE, competent authorities, Dear partners, Dear colleagues, We kindly ask you to provide us with the contact details (name, email address and institution) of the person who will represent your country at the CraNE Governmental Board. We would like to remind you that the first CraNE Governmental Board will be held on April 20th, 2023, from 10.00 to 17.00 in Brussels. For organizational reasons, please let us know if you will be attending the meeting in Brussels or if you wish to participate online. Best regards, The CraNE WP4 Coordination Team Rue Juliette Wytsmanstraat 14 • 1050 Brussels www.sciensano.be <https://sciensano.bams.belnet.be/fmlurlsvc/?fewReq=:B:JVA0Pz0+NCh4MzwgPihnajM+PzQ+Pyh9Z2lgb3p7fGszOTttPjs7aDg4azw4Pjk9bDxtajc7amg4ODZvPmttNzs9Pz5rPzs7Oih6Mz84OTk8PTs4Ozcof2dqMz0/QU9iakNPPjw+OTs8Iz0/QU9iakNNPjw+OTs8KHxtfnozKG0zPT0oZmpiMz4=&url=http%3a%2f%2fwww.sciensano.be%2f> ---------------------------------------------------------------------------- Dear CraNE competent authorities, Dear partners, Dear colleagues, We are pleased to come back to you asking for the designation of a CraNE (Network of Comprehensive Cancer Centres: Preparatory activities on creation of National Comprehensive Cancer Centres and EU Networking) Governmental Board (GB) representative in your country. The objective is to have a representation of experts or professionals who can help and support the thinking regarding the organization of (high quality) cancer care at the national levels towards the design of the EU Network of Comprehensive Cancer Centers. The advancements and preliminary results from the CraNE WPs 5-8 will be regularly presented and discussed to ensure their feasibility and acceptability at national levels. Two face to face meetings and two online meetings have been foreseen for the GB. GB meetings will mainly be designed to be as interactive as possible, with working sessions to get input from the GB members. Therefore, we ask you to carefully designate someone in your country who has experience with cancer care provision and organization, and who can interact in English. More details are provided in the document attached. You can simply respond to this email by providing us with the name, email address and institution of the CraNE Governmental Board member for your country. We are also pleased to inform you that the first CraNE Governmental Board will be held on April 20th, 2023 from 10.00 CET to 17.00 CET in Brussels. Can we ask you to tell us if you will be attending the meeting in Brussels or if you wish to participate online? We very much thank you in advance for your cooperation. Best regards, The CraNE WP4 Coordination Team Rue Juliette Wytsmanstraat 14 • 1050 Brussels www.sciensano.be <https://sciensano.bams.belnet.be/fmlurlsvc/?fewReq=:B:JVA0Pz0+NCh4MzwgPihnajM+PzQ+Pyh9Z2lgb3p7fGszOTttPjs7aDg4azw4Pjk9bDxtajc7amg4ODZvPmttNzs9Pz5rPzs7Oih6Mz84OTk8PTs4Ozcof2dqMz0/QU9iakNPPjw+OTs8Iz0/QU9iakNNPjw+OTs8KHxtfnozKG0zPT0oZmpiMz4=&url=http%3a%2f%2fwww.sciensano.be%2f> Network of Comprehensive Cancer Centres: Preparatory activities on creation of National Comprehensive Cancer Centres and EU Networking CONCERN: invitation for the EU JA CraNE Governmental Board The CraNE Joint Action is proposed for funding in response to the flagship number 5 of the Europe’s Beating Cancer Plan, which defines that the European Commission will establish by 2025, an EU Network linking recognised National Comprehensive Cancer Centres (CCCs) in every Member State. In order to facilitate the establishment of such an EU Network, CraNE will prepare the necessary preconditions, administrative, professional, and those related to high-quality performance. This is necessary to facilitate both the integration of the existing CCCs as well as to support the Member States who still need to develop and certify such centres. The CraNE JA will also provide an assessment on sustainability and feasibility as well as link the development of an EU Network of CCCs and CCCs in individual Member States to the development of national and regional CCCNs. This way, the existing organisational and functional models of cancer care will be taken into account and incorporated into the proposed solution The CraNE WP4 has to support the analysis of the sustainability of the outputs of the Joint Action. In order to properly address the sustainability, one needs to involve the primary actors, active at the national or regional levels, in the Member States. The WP4 results will be translated into, first, a Maturity Model that could be used by EU Member States for assessing their (current) capacity to be part of the EU Network of Comprehensive Cancer Centers (EU NCCCs). Second, the CraNE Blueprint will map all the necessary steps for organizing, at the national level, CCC (networks) and to be part of the EU NCCCs. Twice a year, the CraNE GB will meet to be updated on the activities and main achievements and will provide advices, support and insights on the content and the format of the Maturity model and the Blueprint. Therefore, the attendees are expected to have a good understanding of the organization of cancer care in their country, but also of the related contextual features. We are pleased to invite you to the first CraNE Governmental Board on April 20th, 2023 from 10.00 CET to 17.00 CET in Brussels. It will also be possible to participate online. Join us to create a unique, useful and useable tool to improve cancer care in EU Member States! iPAAC WP4 - Belgian Cancer Centre, Sciensano Head of service : [email protected] Main investigator (WP4 leader): [email protected] Coordination team: [email protected] Memo Kellele: FORMTEXT Kersti Esnar Heidi Alasepp Koopia: FORMTEXT Kellelt: FORMTEXT Made Bambus Kuupäev: FORMTEXT 14.04.2023 Teema: FORMTEXT Eesti esindaja osalemine FORMCHECKBOX otsustamiseks FORMCHECKBOX teadmiseks Sisu/faktid Eesti on liitunud EL ühismeetme CraNE Joint Actioniga : Terviklike vähikeskuste võrgustik: ettevalmistavad tegevused riiklike terviklike vähikeskuste loomiseks ja ELi võrgustike loomiseks ( Joint Action: Network of Comprehensive Cancer Centres: Preparatory activities on creation of National Comprehensive Cancer Centres(CCC) and EU Networking), mis kestab 24 kuud alates 1. oktoobrist 2022 (ehk kuni 1. oktoobrini 2024) ning on kaasrahastatud programmist EU4Health 2021-2027. Pädeva asutusena on konsortsiumilepingus Sotsiaalministeerium ja sidusorganisatsioonina Tartu Ülikool . Projekti juhtorgan palub määrata CraNE JA Governmental Boardi (GB) esindaja . Eeldatakse , et nimetataval isikul peaks olema kogemusi vähiravi korraldusega ja pakkumisega ning talle peaks olema tuttav ka valdkondlik kontekst ning ta peaks suhtlema inglise keeles . G B-le on ette nähtud kaks näost näkku kohtumist ja kaks veebikohtumist . GB koosolekud kavandatakse peamiselt viisil , et need oleksid võimalikult interaktiivsed , koos töösessioonidega , saamaks sisendit kõikidelt GB liikmetelt ( vt manuses CraNe WP4). Eestit esindab seal dr. Kristiina Ojamaa (TÜK). Esimene Governmental Board toimub 20. aprillil 2023 kell 10.00–17.00 Brüsseli s. Kinnitada tuleks tema lennupiletid , mis rahastatakse projekti eelarvest.